priority_rank,trial_id,reason,period_title,arm_id,predicted_graph_weight,risk_percentile,risk_tier,action_hint,intervention_plan,queue_date,due_date,owner,status,outreach_channel,followup_outcome,notes
1,NCT04072835,Overall trial ended,Overall Study,FG000,2.408476524575636,1.0,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2,NCT02104817,Study terminated by sponsor,Overall Study,FG000,2.219005476516797,0.99995558911045,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3,NCT02104817,Study terminated by sponsor,Overall Study,FG001,2.2159025255285827,0.9999111782208998,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4,NCT01712789,Progressive Disease,Overall Study,FG000,2.020845865703722,0.9998667673313496,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
5,NCT03472040,"Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)",Overall Study,FG001,1.8710787007392653,0.9998223564417996,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
6,NCT03868124,Ongoing in study,Overall Study,FG002,1.8242216850988096,0.9997779455522494,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
7,NCT02195479,Death,Overall Study,FG000,1.805735040207539,0.9997335346626992,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
8,NCT02136134,Death,Overall Study,FG000,1.8014580917493848,0.9996891237731492,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
9,NCT03868124,Ongoing in study,Overall Study,FG001,1.7882894971166965,0.999644712883599,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
10,NCT03868124,Ongoing in study,Overall Study,FG000,1.781076335121547,0.9996003019940488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
11,NCT02990338,Progressive disease,Overall Study,FG000,1.762508928968928,0.9995558911044988,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
12,NCT02076009,Death,Overall Study,FG000,1.721639664978371,0.9995114802149488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
13,NCT02252172,Death,Overall Study,FG000,1.6960181421960194,0.9994670693253986,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
14,NCT02990338,Progressive disease,Overall Study,FG001,1.664343683468214,0.9994226584358484,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
15,NCT01734928,Progressive Disease,Treatment Period,FG000,1.582670871442588,0.9993782475462984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
16,NCT02136134,Death,Overall Study,FG001,1.5819066864994002,0.9993338366567482,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
17,NCT03053440,Enrolled in Long-term Extension Study,Overall Study,FG001,1.5512240627627474,0.999289425767198,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
18,NCT02678312,Death,Part 2 Double Blind Epoch,FG004,1.5273685198714688,0.999245014877648,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
19,NCT03758638,Providers not included in the primary outcome.,Overall Study,FG000,1.5215299005213387,0.9992006039880978,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
20,NCT03158688,Death,Overall Study,FG001,1.4467471008489683,0.9991561930985478,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
21,NCT02678312,Death,Part 2 Double Blind Epoch,FG003,1.4194961542460818,0.9991117822089975,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
22,NCT02076009,Death,Overall Study,FG001,1.415791018586389,0.9990673713194476,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
23,NCT03180736,Lack of Efficacy,Overall Study,FG001,1.3808404116286703,0.9990229604298974,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
24,NCT01734928,Progressive Disease,Treatment Period,FG001,1.3508260812357304,0.9989785495403471,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
25,NCT02195479,Death,Overall Study,FG001,1.3399788134385002,0.9989341386507972,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
26,NCT02678312,Subject/guardian Decision,Part 2 Double Blind Epoch,FG004,1.3220826951821332,0.9988897277612472,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
27,NCT02252172,Death,Overall Study,FG001,1.3073697624137188,0.998845316871697,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
28,NCT03277105,Death,Overall Study,FG000,1.2545779159921977,0.9988009059821468,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
29,NCT02312258,Death,Overall Study,FG001,1.2504537737331038,0.9987564950925968,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
30,NCT03277105,Death,Overall Study,FG001,1.2165464983238885,0.9987120842030466,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
31,NCT03689374,Run-in failure,Run-in Period (12 Weeks),FG000,1.2131649081502076,0.9986676733134964,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
32,NCT03277105,Other,Overall Study,FG001,1.2044633268145435,0.9986232624239464,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
33,NCT01239797,Disease progression,Treated Participants,FG001,1.190941771826068,0.9985788515343962,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
34,NCT02252172,End of data collection,Overall Study,FG001,1.1903651423322312,0.998534440644846,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
35,NCT01239797,Disease progression,Treated Participants,FG000,1.1851953320071396,0.998490029755296,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
36,NCT02755597,Death,Overall Study,FG000,1.1414172343319446,0.998445618865746,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
37,NCT03277105,Other,Overall Study,FG000,1.1202927289594935,0.9984012079761958,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
38,NCT03275285,Ongoing,Overall Study,FG001,1.119378420077738,0.9983567970866456,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
39,NCT03758638,Providers not included in the primary outcome.,Overall Study,FG001,1.1031392654453875,0.9983123861970956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
40,NCT02312258,Reason not Specified,Overall Study,FG001,1.0986833874941064,0.9982679753075454,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
41,NCT02076009,End of data collection,Overall Study,FG001,1.0931632530981457,0.9982235644179952,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
42,NCT03180736,Lack of Efficacy,Overall Study,FG000,1.0689780795030364,0.9981791535284452,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
43,NCT00622336,Progression of Disease,Treatment Phase,FG000,1.0427026941450186,0.998134742638895,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
44,NCT02755597,Study terminated by Sponsor,Overall Study,FG000,0.992581445140874,0.9980903317493448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
45,NCT01182441,Patient Still in Follow-up,Overall Study,FG000,0.9785711341386896,0.9980459208597948,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
46,NCT02195479,Discontinued at clinical cutoff (due to end of data collection period),Overall Study,FG001,0.977018963548532,0.9980015099702448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
47,NCT03053440,Enrolled in Long-term Extension Study,Overall Study,FG000,0.9746982591786112,0.9979570990806946,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
48,NCT01850524,Reason not Specified,Overall Study,FG000,0.9529353575462304,0.9979126881911444,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
49,NCT03651765,Discontinued by Sponsor,Overall Study,FG000,0.9509950136264094,0.9978682773015944,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
50,NCT01850524,Reason not Specified,Overall Study,FG001,0.9440010826186412,0.9978238664120442,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
51,NCT01734785,Other Reasons,Open-Label Period,FG003,0.9430552269311306,0.997779455522494,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
52,NCT00103506,Death,Overall Study,FG000,0.9360854763405744,0.997735044632944,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
53,NCT00103506,Death,Overall Study,FG001,0.931799042964682,0.9976906337433938,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
54,NCT02136134,Uspecified,Overall Study,FG001,0.9128399257923032,0.9976462228538436,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
55,NCT03110562,Death,Initial Treatment Period,FG001,0.9097995138457348,0.9976018119642936,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
56,NCT02252172,End of data collection,Overall Study,FG000,0.9029950536465792,0.9975574010747436,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
57,NCT02678312,Subject/guardian Decision,Part 2 Double Blind Epoch,FG003,0.8805922878959818,0.9975129901851936,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
58,NCT02741596,Subject withdrawn-to commercial product,Overall Study,FG001,0.8595289517211806,0.9974685792956433,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
59,NCT01335399,Disease progression,Treatment Period,FG001,0.8567268683459726,0.9974241684060932,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
60,NCT03110562,Death,Initial Treatment Period,FG000,0.8423390540361715,0.9973797575165432,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
61,NCT02076009,End of data collection,Overall Study,FG000,0.8389045707802701,0.997335346626993,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
62,NCT02312258,Death,Overall Study,FG000,0.8162912859802093,0.9972909357374428,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
63,NCT01027949,Death,Overall Study,FG000,0.811061720841716,0.9972465248478928,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
64,NCT00179647,Other,Overall Study,FG000,0.8001210745313507,0.9972021139583426,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
65,NCT02741596,Subject withdrawn-to commercial product,Overall Study,FG000,0.7916073045084818,0.9971577030687924,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
66,NCT01027949,Adverse Event,Overall Study,FG000,0.7910603694248707,0.9971132921792424,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
67,NCT00424047,Progression of disease,On Study at Time of Unblinding,FG001,0.7902254889260714,0.9970688812896922,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
68,NCT01102426,Progressive Disease,Overall Study,FG000,0.7887442894242664,0.997024470400142,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
69,NCT02755597,Study terminated by Sponsor,Overall Study,FG001,0.7762656283154483,0.996980059510592,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
70,NCT01027949,Progressive Disease,Overall Study,FG000,0.7604230277747712,0.996935648621042,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
71,NCT03110562,Participants withdrawn due to company goals,Initial Treatment Period,FG001,0.7588833279464001,0.9968912377314918,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
72,NCT01568866,Disease Progression,Overall Study,FG000,0.7497144151086013,0.9968468268419416,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
73,NCT03158688,Death,Overall Study,FG000,0.7425974467738999,0.9968024159523916,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
74,NCT02678312,Technical Problems,Part 2 Double Blind Epoch,FG003,0.7407173138403175,0.9967580050628414,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
75,NCT01908816,Early termination,Overall Study,FG000,0.7340222932893853,0.9967135941732912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
76,NCT02489968,Other than specified above,Open-label Treatment Period,FG000,0.7331180755147325,0.9966691832837412,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
77,NCT01426425,Inclusion/exclusion criteria not met,Overall Study,FG000,0.7293025060003866,0.996624772394191,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
78,NCT03275285,Ongoing,Overall Study,FG000,0.7272464535789994,0.9965803615046408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
79,NCT00424047,Progression of disease,Blinded Treatment (Up to 03 Aug 2005),FG001,0.7198001688750599,0.9965359506150908,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
80,NCT02312258,Reason not Specified,Overall Study,FG000,0.7088800138413799,0.9964915397255408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
81,NCT01327846,Study terminated by sponsor,Extension Phase,FG003,0.7079304514581254,0.9964471288359906,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
82,NCT01335399,Disease progression,Treatment Period,FG000,0.6957286576280073,0.9964027179464404,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
83,NCT01028053,Screen Failure,Overall Study,FG000,0.6940466192182743,0.9963583070568904,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
84,NCT00689936,Disease Progression,Active Treatment Phase,FG001,0.691137267503542,0.9963138961673402,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
85,NCT01568866,Disease Progression,Overall Study,FG001,0.6893452012691367,0.99626948527779,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
86,NCT00496769,>=1 reason assigned per patient,Open Label,FG002,0.6822612286022326,0.99622507438824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
87,NCT02489968,Other than specified above,Open-label Treatment Period,FG001,0.6821564524288096,0.9961806634986898,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
88,NCT04592419,Sponsor Request,Open-Label Extension Period,FG001,0.6779686522242365,0.9961362526091396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
89,NCT00689936,Disease Progression,Active Treatment Phase,FG002,0.6698232044429759,0.9960918417195896,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
90,NCT02195479,Discontinued at clinical cutoff (due to end of data collection period),Overall Study,FG000,0.6648516591250702,0.9960474308300395,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
91,NCT03037931,Death,Overall Study,FG001,0.6537663436384036,0.9960030199404896,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
92,NCT00732641,Relapse or Progressive Disease,Overall Study,FG001,0.6507795570482939,0.9959586090509392,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
93,NCT01335399,Adverse event unrelated to study drug,Treatment Period,FG000,0.6487046891613203,0.9959141981613892,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
94,NCT03110562,Participants withdrawn due to company goals,Initial Treatment Period,FG000,0.647840074294237,0.9958697872718392,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
95,NCT03325556,Lack of Response in OL period,Open-label Period,FG000,0.6436820090696134,0.995825376382289,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
96,NCT00773747,Lack of Efficacy,Overall Study,FG001,0.6371284073653961,0.9957809654927388,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
97,NCT02929329,Death,Overall Study,FG000,0.6307953939987802,0.9957365546031888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
98,NCT02929329,Death,Overall Study,FG001,0.630592249095209,0.9956921437136386,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
99,NCT01560637,Death,Overall Study,FG000,0.6304900735298318,0.9956477328240884,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
100,NCT04592419,Sponsor Request,Open-Label Extension Period,FG000,0.6283071153319554,0.9956033219345384,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
101,NCT03037931,Death,Overall Study,FG000,0.6028059885673325,0.9955589110449884,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
102,NCT01023308,Disease progression,Overall Study,FG001,0.597574326348928,0.995514500155438,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
103,NCT03860935,Death,Overall Study,FG000,0.5968469284835031,0.995470089265888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
104,NCT01560637,Adverse Event,Overall Study,FG000,0.5908337695911912,0.995425678376338,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
105,NCT00424047,Progression of disease,On Study at Time of Unblinding,FG000,0.5907932376289684,0.9953812674867878,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
106,NCT01027949,Withdrawal by Subject,Overall Study,FG000,0.5894038313688997,0.9953368565972376,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
107,NCT02755597,Death,Overall Study,FG001,0.5885911099260526,0.9952924457076876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
108,NCT01106014,Morbidity or Mortality primary endpoint,Overall Study,FG001,0.586503773821577,0.9952480348181374,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
109,NCT01908816,Early termination,Overall Study,FG001,0.5863104576498612,0.9952036239285872,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
110,NCT00311402,Adverse Event,Overall Study,FG000,0.582135971533343,0.9951592130390372,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
111,NCT00739973,Abnormal test procedure result(s),Single-blind Period (2 to 4 Weeks),FG000,0.5800804734142764,0.995114802149487,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
112,NCT02924064,Other,Overall Study,FG001,0.5715933351668859,0.9950703912599368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
113,NCT02136134,Uspecified,Overall Study,FG000,0.5628252091505456,0.9950259803703868,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
114,NCT03758638,Lost to Follow-up,Overall Study,FG000,0.5570604584466169,0.9949815694808368,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
115,NCT00618956,Adverse Event,Overall Study,FG001,0.5523351680154166,0.9949371585912866,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
116,NCT00960661,Entry criteria not met,Basal Insulin Optimization Phase (BIO),FG000,0.5484358809495735,0.9948927477017364,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
117,NCT03651765,Withdrawal by Subject,Overall Study,FG000,0.5452853449672529,0.9948483368121864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
118,NCT00689936,Disease Progression,Active Treatment Phase,FG000,0.544015744326369,0.9948039259226362,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
119,NCT03472040,"Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)",Overall Study,FG000,0.5349609865474612,0.994759515033086,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
120,NCT00311402,Adverse Event,Overall Study,FG001,0.5305228098575295,0.994715104143536,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
121,NCT00056160,Progression of disease,Up to Unblinding (07 Jun 2005),FG001,0.5270142444559723,0.9946706932539858,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
122,NCT01182441,Patient Still in Follow-up,Overall Study,FG001,0.5252539688473513,0.9946262823644356,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
123,NCT01813435,did not finish experimental regimen,Overall Study,FG000,0.5116812250677879,0.9945818714748856,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
124,NCT03758638,Lost to Follow-up,Overall Study,FG001,0.5098358487771326,0.9945374605853357,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
125,NCT00424047,Progression of disease,Blinded Treatment (Up to 03 Aug 2005),FG000,0.5086765088707048,0.9944930496957854,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
126,NCT01564537,Reason not specified,Overall Study,FG001,0.5069352253999203,0.9944486388062352,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
127,NCT01564537,Reason not specified,Overall Study,FG000,0.5024789217598012,0.9944042279166851,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
128,NCT01102426,Progressive Disease,Overall Study,FG001,0.5016114554131748,0.994359817027135,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
129,NCT02181413,Withdrawal by Subject,Overall Study,FG001,0.501062290942291,0.994315406137585,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
130,NCT02861534,Death,Overall Study,FG001,0.4986265197127485,0.9942709952480348,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
131,NCT02312258,Withdrawal by Patient,Overall Study,FG001,0.4950524405794641,0.9942265843584848,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
132,NCT01327846,Study terminated by sponsor,Extension Phase,FG001,0.4923148711385716,0.9941821734689346,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
133,NCT02861534,Death,Overall Study,FG000,0.4922232712191667,0.9941377625793844,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
134,NCT05093933,Death,Overall Study,FG001,0.4915978769269939,0.9940933516898344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
135,NCT03057951,Adverse Event,Overall Study,FG001,0.4868404139767854,0.9940489408002844,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
136,NCT03814187,Sponsor's Administrative Decision,Overall Study,FG002,0.4857675955128072,0.994004529910734,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
137,NCT01327846,Study terminated by sponsor,Extension Phase,FG000,0.4781947350626783,0.993960119021184,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
138,NCT03057951,Adverse Event,Overall Study,FG000,0.478126860617996,0.993915708131634,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
139,NCT01327846,Study terminated by sponsor,Extension Phase,FG002,0.4765798206718448,0.9938712972420838,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
140,NCT04509674,"Patient refusal to continue, not due to adverse event",Overall Study,FG000,0.4687153302682937,0.9938268863525336,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
141,NCT04072835,Ablation,Overall Study,FG000,0.4629551647091658,0.9937824754629836,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
142,NCT01023308,Adverse Event,Overall Study,FG000,0.4620873739125592,0.9937380645734334,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
143,NCT00773747,Lack of Efficacy,Overall Study,FG000,0.4617829271800892,0.9936936536838832,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
144,NCT03064126,Death,Overall Study,FG000,0.4530308134827375,0.9936492427943332,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
145,NCT04509674,"Patient refusal to continue, not due to adverse event",Overall Study,FG001,0.4453983355584224,0.9936048319047832,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
146,NCT02648347,Death,Overall Study,FG000,0.4450334944995238,0.9935604210152328,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
147,NCT03057977,Adverse Event,Discontinuation From Treatment,FG000,0.4428177467390774,0.9935160101256828,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
148,NCT05093933,Death,Overall Study,FG000,0.4390148007064977,0.9934715992361328,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
149,NCT03651765,Lack of Efficacy,Overall Study,FG000,0.4387586659336904,0.9934271883465826,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
150,NCT03057977,Adverse Event,Discontinuation From Treatment,FG001,0.4328942333949406,0.9933827774570324,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
151,NCT02648347,Death,Overall Study,FG001,0.4313553606408631,0.9933383665674824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
152,NCT01908816,Early termination,Overall Study,FG002,0.4244243446480952,0.9932939556779322,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
153,NCT01734928,Adverse Event,Treatment Period,FG001,0.4222636329774006,0.993249544788382,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
154,NCT01335399,Adverse event unrelated to study drug,Treatment Period,FG001,0.4218410186282439,0.993205133898832,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
155,NCT00179647,Lack of Efficacy,Overall Study,FG000,0.4212296539626172,0.9931607230092818,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
156,NCT01330628,Adverse Event,Overall Study,FG000,0.4210440759195437,0.9931163121197316,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
157,NCT03110562,Withdrawal by Subject,Initial Treatment Period,FG001,0.4202893638696723,0.9930719012301816,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
158,NCT01237223,Abnormal test procedure result(s),"Single Blind(Run-in Period, 4 Weeks)",FG000,0.4162037026744625,0.9930274903406316,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
159,NCT00575588,Study specific discontinuation criteria,Overall Study,FG001,0.4136488105969623,0.9929830794510814,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
160,NCT00496769,>=1 reason assigned per patient,Double Blind,FG001,0.412440037917659,0.9929386685615312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
161,NCT03110562,Withdrawal by Subject,Initial Treatment Period,FG000,0.4111052300137794,0.9928942576719813,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
162,NCT02943785,Withdrawal by Subject,Overall Study,FG001,0.4096989659485414,0.992849846782431,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
163,NCT03860935,Death,Overall Study,FG001,0.4095067019954562,0.992805435892881,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
164,NCT00575588,Study specific discontinuation criteria,Overall Study,FG000,0.4071461354667539,0.9927610250033309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
165,NCT03110562,Death,Crossover Period,FG002,0.3934132257882042,0.9927166141137806,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
166,NCT01176240,Adverse Event,Study 306B,FG000,0.3931575198299105,0.9926722032242306,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
167,NCT02916706,Other,Overall Study,FG001,0.3875421825792453,0.9926277923346803,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
168,NCT03053440,Sponsor's Decision to End the Study,Overall Study,FG000,0.386434892352034,0.9925833814451304,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
169,NCT02755597,Withdrew consent,Overall Study,FG000,0.3862781187250298,0.9925389705555804,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
170,NCT01841762,"Other, 2 PAH-SYMPACT cycles not complete",Screening Period,FG000,0.3812925684138888,0.99249455966603,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
171,NCT00558259,Adverse Event,Overall Study,FG001,0.379977098443928,0.99245014877648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
172,NCT01087502,Adverse Event,Up to Final Analysis (Week 52),FG000,0.3783228410049,0.99240573788693,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
173,NCT01335399,Study drug toxicity,Treatment Period,FG001,0.3775353102971726,0.9923613269973798,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
174,NCT01101035,Voluntary Withdrawal,Overall Study,FG000,0.3757208326943339,0.9923169161078296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
175,NCT00496769,>=1 reason assigned per patient,Double Blind,FG000,0.3756846318993042,0.9922725052182796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
176,NCT03284853,Adverse Event,Overall Study,FG000,0.3710629343993649,0.9922280943287294,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
177,NCT01101035,Voluntary Withdrawal,Overall Study,FG001,0.3708989740979052,0.9921836834391792,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
178,NCT02924064,Other,Overall Study,FG000,0.3690281417854059,0.9921392725496292,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
179,NCT00420849,Lack of Efficacy,Overall Study,FG000,0.3686819186088971,0.9920948616600792,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
180,NCT01243424,Adverse Event,Discontinuation From Treatment,FG001,0.3682110434543161,0.9920504507705288,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
181,NCT03053440,Death,Overall Study,FG000,0.3677196715420336,0.9920060398809788,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
182,NCT01078675,Protocol Violation,Overall Study,FG000,0.3675810661575496,0.9919616289914288,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
183,NCT00622284,Adverse Event,Overall Study,FG001,0.3661726084743448,0.9919172181018786,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
184,NCT03325556,Administrative discont. at study termination,Open-label Period,FG000,0.3654800304806345,0.9918728072123284,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
185,NCT00620542,Protocol Violation,Part A (Run-in - 2 Weeks),FG001,0.3644436147573714,0.9918283963227784,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
186,NCT00853658,Death,Overall Study,FG001,0.3640530973682324,0.9917839854332282,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
187,NCT02680574,Death,Overall Study,FG001,0.3640392830225434,0.991739574543678,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
188,NCT00330759,Death,Overall Study,FG000,0.3626590604598416,0.991695163654128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
189,NCT02680574,Death,Overall Study,FG000,0.3617551608240316,0.991650752764578,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
190,NCT02892149,Death,Overall Study,FG001,0.3615917480143589,0.9916063418750276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
191,NCT00620542,Protocol Violation,Part A (Run-in - 2 Weeks),FG000,0.3611202157393752,0.9915619309854776,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
192,NCT00689936,Continue in Long Term Follow Up,Long-Term Follow Up Phase,FG001,0.3600850195212004,0.9915175200959276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
193,NCT00330759,Death,Overall Study,FG001,0.3599985269078178,0.9914731092063774,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
194,NCT02943785,Adverse Event,Overall Study,FG000,0.3593961426912436,0.9914286983168272,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
195,NCT00853658,Death,Overall Study,FG002,0.3590088315067445,0.9913842874272772,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
196,NCT03785405,Adverse Event,Overall Study,FG000,0.3576791579803766,0.991339876537727,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
197,NCT00385697,Lost to Follow-up,Double-blind Segment 2,FG001,0.3574249591527182,0.9912954656481768,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
198,NCT00732641,Relapse or Progressive Disease,Overall Study,FG000,0.3546216808667343,0.9912510547586268,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
199,NCT02990338,Adverse Event,Overall Study,FG000,0.3538101864262997,0.9912066438690766,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
200,NCT02181413,Withdrawal by Subject,Overall Study,FG000,0.3505044993655552,0.9911622329795264,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
201,NCT00853658,Death,Overall Study,FG000,0.3488036618606731,0.9911178220899765,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
202,NCT02990338,Adverse Event,Overall Study,FG001,0.3484151063707242,0.9910734112004264,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
203,NCT00329238,Adverse Event,Overall Study,FG000,0.3479681989813393,0.9910290003108764,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
204,NCT03725202,Ongoing in Period 2,Period 2 (Week 52 - Week 104),FG006,0.3472354345774998,0.990984589421326,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
205,NCT00863681,Death,Overall Study,FG000,0.3465684770206941,0.990940178531776,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
206,NCT01908699,Progressive Disease,Overall Study,FG000,0.344585261387976,0.990895767642226,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
207,NCT01568866,Adverse Event,Overall Study,FG001,0.3419013965531151,0.9908513567526758,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
208,NCT03080883,Adverse Event,Overall Study,FG000,0.3412881413122918,0.9908069458631256,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
209,NCT03080883,Adverse Event,Overall Study,FG001,0.3410618488444942,0.9907625349735756,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
210,NCT03158688,Decision by sponsor,Overall Study,FG001,0.3404033115177281,0.9907181240840254,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
211,NCT01568866,Adverse Event,Overall Study,FG000,0.3403197618136308,0.9906737131944752,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
212,NCT02678312,Lost to Follow-up,Part 2 Double Blind Epoch,FG004,0.338569165589574,0.99060709686015,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
213,NCT02678312,Technical Problems,Part 2 Double Blind Epoch,FG004,0.338569165589574,0.99060709686015,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
214,NCT02678312,Adverse Event,Part 2 Double Blind Epoch,FG004,0.3384419278879075,0.9905404805258248,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
215,NCT00056160,Progression of disease,Extended Follow-up Cutoff (23 Jul 2008),FG000,0.3375264033513772,0.9904960696362748,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
216,NCT02892149,Death,Overall Study,FG000,0.3374123349839126,0.9904516587467248,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
217,NCT02801669,Withdrawal by Subject,Overall Study,FG000,0.3360652340829466,0.9904072478571746,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
218,NCT01345019,Death,Blinded Treatment Phase,FG000,0.3349355095130358,0.9903628369676244,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
219,NCT04660643,Adverse Event,Open-label Lead-in Period (Week 0 - 36),FG000,0.3344058818702977,0.9903184260780744,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
220,NCT02226120,Death,Overall Study,FG000,0.3279051116188394,0.9902740151885242,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
221,NCT01908699,Progressive Disease,Overall Study,FG001,0.3276101792482837,0.990229604298974,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
222,NCT00662831,Other,Overall Study,FG000,0.3250303467326172,0.990185193409424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
223,NCT00329238,Adverse Event,Overall Study,FG001,0.3243375118806449,0.990140782519874,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
224,NCT01712789,Death,Overall Study,FG000,0.3239517958252775,0.9900963716303236,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
225,NCT01106014,Morbidity or Mortality primary endpoint,Overall Study,FG000,0.3218140499251092,0.9900519607407736,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
226,NCT02867813,Death,Overall Study,FG000,0.3214767308355057,0.9900075498512236,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
227,NCT03472040,Perceived Lack of Efficacy,Overall Study,FG001,0.3199484667383732,0.9899631389616734,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
228,NCT02943785,Adverse Event,Overall Study,FG001,0.3195403698957776,0.9899187280721232,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
229,NCT00773747,Withdrawal by Subject,Overall Study,FG000,0.3193826807204066,0.9898743171825732,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
230,NCT01475825,Adverse Event,Overall Study,FG000,0.3192617739341368,0.989829906293023,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
231,NCT01920711,Death,Overall Study,FG001,0.3190681174175897,0.9897854954034728,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
232,NCT01243424,Adverse Event,Discontinuation From Treatment,FG000,0.318594649304643,0.9897410845139228,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
233,NCT02312258,Withdrawal by Patient,Overall Study,FG000,0.3171786669148911,0.9896966736243727,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
234,NCT02468232,Death,Core Part of Study,FG000,0.3169175774957933,0.9896522627348224,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
235,NCT01778049,Other reason not defined above,Open Label Treatment Period,FG001,0.3167565229963493,0.9896078518452724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
236,NCT01345019,Death,Blinded Treatment Phase,FG001,0.3166672823132144,0.9895634409557224,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
237,NCT01920711,Death,Overall Study,FG000,0.3165017669902384,0.9895190300661724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
238,NCT02073682,Death,Overall Study,FG001,0.3156950144986591,0.9894746191766222,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
239,NCT02801669,Withdrawal by Subject,Overall Study,FG001,0.3151422880725003,0.989430208287072,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
240,NCT00385697,Withdrawal by Subject,Double-blind Segment 2,FG001,0.3125073747803254,0.989385797397522,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
241,NCT03325556,Administrative discont. at study termination,Double-blind Period,FG001,0.3108886014995733,0.9893413865079718,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
242,NCT04072835,Withdrawal of consent,Overall Study,FG000,0.3106541265855456,0.9892969756184216,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
243,NCT03472040,Perceived Lack of Efficacy,Overall Study,FG000,0.3104127613738393,0.9892525647288716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
244,NCT02555878,Death,Overall Study,FG000,0.3100830572776488,0.9892081538393214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
245,NCT00456521,Adverse Event,Overall Study,FG000,0.3093201987292857,0.9891637429497712,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
246,NCT02851407,Other Death,Overall Study,FG000,0.3084919774631744,0.9891193320602212,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
247,NCT01734928,Adverse Event,Treatment Period,FG000,0.3068023491647126,0.9890749211706712,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
248,NCT01272219,Withdrawal criteria,Main + Extension Period: Week 0-172,FG004,0.3066862440442148,0.9890305102811208,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
249,NCT02867813,Death,Overall Study,FG001,0.3052486710909522,0.9889860993915708,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
250,NCT01335399,Study drug toxicity,Treatment Period,FG000,0.3036290150333633,0.9889416885020208,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
251,NCT04264819,Physician Decision,Overall Study,FG000,0.30302517710373,0.9888972776124706,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
252,NCT03325556,Relapse,Double-blind Period,FG002,0.301546136868859,0.9888528667229204,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
253,NCT01764386,Adverse Event,Controlled Treatment Period (CTP),FG000,0.2996100900947321,0.9888084558333704,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
254,NCT00142584,"Sponsor Termination of Study, etc.",Overall Study,FG000,0.2971536009574387,0.9887640449438202,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
255,NCT00474630,Adverse Event,Overall Study,FG000,0.2965050044049287,0.98871963405427,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
256,NCT04588259,Run-in failure,Run-in period,FG001,0.2955005256262503,0.98867522316472,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
257,NCT00420849,Adverse Event,Overall Study,FG000,0.2935465123161804,0.98863081227517,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
258,NCT00385697,Withdrawal by Subject,Double-blind Segment 2,FG003,0.2933525280937001,0.9885864013856196,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
259,NCT01239797,Study drug toxicity,Treated Participants,FG001,0.2930663721355756,0.9885419904960696,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
260,NCT02755597,"Other, not specified",Overall Study,FG000,0.2912627684667361,0.9884975796065196,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
261,NCT00311402,Lack of Efficacy,Overall Study,FG000,0.2910155860313593,0.9884531687169694,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
262,NCT00782340,Treatment failure,Open Label Titration,FG000,0.2903057348850693,0.9884087578274192,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
263,NCT02801669,Death,Overall Study,FG001,0.2900944254000498,0.9883643469378692,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
264,NCT01712789,Adverse Event,Overall Study,FG000,0.2898758964171528,0.988319936048319,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
265,NCT00097981,Adverse Event,Overall Study,FG001,0.2892285649347403,0.9882755251587688,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
266,NCT03080883,Death,Overall Study,FG000,0.2886430695425993,0.9882311142692188,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
267,NCT00689936,Continue in Long Term Follow Up,Long-Term Follow Up Phase,FG002,0.2870602174701091,0.9881867033796689,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
268,NCT03325556,Administrative discont. at study termination,Double-blind Period,FG002,0.2865719555219345,0.9881422924901184,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
269,NCT00377676,Adverse Event,Overall Study,FG000,0.2852924113890178,0.9880978816005684,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
270,NCT02344290,Withdrawal by Subject,Overall Study,FG001,0.2835725335896136,0.9880534707110183,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
271,NCT03472040,Lab Abnormality or Adverse Event (AE),Overall Study,FG001,0.2824922938385321,0.9880090598214682,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
272,NCT01023308,Disease progression,Overall Study,FG000,0.2812670202861786,0.9879646489319182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
273,NCT03053440,Death,Overall Study,FG001,0.2797435878893849,0.987920238042368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
274,NCT02801669,Death,Overall Study,FG000,0.279508344507024,0.987875827152818,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
275,NCT04157751,Adverse Event,Overall Study,FG000,0.2785732710835022,0.9878314162632678,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
276,NCT02344290,Withdrawal by Subject,Overall Study,FG000,0.2783261030790978,0.9877870053737176,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
277,NCT01182441,Death,Overall Study,FG000,0.2782518176575577,0.9877425944841676,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
278,NCT02073682,Death,Overall Study,FG000,0.2765066007267263,0.9876981835946174,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
279,NCT00308139,Withdrawal of Consent,Overall Study,FG001,0.2762063718762302,0.9876537727050672,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
280,NCT01764386,Wk 16 Efficacy and BP Criteria,Controlled Treatment Period (CTP),FG000,0.2759645276096529,0.9876093618155172,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
281,NCT02741596,Subject withdrawn-Other,Overall Study,FG000,0.2751930975173512,0.9875649509259672,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
282,NCT00567255,Adverse Event,Overall Study,FG000,0.2730675829619047,0.987520540036417,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
283,NCT01709513,Adverse Event,Overall Study,FG001,0.2726639979873595,0.9874761291468668,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
284,NCT03053440,Sponsor's Decision to End the Study,Overall Study,FG001,0.2715888913327778,0.9874317182573168,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
285,NCT00308139,Withdrawal of Consent,Overall Study,FG000,0.2708588126443257,0.9873873073677666,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
286,NCT02468232,Death,Core Part of Study,FG001,0.2698907463982042,0.9873428964782164,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
287,NCT01778049,Other reason not defined above,Open Label Treatment Period,FG000,0.2689868985815358,0.9872984855886664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
288,NCT00794573,Lost to Follow-up,Overall Study,FG001,0.268864334573004,0.9872540746991162,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
289,NCT03888066,Study Terminated By Sponsor,Run-in Phase,FG000,0.2688226483066368,0.987209663809566,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
290,NCT03436693,Adverse Event,Overall Study,FG000,0.26727093532376,0.987165252920016,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
291,NCT03158688,Withdrawal by Subject,Overall Study,FG001,0.2650945746041866,0.987120842030466,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
292,NCT01102426,Patient Refusal,Overall Study,FG000,0.2649769645935316,0.9870764311409156,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
293,NCT00380068,Adverse Event,Overall Study,FG000,0.2625130038934224,0.9870320202513656,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
294,NCT00622284,Adverse Event,Overall Study,FG000,0.2620497389364487,0.9869876093618156,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
295,NCT00501059,Consent withdrawn by subject,Overall Study,FG001,0.2609295826534623,0.9869431984722654,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
296,NCT02541383,Death,Overall Study,FG000,0.2608880958129365,0.9868987875827152,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
297,NCT03472040,Withdrawal by Subject,Overall Study,FG001,0.2600958645742166,0.9868543766931652,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
298,NCT01345019,Withdrawal by Subject,Blinded Treatment Phase,FG001,0.2597702151703274,0.986809965803615,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
299,NCT00622336,Adverse Event,Treatment Phase,FG000,0.2589754600568551,0.9867655549140648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
300,NCT00507416,Adverse Event,Overall Study,FG001,0.2584496538688095,0.9867211440245148,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
301,NCT03859427,Death,Overall Study,FG001,0.2581203885601091,0.9866767331349648,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
302,NCT02277691,Pretreatment Event/Adverse Event,Overall Study,FG000,0.2568967154916251,0.9866323222454144,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
303,NCT03988634,Death,Double-Blind,FG001,0.2568133486188096,0.9865879113558644,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
304,NCT01568866,Patient Request,Overall Study,FG001,0.256083666159028,0.9865435004663144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
305,NCT01908816,Early termination,Overall Study,FG003,0.2551982541398609,0.9864990895767642,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
306,NCT00689936,Continue in Long Term Follow Up,Long-Term Follow Up Phase,FG000,0.2546859265085813,0.986454678687214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
307,NCT03057951,"Patient refusal to continue, not due to AE",Overall Study,FG000,0.254467037209742,0.986410267797664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
308,NCT02884206,Death,Double-Blind Period,FG002,0.2535210306878672,0.9863658569081138,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
309,NCT00773747,Adverse Event,Overall Study,FG001,0.2524551813553866,0.9863214460185638,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
310,NCT00507416,Adverse Event,Overall Study,FG002,0.2524251560089484,0.9862770351290135,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
311,NCT02541383,Death,Overall Study,FG002,0.2512875444816071,0.9862326242394636,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
312,NCT04844918,Participants Excluded Due to GCP Compliance Issue,Overall Study,FG000,0.2505240168331549,0.9861882133499134,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
313,NCT02073682,Adverse Event,Overall Study,FG000,0.2496551901959327,0.9861438024603632,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
314,NCT00773747,Adverse Event,Overall Study,FG000,0.2496310734799105,0.9860993915708132,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
315,NCT00056160,Progression of disease,Up to Unblinding (07 Jun 2005),FG000,0.2494804630990575,0.9860549806812632,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
316,NCT00773747,Withdrawal by Subject,Overall Study,FG001,0.2485383909744937,0.986010569791713,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
317,NCT02733185,Death,Overall Study,FG000,0.2485086993733533,0.9859661589021628,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
318,NCT03057951,"Patient refusal to continue, not due to AE",Overall Study,FG001,0.2484307091077878,0.9859217480126128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
319,NCT02073682,PD: Inconvenience of Dosing,Overall Study,FG001,0.2476479945652085,0.9858773371230626,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
320,NCT03325556,Adverse Event,Open-label Period,FG000,0.2474316288889286,0.9858329262335124,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
321,NCT00358215,Death,Overall Study,FG001,0.2473499118285913,0.9857885153439624,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
322,NCT02884206,Adverse Event,LCZ696 Run-in Period,FG000,0.2470791626373809,0.9857441044544122,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
323,NCT00501059,Consent withdrawn by subject,Overall Study,FG000,0.2467979170516071,0.985699693564862,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
324,NCT01239797,Study drug toxicity,Treated Participants,FG000,0.2458897728810318,0.985655282675312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
325,NCT03551496,Death,Overall Study,FG000,0.2456535094536707,0.985610871785762,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
326,NCT02555878,Death,Overall Study,FG001,0.2453130529928969,0.9855664608962118,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
327,NCT04072835,Physician Decision,Overall Study,FG000,0.2446647585895138,0.9855220500066616,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
328,NCT03725202,Ongoing in Period 2,Period 2 (Week 52 - Week 104),FG003,0.2442708395738689,0.9854776391171116,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
329,NCT00910429,Death,Overall Study,FG000,0.2440280723870438,0.9854332282275614,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
330,NCT00179647,Adverse Event,Overall Study,FG000,0.2430318216106944,0.9853888173380112,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
331,NCT00863681,Adverse Event,Overall Study,FG000,0.2429157377854465,0.9853444064484612,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
332,NCT00358215,Death,Overall Study,FG000,0.2425089550694644,0.985299995558911,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
333,NCT03080883,Death,Overall Study,FG001,0.2424532835670635,0.9852555846693608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
334,NCT00558259,Adverse Event,Overall Study,FG000,0.241517591318274,0.9852111737798108,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
335,NCT01330628,Adverse Event,Overall Study,FG001,0.2405177822218331,0.9851667628902608,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
336,NCT02195479,Withdrawal by Subject,Overall Study,FG001,0.2398843809850097,0.9851223520007104,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
337,NCT00622336,Other,Treatment Phase,FG000,0.239636386155615,0.9850779411111604,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
338,NCT02195479,Withdrawal by Subject,Overall Study,FG000,0.2392878362615275,0.9850335302216104,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
339,NCT03988634,Subject decision,Double-Blind,FG000,0.2370246083319841,0.9849891193320602,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
340,NCT04657016,Withdrawal by Subject,Overall Study,FG000,0.236992252923978,0.98494470844251,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
341,NCT04537923,Withdrawal by Subject,Overall Study,FG003,0.2362083251361003,0.98490029755296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
342,NCT01818752,Adverse Event,Overall Study,FG001,0.2359714016592957,0.9848558866634098,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
343,NCT01764386,Wk 42 Efficacy and BP Criteria,Uncontrolled Treatment Period (UTP),FG001,0.2355724240569938,0.9848114757738596,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
344,NCT02963935,Unclassified,Overall Study,FG001,0.2350275394270239,0.9847670648843097,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
345,NCT03859427,Death,Overall Study,FG000,0.2343371749944245,0.9847226539947596,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
346,NCT02733185,Death,Overall Study,FG003,0.2342730302188094,0.9846782431052092,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
347,NCT01345019,Withdrawal by Subject,Blinded Treatment Phase,FG000,0.234244644746756,0.9846338322156593,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
348,NCT04844918,Participants Excluded Due to GCP Compliance Issue,Overall Study,FG002,0.2334567485766368,0.9845894213261092,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
349,NCT00507416,Adverse Event,Overall Study,FG000,0.2315544699246033,0.9845450104365592,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
350,NCT03758638,Pregnancy,Overall Study,FG001,0.2311287264796822,0.984500599547009,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
351,NCT02546323,Withdrawal by Subject,Overall Study,FG000,0.2283563961821827,0.9844561886574588,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
352,NCT01023308,Adverse Event,Overall Study,FG001,0.2278920647340773,0.9844117777679088,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
353,NCT03080883,Withdrawal by Subject,Overall Study,FG001,0.2277368934031944,0.9843673668783586,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
354,NCT01603615,Personal Reasons,Overall Study,FG000,0.2273533049535916,0.9843229559888084,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
355,NCT00332488,Withdrawal by Subject,Initial Treatment Phase (Weeks 0 - 12),FG000,0.2265868938186113,0.9842785450992584,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
356,NCT00332488,Various,Initial Treatment Phase (Weeks 0 - 12),FG002,0.2264966538796233,0.9842341342097082,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
357,NCT02924727,Death,Overall Study,FG001,0.2263704019947422,0.984189723320158,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
358,NCT02344290,Lost to Follow-up,Overall Study,FG000,0.2261565004763692,0.984145312430608,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
359,NCT00838916,Withdrawal by Subject,Treatment Period (156 Weeks),FG000,0.2260549811958033,0.984100901541058,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
360,NCT00332488,Withdrawal by Subject,Initial Treatment Phase (Weeks 0 - 12),FG002,0.2258756572283732,0.9840564906515078,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
361,NCT00568178,Termination of Trial,Open Label Extension,FG005,0.224833260277232,0.9840120797619576,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
362,NCT04844918,Participants Excluded Due to GCP Compliance Issue,Overall Study,FG001,0.2235539953972321,0.9839676688724076,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
363,NCT01243424,Withdrawal by Subject,Discontinuation From Treatment,FG001,0.2225577511030953,0.9839232579828574,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
364,NCT01087502,Adverse Event,Up to Final Analysis (Week 52),FG001,0.220568294612143,0.9838788470933072,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
365,NCT00568178,Termination of Trial,Open Label Extension,FG004,0.2201998354264582,0.9838344362037572,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
366,NCT01788358,Adverse Event,Overall Study,FG000,0.2196644730627179,0.983790025314207,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
367,NCT00094770,Lack of Efficacy,Year 2 (Week 0 to Week 104),FG000,0.2193742304155753,0.9837456144246568,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
368,NCT01396083,Adverse Event,Overall Study,FG001,0.2177940333936508,0.9837012035351068,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
369,NCT01475825,Adverse Event,Overall Study,FG002,0.2172845311566068,0.9836567926455568,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
370,NCT00794573,Lost to Follow-up,Overall Study,FG000,0.2169116762541962,0.9836123817560066,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
371,NCT00657150,Adverse Event,Treatment,FG000,0.2165256330744346,0.9835679708664564,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
372,NCT05412004,Withdrawal by Subject,Overall Study,FG001,0.2159855191214487,0.9835235599769064,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
373,NCT03354273,Withdrawal by Subject,Overall Study,FG000,0.2156337624058831,0.9834791490873562,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
374,NCT01101035,Reason not Specified,Overall Study,FG001,0.2154070641088691,0.983434738197806,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
375,NCT04660643,Withdrawal by Subject,Open-label Lead-in Period (Week 0 - 36),FG000,0.2149871386774297,0.983390327308256,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
376,NCT04657016,Lost to Follow-up,Overall Study,FG000,0.2146620038445727,0.9833459164187058,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
377,NCT00311402,Lack of Efficacy,Overall Study,FG001,0.2144419196694346,0.9833015055291556,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
378,NCT01134393,Adverse Event,Overall Study,FG000,0.2142540158171231,0.9832570946396056,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
379,NCT01239797,Adverse event unrelated to study drug,Treated Participants,FG001,0.2140720367129067,0.9832126837500555,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
380,NCT02546323,Withdrawal by Subject,Overall Study,FG001,0.2139521796962104,0.9831682728605052,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
381,NCT01243424,Withdrawal by Subject,Discontinuation From Treatment,FG000,0.213594005995635,0.9831238619709552,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
382,NCT01734928,Other Reasons,Treatment Period,FG000,0.2133260592353276,0.9830794510814052,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
383,NCT03725202,Adverse Event,Period 1 (Baseline - Week 52),FG002,0.2131416056020733,0.9830350401918552,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
384,NCT02344290,Lost to Follow-up,Overall Study,FG001,0.211964019995635,0.982990629302305,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
385,NCT00106704,Lack of Efficacy,Overall Study,FG001,0.2115656641310219,0.9829462184127548,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
386,NCT00221104,Others,Overall Study,FG001,0.2105723125231547,0.9829018075232048,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
387,NCT05822830,Withdrawal by Subject,Overall Study,FG000,0.2103103921875992,0.9828573966336546,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
388,NCT02884206,Adverse Event,Valsartan Run-in Period,FG000,0.209945765894027,0.9828129857441044,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
389,NCT01102426,Death (non-related to the study,Overall Study,FG000,0.2095673211661706,0.9827685748545544,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
390,NCT01813435,did not finish experimental regimen,Overall Study,FG001,0.2092507163582045,0.9827241639650042,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
391,NCT02541383,Death,Overall Study,FG003,0.2086855221828371,0.982679753075454,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
392,NCT03472040,Other - Not Otherwise Specified (NOS),Overall Study,FG001,0.2083515930798515,0.982635342185904,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
393,NCT01272219,Withdrawal criteria,Main + Extension Period: Week 0-172,FG005,0.2074941651971429,0.982590931296354,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
394,NCT00736099,Adverse Event,Overall Study,FG000,0.2073849705953573,0.9825465204068038,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
395,NCT00839527,Withdrawal by Subject,Treatment Period (TP) (156 Weeks),FG002,0.2073122436218254,0.9825021095172536,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
396,NCT00385697,Withdrawal by Subject,Double-blind Segment 2,FG002,0.2067562928859424,0.9824576986277036,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
397,NCT01137812,Patient met glycemic withdrawal criteria,Overall Study,FG001,0.2055835255259521,0.9824132877381534,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
398,NCT03541174,Other reasons,Part 2 Single-Blind,FG003,0.2052485888218244,0.9823688768486032,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
399,NCT02943785,Withdrawal by Subject,Overall Study,FG000,0.2049357642272512,0.9823244659590532,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
400,NCT03110562,Participants withdrawn due to company goals,Crossover Period,FG002,0.204900799470893,0.982280055069503,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
401,NCT02270736,Withdrawal by Subject,OLEX Period (up to 48 Weeks),FG003,0.2043495123766566,0.9822356441799528,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
402,NCT05822830,Withdrawal by Subject,Overall Study,FG001,0.2042129216891963,0.9821912332904028,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
403,NCT01818752,Adverse Event,Overall Study,FG000,0.2041980276205951,0.9821468224008528,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
404,NCT01734928,Withdrawal of Consent,Treatment Period,FG000,0.2036886090598512,0.9821024115113026,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
405,NCT01101035,Reason not Specified,Overall Study,FG000,0.2031294262001192,0.9820580006217524,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
406,NCT01709513,Adverse Event,Overall Study,FG002,0.2029908823369542,0.9820135897322024,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
407,NCT01755156,Withdrawal by Subject,Phase B (Weeks 24-104),FG001,0.2022831983063391,0.9819691788426522,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
408,NCT00069784,Withdrawal by Subject,Overall Study,FG000,0.202005880899504,0.981924767953102,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
409,NCT00622284,Lack of Efficacy,Overall Study,FG000,0.2019057550803275,0.981880357063552,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
410,NCT00856284,Hyperglycemic rescue,Overall Study,FG002,0.2008617415525298,0.9818359461740018,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
411,NCT00439725,Study terminated by sponsor,Treatment Period,FG000,0.20076179317876,0.9817915352844516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
412,NCT03548987,Adverse Event,Run-in Period (Week 0 to Week 20),FG000,0.2002603247867081,0.9817471243949016,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
413,NCT00856284,Hyperglycemic rescue,Overall Study,FG000,0.2001176635169345,0.9817027135053517,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
414,NCT03180736,Withdrawal by Subject,Overall Study,FG001,0.199001012038988,0.9816583026158014,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
415,NCT04264819,Adverse Event,Overall Study,FG000,0.198293628028274,0.9816138917262512,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
416,NCT00549302,Death,Open-Label,FG002,0.1982635622928668,0.9815694808367011,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
417,NCT02136134,Withdrawal by Subject,Overall Study,FG000,0.1978198430263292,0.981525069947151,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
418,NCT01560637,Withdrawal by Subject,Overall Study,FG000,0.1972789898526884,0.981480659057601,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
419,NCT01652716,Withdrawal by Subject,Overall Study,FG000,0.1971870621523807,0.9814362481680508,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
420,NCT03064126,Withdrawal by Subject,Overall Study,FG000,0.1970854147244444,0.9813918372785008,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
421,NCT01568866,Patient Request,Overall Study,FG000,0.1959468926152183,0.9813474263889506,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
422,NCT00094302,Death,Overall Study,FG000,0.1959277091083035,0.9813030154994004,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
423,NCT03354273,Technical Problems,Overall Study,FG000,0.1958203695198005,0.9812586046098504,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
424,NCT00657150,Adverse Event,Treatment,FG001,0.1953019831593749,0.9812141937203002,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
425,NCT00439725,Study terminated by sponsor,Treatment Period,FG001,0.1950652940536111,0.98116978283075,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
426,NCT02229396,Withdrawal by Subject,Overall Study,FG000,0.1945756063699306,0.9811253719412,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
427,NCT01115855,Adverse Event,Overall Study,FG001,0.1941453536910612,0.98108096105165,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
428,NCT00168818,Adverse Event,Treatment,FG001,0.1939594026636606,0.9810365501620998,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
429,NCT00106704,Lack of Efficacy,Overall Study,FG000,0.1938241776574108,0.9809921392725496,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
430,NCT02916706,Withdrawal by Subject,Overall Study,FG001,0.193448373208502,0.9809477283829996,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
431,NCT02541383,Death,Overall Study,FG001,0.1932727977802381,0.9809033174934494,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
432,NCT00271817,Adverse Event,Part 1,FG002,0.1930941705798016,0.9808589066038992,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
433,NCT02733185,Death,Overall Study,FG002,0.1929731348120636,0.9808144957143492,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
434,NCT01239797,Adverse event unrelated to study drug,Treated Participants,FG000,0.192637494445119,0.980770084824799,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
435,NCT00413413,Subject no longer requires study drug,Single-Blind,FG001,0.1923667954378671,0.9807256739352488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
436,NCT00740051,Withdrawal by Subject,Overall Study,FG001,0.1923311193931846,0.9806812630456988,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
437,NCT02924727,Death,Overall Study,FG000,0.1923285481038094,0.9806368521561488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
438,NCT01182441,Death,Overall Study,FG001,0.191958802310248,0.9805924412665986,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
439,NCT02073682,Adverse Event,Overall Study,FG001,0.1917414854493156,0.9805480303770484,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
440,NCT00740051,Lost to Follow-up,Overall Study,FG001,0.1915095310135417,0.9805036194874984,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
441,NCT00094770,Lack of Efficacy,Year 2 (Week 0 to Week 104),FG001,0.1910808156167956,0.9804592085979482,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
442,NCT00863681,Death,Overall Study,FG001,0.191074339220496,0.980414797708398,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
443,NCT02555878,Withdrawal by Subject,Overall Study,FG001,0.1909594542098513,0.980370386818848,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
444,NCT00617123,Did Not Meet Protocol Eligibility,Referral Screening Period,FG000,0.1907982464469244,0.9803259759292978,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
445,NCT02851407,Other Death,Overall Study,FG001,0.1906182564195453,0.9802815650397476,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
446,NCT02555878,Withdrawal by Subject,Overall Study,FG000,0.1904969422843751,0.9802371541501976,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
447,NCT00707993,Hyperglycemic Rescue,Overall Study,FG000,0.1896892450957834,0.9801927432606476,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
448,NCT02229396,Withdrawal by Subject,Overall Study,FG002,0.189364402167758,0.9801483323710974,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
449,NCT03064126,Death,Overall Study,FG001,0.1889522613354265,0.9801039214815472,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
450,NCT01682759,Withdrawal by Subject,Overall Study,FG000,0.1887211703308531,0.9800595105919973,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
451,NCT00902174,Adverse Event,Overall Study,FG000,0.1885807239332738,0.980015099702447,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
452,NCT03053440,Withdrawal by Subject,Overall Study,FG000,0.1881454514117859,0.979970688812897,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
453,NCT02884206,Death,Double-Blind Period,FG001,0.1880604676250099,0.9799262779233467,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
454,NCT02918279,Withdrawal by Subject,Overall Study,FG001,0.1878862230103867,0.9798818670337966,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
455,NCT00996281,Adverse Event,Overall Study,FG000,0.1878555955262202,0.9798374561442466,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
456,NCT00849056,Withdrawal by Subject,Treatment Period (TP) (156 Weeks),FG000,0.1872969783245136,0.9797930452546963,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
457,NCT02733185,Death,Overall Study,FG001,0.1871695363784128,0.9797486343651464,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
458,NCT00826280,Reversible ischemic defect not present,Overall Study,FG002,0.1858311375356845,0.9797042234755964,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
459,NCT00657150,Withdrawal by Subject,Overall Study,FG000,0.1852373901188691,0.979659812586046,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
460,NCT00221104,Withdrawal by Subject,Overall Study,FG000,0.185166072553006,0.979615401696496,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
461,NCT01084005,Adverse Event,Overall Study,FG001,0.1845069066681844,0.979570990806946,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
462,NCT00485758,Adverse Event,Overall Study,FG000,0.1843498639590178,0.9795265799173958,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
463,NCT01682759,Withdrawal by Subject,Overall Study,FG001,0.1836172890968651,0.9794821690278456,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
464,NCT00129545,Device not implanted,Overall Study,FG001,0.1825045351782935,0.9794377581382956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
465,NCT05275400,Withdrawal by Subject,Treatment Period,FG000,0.1823973235329167,0.9793933472487454,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
466,NCT01964326,Lost to Follow-up,Overall Study,FG000,0.181688618050754,0.9793489363591952,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
467,NCT00826280,Reversible ischemic defect not present,Overall Study,FG000,0.1816628789841368,0.9793045254696452,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
468,NCT00996658,Other,Overall Study,FG000,0.1815187404532937,0.979260114580095,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
469,NCT00202878,Death,Overall Study,FG000,0.1811708331145237,0.9792157036905448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
470,NCT03988634,Death,Double-Blind,FG000,0.1811625148925992,0.9791712928009948,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
471,NCT00129545,Death,Overall Study,FG001,0.1810394168600098,0.9791268819114448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
472,NCT00202878,Death,Overall Study,FG001,0.1809837326174405,0.9790824710218946,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
473,NCT04072835,Lost to Follow-up,Overall Study,FG000,0.1805549230904167,0.9790380601323444,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
474,NCT00954447,Adverse Event,Overall Study,FG000,0.1803668897015279,0.9789936492427944,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
475,NCT01239797,Participants request to discontinue study treatment,Treated Participants,FG000,0.1801792727019641,0.9789492383532442,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
476,NCT04915729,Death,Overall Study,FG001,0.1799173020357639,0.978904827463694,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
477,NCT01734928,Withdrawal of Consent,Treatment Period,FG001,0.1795918739251885,0.978860416574144,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
478,NCT00385697,Lost to Follow-up,Double-blind Segment 2,FG002,0.1795746281590079,0.9788160056845938,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
479,NCT00385697,Lost to Follow-up,Double-blind Segment 2,FG004,0.1793998292747222,0.9787715947950436,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
480,NCT00853827,Administrative problems,Double Blind Period (103 Weeks),FG001,0.1793450133378272,0.9787271839054936,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
481,NCT03785405,Physician Decision,Overall Study,FG000,0.1792256738272916,0.9786827730159436,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
482,NCT00097981,Adverse Event,Overall Study,FG000,0.1792113853848711,0.9786383621263934,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
483,NCT01964326,Withdrawal by Subject,Overall Study,FG000,0.1790023402498314,0.9785939512368432,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
484,NCT02865850,Death,Overall Study,FG001,0.1789241152678194,0.9785495403472932,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
485,NCT00094302,Death,Overall Study,FG001,0.1788207884661211,0.978505129457743,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
486,NCT01106014,Adverse Event,Overall Study,FG000,0.1783450508320636,0.9784607185681928,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
487,NCT05040971,Lost to Follow-up,Overall Study,FG000,0.1782422691241169,0.9784163076786428,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
488,NCT04072835,Participant no longer meets the inclusion/exclusion criteria,Overall Study,FG000,0.1779326900265477,0.9783718967890926,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
489,NCT00086515,Lack of Efficacy,Phase B (Weeks 24-104),FG000,0.1778731057022421,0.9783274858995424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
490,NCT00232180,Death,Double-blind (DB) Phase,FG001,0.1777494165949208,0.9782830750099925,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
491,NCT00618956,Adverse Event,Overall Study,FG000,0.177607821899752,0.9782386641204424,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
492,NCT04157751,Adverse Event,Overall Study,FG001,0.1775954226330247,0.9781942532308924,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
493,NCT00877929,Adverse Event,Overall Study,FG001,0.1774376408793058,0.978149842341342,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
494,NCT01755156,Withdrawal by Subject,Phase B (Weeks 24-104),FG000,0.1769760287411409,0.978105431451792,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
495,NCT00082628,Subjects Did Not Complete Week 12,Treatment Period I (Week 1 to Week 12),FG001,0.1765580006523611,0.978061020562242,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
496,NCT04873934,Lost to Follow-up,Overall Study,FG000,0.1765017561776487,0.9780166096726918,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
497,NCT01507831,Last visit outside protocol visit window,Overall Study,FG001,0.1764538447543948,0.9779721987831416,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
498,NCT01215253,Withdrawal by Subject,Overall Study,FG000,0.176351844687381,0.9779277878935916,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
499,NCT00856284,Hyperglycemic rescue,Overall Study,FG001,0.1762804500608037,0.9778833770040414,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
500,NCT03551496,Death,Overall Study,FG001,0.1760884504591964,0.9778389661144912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
501,NCT01335399,Other reasons,Treatment Period,FG000,0.1753794938026784,0.9777945552249412,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
502,NCT01335399,Participant request to discontinue,Treatment Period,FG000,0.1753414976089284,0.9777501443353912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
503,NCT01335399,Other reasons,Treatment Period,FG001,0.1753359250630951,0.9777057334458408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
504,NCT03353350,Withdrawal by Subject,30-week Core Treatment Period,FG003,0.1752118854252198,0.9776613225562908,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
505,NCT03353350,Withdrawal by Subject,30-week Core Treatment Period,FG002,0.1750641364087616,0.9776169116667408,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
506,NCT03353350,Withdrawal by Subject,30-week Core Treatment Period,FG000,0.1749138721717377,0.9775725007771906,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
507,NCT03180736,Death,Overall Study,FG000,0.1747467521812301,0.9775280898876404,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
508,NCT00056160,Adverse Event,Extended Follow-up Cutoff (23 Jul 2008),FG000,0.1744800441172122,0.9774836789980904,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
509,NCT01560637,Progressive Disease,Overall Study,FG000,0.1744328108730356,0.9774392681085402,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
510,NCT00093015,Death,Overall Study,FG001,0.1743398519911354,0.97739485721899,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
511,NCT00826280,Reversible ischemic defect not present,Overall Study,FG001,0.1737229536308676,0.97735044632944,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
512,NCT01617434,Withdrawal Criteria,Overall Study,FG001,0.1731227632587003,0.9773060354398898,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
513,NCT00168818,Adverse Event,Treatment,FG000,0.1727886243563295,0.9772616245503396,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
514,NCT00286429,Lack of Efficacy,Overall Study,FG000,0.1723976821268553,0.9772172136607896,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
515,NCT01001572,Abnormal Test Procedure Result(s),Single-Blind Valsartan 160 mg,FG000,0.1719175910664781,0.9771728027712396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
516,NCT04264819,Withdrawal by Subject,Overall Study,FG000,0.1718553285704761,0.9771283918816894,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
517,NCT00093015,Death,Overall Study,FG000,0.1712787457955998,0.9770839809921392,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
518,NCT01294462,Withdrawal by Subject,Overall Study,FG000,0.1712154784798811,0.9770395701025892,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
519,NCT00308737,Withdrawal by Subject,Overall Study,FG000,0.1712129192135415,0.976995159213039,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
520,NCT01890122,Lack of Efficacy,Overall Study,FG003,0.1711510307470733,0.9769507483234888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
521,NCT03952143,Withdrawal by Subject,Treatment Period,FG002,0.1706418835952795,0.9769063374339388,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
522,NCT00329238,Withdrawal by Subject,Overall Study,FG000,0.1705254200455953,0.9768619265443886,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
523,NCT03080883,Withdrawal by Subject,Overall Study,FG000,0.1701273746760714,0.9768175156548384,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
524,NCT01214239,Withdrawal by Subject,Overall Study,FG001,0.1700310772906051,0.9767731047652884,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
525,NCT01818752,Disease Progression,Overall Study,FG000,0.169804329047629,0.9767286938757384,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
526,NCT00662831,Other,Overall Study,FG001,0.1693575978628868,0.9766842829861884,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
527,NCT02926950,At the participant's own request,Overall Study,FG001,0.1692826112012599,0.976639872096638,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
528,NCT01734928,Death,Treatment Period,FG000,0.1687560218378274,0.976595461207088,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
529,NCT01664247,Unclassified,Overall Study,FG001,0.1687050795966765,0.976551050317538,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
530,NCT01712789,Miscellaneous,Overall Study,FG000,0.1684368093450396,0.9765066394279878,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
531,NCT01294462,Withdrawal by Subject,Overall Study,FG001,0.1680894992914585,0.9764622285384376,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
532,NCT02441218,Death,Overall Study,FG001,0.1677271878567308,0.9764178176488876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
533,NCT00097981,Transplant planned,Overall Study,FG000,0.1674852777314285,0.9763734067593374,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
534,NCT03725202,Adverse Event,Period 1 (Baseline - Week 52),FG000,0.1673976005309226,0.9763289958697872,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
535,NCT01620489,Withdrawal Criteria,Overall Study,FG001,0.1673396150359821,0.9762845849802372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
536,NCT03693430,Lost to Follow-up,Overall Study,FG001,0.1673301758183928,0.9762401740906872,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
537,NCT04252287,Withdrawal by Subject,Overall Study,FG000,0.1673026371442377,0.9761957632011368,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
538,NCT00432276,Hyperglycemic Rescue,Overall Study,FG001,0.1672117024690619,0.9761513523115868,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
539,NCT01850524,Withdrawal by Subject,Overall Study,FG000,0.167029882855744,0.9761069414220368,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
540,NCT01644188,Adverse Event,Overall Study,FG000,0.1667089531832341,0.9760625305324866,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
541,NCT00330759,Withdrawal by Subject,Overall Study,FG000,0.166534156897629,0.9760181196429364,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
542,NCT03053440,Withdrawal by Subject,Overall Study,FG001,0.1661341042811308,0.9759737087533864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
543,NCT01115855,Adverse Event,Overall Study,FG000,0.1660838016455951,0.9759292978638362,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
544,NCT00856986,Adverse Event,"Run-in Period, Weeks -12-0",FG003,0.1660206716498808,0.975884886974286,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
545,NCT02073682,Cancer Progression,Overall Study,FG000,0.1659998235353671,0.975840476084736,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
546,NCT01663402,Two consecutive LDL-C <15 mg/dL,Overall Study,FG001,0.1651020596653073,0.975796065195186,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
547,NCT02755597,Withdrew consent,Overall Study,FG001,0.1648348545598312,0.9757516543056356,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
548,NCT00707993,Hyperglycemic Rescue,Overall Study,FG001,0.1645486704932186,0.9757072434160856,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
549,NCT00221104,Others,Overall Study,FG000,0.1643881831018054,0.9756628325265356,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
550,NCT03611582,Adverse Event,Overall Study,FG000,0.1642113404167874,0.9756184216369854,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
551,NCT03541174,Adverse Event,Part 2 Single-Blind,FG003,0.1637673826585118,0.9755740107474352,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
552,NCT03888066,Withdrawal by Subject,Run-in Phase,FG000,0.1634777789282162,0.9755295998578852,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
553,NCT01330628,Withdrawn,Overall Study,FG000,0.1633640526868748,0.975485188968335,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
554,NCT03758638,Pregnancy,Overall Study,FG000,0.1632799143718253,0.9754407780787848,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
555,NCT03214380,Withdrawal by Subject,Lead-in,FG000,0.1632762060617955,0.9753963671892348,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
556,NCT01908699,Withdrawal by Subject,Overall Study,FG000,0.1629766306439881,0.9753519562996846,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
557,NCT00097981,Transplant planned,Overall Study,FG001,0.1627833602627976,0.9753075454101344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
558,NCT04184622,Withdrawal by Subject,Primary Treatment Period,FG000,0.162530926488264,0.9752631345205844,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
559,NCT02525939,Death,Overall Study,FG000,0.1622121816306007,0.9752187236310343,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
560,NCT02525939,Death,Overall Study,FG001,0.161952916634559,0.9751743127414844,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
561,NCT01084005,Protocol Violation,Overall Study,FG001,0.1618941538490673,0.975129901851934,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
562,NCT04072835,Participant wanted to try other therapy or treatment,Overall Study,FG000,0.1614582879313591,0.975085490962384,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
563,NCT02942576,Adverse Event,Overall Study,FG000,0.1614512002209125,0.975041080072834,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
564,NCT00915772,Lack of Efficacy,Overall Study,FG001,0.1608727895626091,0.9749966691832838,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
565,NCT00152971,Adverse Event,Treatment,FG002,0.1604489112014485,0.9749522582937336,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
566,NCT03759392,Adverse Event,Overall Study,FG000,0.160271408832462,0.9749078474041836,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
567,NCT02833948,were not scanned,Overall Study,FG001,0.1602675749906845,0.9748634365146334,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
568,NCT04429503,Lost to Follow-up,Main Study (Up to Wk 96),FG001,0.1601540335576984,0.9748190256250832,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
569,NCT02441218,Death,Overall Study,FG000,0.1600418058162745,0.9747746147355332,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
570,NCT00249795,Withdrawal by Subject,Overall Study,FG001,0.1599236764114529,0.9747302038459832,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
571,NCT01102426,Adverse Events (treatment-related),Overall Study,FG000,0.1594968364218849,0.9746857929564328,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
572,NCT01243424,Other than listed above,Discontinuation From Treatment,FG000,0.1592074741142062,0.9746413820668828,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
573,NCT05412004,Withdrawal by Subject,Overall Study,FG003,0.158613671663383,0.9745969711773328,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
574,NCT01272219,Adverse Event,Main + Extension Period: Week 0-172,FG004,0.1585327227375992,0.9745525602877826,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
575,NCT02076009,Withdrawal by Subject,Overall Study,FG000,0.1583770698906052,0.9745081493982324,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
576,NCT02252172,Withdrawal by Subject,Overall Study,FG000,0.1583012902425497,0.9744637385086824,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
577,NCT02017171,Withdrawal by Subject,Overall Study,FG000,0.1578346392450098,0.9744193276191322,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
578,NCT01734928,Other Reasons,Treatment Period,FG001,0.1577726016350298,0.974374916729582,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
579,NCT02476006,Adverse Event,Overall Study,FG000,0.1575757624566765,0.974330505840032,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
580,NCT00329238,Withdrawal by Subject,Overall Study,FG001,0.1569392606710121,0.974286094950482,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
581,NCT01442038,Participant Withdrew Consent,Overall Study,FG000,0.1568138692892659,0.9742416840609316,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
582,NCT03436693,Withdrawal by Subject,Overall Study,FG001,0.1565414900464069,0.9741972731713816,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
583,NCT00695955,Lost to Follow-up,Cohort 2,FG000,0.1564744383854265,0.9741528622818316,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
584,NCT00168818,Adverse Event,Treatment,FG002,0.1564733128098711,0.9741084513922814,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
585,NCT01492361,Withdrawal by Subject,Overall Study,FG001,0.155388606997361,0.9740640405027312,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
586,NCT01001572,Administrative problems,Single-Blind Valsartan 160 mg,FG000,0.1546176957095535,0.9740196296131812,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
587,NCT02586155,Death,Overall Study,FG001,0.1545707862843803,0.973975218723631,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
588,NCT03057977,Withdrawal by Subject,Discontinuation From Treatment,FG000,0.1545324242401389,0.9739308078340808,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
589,NCT03735979,Lost to Follow-up,Overall Study,FG002,0.1544570579835318,0.9738863969445308,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
590,NCT04429503,Death,Main Study (Up to Wk 96),FG001,0.1536691029670437,0.9738419860549808,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
591,NCT01713530,Withdrawal criteria,Overall Study,FG000,0.1535147806425893,0.9737975751654304,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
592,NCT02558231,Death,Overall Study,FG001,0.1534622074863393,0.9737531642758804,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
593,NCT04807400,Participant Decision,Overall Study,FG002,0.1534250690708314,0.9737087533863305,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
594,NCT01568866,Physician Decision,Overall Study,FG000,0.1528623104537598,0.9736643424967802,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
595,NCT00713830,Adverse Event,Overall Study,FG001,0.1527421324928869,0.97361993160723,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
596,NCT01986881,Death,Overall Study,FG002,0.1525617402921698,0.97357552071768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
597,NCT01539083,Physician Decision,Before Randomization (VCD Induction),FG000,0.1525029788401588,0.9735311098281298,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
598,NCT03325556,Withdrawal by Subject,Open-label Period,FG000,0.1523845139479066,0.9734866989385798,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
599,NCT00910429,Death,Overall Study,FG001,0.1521054017344643,0.9734422880490295,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
600,NCT00982644,Unclassified,Main: Week 0 to 52 (NN1250-3579),FG000,0.1520601664432739,0.9733978771594796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
601,NCT03651765,Adverse Event,Overall Study,FG000,0.1519881515055454,0.9733534662699294,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
602,NCT00402103,Adverse Event,Overall Study,FG000,0.1519147797937302,0.9733090553803792,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
603,NCT00736099,Other reason,Overall Study,FG000,0.1517557442039882,0.9732646444908292,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
604,NCT02943785,Physician Decision,Overall Study,FG001,0.151629777381637,0.9732202336012792,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
605,NCT00202878,Withdrawal by Subject,Overall Study,FG001,0.1515298702759622,0.9731758227117288,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
606,NCT02100514,Withdrawal by Subject,Treatment Period,FG001,0.1515216425968452,0.9731314118221788,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
607,NCT00232180,Death,Double-blind (DB) Phase,FG000,0.1514829042328246,0.9730870009326288,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
608,NCT00087516,Lack of Efficacy,Overall Study,FG000,0.1514708498569246,0.9730425900430786,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
609,NCT01539083,Adverse Event,Before Randomization (VCD Induction),FG000,0.1514440753274206,0.9729981791535284,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
610,NCT00622284,Other reason (not specified),Overall Study,FG000,0.1511856008466865,0.9729537682639784,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
611,NCT03651765,Physician Decision,Overall Study,FG000,0.1511228347345038,0.972864946484878,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
612,NCT03651765,Miscellaneous,Overall Study,FG000,0.1511228347345038,0.972864946484878,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
613,NCT03651765,Withdrawal by Parent/Guardian,Overall Study,FG000,0.1511228347345038,0.972864946484878,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
614,NCT02185417,Death,Overall Study,FG000,0.1505025853060119,0.972776124705778,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
615,NCT04847557,Death,Overall Study,FG000,0.1504798366306845,0.9727317138162276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
616,NCT00489736,Lack of Efficacy,Overall Study,FG000,0.1504380465731248,0.9726873029266776,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
617,NCT02073682,ID: Benefit/Risk Judgment,Overall Study,FG001,0.1503151550254267,0.9726428920371276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
618,NCT01850524,Withdrawal by Subject,Overall Study,FG001,0.1499849374046428,0.9725984811475774,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
619,NCT00403767,Adverse Event,Overall Study,FG000,0.1498454689558405,0.9725540702580272,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
620,NCT00332488,Physician Decision,Initial Treatment Phase (Weeks 0 - 12),FG000,0.1494092746152678,0.9725096593684772,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
621,NCT00202878,Withdrawal by Subject,Overall Study,FG000,0.1492978367140575,0.972465248478927,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
622,NCT00329238,Other reason (not specified),Overall Study,FG001,0.1492120466570806,0.9724208375893768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
623,NCT00330759,Disease progression,Overall Study,FG001,0.1489855857497194,0.9723764266998268,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
624,NCT01818752,Disease Progression,Overall Study,FG001,0.1487630048140575,0.9723320158102768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
625,NCT00736099,Withdrawal by Subject,Overall Study,FG000,0.1486928295756351,0.9722876049207264,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
626,NCT02943785,Death,Overall Study,FG000,0.1486721521263294,0.9722431940311764,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
627,NCT01243424,Other than listed above,Discontinuation From Treatment,FG001,0.1485356136413492,0.9721987831416264,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
628,NCT01492361,Withdrawal by Subject,Overall Study,FG000,0.1485057517358134,0.9721543722520762,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
629,NCT02866175,Adverse Event,Overall Study,FG000,0.1483886944836607,0.972109961362526,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
630,NCT02185417,Death,Overall Study,FG001,0.1483080372604762,0.972065550472976,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
631,NCT03814187,Death,Overall Study,FG001,0.1482060693972025,0.9720211395834258,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
632,NCT02943785,Death,Overall Study,FG001,0.1481087869921726,0.9719767286938756,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
633,NCT02195479,Lost to Follow-up,Overall Study,FG000,0.147852646046369,0.9719323178043257,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
634,NCT00689936,Adverse Event,Active Treatment Phase,FG002,0.1477744790815873,0.9718879069147756,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
635,NCT04518306,Participant moved to open-label extension (OLE) study,Double-Blind Period,FG000,0.1475826553952677,0.9718434960252254,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
636,NCT00330759,Withdrawal by Subject,Overall Study,FG001,0.1475236506562671,0.9717990851356751,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
637,NCT03814187,Death,Overall Study,FG000,0.1474558578982441,0.9717546742461252,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
638,NCT04518306,Participant moved to open-label extension (OLE) study,Double-Blind Period,FG001,0.1473583681079066,0.9717102633565752,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
639,NCT00152971,Adverse Event,Treatment,FG000,0.146965945861654,0.9716658524670247,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
640,NCT03481634,Withdrawal by Subject,Overall Study,FG001,0.1468789797670734,0.9716214415774748,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
641,NCT02865850,Death,Overall Study,FG000,0.146667008143748,0.9715770306879248,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
642,NCT01131676,Adverse Event,Discontinuation From Treatment,FG000,0.1466217125100098,0.9715326197983746,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
643,NCT00249795,Withdrawal by Subject,Overall Study,FG000,0.1465808076200541,0.9714882089088244,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
644,NCT01272219,Withdrawal criteria,Main Period: Week 0 to Week 56,FG004,0.1464180401412499,0.9714437980192744,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
645,NCT04429503,Withdrawal by Subject,Main Study (Up to Wk 96),FG001,0.1462957293123511,0.9713993871297242,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
646,NCT00839527,Withdrawal by Subject,Treatment Period (TP) (156 Weeks),FG001,0.1462304798062798,0.971354976240174,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
647,NCT01624142,Withdrawal by Subject,Overall Study,FG000,0.1459011752210317,0.971310565350624,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
648,NCT00740051,Withdrawal by Subject,Overall Study,FG000,0.1456044892516962,0.971266154461074,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
649,NCT00740051,Protocol Violation,Overall Study,FG001,0.1452961823001784,0.9712217435715236,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
650,NCT03814187,Withdrew Consent,Overall Study,FG001,0.1452051154621726,0.9711773326819736,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
651,NCT00087516,Lack of Efficacy,Overall Study,FG001,0.1449514546912995,0.9711329217924236,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
652,NCT02634333,Withdrawal by Subject,Overall Study,FG001,0.1449108079137282,0.9710885109028734,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
653,NCT00095238,Adverse Event,Overall Study,FG000,0.1447593502741964,0.9710441000133232,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
654,NCT03814187,Withdrew Consent,Overall Study,FG000,0.1444944117462499,0.9709996891237732,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
655,NCT02476006,Participant did not wish to continue,Overall Study,FG000,0.144442535380982,0.970955278234223,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
656,NCT00838916,Adverse Event,Treatment Period (156 Weeks),FG000,0.1444233788888692,0.9709108673446728,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
657,NCT03725202,Adverse Event,Period 1 (Baseline - Week 52),FG001,0.1443749950688192,0.9708664564551228,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
658,NCT00121667,Lack of Efficacy,Short Term (ST) + Long Term (LT) Period,FG003,0.1443213464800893,0.9708220455655728,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
659,NCT01134393,Protocol Violation,Overall Study,FG000,0.1442776924978571,0.9707776346760224,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
660,NCT03725202,Ongoing in Period 2,Period 2 (Week 52 - Week 104),FG004,0.1441253707984026,0.9707332237864724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
661,NCT02104817,Death,Overall Study,FG000,0.1437951007206602,0.9706888128969224,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
662,NCT01507831,Adverse Event,Overall Study,FG001,0.1433739133622322,0.9706444020073722,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
663,NCT04660643,Withdrawal by Subject,Double-blind Study Period (Week 36 - 92),FG001,0.143338876192002,0.970599991117822,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
664,NCT03110562,Lost to Follow-up,Initial Treatment Period,FG000,0.1430140480113473,0.970555580228272,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
665,NCT00064753,Death,Overall Study,FG000,0.1429511779416568,0.9705111693387218,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
666,NCT00657150,Other,Overall Study,FG000,0.142898046494293,0.9704667584491716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
667,NCT05822830,Lost to Follow-up,Overall Study,FG001,0.1428299664856746,0.9704223475596216,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
668,NCT04252287,Withdrawal by Subject,Overall Study,FG001,0.1425198548631628,0.9703779366700716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
669,NCT00291330,Adverse Event,Overall Study,FG000,0.1425137695717235,0.9703335257805212,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
670,NCT01986881,Death,Overall Study,FG001,0.1425036687103545,0.9702891148909712,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
671,NCT02866175,Adverse Event,Overall Study,FG001,0.1423893199430952,0.9702447040014212,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
672,NCT00308737,Withdrawal by Subject,Overall Study,FG001,0.1422538893920833,0.9702002931118712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
673,NCT00475852,Death,Overall Study,FG001,0.1421527210920337,0.970155882222321,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
674,NCT02926950,At the participant's own request,Overall Study,FG000,0.141786986060853,0.9701114713327708,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
675,NCT01101035,Lost to Follow-up,Overall Study,FG000,0.1416382482973313,0.9700670604432208,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
676,NCT00853827,Administrative problems,Double Blind Period (103 Weeks),FG000,0.141416426077887,0.9700226495536706,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
677,NCT00954447,Withdrawal by Subject,Overall Study,FG000,0.1413144905343054,0.9699782386641204,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
678,NCT00657150,Other,Overall Study,FG001,0.1411829380486977,0.9699338277745704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
679,NCT00996658,Other,Overall Study,FG001,0.1411520282961308,0.9698894168850202,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
680,NCT00680186,Adverse Event,Overall Study,FG000,0.1409839226822989,0.96984500599547,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
681,NCT00689936,Adverse Event,Active Treatment Phase,FG001,0.1408622515834821,0.96980059510592,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
682,NCT01986881,Death,Overall Study,FG000,0.1406880410399974,0.96975618421637,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
683,NCT00475852,Death,Overall Study,FG000,0.1406560822337897,0.9697117733268196,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
684,NCT03683030,Enrolled but no catheter inserted,Overall Study,FG001,0.1404484299198593,0.9696673624372696,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
685,NCT02678312,Adverse Event,Part 2 Double Blind Epoch,FG003,0.1404028642020531,0.9696229515477196,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
686,NCT01830543,Adverse Event,Overall Study,FG000,0.140402272503125,0.9695785406581694,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
687,NCT00602472,Adverse Event,Overall Study,FG001,0.1400801626154761,0.9695341297686192,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
688,NCT01101035,Lost to Follow-up,Overall Study,FG001,0.1400443454385515,0.9694897188790692,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
689,NCT03080883,Other Complicating Disease,Overall Study,FG000,0.1400374746859523,0.969445307989519,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
690,NCT02678312,Lost to Follow-up,Part 1 Open Label Epoch- Period 1,FG000,0.1399298199186603,0.9694008970999688,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
691,NCT02963935,Unclassified,Overall Study,FG000,0.1399135797192756,0.9693564862104188,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
692,NCT02678312,Physician Decision,Part 1 Open Label Epoch- Period 1,FG000,0.1399043123915769,0.9693120753208688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
693,NCT04844918,Adverse Event,Overall Study,FG001,0.1395902093590673,0.9692676644313184,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
694,NCT01709513,Adverse Event,Overall Study,FG000,0.1395612187069643,0.9692232535417684,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
695,NCT02678312,Adverse Event,Part 1 Open Label Epoch- Period 1,FG000,0.1392294620982435,0.9691788426522184,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
696,NCT00308139,Adverse Event,Overall Study,FG000,0.1389809795711705,0.9691344317626682,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
697,NCT00915772,Adverse Event,Overall Study,FG001,0.1389175478179364,0.969090020873118,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
698,NCT04058067,Withdrawal by Subject,Overall Study,FG001,0.1387117064179662,0.969045609983568,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
699,NCT00424047,Withdrawal by Subject,On Study at Time of Unblinding,FG000,0.1385255967203274,0.9690011990940178,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
700,NCT02307513,Adverse Event,Active Treatment Phase (Weeks 13-64),FG001,0.1384034456299404,0.9689567882044676,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
701,NCT00546052,Lost to Follow-up,Overall Study,FG000,0.138279193808621,0.9689123773149176,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
702,NCT02229396,Withdrawal by Subject,Overall Study,FG001,0.1382231453821526,0.9688679664253677,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
703,NCT00064753,Death,Overall Study,FG001,0.1381893699425397,0.9688235555358172,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
704,NCT02017171,Lost to Follow-up,Overall Study,FG000,0.1381582008079662,0.9687791446462672,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
705,NCT01908699,Death,Overall Study,FG001,0.1380381737984126,0.9687347337567171,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
706,NCT03888066,Sponsor Request,Run-in Phase,FG000,0.137988568581516,0.968690322867167,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
707,NCT01908699,Adverse Event,Overall Study,FG001,0.1379140758780653,0.968645911977617,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
708,NCT02866175,Withdrawal by Subject,Overall Study,FG001,0.1376081642573214,0.9686015010880668,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
709,NCT00954447,Adverse Event,Overall Study,FG001,0.1371268680775701,0.9685570901985168,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
710,NCT03354273,Investigational Medicinal Product (IMP) Supply Issues,Overall Study,FG000,0.1368011172191748,0.9684904738641916,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
711,NCT03354273,Screen Failure,Overall Study,FG000,0.1368011172191748,0.9684904738641916,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
712,NCT04915729,Death,Overall Study,FG000,0.1365547055821626,0.9684238575298664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
713,NCT00306384,Voluntary withdrawal,Overall Study,FG000,0.1357281181046626,0.9683794466403162,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
714,NCT00412984,Withdrawal by Subject,Overall Study,FG001,0.1357056292725396,0.968335035750766,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
715,NCT01335399,Participant request to discontinue,Treatment Period,FG001,0.1349851506804543,0.968290624861216,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
716,NCT00064753,Lost to Follow-up,Overall Study,FG001,0.134544516795486,0.968246213971666,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
717,NCT00489736,Adverse Event,Overall Study,FG001,0.1342021739899702,0.9682018030821158,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
718,NCT01176240,Lack of Efficacy,Study 306B,FG000,0.1339955485720536,0.9681573921925656,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
719,NCT00403767,Adverse Event,Overall Study,FG001,0.1339710393562003,0.9681129813030156,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
720,NCT00558428,Adverse Event,Overall Study,FG001,0.1339533380414591,0.9680685704134654,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
721,NCT02412878,Withdrawal by Subject,Overall Study,FG000,0.1336288157995336,0.9680241595239152,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
722,NCT01176240,Adverse Event,Study 306B,FG001,0.1336093070402084,0.9679797486343652,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
723,NCT02017171,Lost to Follow-up,Overall Study,FG001,0.1333807790380854,0.967935337744815,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
724,NCT02558296,Withdrawal by Subject,Completed the Study,FG000,0.1333360062751785,0.9678909268552648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
725,NCT03158688,Withdrawal by Subject,Overall Study,FG000,0.1331873905371111,0.9678465159657148,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
726,NCT03735979,Lost to Follow-up,Overall Study,FG001,0.1331080105404463,0.9678021050761648,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
727,NCT04560998,Withdrawal by Subject,Overall Study,FG000,0.1330639997857241,0.9677576941866144,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
728,NCT05352815,Withdrawal by Subject,Overall Study,FG000,0.1329799409081053,0.9677132832970644,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
729,NCT03285594,At the Participant's Own Request,Overall Study,FG002,0.1329198295880259,0.9676688724075144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
730,NCT00910429,Adverse Event,Overall Study,FG000,0.1326473724298709,0.9676244615179642,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
731,NCT02963935,Adverse Event,Overall Study,FG000,0.1326241538086505,0.967580050628414,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
732,NCT01134393,Withdrawal by Subject,Overall Study,FG000,0.1325024691841666,0.967535639738864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
733,NCT02586155,Death,Overall Study,FG000,0.1324375881175,0.9674912288493138,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
734,NCT00972283,Unclassified,Main: Week 0 to 52 (NN1250-3582),FG000,0.1322488188142561,0.9674468179597636,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
735,NCT00221104,Withdrawal by Subject,Overall Study,FG001,0.1322179790664186,0.9674024070702136,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
736,NCT01046110,Unclassified,Overall Study,FG000,0.1319353719863195,0.9673579961806636,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
737,NCT02634333,Lost to Follow-up,Overall Study,FG000,0.1318403609942162,0.9673135852911132,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
738,NCT00696384,Withdrawal by Subject,Open Label Phase,FG000,0.1318303472791666,0.9672691744015632,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
739,NCT01102426,Patient Refusal,Overall Study,FG001,0.131732745435139,0.9672247635120133,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
740,NCT00056160,Adverse Event,Up to Unblinding (07 Jun 2005),FG000,0.1314358423847322,0.967180352622463,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
741,NCT03325556,Relapse,Double-blind Period,FG001,0.1314282737348709,0.967135941732913,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
742,NCT00689936,Adverse Event,Active Treatment Phase,FG000,0.1313442692606249,0.9670915308433627,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
743,NCT00915772,Adverse Event,Overall Study,FG000,0.1311495925382043,0.9670471199538128,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
744,NCT00424047,Withdrawal by Subject,Blinded Treatment (Up to 03 Aug 2005),FG000,0.1309700238956304,0.9670027090642626,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
745,NCT00306384,Voluntary withdrawal,Overall Study,FG001,0.130916415520843,0.9669582981747123,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
746,NCT00657150,Withdrawal by Subject,Overall Study,FG001,0.1309084109498115,0.9669138872851624,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
747,NCT05822830,Lost to Follow-up,Overall Study,FG000,0.1308618889915971,0.9668694763956122,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
748,NCT03785405,Death,Overall Study,FG000,0.1307863304993046,0.966825065506062,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
749,NCT00617123,Did Not Meet Protocol Eligibility,Referral Screening Period,FG001,0.1307381171710119,0.966780654616512,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
750,NCT00489541,No 9-Month Angiography Performed,9-Month Angiographic Follow-up,FG000,0.1306435537673367,0.966736243726962,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
751,NCT02916706,Withdrawal by Subject,Overall Study,FG000,0.1305471747883928,0.9666918328374118,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
752,NCT00064753,Lost to Follow-up,Overall Study,FG000,0.1305166578595138,0.9666474219478616,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
753,NCT02104817,Death,Overall Study,FG001,0.1304039621603571,0.9666030110583116,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
754,NCT01178073,Adverse Event,Overall Study,FG000,0.1302853480374008,0.9665586001687614,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
755,NCT03988634,Subject decision,Double-Blind,FG001,0.1300912417038688,0.9665141892792112,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
756,NCT01313676,Decision by Participant or Proxy,Overall Study,FG000,0.130022252070754,0.9664697783896612,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
757,NCT00797862,Adverse Event,Overall Study,FG000,0.1299751382671827,0.966425367500111,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
758,NCT00103506,Study closed by sponsor,Overall Study,FG001,0.129773656132996,0.9663809566105608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
759,NCT01854918,Withdrawal by Subject,All-IP Period (Years 2 and 3),FG001,0.1297433470870833,0.9663365457210108,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
760,NCT03683030,Enrolled but screen failures,Overall Study,FG000,0.1297051848444445,0.9662921348314608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
761,NCT03725202,Withdrew consent,Period 1 (Baseline - Week 52),FG002,0.1296972099900296,0.9662477239419106,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
762,NCT01370616,Withdrawal by Subject,Overall Study,FG001,0.1296085290512455,0.9662033130523604,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
763,NCT00359762,Subject Decision,Period II,FG004,0.129560555301012,0.9661589021628104,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
764,NCT00129545,Death,Overall Study,FG002,0.1294466220597717,0.9661144912732602,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
765,NCT01370616,Withdrawal by Subject,Overall Study,FG000,0.129397249830561,0.96607008038371,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
766,NCT00129545,Withdrawal by Subject,Overall Study,FG002,0.1293105911976884,0.96602566949416,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
767,NCT04157751,Withdrawal by Subject,Overall Study,FG001,0.1288511098314365,0.9659812586046098,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
768,NCT03354273,Issues With Performing Invasive Coronary Angiography (ICA),Overall Study,FG000,0.1288145565548889,0.9659368477150596,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
769,NCT00715624,Adverse Event,Overall Study,FG001,0.1287305769020834,0.9658924368255096,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
770,NCT00660179,Death,Overall Study,FG001,0.1285281909641964,0.9658480259359596,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
771,NCT03651765,Lost to Follow-up,Overall Study,FG000,0.1285187516047718,0.9658036150464092,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
772,NCT01623115,Last visit outside protocol visit window,Overall Study,FG001,0.1283384689201488,0.9657592041568592,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
773,NCT00614939,Withdrawal by Subject,Overall Study,FG001,0.1282628341100596,0.9657147932673092,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
774,NCT02541383,Death,Overall Study,FG005,0.1279252689479464,0.965670382377759,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
775,NCT02769481,Withdrawal by Subject,Overall Study,FG001,0.1278671988314583,0.965625971488209,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
776,NCT01046110,Unclassified,Overall Study,FG001,0.1277223701622619,0.9655815605986589,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
777,NCT00385697,Adverse Event,Double-blind Segment 2,FG001,0.1276806433200794,0.9655371497091086,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
778,NCT00159861,Death,Extension Study - up to 3 Years,FG001,0.1276030952391269,0.9654927388195584,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
779,NCT03211858,Other than specified above,Overall Study,FG000,0.1272316968918056,0.9654483279300085,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
780,NCT01131676,Adverse Event,Discontinuation From Treatment,FG002,0.1265596239732837,0.9654039170404584,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
781,NCT02307513,Lack of Efficacy,Placebo Controlled Phase (Weeks 0-12),FG000,0.1265043008925893,0.9653595061509082,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
782,NCT01406717,Withdrawal by Subject,Overall Study,FG000,0.1262969637949999,0.965315095261358,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
783,NCT01680341,Unclassified,Overall Study,FG000,0.1260693548927182,0.965270684371808,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
784,NCT00680186,Adverse Event,Overall Study,FG001,0.126039355255387,0.965226273482258,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
785,NCT01131676,Adverse Event,Discontinuation From Treatment,FG001,0.1259533072571528,0.9651818625927078,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
786,NCT00412984,Withdrawal by Subject,Overall Study,FG000,0.1259458561555457,0.9651374517031576,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
787,NCT00424047,Adverse Event,On Study at Time of Unblinding,FG000,0.1258794326706006,0.9650930408136076,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
788,NCT01272219,Adverse Event,Main Period: Week 0 to Week 56,FG004,0.1257755313087599,0.9650486299240574,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
789,NCT03952143,Withdrawal by Subject,Lead-In Period,FG000,0.1254687338567063,0.9650042190345072,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
790,NCT00695955,Lost to Follow-up,Cohort 1,FG000,0.1254429681580015,0.9649598081449572,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
791,NCT00838903,Withdrawal by Subject,Treatment Period (156 Weeks),FG002,0.1253632523297123,0.964915397255407,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
792,NCT03158688,Decision by sponsor,Overall Study,FG000,0.1253310185051379,0.9648709863658568,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
793,NCT01885208,Unclassified,Overall Study,FG001,0.1252819386500298,0.9648265754763068,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
794,NCT00249873,Withdrawal by Subject,Overall Study,FG000,0.125266352098373,0.9647821645867568,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
795,NCT00330759,Disease progression,Overall Study,FG000,0.1251837491612896,0.9647377536972066,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
796,NCT02513303,Withdrawal by Subject,Overall Study,FG000,0.1249787378786408,0.9646933428076564,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
797,NCT00283686,Lost to Follow-up,Overall Study,FG001,0.1246764180549259,0.9646489319181064,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
798,NCT00232180,Withdrawal by Subject,Double-blind (DB) Phase,FG001,0.1245629120730058,0.9646045210285562,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
799,NCT00614939,Study specific discontinuation criteris,Overall Study,FG001,0.1243556625261609,0.964560110139006,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
800,NCT03481634,Withdrawal by Subject,Overall Study,FG000,0.124009338800744,0.964515699249456,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
801,NCT00838903,Withdrawal by Subject,Treatment Period (156 Weeks),FG001,0.1237141669576784,0.9644712883599058,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
802,NCT01603615,Lost to Follow-up,Overall Study,FG000,0.1237004941924801,0.9644268774703556,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
803,NCT03180736,Death,Overall Study,FG001,0.1236942566362797,0.9643824665808056,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
804,NCT03180736,Physician Decision,Overall Study,FG001,0.123681648794613,0.9643380556912556,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
805,NCT00618956,Withdrawal by Subject,Overall Study,FG001,0.1235677103811011,0.9642936448017054,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
806,NCT01539083,Death,After Randomization (TP and VTP),FG002,0.1234504093441766,0.9642492339121552,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
807,NCT02963922,Adverse Event,Overall Study,FG000,0.1233910221888879,0.9642048230226052,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
808,NCT00707031,Adverse Event,Overall Study,FG001,0.123389877123383,0.964160412133055,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
809,NCT00707031,Adverse Event,Overall Study,FG000,0.123161723950764,0.9641160012435048,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
810,NCT03080883,Disease Progression,Overall Study,FG001,0.1227502656411904,0.9640715903539548,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
811,NCT02551874,Did not enter long-term study,Overall Study,FG001,0.1227501900415177,0.9640271794644046,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
812,NCT02195479,Lost to Follow-up,Overall Study,FG001,0.1226360971174007,0.9639827685748544,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
813,NCT00602472,Protocol Violation,Overall Study,FG001,0.1225989097083629,0.9639383576853044,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
814,NCT01624142,Study Closure,Overall Study,FG000,0.1225291677098898,0.9638939467957544,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
815,NCT01524289,Adverse Event,Overall Study,FG000,0.1223121830685902,0.963849535906204,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
816,NCT03057977,Withdrawal by Subject,Discontinuation From Treatment,FG001,0.1222922548182142,0.963805125016654,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
817,NCT01663402,Poor compliance to protocol,Overall Study,FG000,0.1221949430238394,0.963760714127104,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
818,NCT00662831,Adverse Event,Overall Study,FG000,0.1221901886210317,0.963716303237554,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
819,NCT01101035,Adverse Event,Overall Study,FG000,0.1221175391777381,0.9636718923480038,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
820,NCT00305604,Withdrawal by Subject,Overall Study,FG001,0.1219886443488592,0.9636274814584536,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
821,NCT02990338,Withdrawal by Subject,Overall Study,FG001,0.1219772701929762,0.9635830705689036,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
822,NCT02110901,Lost to Follow-up,Overall Study,FG000,0.1219650887559315,0.9635386596793534,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
823,NCT00622284,Withdrawal by Subject,Overall Study,FG000,0.1218944415822719,0.9634942487898032,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
824,NCT00660179,Death,Overall Study,FG000,0.121830271098254,0.9634498379002532,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
825,NCT01297920,Adverse Event,Overall Study,FG000,0.1218106970845239,0.963405427010703,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
826,NCT03211858,Other than specified above,Overall Study,FG001,0.1217424632617857,0.9633610161211528,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
827,NCT02634333,Death,Overall Study,FG000,0.1217011909627173,0.9633166052316028,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
828,NCT02076009,Withdrawal by Subject,Overall Study,FG001,0.1216098409348909,0.9632721943420528,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
829,NCT00740051,Lack of Efficacy,Overall Study,FG001,0.1215057515254761,0.9632277834525026,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
830,NCT00915772,Adverse Event,Overall Study,FG002,0.1214461639065584,0.9631833725629524,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
831,NCT00689936,Study Close Out,Active Treatment Phase,FG000,0.1213264448544047,0.9631389616734024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
832,NCT04929249,Lost to Follow-up,Overall Study,FG001,0.1212474935586309,0.9630945507838522,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
833,NCT01272219,Withdrawal criteria,Main Period: Week 0 to Week 56,FG005,0.1211708790231845,0.963050139894302,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
834,NCT04873934,Lost to Follow-up,Overall Study,FG001,0.1210935045495832,0.963005729004752,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
835,NCT00044213,Withdrawal by Subject,Overall Study,FG002,0.1210815255160218,0.9629613181152018,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
836,NCT03436693,Adverse Event,Overall Study,FG001,0.1208896574196726,0.9629169072256516,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
837,NCT03683030,Enrolled but no catheter inserted,Overall Study,FG000,0.1208517167669732,0.9628724963361016,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
838,NCT01676220,Personal Reason,Overall Study,FG001,0.1207959133750297,0.9628280854465516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
839,NCT04509674,"Adverse event, non-fatal event",Overall Study,FG001,0.1207676123282243,0.9627836745570014,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
840,NCT00571649,Adverse Event,Treatment Period,FG000,0.1206605198369445,0.9627392636674512,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
841,NCT00106704,Patient Received Glycemic Medication,Overall Study,FG001,0.1204559165909722,0.9626948527779012,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
842,NCT02252172,Withdrawal by Subject,Overall Study,FG001,0.1204421007452985,0.962650441888351,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
843,NCT01345019,Adverse Event,Open Label Treatment Phase,FG001,0.1202950506756548,0.9626060309988008,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
844,NCT00601250,Withdrawal by Subject,Overall Study,FG001,0.1202849580413798,0.9625616201092508,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
845,NCT03355664,Lost to Follow-up,Overall Study,FG000,0.1202191034114285,0.9625172092197006,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
846,NCT00103506,Study closed by sponsor,Overall Study,FG000,0.1198986458263392,0.9624727983301504,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
847,NCT00633893,Adverse Event,Overall Study,FG002,0.1197464918634028,0.9624283874406004,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
848,NCT03061214,Withdrawal by Subject,Overall Study,FG001,0.1197260073106845,0.9623839765510503,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
849,NCT03860935,Withdrawal of Consent,Overall Study,FG000,0.1196593287997223,0.9623395656615004,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
850,NCT04847557,Death,Overall Study,FG001,0.1196359531835614,0.96229515477195,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
851,NCT04657016,Withdrawal by Subject,Overall Study,FG001,0.1196186121322916,0.9622507438824,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
852,NCT00095238,Adverse Event,Overall Study,FG001,0.119164890077242,0.96220633299285,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
853,NCT02226120,Adverse Event,Overall Study,FG000,0.1190645161588576,0.9621619221032998,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
854,NCT04072835,Adverse Event,Overall Study,FG000,0.1189125238345734,0.9621175112137496,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
855,NCT00734474,Adverse Event,Overall Study,FG007,0.1188759554038293,0.9620731003241996,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
856,NCT04072835,Participant non-compliance / Protocol violation(s),Overall Study,FG000,0.1188548832283234,0.9620286894346494,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
857,NCT00554216,Withdrawal by Subject,Overall Study,FG000,0.1188184353644642,0.9619842785450992,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
858,NCT00554216,Lost to Follow-up,Overall Study,FG000,0.1186832423594641,0.9619398676555492,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
859,NCT01712789,Withdrawal by Subject,Overall Study,FG000,0.1186272252291963,0.961895456765999,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
860,NCT00532779,Adverse Event,Overall Study,FG000,0.1185547663639682,0.9618510458764488,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
861,NCT04740905,Withdrawal by Subject,Part 2 (Week 24 to Week 72),FG000,0.1183872017308631,0.9618066349868988,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
862,NCT03541174,Withdrawal by Subject,Part 2 Single-Blind,FG003,0.118371407611635,0.9617622240973488,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
863,NCT04844918,Adverse Event,Overall Study,FG000,0.118300139068125,0.9617178132077986,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
864,NCT05352815,Withdrawal by Subject,Overall Study,FG001,0.1180052275544543,0.9616734023182484,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
865,NCT01568866,Physician Decision,Overall Study,FG001,0.1179202282557631,0.9616289914286984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
866,NCT04058067,Withdrawal by Subject,Overall Study,FG000,0.1175070459931448,0.9615845805391482,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
867,NCT01830543,Adverse Event,Overall Study,FG001,0.1174779883840476,0.961540169649598,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
868,NCT00332488,Withdrawal by Subject,Initial Treatment Phase (Weeks 0 - 12),FG001,0.1173970983638501,0.961495758760048,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
869,NCT00332488,Physician Decision,Initial Treatment Phase (Weeks 0 - 12),FG002,0.1173754890922727,0.9614513478704978,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
870,NCT05413369,Withdrawal by Subject,Overall Study,FG000,0.1173340027129464,0.9614069369809476,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
871,NCT01620489,Withdrawal Criteria,Overall Study,FG000,0.1172098827640375,0.9613625260913976,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
872,NCT03066830,At the Participant's own Request,Overall Study,FG001,0.1171082860654464,0.9613181152018476,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
873,NCT00838903,Withdrawal by Subject,Treatment Period (156 Weeks),FG003,0.1170688901270932,0.9612737043122974,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
874,NCT00734474,Adverse Event,Overall Study,FG004,0.117036272519365,0.9612292934227472,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
875,NCT01620489,Adverse Event,Overall Study,FG000,0.1169810096783828,0.9611848825331972,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
876,NCT01176240,Withdrawal by Subject,Study 306B,FG000,0.1169352344404464,0.961140471643647,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
877,NCT01239797,Participants request to discontinue study treatment,Treated Participants,FG001,0.1169177760070237,0.9610960607540968,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
878,NCT00695955,Withdrawal by Subject,Cohort 2,FG000,0.1168327540057793,0.9610516498645468,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
879,NCT01475825,Did not enter OLC,Overall Study,FG000,0.1166890048173808,0.9610072389749966,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
880,NCT02207491,Adverse Event,Overall Study,FG000,0.1164221421159524,0.9609628280854464,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
881,NCT01830543,Adverse Event,Overall Study,FG002,0.1162418223827381,0.9609184171958964,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
882,NCT01023308,Withdrawal by Subject,Overall Study,FG000,0.1158960379274999,0.9608740063063465,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
883,NCT00482729,Lost to Follow-up,Overall Study,FG000,0.1158787943303472,0.9608295954167962,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
884,NCT01475825,Did not enter OLC,Overall Study,FG002,0.1158030424208928,0.960785184527246,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
885,NCT00479388,Adverse Event,Overall Study,FG000,0.1157560100250296,0.960740773637696,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
886,NCT04807400,Participant Decision,Overall Study,FG000,0.1157482587575496,0.9606963627481458,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
887,NCT00291330,Adverse Event,Overall Study,FG001,0.1157474337783738,0.9606519518585958,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
888,NCT01475825,Adverse Event,Overall Study,FG001,0.1156446042713095,0.9606075409690455,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
889,NCT01964326,Physician Decision,Overall Study,FG000,0.1156076405715775,0.9605631300794956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
890,NCT01345019,Death,Open Label Treatment Phase,FG000,0.1153963629913095,0.9605187191899454,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
891,NCT04807400,Withdrawal by Subject,Overall Study,FG002,0.1153639920077579,0.9604743083003952,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
892,NCT04847557,Withdrawal by Subject,Overall Study,FG001,0.1152744683788195,0.9604298974108452,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
893,NCT00689936,Death,Active Treatment Phase,FG000,0.1152734968518155,0.9603854865212952,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
894,NCT01442038,Participant Withdrew Consent,Overall Study,FG001,0.115239775771875,0.9603410756317448,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
895,NCT01841762,Adverse Event,Treatment Period,FG000,0.1151931108191666,0.9602966647421948,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
896,NCT00121667,Lack of Efficacy,Short Term (ST) + Long Term (LT) Period,FG000,0.1151185200466368,0.9602522538526448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
897,NCT00097981,Other,Overall Study,FG000,0.1150003586453968,0.9602078429630946,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
898,NCT02017171,Withdrawal by Subject,Overall Study,FG001,0.1149949177767856,0.9601634320735444,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
899,NCT00152971,Adverse Event,Treatment,FG001,0.1149297096689492,0.9601190211839944,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
900,NCT01508910,Withdrawal by Subject,Treatment,FG002,0.1149128545146726,0.9600746102944442,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
901,NCT01345019,Withdrawal by Subject,Open Label Treatment Phase,FG000,0.1149063610708333,0.960030199404894,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
902,NCT00734474,Adverse Event,Overall Study,FG002,0.1146797528312103,0.959985788515344,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
903,NCT01908699,Withdrawal by Subject,Overall Study,FG001,0.1144572865909913,0.9599413776257938,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
904,NCT01788358,Withdrawal by Subject,Overall Study,FG000,0.114381420236865,0.9598969667362436,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
905,NCT01087502,Adverse Event,Up to Interim Analysis (Week 12),FG000,0.1143220071912509,0.9598525558466936,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
906,NCT01968967,Withdrawal by Subject,Treatment Period,FG000,0.1143065477470834,0.9598081449571436,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
907,NCT01087502,Study site excluded from analysis,Up to Final Analysis (Week 52),FG001,0.114273535751251,0.9597637340675934,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
908,NCT01087502,Other reason not described above,Up to Final Analysis (Week 52),FG000,0.1142094033408343,0.9597193231780432,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
909,NCT03611582,Lost to Follow-up,Overall Study,FG000,0.1141876935149503,0.9596749122884932,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
910,NCT04592419,Withdrawal by Subject,Primary Study (Through Year 1),FG001,0.1141214259818749,0.959630501398943,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
911,NCT00249873,Withdrawal by Subject,Overall Study,FG001,0.1140171574332357,0.9595860905093928,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
912,NCT01297920,Adverse Event,Overall Study,FG002,0.1139469871880951,0.9595416796198428,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
913,NCT03199053,Withdrawal by Subject,ST Period,FG002,0.1138550327932043,0.9594972687302926,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
914,NCT02963922,Other,Overall Study,FG001,0.1137811977623899,0.9594528578407424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
915,NCT03087773,Lost to Follow-up,Overall Study,FG000,0.1137631704609325,0.9594084469511924,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
916,NCT02769481,Withdrawal by Subject,Overall Study,FG000,0.1137498426787499,0.9593640360616424,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
917,NCT02926950,Reason not Specified,Overall Study,FG000,0.1137148200672619,0.9593196251720922,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
918,NCT00819091,Adverse Event,Overall Study,FG001,0.1137025039758341,0.959275214282542,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
919,NCT01908816,Unsatisfactory therapeutic effect,Overall Study,FG001,0.1136123512308928,0.959230803392992,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
920,NCT00358215,Withdrawal by Subject,Overall Study,FG000,0.1135830967976191,0.9591863925034418,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
921,NCT00064753,Withdrawal by Subject,Overall Study,FG000,0.1135057810110219,0.9591419816138916,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
922,NCT02513303,Death,Overall Study,FG000,0.1134916160130952,0.9590975707243417,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
923,NCT02924064,Withdrawal by Subject,Overall Study,FG001,0.1131329331512508,0.9590531598347914,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
924,NCT02307513,Withdrawal by Subject,Active Treatment Phase (Weeks 13-64),FG001,0.112923324778115,0.9590087489452414,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
925,NCT05412004,Assigned Treatment by Mistake,Overall Study,FG001,0.1128649599994048,0.9589643380556911,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
926,NCT00954447,Other,Overall Study,FG000,0.1127212234930555,0.9589199271661412,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
927,NCT01313676,Decision by Participant or Proxy,Overall Study,FG001,0.1127161210546727,0.9588755162765912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
928,NCT01345019,Death,Open Label Treatment Phase,FG001,0.1125432075471727,0.9588311053870407,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
929,NCT00168805,Adverse Event,Treatment,FG002,0.1124700109370236,0.9587866944974908,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
930,NCT00954447,Withdrawal by Subject,Overall Study,FG001,0.112423941590496,0.9587422836079408,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
931,NCT04760626,Withdrawal by Subject,Overall Study,FG000,0.1123564926694344,0.9586978727183906,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
932,NCT00680186,Withdrawal by Subject,Overall Study,FG001,0.1123250360834135,0.9586534618288404,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
933,NCT02507687,Withdrawal by Subject,Overall Study,FG003,0.1122958826901091,0.9586090509392904,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
934,NCT00142584,Withdrawal by Subject,Overall Study,FG000,0.1122409179809777,0.9585646400497402,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
935,NCT02307513,Withdrawal by Subject,Active Treatment Phase (Weeks 13-64),FG000,0.1120809237825495,0.95852022916019,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
936,NCT02507687,Withdrawal by Subject,Overall Study,FG002,0.1119863676704662,0.95847581827064,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
937,NCT01524289,Withdrawal by Subject,Overall Study,FG000,0.1118136581099693,0.95843140738109,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
938,NCT03353350,Withdrawal by Subject,30-week Core Treatment Period,FG001,0.1117333118339683,0.9583869964915396,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
939,NCT00838916,Lost to Follow-up,Follow-up Period (8 Weeks),FG000,0.1117331470459821,0.9583425856019896,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
940,NCT00044213,Withdrawal by Subject,Overall Study,FG003,0.1116316523077084,0.9582981747124396,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
941,NCT03353350,Withdrawal by Subject,26-week Treatment Extension Period,FG003,0.111582174168492,0.9582537638228894,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
942,NCT03472040,Withdrawal by Subject,Overall Study,FG000,0.1115057944443452,0.9582093529333392,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
943,NCT00121667,Lack of Efficacy,Short Term (ST) + Long Term (LT) Period,FG001,0.111421272548859,0.9581649420437892,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
944,NCT01101035,Adverse Event,Overall Study,FG001,0.1113184702522619,0.958120531154239,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
945,NCT00094770,Lack of Efficacy,Year 1 ( Week 0 to Week 52),FG000,0.1113090988405059,0.9580761202646888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
946,NCT01704261,Withdrawal by Subject,Overall Study,FG001,0.1112758016143452,0.9580317093751388,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
947,NCT03066830,At the Participant's own Request,Overall Study,FG000,0.1112724737799901,0.9579872984855886,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
948,NCT03785405,Physician Decision,Overall Study,FG001,0.1110075752784523,0.9579428875960384,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
949,NCT02916706,Other,Overall Study,FG000,0.1109111084167865,0.9578984767064884,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
950,NCT00618774,Adverse Event,Overall Study,FG000,0.1108546350969056,0.9578540658169384,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
951,NCT03448419,Adverse Event,Overall Study,FG000,0.110684480485615,0.9578096549273882,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
952,NCT01557166,Adverse Event,Overall Study,FG000,0.1106517800716719,0.957765244037838,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
953,NCT01313676,Decision by Participant or Proxy,Overall Study,FG002,0.1106400083159028,0.957720833148288,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
954,NCT04873934,Subject decision,Overall Study,FG001,0.1105457474139483,0.9576764222587378,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
955,NCT00622284,Other reason (not specified),Overall Study,FG001,0.1104720306807737,0.9576320113691876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
956,NCT03481634,Withdrawal by Subject,Overall Study,FG002,0.1104625699934225,0.9575876004796376,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
957,NCT00622284,Withdrawal by Subject,Overall Study,FG001,0.110448950827113,0.9575431895900874,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
958,NCT02733185,Withdrawal by Subject,Overall Study,FG003,0.1102552092640476,0.9574987787005372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
959,NCT01557166,Withdrawn consent,Overall Study,FG001,0.1102325950573068,0.9574543678109873,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
960,NCT00789737,Withdrawal by Subject,Overall Study,FG001,0.1100902565577732,0.9574099569214372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
961,NCT01764386,Adverse Event,Uncontrolled Treatment Period (UTP),FG001,0.110055532133869,0.9573655460318872,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
962,NCT01499095,Received Rescue Therapy,Overall Study,FG001,0.1099747464079166,0.9573211351423369,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
963,NCT04184622,Lost to Follow-up,Primary Treatment Period,FG000,0.1097630304842261,0.9572767242527868,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
964,NCT01345019,Withdrawal by Subject,Open Label Treatment Phase,FG001,0.1097624264612103,0.9572323133632368,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
965,NCT00732641,Other,Overall Study,FG000,0.1096305170136607,0.9571879024736866,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
966,NCT01137812,Patient met glycemic withdrawal criteria,Overall Study,FG000,0.109373009355982,0.9571434915841364,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
967,NCT04509674,"Adverse event, non-fatal event",Overall Study,FG000,0.1092435744442857,0.9570990806945864,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
968,NCT02884206,Patient/guardian decision,LCZ696 Run-in Period,FG000,0.1091908392302381,0.9570546698050362,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
969,NCT00437645,Adverse Event,Overall Study,FG001,0.109176182396994,0.957010258915486,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
970,NCT00689611,Lost to Follow-up,Overall Study,FG001,0.1090923592170435,0.956965848025936,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
971,NCT00849017,Withdrawal by Subject,Treatment Period (156 Weeks),FG000,0.1090920770364582,0.956921437136386,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
972,NCT03651765,Non-Compliance with Study Drug,Overall Study,FG000,0.1090067367025009,0.9568770262468356,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
973,NCT00309244,Withdrawal by Subject,Overall Study,FG000,0.108861519912351,0.9568326153572856,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
974,NCT04740905,Withdrawal by Subject,Part 2 (Week 24 to Week 72),FG001,0.1088224828413095,0.9567882044677356,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
975,NCT03725202,Ongoing in Period 2,Period 2 (Week 52 - Week 104),FG007,0.1086559724122924,0.9567437935781854,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
976,NCT00781391,Death,Overall Study,FG000,0.1084377671058929,0.9566993826886352,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
977,NCT04509674,Other reason than listed,Overall Study,FG000,0.1083638534341666,0.9566549717990852,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
978,NCT01680341,Unclassified,Overall Study,FG001,0.1082581782050198,0.956610560909535,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
979,NCT00232180,Withdrawal by Subject,Double-blind (DB) Phase,FG000,0.1081656744501191,0.9565661500199848,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
980,NCT03888066,Adverse Event,Treatment Phase (Overall Study),FG000,0.1079197625628572,0.9565217391304348,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
981,NCT00849056,Withdrawal by Subject,Treatment Period (TP) (156 Weeks),FG001,0.1078339072562201,0.9564773282408848,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
982,NCT03888066,Not treated with Patiromer during Run-in,Run-in Phase,FG000,0.1077527478749406,0.9564329173513344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
983,NCT02505334,Lack of Efficacy,Main Treatment Period,FG001,0.107690729812509,0.9563885064617844,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
984,NCT04807400,Participant Decision,Overall Study,FG001,0.1076877525212401,0.9563440955722344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
985,NCT00695955,Adverse Event,Cohort 1,FG000,0.1073679031164484,0.9562996846826842,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
986,NCT00863681,Withdrawal by Subject,Overall Study,FG000,0.1073481484030258,0.956255273793134,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
987,NCT03332771,At the Participant's own request,Overall Study,FG001,0.1073018556695437,0.956210862903584,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
988,NCT00174785,Adverse Event,Overall Study,FG000,0.1071152271005258,0.9561664520140338,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
989,NCT00667719,Adverse Event,Overall Study,FG000,0.1070776211601289,0.9561220411244836,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
990,NCT00532779,Adverse Event,Overall Study,FG001,0.1067013459022519,0.9560776302349336,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
991,NCT01652716,Withdrawal by Subject,Overall Study,FG001,0.1066206347580357,0.9560332193453834,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
992,NCT03611582,other,Overall Study,FG000,0.1066114090135814,0.9559888084558332,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
993,NCT02867813,Lost to Follow-up,Overall Study,FG000,0.1064932019459921,0.9559443975662832,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
994,NCT02541383,Death,Overall Study,FG004,0.1063960301301883,0.9558999866767331,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
995,NCT02833948,were not scanned,Overall Study,FG000,0.1063410414529861,0.955855575787183,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
996,NCT02546323,Adverse Event,Overall Study,FG000,0.1062899379434311,0.9558111648976328,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
997,NCT00424047,Adverse Event,Blinded Treatment (Up to 03 Aug 2005),FG000,0.1061816140237995,0.9557667540080828,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
998,NCT00434954,Protocol Violation,Overall Study,FG000,0.1061796563186408,0.9557223431185328,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
999,NCT01435616,Withdrawal by Subject,Overall Study,FG000,0.1059804107846627,0.9556779322289826,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1000,NCT00689611,Lost to Follow-up,Overall Study,FG000,0.1058790723489483,0.9556335213394324,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1001,NCT01215253,Withdrawal by Subject,Overall Study,FG001,0.1058328787789286,0.9555891104498824,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1002,NCT04844918,Withdrawal by Subject,Overall Study,FG000,0.1057912655220238,0.9555446995603322,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1003,NCT00894387,Death,Overall Study,FG000,0.1056691697894562,0.955500288670782,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1004,NCT01396083,Unsatisfactory therapeutic effect,Overall Study,FG001,0.1055200074966766,0.955455877781232,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1005,NCT01313676,Decision by Participant or Proxy,Overall Study,FG003,0.1053790942262896,0.955411466891682,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1006,NCT04588259,Withdrawn before randomisation,Run-in period,FG001,0.1051432092588391,0.9553670560021316,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1007,NCT01272219,Withdrawal criteria,Main Period: Week 0 to Week 56,FG000,0.1049139151697321,0.9553226451125816,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1008,NCT02324569,Pretreatment Event/Adverse Event,Overall Study,FG001,0.1048887007771726,0.9552782342230316,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1009,NCT00614939,Study specific discontinuation criteris,Overall Study,FG000,0.1046930011100893,0.9552338233334814,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1010,NCT00305604,Lack of Efficacy,Overall Study,FG001,0.1046782102493155,0.9551894124439312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1011,NCT01167881,Other not defined above,Overall Study,FG001,0.1046738599106547,0.9551450015543812,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1012,NCT00996658,Adverse Event,Overall Study,FG001,0.1046337699130256,0.955100590664831,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1013,NCT00457002,Withdrawal by Subject,Overall Study,FG000,0.1045654949920536,0.9550561797752808,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1014,NCT00695955,Withdrawal by Subject,Cohort 1,FG000,0.1043578200035317,0.9550117688857308,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1015,NCT00996658,Lost to Follow-up,Overall Study,FG001,0.1043429284100494,0.9549673579961808,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1016,NCT04093752,Withdrawal by Subject,Overall Study,FG003,0.1041708644319344,0.9549229471066304,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1017,NCT03548987,other,Maintenance Period (Week 20 to Week 68),FG001,0.1041664096217612,0.9548785362170804,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1018,NCT02798471,Adverse Event,Overall Study,FG000,0.1040782168334821,0.9548341253275304,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1019,NCT01908699,Death,Overall Study,FG000,0.1040055340101885,0.9547897144379802,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1020,NCT01426425,Exited prior to EP study,Overall Study,FG000,0.1038506688808333,0.95474530354843,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1021,NCT03954834,Withdrawal by Subject,Overall Study,FG002,0.1036241143682142,0.95470089265888,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1022,NCT01128894,Adverse Event,Overall Study,FG001,0.1035769598714385,0.9546564817693298,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1023,NCT00894387,Death,Overall Study,FG001,0.10335813205375,0.9546120708797796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1024,NCT05662332,Withdrawal by Subject,Overall Study,FG000,0.1031961609145933,0.9545676599902296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1025,NCT02798471,Physician Decision,Overall Study,FG001,0.1030844046844344,0.9545232491006796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1026,NCT02073682,Cancer Progression,Overall Study,FG001,0.1029986352315178,0.9544788382111292,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1027,NCT05662332,Withdrawal by Subject,Overall Study,FG001,0.1029924958010516,0.9544344273215792,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1028,NCT00781391,Death,Overall Study,FG001,0.1027594373040475,0.9543900164320293,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1029,NCT04657016,Lost to Follow-up,Overall Study,FG001,0.1027038562851191,0.954345605542479,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1030,NCT00553787,Withdrawal by Subject,Overall Study,FG000,0.1026288380555059,0.954301194652929,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1031,NCT02136134,Withdrawal by Subject,Overall Study,FG001,0.1026175580406746,0.9542567837633787,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1032,NCT00571649,Adverse Event,Treatment Period,FG001,0.1025632066426975,0.9542123728738288,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1033,NCT00763815,Adverse Event,Overall Study,FG001,0.1025139445868154,0.9541679619842786,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1034,NCT01106651,Other,Overall Study,FG000,0.1024965867704364,0.9541235510947284,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1035,NCT01898923,Withdrawal by Subject,Overall Study,FG001,0.1022481458213194,0.9540791402051784,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1036,NCT00773747,Physician Decision,Overall Study,FG000,0.1022098337232241,0.9540347293156282,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1037,NCT05142722,Lost to Follow-up,Overall Study,FG001,0.1020310543531548,0.953990318426078,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1038,NCT00839527,Withdrawal by Subject,Treatment Period (TP) (156 Weeks),FG000,0.1019949985146824,0.953945907536528,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1039,NCT00283686,Lost to Follow-up,Overall Study,FG002,0.1017719050608531,0.953901496646978,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1040,NCT00689936,Miscellaneous,Active Treatment Phase,FG000,0.1014890593032143,0.9538570857574276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1041,NCT01406717,Withdrawal by Subject,Overall Study,FG001,0.101384014290863,0.9538126748678776,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1042,NCT02634333,Withdrawal by Subject,Overall Study,FG000,0.1013580395773014,0.9537682639783276,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1043,NCT01885208,Unclassified,Overall Study,FG000,0.1012107534495734,0.9537238530887774,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1044,NCT00781391,Death,Overall Study,FG002,0.1011731882554464,0.9536794421992272,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1045,NCT03064126,Withdrawal by Subject,Overall Study,FG001,0.1011515564310813,0.9536350313096772,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1046,NCT02073682,ID: Benefit/Risk Judgment,Overall Study,FG000,0.1009179348142941,0.953590620420127,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1047,NCT02414841,Death,Overall Study,FG000,0.1007988325979663,0.9535462095305768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1048,NCT03611582,other,Overall Study,FG001,0.1007318312522618,0.9535017986410268,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1049,NCT00403767,Consent withdrawn,Overall Study,FG001,0.1006738329846321,0.9534573877514768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1050,NCT00403767,Consent withdrawn,Overall Study,FG000,0.1006464926014882,0.9534129768619264,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1051,NCT00457002,Adverse Event,Overall Study,FG000,0.1005342532402597,0.9533685659723764,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1052,NCT00329238,Other reason (not specified),Overall Study,FG000,0.10046362276,0.9533241550828264,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1053,NCT00358215,Withdrawal by Subject,Overall Study,FG001,0.1004141573147619,0.9532797441932762,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1054,NCT03277105,Withdrawal by Subject,Overall Study,FG001,0.1002161016092459,0.953235333303726,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1055,NCT01098539,Adverse Event,Overall Study,FG000,0.1000916272618946,0.953190922414176,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1056,NCT00849017,Lost to Follow-up,Follow-up Period (8 Weeks),FG002,0.1000555846451586,0.9531465115246258,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1057,NCT01964326,Adverse Event,Overall Study,FG000,0.100054289156012,0.9531021006350756,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1058,NCT01178073,Adverse Event,Overall Study,FG001,0.1000086591130456,0.9530576897455256,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1059,NCT01968967,Withdrawal by Subject,Treatment Period,FG001,0.1000016330528868,0.9530132788559756,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1060,NCT01098539,Adverse Event,Overall Study,FG001,0.0999245243495137,0.9529688679664252,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1061,NCT01098539,Withdrawal by Subject,Overall Study,FG001,0.0998860243365375,0.9529244570768752,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1062,NCT03888066,Consent withdrawn by subject,Treatment Phase (Overall Study),FG001,0.0998122912916801,0.9528800461873252,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1063,NCT00695955,Adverse Event,Cohort 2,FG000,0.0997924389794048,0.952835635297775,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1064,NCT03277105,Withdrawal by Subject,Overall Study,FG000,0.0997554968029364,0.952791224408225,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1065,NCT00877929,Adverse Event,Overall Study,FG000,0.0997011075118055,0.9527468135186749,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1066,NCT00091949,Withdrawal by Subject,Overall Study,FG000,0.099519827508611,0.9527024026291246,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1067,NCT01674647,Adverse Event,Treatment Period,FG000,0.0995068129515477,0.9526579917395746,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1068,NCT01798706,Adverse Event,Overall Study,FG000,0.0993413834032243,0.9526135808500245,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1069,NCT02513303,Withdrawal by Subject,Overall Study,FG001,0.0990830355365574,0.9525691699604744,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1070,NCT02229396,Lost to Follow-up,Overall Study,FG002,0.0990738896426176,0.9525247590709242,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1071,NCT00004562,Lost to Follow-up,Overall Study,FG000,0.098940873023593,0.952480348181374,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1072,NCT03548935,Lost to Follow-up,Overall Study,FG000,0.0987511617307277,0.952435937291824,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1073,NCT00064753,Withdrawal by Subject,Overall Study,FG001,0.0987026217006547,0.952391526402274,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1074,NCT03338010,Withdrawal by Subject,Overall Study,FG000,0.098684396759732,0.9523471155127238,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1075,NCT04093752,Adverse Event,Overall Study,FG001,0.0985667478785019,0.9523027046231736,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1076,NCT00308139,Adverse Event,Overall Study,FG001,0.0985539732691468,0.9522582937336236,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1077,NCT00412984,Adverse Event,Overall Study,FG001,0.0985404336363988,0.9522138828440734,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1078,NCT01167881,Adverse Event,Overall Study,FG001,0.098503121914256,0.9521694719545232,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1079,NCT00827606,Other,Overall Study,FG001,0.0984875906500099,0.9521250610649732,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1080,NCT02926937,At the Participant's own Request,Overall Study,FG000,0.0983851375129365,0.952080650175423,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1081,NCT00654381,Adverse Event,Extension Stage,FG002,0.0982697052548711,0.9520362392858728,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1082,NCT01583218,Death,Overall Study,FG001,0.0981875035046429,0.9519918283963228,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1083,NCT04520256,Lost to Follow-up,Overall Study,FG023,0.0979942903034822,0.9519474175067728,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1084,NCT00225277,Withdrawal by Subject,Overall Study,FG000,0.0979812822599207,0.9519030066172224,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1085,NCT02733185,Lost to Follow-up,Overall Study,FG001,0.0977328854127876,0.9518585957276724,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1086,NCT03448419,Adverse Event,Overall Study,FG001,0.097597243266627,0.9518141848381224,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1087,NCT01272232,Adverse Event,Weeks 0-56,FG000,0.0975961611387004,0.9517697739485722,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1088,NCT03772041,Adverse Event,Overall Study,FG000,0.0975565383558332,0.951725363059022,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1089,NCT03448406,Adverse Event,Overall Study,FG001,0.0974849194652579,0.951680952169472,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1090,NCT00457002,Withdrawal by Subject,Overall Study,FG001,0.0974216715099702,0.9516365412799218,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1091,NCT03067441,Withdrawal by Subject,Overall Study,FG001,0.0973723564527137,0.9515921303903716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1092,NCT01102426,Physician Decision,Overall Study,FG000,0.0973659000173214,0.9515255140560466,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1093,NCT01102426,Adverse Events (unrelated to,Overall Study,FG000,0.0973659000173214,0.9515255140560466,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1094,NCT02558231,Withdrawal by Subject,Overall Study,FG000,0.0973116431387796,0.9514588977217212,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1095,NCT01335399,Administrative reasons by Sponsor,Treatment Period,FG001,0.0971427085917459,0.9514144868321712,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1096,NCT03888066,Randomization Criterion #1,Run-in Phase,FG000,0.0971292544636408,0.9513700759426212,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1097,NCT02558231,Lost to Follow-up,Overall Study,FG000,0.0970786556321129,0.951325665053071,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1098,NCT02558231,Physician Decision,Overall Study,FG000,0.0970388951769344,0.9512812541635208,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1099,NCT00954447,Other,Overall Study,FG001,0.097033389579752,0.9512368432739708,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1100,NCT01106014,Withdrawal by Subject,Overall Study,FG000,0.0969159781278473,0.9511924323844206,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1101,NCT01890122,Lack of Efficacy,Overall Study,FG001,0.0968742306377976,0.9511480214948704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1102,NCT00740051,Adverse Event,Overall Study,FG001,0.0968467266776289,0.9511036106053204,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1103,NCT02558296,Death,Completed the Study,FG000,0.0967298099131051,0.9510591997157704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1104,NCT00377676,Withdrawal by Subject,Overall Study,FG000,0.0966125483679167,0.95101478882622,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1105,NCT00915772,Lack of Efficacy,Overall Study,FG000,0.0966102275911111,0.95097037793667,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1106,NCT04760626,Withdrawal by Subject,Overall Study,FG001,0.0966070597422916,0.95092596704712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1107,NCT00740051,Other reason (not specified),Overall Study,FG000,0.096541057952748,0.95088155615757,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1108,NCT03861039,Adverse Event,Overall Study,FG002,0.0964423981610866,0.9508371452680198,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1109,NCT03199053,Lost to Follow-up,Non-treatment Follow-up Period,FG002,0.0962816906627679,0.9507927343784696,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1110,NCT01583218,Death,Overall Study,FG000,0.0962285023108929,0.9507483234889196,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1111,NCT00887978,Adverse Event,Overall Study,FG000,0.0961443986653274,0.9507039125993694,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1112,NCT01272219,Withdrawal criteria,Main Period: Week 0 to Week 56,FG003,0.0960534751761706,0.9506595017098192,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1113,NCT00159861,Death,Extension Study - up to 3 Years,FG000,0.096043059908631,0.9506150908202692,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1114,NCT00386607,Adverse Event,Core,FG000,0.0958488437093354,0.950570679930719,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1115,NCT00509262,Withdrawal by Subject,Overall Study,FG000,0.0958265373419048,0.9505262690411688,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1116,NCT01336023,Withdrawal Criteria,Week 0 to Week 26,FG001,0.0957629748958035,0.9504818581516188,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1117,NCT04509674,Other reason than listed,Overall Study,FG001,0.0956495721937103,0.9504374472620688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1118,NCT00960661,Withdrawal by Subject,Basal Insulin Optimization Phase (BIO),FG000,0.095613795250119,0.9503930363725186,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1119,NCT00311402,Withdrawal by Subject,Overall Study,FG001,0.0955880714306449,0.9503486254829684,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1120,NCT04157751,Withdrawal by Subject,Overall Study,FG000,0.0954922545692261,0.9503042145934184,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1121,NCT00518882,Adverse Event,"Double-Blind, Week 0-26",FG001,0.0953922345023114,0.9502598037038682,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1122,NCT05064735,Withdrawal by Subject,Overall Study,FG001,0.09514987409751,0.950215392814318,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1123,NCT00412984,Adverse Event,Overall Study,FG000,0.0951000327942559,0.950170981924768,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1124,NCT01663402,Poor compliance to protocol,Overall Study,FG001,0.0950718833563195,0.9501265710352178,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1125,NCT01106014,Adverse Event,Overall Study,FG001,0.094942826943512,0.9500821601456676,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1126,NCT00719563,Adverse Event,Overall Study,FG000,0.0947610381269642,0.9500377492561176,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1127,NCT00168818,Withdrawal by Subject,Overall Study,FG000,0.0946449257390178,0.9499933383665676,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1128,NCT01674647,Protocol Violation,Treatment Period,FG000,0.0946184116890774,0.9499489274770172,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1129,NCT00614380,Adverse Event,Overall Study,FG000,0.0945866155258036,0.9499045165874672,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1130,NCT01709513,Other,Overall Study,FG001,0.0945526572686499,0.9498601056979172,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1131,NCT02188784,Withdrawal by Subject,Overall Study,FG001,0.0944172736888689,0.949815694808367,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1132,NCT02324569,Pretreatment Event/Adverse Event,Overall Study,FG000,0.0944151546724107,0.9497712839188168,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1133,NCT00849017,Adverse Event,Treatment Period (156 Weeks),FG002,0.0944057520429563,0.9497268730292668,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1134,NCT01603615,Did not Receive Treatment,Overall Study,FG000,0.0942447994934409,0.9496824621397166,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1135,NCT01406717,Lost to Follow-up,Overall Study,FG000,0.094168994615506,0.9496380512501664,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1136,NCT01644188,Poor compliance to protocol,Overall Study,FG000,0.0941340278972619,0.9495936403606164,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1137,NCT00794573,Withdrawal by Subject,Overall Study,FG001,0.0941013841559225,0.9495492294710663,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1138,NCT00917267,Adverse Event,Overall Study,FG001,0.094081291396369,0.949504818581516,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1139,NCT00091949,Withdrawal by Subject,Overall Study,FG001,0.0940191655129563,0.949460407691966,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1140,NCT04093752,Adverse Event,Overall Study,FG002,0.0940091159650496,0.949415996802416,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1141,NCT01182441,Implant Attempt Unsuccessful,Overall Study,FG000,0.0938496711742261,0.949371585912866,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1142,NCT01087502,Adverse Event,Up to Interim Analysis (Week 12),FG001,0.0938039142373314,0.9493271750233158,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1143,NCT00641043,Adverse Event,Overall Study,FG000,0.0937916556489087,0.9492827641337656,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1144,NCT03814187,Lost to Follow-up,Overall Study,FG001,0.093726933925119,0.9492383532442156,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1145,NCT00457002,Adverse Event,Overall Study,FG001,0.0937173781989286,0.9491939423546654,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1146,NCT00332488,Adverse Event,Initial Treatment Phase (Weeks 0 - 12),FG000,0.0936785696446528,0.9491495314651152,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1147,NCT02585778,Adverse Event,Overall Study,FG000,0.0936583412478571,0.9491051205755652,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1148,NCT01272232,Withdrawal criteria,Weeks 0-56,FG002,0.0934931371067857,0.949060709686015,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1149,NCT01182441,Withdrawal by Subject,Overall Study,FG001,0.0933211044745535,0.9490162987964648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1150,NCT01087502,Protocol Violation,Up to Final Analysis (Week 52),FG000,0.0932594490897123,0.9489718879069148,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1151,NCT01594333,Death,Overall Study,FG000,0.0932428957539619,0.9489274770173648,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1152,NCT00143507,Death,Overall Study,FG000,0.0932109425616667,0.9488830661278146,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1153,NCT04660643,Lost to Follow-up,Open-label Lead-in Period (Week 0 - 36),FG000,0.0931357358904266,0.9488386552382644,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1154,NCT01087502,Other reason not described above,Up to Final Analysis (Week 52),FG001,0.0930913323015575,0.9487942443487144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1155,NCT00680186,Withdrawal by Subject,Overall Study,FG000,0.09303194869499,0.9487498334591642,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1156,NCT02990338,Withdrawal by Subject,Overall Study,FG000,0.0930050331830159,0.948705422569614,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1157,NCT02990338,Physician's decision,Overall Study,FG001,0.0930031829700595,0.9486388062352888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1158,NCT02990338,Treatment extension study,Overall Study,FG001,0.0930031829700595,0.9486388062352888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1159,NCT00494871,Adverse Event,Double-blind (DB) Treatment Period,FG000,0.0929687461264782,0.9485721899009636,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1160,NCT02798471,Subject withdrew consent,Overall Study,FG001,0.0929508732186607,0.9485277790114136,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1161,NCT01564537,Withdrawal by Subject,Overall Study,FG001,0.0929500091183928,0.9484833681218636,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1162,NCT00332488,Withdrawal by Subject,Transfer Treatment Phase (Weeks 12 - 24),FG002,0.0929369229893849,0.9484389572323134,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1163,NCT03332771,At the Participant's own request,Overall Study,FG003,0.0925251913723863,0.9483945463427632,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1164,NCT01375647,Withdrawal by Subject,Overall Study,FG002,0.0924515846085318,0.9483501354532132,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1165,NCT00121641,Lack of Efficacy,24-week Short-term Treatment Period,FG004,0.0923584741518948,0.948305724563663,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1166,NCT02924064,Withdrawal by Subject,Overall Study,FG000,0.0922314882792162,0.9482613136741128,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1167,NCT02733185,Withdrawal by Subject,Overall Study,FG002,0.0921933533776884,0.9482169027845628,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1168,NCT01908699,Adverse Event,Overall Study,FG000,0.0921910156348596,0.9481724918950126,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1169,NCT01908699,Physician Decision,Overall Study,FG001,0.0921535205427976,0.9481280810054624,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1170,NCT01908699,Physician Decision,Overall Study,FG000,0.0921349772541255,0.9480836701159124,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1171,NCT02733185,Lost to Follow-up,Overall Study,FG000,0.092080472414127,0.9480392592263625,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1172,NCT03037931,Withdrawal by Subject,Overall Study,FG000,0.0920649274432043,0.947994848336812,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1173,NCT02943785,Did not receive any study medication,Overall Study,FG001,0.0920417889305292,0.947950437447262,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1174,NCT00618956,Withdrawal by Subject,Overall Study,FG000,0.0918939866320734,0.947906026557712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1175,NCT00618956,Lost to Follow-up,Overall Study,FG001,0.0918767732762698,0.9478616156681618,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1176,NCT03551496,Withdrawal by Subject,Overall Study,FG000,0.0918003143971527,0.9478172047786118,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1177,NCT00954447,Lack of Efficacy,Overall Study,FG000,0.0917891894332341,0.9477727938890615,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1178,NCT01676220,Personal Reason,Overall Study,FG000,0.0917181140589583,0.9477283829995116,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1179,NCT01178073,Adverse Event,Overall Study,FG002,0.0916757098535687,0.9476839721099614,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1180,NCT00143598,Withdrawal by Subject,Overall Study,FG001,0.0914868104663034,0.9476395612204112,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1181,NCT00308139,Lost to Follow-up,Overall Study,FG000,0.0914660678620608,0.9475951503308612,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1182,NCT00121667,Lack of Efficacy,Short Term (ST) Period,FG003,0.0914525300841567,0.947550739441311,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1183,NCT01106651,Other,Overall Study,FG001,0.0914246597449405,0.9475063285517608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1184,NCT01239797,Other reasons,Treated Participants,FG001,0.0913365569624105,0.9474619176622108,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1185,NCT00514735,Withdrawal by Subject,Overall Study,FG000,0.0912575196601786,0.9474175067726608,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1186,NCT00461630,Death,Overall Study,FG000,0.0912365786537202,0.9473730958831106,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1187,NCT00095238,Subject Withdrew Consent,Overall Study,FG001,0.0912319217934524,0.9473286849935604,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1188,NCT00689936,Miscellaneous,Active Treatment Phase,FG002,0.0912143892394628,0.9472842741040104,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1189,NCT00839527,Adverse Event,Treatment Period (TP) (156 Weeks),FG001,0.0912101897635256,0.9472398632144602,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1190,NCT00311402,Withdrawal by Subject,Overall Study,FG000,0.0911878210538294,0.94719545232491,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1191,NCT00782340,Enrollment capped,Open Label Titration,FG000,0.0911862630511743,0.94715104143536,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1192,NCT00004562,Lost to Follow-up,Overall Study,FG001,0.0911215921336408,0.9471066305458098,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1193,NCT00839527,Lost to Follow-up,Follow-up Period (FUP) (8 Weeks),FG002,0.0910853814647656,0.9470622196562596,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1194,NCT00359762,Subject Decision,Period II,FG000,0.0910826848603075,0.9470178087667096,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1195,NCT05462756,Withdrawal by Subject,Treatment Period,FG001,0.0910236162134524,0.9469733978771596,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1196,NCT01239797,Other reasons,Treated Participants,FG000,0.0908074187952677,0.9469289869876094,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1197,NCT03061214,Withdrawal by Subject,Overall Study,FG000,0.0908073555979265,0.9468845760980592,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1198,NCT01507831,Consent withdrawn by participant,Overall Study,FG001,0.0907948123069147,0.9468401652085092,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1199,NCT00168805,Adverse Event,Treatment,FG001,0.0907742497228571,0.946795754318959,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1200,NCT00643201,Adverse Event,"Randomized, Completed 6 Months of Study",FG001,0.0906819435764583,0.9467513434294088,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1201,NCT00680186,Protocol Violation,Overall Study,FG000,0.0906540338129068,0.9467069325398588,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1202,NCT00660179,Death,Overall Study,FG002,0.0905226127307974,0.9466625216503086,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1203,NCT00536744,Adverse Event,Overall Study,FG000,0.09052143905625,0.9466181107607584,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1204,NCT03988634,Physician Decision,Double-Blind,FG000,0.0904888811878968,0.9465736998712084,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1205,NCT01535261,Withdrawal by Subject,Overall Study,FG000,0.0904080476204762,0.9465292889816584,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1206,NCT00553787,Lost to Follow-up,Overall Study,FG000,0.0904045880870508,0.9464848780921082,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1207,NCT04760626,Lost to Follow-up,Overall Study,FG001,0.0903899484928192,0.946440467202558,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1208,NCT00266695,Withdrawal by Subject,Overall Study,FG000,0.0903874036244543,0.946396056313008,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1209,NCT00602472,Withdrawal by Subject,Overall Study,FG001,0.0903512992769345,0.9463516454234578,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1210,NCT04560998,Withdrawal by Subject,Overall Study,FG001,0.0903306651617956,0.9463072345339076,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1211,NCT00494871,Adverse Event,Double-blind (DB) Treatment Period,FG001,0.0902205104832044,0.9462628236443577,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1212,NCT04657003,Withdrawal by Subject,Overall Study,FG000,0.0900829138748413,0.9462184127548074,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1213,NCT00168818,Withdrawal by Subject,Overall Study,FG001,0.0900670481315575,0.9461740018652574,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1214,NCT00781937,Withdrawal by Subject,Main Trial Period Through Week 56,FG001,0.0899604397355953,0.9461295909757071,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1215,NCT00143598,Death,Overall Study,FG000,0.0898726300988232,0.9460851800861572,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1216,NCT01968954,Withdrawal by Subject,Overall Study,FG001,0.0898254171883532,0.946040769196607,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1217,NCT02634333,Death,Overall Study,FG001,0.0897972727599702,0.9459963583070568,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1218,NCT00143507,Death,Overall Study,FG001,0.0897016762058632,0.9459519474175068,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1219,NCT00143598,Death,Overall Study,FG001,0.0896107178691208,0.9459075365279568,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1220,NCT00696384,Adverse Event,Open Label Phase,FG000,0.0895472984768651,0.9458631256384066,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1221,NCT01167881,Adverse Event,Overall Study,FG000,0.0894501848424107,0.9458187147488564,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1222,NCT00329238,Protocol Violation,Overall Study,FG001,0.0894329017600892,0.9457743038593064,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1223,NCT02867813,Lost to Follow-up,Overall Study,FG001,0.0893770366762897,0.9457298929697562,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1224,NCT02851407,Disease relapse,Overall Study,FG000,0.0892878473525,0.945685482080206,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1225,NCT02033889,Withdrawal by Subject,Overall Study,FG000,0.0890737514118933,0.945641071190656,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1226,NCT02884206,Patient/guardian decision,Double-Blind Period,FG002,0.0890726742886507,0.9455966603011058,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1227,NCT00168805,Adverse Event,Treatment,FG000,0.0890368656888194,0.9455522494115556,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1228,NCT03110562,Withdrawal by Subject,Crossover Period,FG002,0.089007642850248,0.9455078385220056,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1229,NCT01499095,Received Rescue Therapy,Overall Study,FG000,0.0887369769226388,0.9454634276324556,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1230,NCT03110562,Lost to Follow-up,Initial Treatment Period,FG001,0.0886755489363988,0.9454190167429054,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1231,NCT00121641,Subject Withdrew Consent,48-month Short Term + Long Term Period,FG001,0.0885917606290774,0.9453746058533552,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1232,NCT01621178,Withdrawal by Subject,Overall Study,FG002,0.0884383390017642,0.9453301949638052,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1233,NCT01539083,Progressive Disease,Before Randomization (VCD Induction),FG000,0.0884119825741651,0.945285784074255,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1234,NCT03180736,Withdrawal by Subject,Overall Study,FG000,0.0884119675912229,0.9452413731847048,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1235,NCT02733185,Lost to Follow-up,Overall Study,FG002,0.0883700409907539,0.9451969622951548,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1236,NCT00545584,Only one reason for discontinuation,Overall Study,FG000,0.0883581483243849,0.9451525514056046,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1237,NCT00890409,Lost to Follow-up,Overall Study,FG001,0.0883296981251983,0.9451081405160544,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1238,NCT00121667,Lack of Efficacy,Short Term (ST) + Long Term (LT) Period,FG002,0.0882650854742162,0.9450637296265044,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1239,NCT00968708,Adverse Event,Overall Study,FG000,0.0881319303315773,0.9450193187369544,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1240,NCT00359762,Adverse Event,Period II,FG004,0.0879799102423908,0.9449749078474042,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1241,NCT00113087,Death or Transplant,Overall Study,FG001,0.0879236829080555,0.944930496957854,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1242,NCT00996281,Adverse Event,Overall Study,FG001,0.0878856935668589,0.944886086068304,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1243,NCT00662831,Adverse Event,Overall Study,FG001,0.0878764546990476,0.9448416751787538,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1244,NCT02561078,Withdrawal by Subject,Overall Study,FG000,0.0878742380538873,0.9447972642892036,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1245,NCT03242252,At the Participant's own Request,Overall Study,FG000,0.0878718596225595,0.9447528533996536,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1246,NCT00044213,Withdrawal by Subject,Overall Study,FG001,0.0877065048730158,0.9447084425101034,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1247,NCT04929249,Subject decision,Overall Study,FG001,0.0876794950243947,0.9446418261757784,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1248,NCT04929249,Withdrew consent,Overall Study,FG001,0.0876794950243947,0.9446418261757784,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1249,NCT01713530,Withdrawal criteria,Overall Study,FG001,0.0876768478648981,0.9445752098414532,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1250,NCT00849017,Withdrawal by Subject,Treatment Period (156 Weeks),FG001,0.0876001794070733,0.9445307989519032,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1251,NCT01631227,withdrawn consent,Overall Study,FG000,0.087424810088869,0.9444863880623529,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1252,NCT00961636,Adverse Event,Overall Study,FG001,0.0874144696626784,0.9444419771728028,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1253,NCT00545584,Only one reason for discontinuation,Overall Study,FG001,0.0873842224580754,0.9443975662832528,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1254,NCT01704261,Withdrawal by Subject,Overall Study,FG000,0.0872358731600596,0.9443531553937026,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1255,NCT00482729,Withdrawal by Subject,Overall Study,FG001,0.0872339442386309,0.9443087445041524,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1256,NCT00827606,LDL below 2.59 mmol/L,Overall Study,FG001,0.0871541597450766,0.9442643336146024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1257,NCT02551874,Did not enter long-term study,Overall Study,FG000,0.0871231436972207,0.9442199227250522,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1258,NCT00489736,Adverse Event,Overall Study,FG000,0.0870668114318055,0.944175511835502,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1259,NCT00094302,Withdrawal by Subject,Overall Study,FG001,0.087018794459246,0.944131100945952,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1260,NCT01033071,Adverse Event,Overall Study,FG001,0.0869879297242658,0.9440866900564018,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1261,NCT01885559,Less than full participation,Overall Study,FG001,0.0869680324144741,0.9440422791668516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1262,NCT01102426,Death (non-related to the study,Overall Study,FG001,0.0869623755769444,0.9439756628325264,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1263,NCT01102426,Adverse Events (treatment-related),Overall Study,FG001,0.0869623755769444,0.9439756628325264,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1264,NCT00358215,Adverse Event,Overall Study,FG000,0.0869293577099503,0.9439090464982014,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1265,NCT03078478,Withdrawal by Subject,Maintenance Period 1 (36 Weeks),FG000,0.0868599227638294,0.9438646356086512,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1266,NCT01306214,Withdrawal by Subject,Overall Study,FG000,0.0868302311666937,0.9438202247191012,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1267,NCT03078478,Withdrawal by Subject,Maintenance Period 1 (36 Weeks),FG001,0.0866850831554961,0.943775813829551,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1268,NCT01239797,Administrative reason by sponsor,Treated Participants,FG000,0.0866613404275197,0.9437314029400008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1269,NCT00318461,Lack of Efficacy,"Open-Label Extension, 18 Months",FG004,0.0866436921884341,0.9436869920504508,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1270,NCT01167881,"Patient refusal to cont., not due to AE",Overall Study,FG000,0.0865946195877679,0.9436425811609006,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1271,NCT04429503,Withdrawal by Subject,Extension Phase (Wk 96 to Wk 156),FG004,0.0865609205503273,0.9435981702713504,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1272,NCT00286429,Lack of Efficacy,Overall Study,FG001,0.0864918045084424,0.9435537593818004,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1273,NCT00849056,Lost to Follow-up,Follow-up Period (FUP) (8 Weeks),FG000,0.0864796072850891,0.9435093484922504,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1274,NCT00660907,Adverse Event,Overall Study,FG000,0.0864665303880059,0.9434649376027002,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1275,NCT03548987,Run-in failure,Run-in Period (Week 0 to Week 20),FG000,0.0864646325151388,0.94342052671315,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1276,NCT02715258,Lost to Follow-up,Overall Study,FG000,0.0863952897744642,0.9433761158236,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1277,NCT04184622,Withdrawal by Subject,Primary Treatment Period,FG002,0.0863804187796725,0.9433317049340498,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1278,NCT03917472,Withdrawal by Subject,Overall Study,FG000,0.0863754834915673,0.9432872940444996,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1279,NCT00797862,Adverse Event,Overall Study,FG002,0.0863689467019046,0.9432428831549496,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1280,NCT00661999,Withdrawal by Subject,Overall Study,FG000,0.0861888954347436,0.9431984722653994,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1281,NCT00093015,Withdrawal by Subject,Overall Study,FG000,0.0861381950102381,0.9431540613758492,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1282,NCT01003184,Adverse Event,Overall Study,FG000,0.0861335343263392,0.9431096504862992,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1283,NCT01644175,Adverse Event,Overall Study,FG001,0.0861154314832909,0.9430652395967491,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1284,NCT00622336,Death,Treatment Phase,FG000,0.0859298864568029,0.943020828707199,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1285,NCT04844918,Adverse Event,Overall Study,FG002,0.0858741341672023,0.9429764178176488,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1286,NCT00890409,Lost to Follow-up,Overall Study,FG000,0.085805103749484,0.9429320069280988,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1287,NCT01296412,Adverse Event,Overall Study,FG001,0.0857550321821567,0.9428875960385488,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1288,NCT01475825,Withdrawal by Subject,Overall Study,FG002,0.0857436762607242,0.9428431851489986,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1289,NCT04660643,Withdrawal by Subject,Double-blind Study Period (Week 36 - 92),FG002,0.0856845407580258,0.9427987742594484,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1290,NCT01475825,Did not enter OLC,Overall Study,FG003,0.0856266401026291,0.9427543633698984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1291,NCT00532779,Withdrawal by Subject,Overall Study,FG002,0.0855418164033423,0.9427099524803482,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1292,NCT00838916,Withdrawal by Subject,Treatment Period (156 Weeks),FG001,0.0855178051813293,0.942665541590798,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1293,NCT01475825,Did not enter OLC,Overall Study,FG001,0.085509572911379,0.942621130701248,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1294,NCT01313676,Adverse Event,Overall Study,FG000,0.0854751107004762,0.942576719811698,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1295,NCT04520256,Lost to Follow-up,Overall Study,FG020,0.0854748436746328,0.9425323089221476,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1296,NCT03888066,Adverse Event,Treatment Phase (Overall Study),FG001,0.0854737533331168,0.9424878980325976,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1297,NCT01475825,Adverse Event,Overall Study,FG003,0.0853462724069147,0.9424434871430476,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1298,NCT01898923,Lack of Efficacy,Overall Study,FG001,0.0853286937435118,0.9423990762534974,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1299,NCT00863681,Adverse Event,Overall Study,FG001,0.0853262933246725,0.9423546653639472,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1300,NCT04592419,Adverse Event,Primary Study (Through Year 1),FG000,0.0852613214553769,0.9423102544743972,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1301,NCT00432276,Hyperglycemic Rescue,Overall Study,FG000,0.0851597943634126,0.942265843584847,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1302,NCT00121641,Lack of Efficacy,48-month Short Term + Long Term Period,FG001,0.085112829506994,0.9422214326952968,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1303,NCT02993406,Withdrawal by Subject,Overall Study,FG001,0.0850952180574999,0.9421770218057468,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1304,NCT03785405,Death,Overall Study,FG001,0.0850828894888986,0.9421326109161966,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1305,NCT03888066,Consent withdrawn by subject,Treatment Phase (Overall Study),FG000,0.0850640336305572,0.9420882000266464,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1306,NCT04184622,Withdrawal by Subject,Safety Follow-up Period,FG000,0.0849020837769048,0.9420437891370964,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1307,NCT00790205,Withdrawal by Subject,Overall Study,FG001,0.0848953380134027,0.9419993782475464,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1308,NCT01854918,Withdrawal by Subject,All-IP Period (Years 2 and 3),FG000,0.0848236165498512,0.9419549673579962,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1309,NCT03448406,Adverse Event,Overall Study,FG000,0.0848210570658035,0.941910556468446,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1310,NCT00482729,Withdrawal by Subject,Overall Study,FG000,0.0848207527870238,0.941866145578896,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1311,NCT03242018,Adverse Event,Overall Study,FG001,0.0848102758680356,0.9418217346893458,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1312,NCT03785405,Guardian decision,Overall Study,FG000,0.0847806927228867,0.9417773237997956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1313,NCT00283686,Lost to Follow-up,Overall Study,FG000,0.0847445110850694,0.9417329129102456,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1314,NCT00739674,Lost to Follow-up,Overall Study,FG000,0.084736356565873,0.9416885020206954,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1315,NCT03242018,Adverse Event,Overall Study,FG000,0.084653429959107,0.9416440911311452,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1316,NCT00915772,Refused to continue trial medication,Overall Study,FG001,0.0845650752320039,0.9415996802415952,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1317,NCT01755156,Withdrawal by Subject,Phase A (Weeks 0-24),FG001,0.0845458323292261,0.9415552693520453,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1318,NCT05064735,Withdrawal by Subject,Overall Study,FG000,0.0844347421845435,0.941510858462495,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1319,NCT01830543,Subject Decision,Overall Study,FG002,0.0844236743502961,0.9414664475729448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1320,NCT05064735,Site Closure,Overall Study,FG000,0.0844123532892756,0.9414220366833947,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1321,NCT00461630,Death,Overall Study,FG001,0.0842980820337797,0.9413776257938448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1322,NCT01717313,Withdrawal by Subject,Phase A (Weeks 0 to 24),FG000,0.0842913002252678,0.9413332149042946,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1323,NCT00567255,Lost to Follow-up,Overall Study,FG000,0.0842746117581944,0.9412888040147444,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1324,NCT05064735,Lost to Follow-up,Overall Study,FG000,0.0842151283474503,0.9412443931251944,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1325,NCT03136484,Withdrawal by Subject,Overall Study,FG000,0.0842014794284425,0.9411999822356442,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1326,NCT01106014,Withdrawal by Subject,Overall Study,FG001,0.0841638555335317,0.941155571346094,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1327,NCT03444324,Lost to Follow-up,Overall Study,FG000,0.0841516050116863,0.941111160456544,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1328,NCT00095238,Subject Withdrew Consent,Overall Study,FG000,0.0841418418871131,0.941066749566994,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1329,NCT00614380,Non compliant with the protocol,Overall Study,FG000,0.0840129966741368,0.9410223386774436,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1330,NCT02546323,Met Withdrawal Criteria,Overall Study,FG001,0.0839663363549702,0.9409779277878936,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1331,NCT05024032,Withdrawal by Subject,Overall Study,FG002,0.0838528844139781,0.9409335168983436,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1332,NCT03495102,Withdrawal by Subject,Overall Study,FG001,0.0837997276217559,0.9408891060087934,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1333,NCT00482729,Lost to Follow-up,Overall Study,FG001,0.0837708963736183,0.9408446951192432,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1334,NCT00660907,Withdrawal by Subject,Overall Study,FG001,0.0837419297495535,0.9408002842296932,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1335,NCT01310777,Adverse Event,Overall Study,FG000,0.0836424540250198,0.940755873340143,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1336,NCT01621178,Withdrawal by Subject,Overall Study,FG001,0.0835199347069146,0.9407114624505928,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1337,NCT03814187,Lost to Follow-up,Overall Study,FG000,0.0834638238988789,0.9406670515610428,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1338,NCT00715624,Withdrawal by Subject,Overall Study,FG001,0.0834052617531052,0.9406226406714928,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1339,NCT00121641,Lack of Efficacy,48-month Short Term + Long Term Period,FG003,0.0833446236004166,0.9405782297819424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1340,NCT00121641,Lack of Efficacy,48-month Short Term + Long Term Period,FG000,0.0832631415249999,0.9405338188923924,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1341,NCT02866175,Withdrawal by Subject,Overall Study,FG000,0.083120374126617,0.9404894080028424,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1342,NCT01176240,Protocol Violation,Study 306B,FG001,0.0830157371310849,0.9404449971132922,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1343,NCT00232180,Adverse Event,Double-blind (DB) Phase,FG001,0.0829888822059325,0.940400586223742,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1344,NCT00308737,Adverse Event,Overall Study,FG000,0.0829799396278472,0.940356175334192,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1345,NCT01176240,Lack of Efficacy,Study 306B,FG001,0.0829155482123349,0.9403117644446418,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1346,NCT00601250,Adverse Event,Overall Study,FG001,0.0828917886835118,0.9402673535550916,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1347,NCT00567255,Withdrawal by Subject,Overall Study,FG000,0.0828859385040376,0.9402229426655416,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1348,NCT03439254,Adverse Event,Double-blind Phase (18 Months),FG002,0.0827736824579879,0.9401785317759914,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1349,NCT02030600,Protocol Violation,Treatment Period 1,FG000,0.0827561290619146,0.9401341208864412,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1350,NCT00601250,Other incl. lack of efficacy,Overall Study,FG001,0.0827342036480951,0.9400897099968912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1351,NCT01791153,Adverse Event,Part 1: Blinded Period,FG000,0.0825282299228457,0.9400452991073412,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1352,NCT00142584,Lost to Follow-up,Overall Study,FG000,0.0824323250009524,0.940000888217791,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1353,NCT00121667,Subject Withdrew Consent,Short Term (ST) + Long Term (LT) Period,FG000,0.0823878175045734,0.9399564773282408,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1354,NCT02427802,protocol specific treatment unrelated,Overall Study,FG000,0.0823589458099686,0.9399120664386909,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1355,NCT00143598,Withdrawal by Subject,Overall Study,FG000,0.0822806434635614,0.9398676555491406,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1356,NCT04588259,Withdrawal by Subject,Treatment period,FG001,0.0822166370100179,0.9398232446595906,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1357,NCT00456521,Withdrawal by Subject,Overall Study,FG000,0.0821862203672717,0.9397788337700403,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1358,NCT01177813,Withdrawal by Subject,Overall Study,FG000,0.0821340941919444,0.9397344228804902,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1359,NCT01177813,Lost to Follow-up,Overall Study,FG000,0.0821098663346527,0.9396900119909402,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1360,NCT01272232,Withdrawal criteria,Weeks 0-56,FG000,0.0820449397761507,0.93964560110139,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1361,NCT01652729,Withdrawal by Subject,Overall Study,FG000,0.0819911518728571,0.93960119021184,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1362,NCT00225277,Adverse Event,Overall Study,FG001,0.081865695447938,0.93955677932229,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1363,NCT02229396,Other,Overall Study,FG001,0.0818410072110416,0.9395123684327396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1364,NCT04588259,Withdrawal by Subject,Treatment period,FG000,0.0818200915207917,0.9394679575431896,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1365,NCT00225277,Withdrawal by Subject,Overall Study,FG001,0.0817846267000213,0.9394235466536396,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1366,NCT00849017,Lost to Follow-up,Follow-up Period (8 Weeks),FG000,0.0817581952637202,0.9393791357640894,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1367,NCT01306214,Withdrawal by Subject,Overall Study,FG001,0.0817439703934523,0.9393347248745392,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1368,NCT03332771,At the Participant's own request,Overall Study,FG000,0.0817241631232836,0.9392903139849892,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1369,NCT02307513,Withdrawal by Subject,Placebo Controlled Phase (Weeks 0-12),FG000,0.0816998266335714,0.939245903095439,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1370,NCT01313676,Adverse Event,Overall Study,FG002,0.0816600418742261,0.9392014922058888,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1371,NCT03888066,Physician Decision,Treatment Phase (Overall Study),FG000,0.0816023818023528,0.9391570813163388,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1372,NCT00271817,Adverse Event,Part 1,FG000,0.0815337385010829,0.9391126704267888,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1373,NCT03259789,Lost to Follow-up,Overall Study,FG001,0.0815155957468551,0.9390682595372384,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1374,NCT01194830,Other Reason,Overall Study,FG000,0.081477322506498,0.9390238486476884,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1375,NCT03259789,Withdrawal by Subject,Overall Study,FG000,0.0814745675224107,0.9389794377581384,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1376,NCT00849056,Adverse Event,Treatment Period (TP) (156 Weeks),FG000,0.081251965917371,0.9389350268685882,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1377,NCT00507416,Progressive Disease,Overall Study,FG000,0.0812245637337103,0.938890615979038,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1378,NCT01131676,"Refusal to continue, not due to AE",Discontinuation From Treatment,FG000,0.0812238808185317,0.938846205089488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1379,NCT03689374,Withdrawal by Subject,Treatment Period (Week 0 to 52),FG002,0.0811875009331646,0.9388017941999378,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1380,NCT00614939,Withdrawal by Subject,Overall Study,FG000,0.0811721779923413,0.9387573833103876,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1381,NCT02558296,Withdrawal by Subject,Completed the Study,FG001,0.0810235218502579,0.9387129724208376,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1382,NCT02866175,Death,Overall Study,FG000,0.0810104956892062,0.9386685615312876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1383,NCT00696384,Lost to Follow-up,Open Label Phase,FG000,0.0809677826475595,0.9386241506417372,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1384,NCT00168805,Other,Overall Study,FG000,0.0809663371559921,0.9385797397521872,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1385,NCT00159861,Reason Unspecified,Extension Study - up to 3 Years,FG001,0.0808879873787202,0.9385353288626372,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1386,NCT01001572,Condition no longer requires study drug,Single-Blind Valsartan 160 mg,FG000,0.0808673493248412,0.938490917973087,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1387,NCT00622336,Lack of therapeutic effect,Treatment Phase,FG000,0.0808474549268651,0.9384465070835368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1388,NCT04964544,Withdrawal by Subject,Overall Study,FG000,0.0808451955461012,0.9384020961939868,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1389,NCT02414841,Death,Overall Study,FG001,0.0808395719168055,0.9383576853044366,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1390,NCT00549302,Adverse Event,Double-Blind,FG001,0.0808378208136607,0.9383132744148864,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1391,NCT01115855,Other,Overall Study,FG000,0.0808191680089385,0.9382688635253364,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1392,NCT00970489,Death/Withdrew/Criteria Violation,Overall Study,FG000,0.0808044127053372,0.9382244526357862,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1393,NCT00554216,Lost to Follow-up,Overall Study,FG002,0.0807676028210506,0.938180041746236,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1394,NCT01451398,Withdrawal by Subject,Overall Study,FG001,0.080752612993125,0.938135630856686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1395,NCT00434954,Protocol Violation,Overall Study,FG001,0.0807284241036011,0.938091219967136,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1396,NCT00622336,Withdrawal by Subject,Treatment Phase,FG000,0.0807211078399901,0.938046809077586,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1397,NCT01594333,Death,Overall Study,FG001,0.0807136184307737,0.9380023981880355,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1398,NCT02023879,Other than specified above,Extension Open Label Treatment,FG001,0.0806778407206348,0.9379579872984856,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1399,NCT01076075,other,Overall Study,FG000,0.0806724889175991,0.9379135764089356,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1400,NCT01076075,Withdrawal by Subject,Overall Study,FG001,0.0806603028913491,0.9378691655193854,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1401,NCT02023879,Adverse Event,Extension Open Label Treatment,FG001,0.0806317576801785,0.9378247546298352,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1402,NCT02558296,Lost to Follow-up,Completed the Study,FG000,0.0805009893941964,0.9377803437402852,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1403,NCT04880850,Withdrawal by Subject,Overall Study,FG001,0.080490822078115,0.937735932850735,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1404,NCT00179647,Death,Overall Study,FG000,0.0804637763412599,0.9376915219611848,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1405,NCT00286429,Lack of Efficacy,Overall Study,FG002,0.0803452015934226,0.9376471110716348,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1406,NCT00395746,Lack of Efficacy,Overall Study,FG002,0.0803217055516071,0.9376027001820848,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1407,NCT00283686,Lost to Follow-up,Overall Study,FG003,0.0802669497206845,0.9375582892925344,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1408,NCT00168818,Withdrawal by Subject,Overall Study,FG002,0.0802148767584325,0.9375138784029844,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1409,NCT04915729,Lost to Follow-up,Overall Study,FG000,0.0801950981327182,0.9374694675134344,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1410,NCT00121641,Lack of Efficacy,48-month Short Term + Long Term Period,FG004,0.0800759340622914,0.9374250566238842,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1411,NCT01313676,Adverse Event,Overall Study,FG001,0.0800028151640475,0.937380645734334,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1412,NCT00121641,Subject Withdrew Consent,48-month Short Term + Long Term Period,FG000,0.07999889823247,0.937336234844784,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1413,NCT03917472,Lost to Follow-up,Overall Study,FG000,0.0799622527094642,0.9372918239552338,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1414,NCT00121641,Lack of Efficacy,24-week Short-term Treatment Period,FG003,0.079961394996101,0.9372474130656836,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1415,NCT03472040,Lab Abnormality or Adverse Event (AE),Overall Study,FG000,0.0799525570931944,0.9372030021761336,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1416,NCT00368277,Adverse Event,Overall Study,FG001,0.0799126475789202,0.9371585912865836,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1417,NCT04157751,Other reason not stated above,Overall Study,FG001,0.0798480101618947,0.9371141803970332,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1418,NCT00982644,Protocol Violation,Main: Week 0 to 52 (NN1250-3579),FG000,0.0798303852756548,0.9370697695074832,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1419,NCT00657150,Withdrawal by Subject,Treatment,FG000,0.0797533515016765,0.9370253586179332,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1420,NCT00300274,Death,Overall Study,FG000,0.0797239644140377,0.936980947728383,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1421,NCT04157751,Other reason not stated above,Overall Study,FG000,0.0797231578177281,0.9369365368388328,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1422,NCT01999218,Withdrawal by Subject,Overall Study,FG002,0.0796632584080077,0.9368921259492828,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1423,NCT02585713,Withdrew prior to treatment,Overall Study,FG001,0.0796126886038988,0.9368477150597326,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1424,NCT00286468,Hyperglycemic Rescue,Overall Study,FG002,0.0795922816296726,0.9368033041701824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1425,NCT00056160,Other,Extended Follow-up Cutoff (23 Jul 2008),FG000,0.0795747755312614,0.9367588932806324,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1426,NCT01485614,Withdrawal by Parent/Guardian,Weeks 0-20,FG000,0.0795534989112203,0.9367144823910823,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1427,NCT02468232,Subject/Guardian decision,OLE Part of Study,FG003,0.0795508281722816,0.936670071501532,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1428,NCT00366249,Adverse Event,Overall Study,FG000,0.0794934599798908,0.936625660611982,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1429,NCT02468232,Adverse Event,OLE Part of Study,FG003,0.0794446103864482,0.936581249722432,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1430,NCT04986202,Death,Overall Study,FG002,0.0794300521870039,0.936536838832882,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1431,NCT00240331,Withdrawal by Subject,Overall Study,FG001,0.0794181744511101,0.9364924279433317,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1432,NCT01485614,Withdrawal by Subject,Weeks 20-54,FG000,0.079409462013125,0.9364480170537816,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1433,NCT00853827,Adverse Event,Double Blind Period (103 Weeks),FG000,0.0794030065861607,0.9364036061642316,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1434,NCT02993406,Withdrawal by Subject,Overall Study,FG000,0.0793513486547023,0.9363591952746814,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1435,NCT02110901,Lost to Follow-up,Overall Study,FG001,0.0793276228699504,0.9363147843851312,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1436,NCT03037931,Withdrawal by Subject,Overall Study,FG001,0.079315613966875,0.9362703734955812,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1437,NCT00094302,Withdrawal by Subject,Overall Study,FG000,0.0792896635891666,0.936225962606031,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1438,NCT03064126,Lost to Follow-up,Overall Study,FG000,0.0792551396204392,0.9361815517164808,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1439,NCT04986202,Death,Overall Study,FG000,0.0792438138439086,0.9361371408269308,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1440,NCT00654381,Adverse Event,Extension Stage,FG003,0.0791641162345335,0.9360705244926056,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1441,NCT00654381,Adverse Event,2nd Stage,FG004,0.0791641162345335,0.9360705244926056,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1442,NCT01663402,Adverse Event,Overall Study,FG001,0.0790541331182141,0.9360039081582804,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1443,NCT03355664,Lost to Follow-up,Overall Study,FG001,0.0789329004015178,0.9359594972687304,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1444,NCT00097981,Other,Overall Study,FG001,0.0789194923849602,0.9359150863791802,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1445,NCT00915772,Any other reason,Overall Study,FG001,0.0789008007978373,0.93587067548963,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1446,NCT02715726,Other than specified above,Overall Study,FG001,0.0788514282395833,0.93582626460008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1447,NCT03332771,Reason Not Specified,Overall Study,FG003,0.0788419822033134,0.9357818537105298,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1448,NCT01564537,Withdrawal by Subject,Overall Study,FG000,0.0787486777317974,0.9357374428209796,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1449,NCT04740931,Withdrawal by Subject,Part 2 (Week 24 to Week 72),FG001,0.0787101034368353,0.9356930319314296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1450,NCT00915772,Any other reason,Overall Study,FG002,0.0786997152150396,0.9356486210418796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1451,NCT02851407,"Adverse event, serious fatal",Overall Study,FG001,0.0786882516568055,0.9356042101523292,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1452,NCT03199053,Withdrawal by Subject,ST Period,FG001,0.0785188567566333,0.9355597992627792,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1453,NCT04740931,Withdrawal by Subject,Part 2 (Week 24 to Week 72),FG000,0.0785033579308333,0.9355153883732292,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1454,NCT02634333,Lost to Follow-up,Overall Study,FG001,0.0783499377824603,0.935470977483679,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1455,NCT00968708,Adverse Event,Overall Study,FG001,0.0783306608640178,0.9354265665941288,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1456,NCT01535261,Adverse Event,Overall Study,FG000,0.0783288922702678,0.9353821557045788,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1457,NCT00518882,Completed extension 1 (weeks 26-40),"Open-Label Extension, Week 26-78",FG001,0.0783062212401784,0.9353377448150286,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1458,NCT01294436,Withdrawal by Subject,Overall Study,FG001,0.0782701995860812,0.9352933339254784,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1459,NCT02446990,Death,Overall Study,FG000,0.0782448501250397,0.9352489230359284,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1460,NCT03199053,Lost to Follow-up,Non-treatment Follow-up Period,FG001,0.0781929383209389,0.9352045121463785,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1461,NCT05259033,Withdrawal by Subject,Overall Study,FG000,0.0781331076945337,0.935160101256828,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1462,NCT01968954,Withdrawal by Subject,Overall Study,FG000,0.0780205108795421,0.935115690367278,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1463,NCT01027949,Lost to Follow-up,Overall Study,FG000,0.0779430436042163,0.935071279477728,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1464,NCT01663402,Adverse Event,Overall Study,FG000,0.0778494774989284,0.935026868588178,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1465,NCT00849017,Lost to Follow-up,Follow-up Period (8 Weeks),FG001,0.0777548422169543,0.9349824576986278,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1466,NCT00858637,Adverse Event,Active Comparison Phase,FG000,0.0776785843236344,0.9349380468090775,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1467,NCT01729871,Other,Overall Study,FG001,0.0776713838745833,0.9348936359195276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1468,NCT00719563,Adverse Event,Overall Study,FG001,0.0776059370199405,0.9348492250299774,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1469,NCT00542386,Lack of Efficacy,Overall Study,FG000,0.0775730328823214,0.9348048141404272,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1470,NCT00528879,Lack of Efficacy,Long-term Period (Weeks 24 to 102),FG000,0.077551355137619,0.9347604032508772,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1471,NCT01131676,Other than those specified,Discontinuation From Treatment,FG000,0.0774726585303868,0.934715992361327,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1472,NCT00121641,Subject Withdrew Consent,48-month Short Term + Long Term Period,FG003,0.0774107588091964,0.9346715814717768,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1473,NCT03758638,Withdrawal by Subject,Overall Study,FG000,0.0773959665773214,0.9346271705822268,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1474,NCT01764386,Lost to Follow-up,Uncontrolled Treatment Period (UTP),FG000,0.0773341346111012,0.9345827596926768,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1475,NCT01764386,Lost to Follow-up,Controlled Treatment Period (CTP),FG000,0.0773324804552679,0.9345383488031264,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1476,NCT01755156,Lost to Follow-up,Phase B (Weeks 24-104),FG000,0.0773225370696725,0.9344939379135764,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1477,NCT00571649,Withdrawal by Subject,Treatment Period,FG000,0.0772958836774801,0.9344495270240264,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1478,NCT00308139,Investigator Decision,Overall Study,FG000,0.0772481865725893,0.9344051161344762,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1479,NCT00108082,Adverse Event,Overall Study,FG002,0.0772010362012995,0.934360705244926,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1480,NCT01764386,Lost to Follow-up,Uncontrolled Treatment Period (UTP),FG001,0.0771503060640774,0.934316294355376,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1481,NCT00286468,Hyperglycemic Rescue,Overall Study,FG001,0.0770614409513095,0.9342718834658258,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1482,NCT00093015,Withdrawal by Subject,Overall Study,FG001,0.0769885219952967,0.9342274725762756,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1483,NCT02918279,Lost to Follow-up,Overall Study,FG001,0.0769257652298513,0.9341830616867256,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1484,NCT03574597,Lost to Follow-up,Overall Study,FG000,0.0769015657520932,0.9341386507971756,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1485,NCT03683030,Enrolled but screen failures,Overall Study,FG001,0.076828480778492,0.9340942399076252,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1486,NCT00856284,Adverse Event,Overall Study,FG002,0.0767380167091071,0.9340498290180752,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1487,NCT01813435,Lost to Follow-up,Overall Study,FG000,0.0766341253520435,0.9340054181285252,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1488,NCT00113087,Death or Transplant,Overall Study,FG000,0.0766104882783829,0.933961007238975,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1489,NCT04429503,Death,Main Study (Up to Wk 96),FG000,0.0765370888352976,0.9339165963494248,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1490,NCT04429503,Adverse Event,Main Study (Up to Wk 96),FG001,0.0765123780685715,0.9338721854598748,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1491,NCT04429503,Withdrawal by Subject,Main Study (Up to Wk 96),FG000,0.0764626870557143,0.9338277745703246,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1492,NCT04429503,Decision by the investigator/sponsor,Main Study (Up to Wk 96),FG001,0.076440257815,0.9337833636807744,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1493,NCT04809220,Withdrawal by Subject,Overall Study,FG000,0.0763482536131548,0.9337389527912244,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1494,NCT00168805,Other,Overall Study,FG002,0.0763440826052254,0.9336945419016744,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1495,NCT03087773,Lost to Follow-up,Overall Study,FG001,0.0763194659531746,0.933650131012124,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1496,NCT03087773,Withdrawal by Subject,Overall Study,FG000,0.07630991650125,0.933605720122574,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1497,NCT02446990,Death,Overall Study,FG001,0.0762652365158036,0.933561309233024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1498,NCT02197416,Other reasons,Overall Study,FG002,0.0762311649580655,0.9335168983434738,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1499,NCT02741596,Adverse Event,Overall Study,FG001,0.0762000181952083,0.9334724874539236,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1500,NCT02681094,Study specific discontinuation criteria,2 - Enrolled Participants Set,FG002,0.0761387444567063,0.9334280765643737,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1501,NCT03725202,Withdrew consent,Period 1 (Baseline - Week 52),FG001,0.0761277284865575,0.9333836656748234,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1502,NCT01214239,Adverse Event,Overall Study,FG001,0.0760901929547917,0.9333392547852734,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1503,NCT01214239,Withdrawal by Subject,Overall Study,FG000,0.0760512673438393,0.9332948438957231,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1504,NCT03172494,Adverse Event,Overall Study,FG002,0.075887556007113,0.9332504330061732,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1505,NCT00838916,Withdrawn from Follow-up Participation,Follow-up Period (8 Weeks),FG000,0.0758750368408929,0.933206022116623,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1506,NCT03814187,Other reasons,Overall Study,FG001,0.0758415549784226,0.9331616112270728,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1507,NCT02161562,Protocol Violation,Overall Study,FG000,0.0758351716483615,0.9331172003375228,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1508,NCT03574597,Lost to Follow-up,Overall Study,FG001,0.0758274963133432,0.9330727894479728,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1509,NCT00961636,Flushing Symptoms,Overall Study,FG001,0.0758171219576316,0.9330283785584226,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1510,NCT02107898,Adverse Event,Overall Study,FG001,0.0758125801672808,0.9329839676688724,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1511,NCT04848480,Withdrawal by Subject,Main Phase (26 Weeks),FG000,0.0757622541786409,0.9329395567793224,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1512,NCT03080883,Other Complicating Disease,Overall Study,FG001,0.075741633955,0.9328951458897722,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1513,NCT00474630,Adverse Event,Overall Study,FG001,0.0757401746785713,0.932850735000222,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1514,NCT00542386,Lack of Efficacy,Overall Study,FG005,0.0756415671429464,0.932806324110672,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1515,NCT02507687,Withdrawal by Subject,Overall Study,FG001,0.0755511017916713,0.9327619132211218,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1516,NCT02943785,Physician Decision,Overall Study,FG000,0.0755453275923728,0.9327175023315716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1517,NCT02798471,Other,Overall Study,FG000,0.0754884220060281,0.9326730914420216,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1518,NCT02715258,Withdrawal by Subject,Overall Study,FG000,0.0754491418146512,0.9326286805524716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1519,NCT00643201,Adverse Event,"Randomized, Completed 6 Months of Study",FG000,0.0754378539308333,0.9325842696629212,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1520,NCT00252694,Withdrawal by Subject,Overall Study,FG001,0.0754264758431349,0.9325398587733712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1521,NCT00124072,Death,Overall Study,FG000,0.0753722379735417,0.9324954478838212,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1522,NCT03066830,Lost to Follow-up,Overall Study,FG000,0.0753613408980357,0.932451036994271,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1523,NCT02507687,"Other, Not Specified",Overall Study,FG003,0.0753580254205502,0.9324066261047208,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1524,NCT00240331,Withdrawal by Subject,Overall Study,FG000,0.0753453327053273,0.9323622152151708,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1525,NCT00809965,Withdrawal by Subject,Overall Study,FG001,0.0753427331699405,0.9323178043256206,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1526,NCT02414841,Lost to Follow-up,Overall Study,FG000,0.0753264045381448,0.9322733934360704,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1527,NCT02414841,Received a Kidney Transplant,Overall Study,FG000,0.0753107099288293,0.9322289825465204,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1528,NCT00567255,Adverse Event,Overall Study,FG001,0.07526920147738,0.9321845716569704,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1529,NCT01954394,Adverse Event,Overall Study,FG001,0.0751912646159424,0.93214016076742,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1530,NCT03332771,Reason Not Specified,Overall Study,FG001,0.0751851220581547,0.93209574987787,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1531,NCT05275400,Withdrawal by Subject,Treatment Period,FG001,0.0750998117987797,0.93205133898832,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1532,NCT00225277,Adverse Event,Overall Study,FG000,0.0750898814911424,0.9320069280987698,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1533,NCT01769378,Withdrawal by Subject,Overall Study,FG000,0.0750274748423105,0.9319625172092196,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1534,NCT01958671,Withdrawal by Subject,Overall Study,FG002,0.074929712180746,0.9319181063196696,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1535,NCT04880850,Withdrawal by Subject,Overall Study,FG000,0.0748753305192262,0.9318736954301194,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1536,NCT00550953,Adverse Event,Overall Study,FG000,0.0748724584140178,0.9318292845405692,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1537,NCT00975286,Adverse Event,Overall Study,FG001,0.0747354480025198,0.9317848736510193,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1538,NCT01769378,Adverse Event,Overall Study,FG000,0.0747327899037093,0.9317404627614692,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1539,NCT05763875,Subject decision,Overall Study,FG000,0.0747132801133334,0.931696051871919,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1540,NCT00501059,Other,Overall Study,FG001,0.0746774123021328,0.9316516409823687,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1541,NCT01313676,Adverse Event,Overall Study,FG003,0.0746646125586308,0.9316072300928188,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1542,NCT01210001,"Patient refusal to continue,not due toAE",Overall Study,FG000,0.074601367625863,0.9315628192032688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1543,NCT03242252,At the Participant's own Request,Overall Study,FG002,0.0744757543940972,0.9315184083137186,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1544,NCT02164864,"Consent withdrawn, not due to AE",Overall Study,FG002,0.0744677568506249,0.9314739974241684,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1545,NCT04520256,Lost to Follow-up,Overall Study,FG000,0.0744591737719422,0.9314295865346184,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1546,NCT04520256,Lost to Follow-up,Overall Study,FG015,0.0744309774524184,0.931296353865968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1547,NCT04520256,Lost to Follow-up,Overall Study,FG005,0.0744309774524184,0.931296353865968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1548,NCT04520256,Lost to Follow-up,Overall Study,FG007,0.0744309774524184,0.931296353865968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1549,NCT04520256,Lost to Follow-up,Overall Study,FG004,0.0744309774524184,0.931296353865968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1550,NCT04520256,Lost to Follow-up,Overall Study,FG016,0.0744309774524184,0.931296353865968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1551,NCT01167881,"Patient refusal to cont., not due to AE",Overall Study,FG001,0.0743951179443452,0.9311631211973176,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1552,NCT03859427,Withdrawal by Subject,Overall Study,FG001,0.074345547982721,0.9311187103077676,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1553,NCT00420849,Withdrawal by Subject,Overall Study,FG000,0.0743039972361905,0.9310742994182174,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1554,NCT00121667,Subject Withdrew Consent,Short Term (ST) + Long Term (LT) Period,FG001,0.0742492037351289,0.9310298885286672,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1555,NCT00663260,Adverse Event,Overall Study,FG000,0.0742422184343849,0.9309854776391172,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1556,NCT01128894,Adverse Event,Overall Study,FG000,0.0742035992078571,0.930941066749567,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1557,NCT00968812,Adverse Event,Overall Study,FG001,0.0740395140099503,0.9308966558600168,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1558,NCT01134393,Other,Overall Study,FG000,0.073967722482619,0.9308522449704668,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1559,NCT00680186,Protocol Violation,Overall Study,FG001,0.0739432868547691,0.9308078340809166,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1560,NCT00790205,Withdrawal by Subject,Overall Study,FG000,0.0739252606760713,0.9307634231913664,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1561,NCT01734928,Death,Treatment Period,FG001,0.0739047102207751,0.9307190123018164,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1562,NCT00809965,Withdrawal by Subject,Overall Study,FG002,0.0738988000444643,0.9306746014122664,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1563,NCT00094770,Lack of Efficacy,Year 1 ( Week 0 to Week 52),FG001,0.0738318525290079,0.930630190522716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1564,NCT05142722,Withdrawal by Subject,Overall Study,FG001,0.073810435603254,0.930585779633166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1565,NCT02273050,Withdrawal by Subject,Overall Study,FG000,0.0737977559886741,0.930541368743616,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1566,NCT00103506,Withdrawal by Subject,Overall Study,FG001,0.073771235198244,0.9304969578540658,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1567,NCT00621140,Other incl. lack of efficacy,Overall Study,FG000,0.0737662179176785,0.9304525469645156,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1568,NCT00621140,Withdrawal by Subject,Overall Study,FG001,0.0736809856535119,0.9304081360749656,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1569,NCT02681094,Study-specific discontinuation criteria,1 -Modified Enrolled Participants Set,FG002,0.0736240305092559,0.9303637251854154,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1570,NCT00954447,Lost to Follow-up,Overall Study,FG001,0.0735722742912473,0.9303193142958652,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1571,NCT01009580,Unclassified,Overall Study,FG001,0.0735323316662797,0.9302749034063152,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1572,NCT00286468,Hyperglycemic Rescue,Overall Study,FG000,0.0734864690151488,0.9302304925167652,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1573,NCT00618956,Lost to Follow-up,Overall Study,FG000,0.0734862486779762,0.930186081627215,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1574,NCT00501059,Other,Overall Study,FG000,0.0733886641411209,0.9301416707376648,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1575,NCT00306384,Adverse Event,Overall Study,FG000,0.0733126590307143,0.9300972598481148,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1576,NCT00978627,Unclassified,Main: Week 0 to 26 (NN5401-3594),FG000,0.0733056484180654,0.9300528489585648,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1577,NCT00168805,Other,Overall Study,FG001,0.0731691142370112,0.9300084380690146,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1578,NCT01885559,Lost to Follow-up,Overall Study,FG001,0.0731442530402272,0.9299640271794644,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1579,NCT00715624,Familial and personal reasons,Overall Study,FG001,0.0730869275612202,0.9299196162899144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1580,NCT01023308,Death,Overall Study,FG000,0.0730842825576037,0.9298752054003642,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1581,NCT00286455,Hyperglycemia rescue,Overall Study,FG000,0.0730831682270039,0.929830794510814,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1582,NCT01644188,Adverse Event,Overall Study,FG001,0.0730688088620977,0.929786383621264,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1583,NCT04591626,Withdrawal by Subject,Overall Study,FG000,0.0730536699295418,0.9297419727317138,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1584,NCT00168805,Withdrawal by Subject,Overall Study,FG002,0.0729884309370635,0.9296975618421636,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1585,NCT03242018,Adverse Event,Overall Study,FG002,0.0728871866491865,0.9296531509526136,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1586,NCT02735044,"Other, not specified above",Overall Study,FG001,0.0728361842124603,0.9296087400630636,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1587,NCT00087516,Lack of Efficacy,Overall Study,FG002,0.0728310085069715,0.9295643291735134,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1588,NCT00532779,Lost to Follow-up,Overall Study,FG000,0.0726718537959622,0.9295199182839632,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1589,NCT00794573,Withdrawal by Subject,Overall Study,FG000,0.0726678003428661,0.9294755073944132,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1590,NCT00680017,Adverse Event,Overall Study,FG000,0.0726589690235317,0.929431096504863,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1591,NCT00713830,Familial and Personal Reasons,Overall Study,FG001,0.0726207281542983,0.9293866856153128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1592,NCT00818883,Adverse Event,Overall Study,FG000,0.0725483417205456,0.9293422747257628,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1593,NCT04807400,Withdrawal by Subject,Overall Study,FG000,0.072517868027629,0.9292978638362126,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1594,NCT01239797,Participant withdrew consent,Treated Participants,FG001,0.0724555590052977,0.9292534529466624,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1595,NCT00996281,Withdrawal by Subject,Overall Study,FG000,0.0724202917713095,0.9292090420571124,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1596,NCT02252172,Lost to Follow-up,Overall Study,FG000,0.0723606724927678,0.9291646311675624,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1597,NCT01644175,Last visit outside protocol visit window,Overall Study,FG001,0.072322015213502,0.9291202202780122,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1598,NCT01819129,Withdrawal Criteria,Overall Study,FG000,0.0722964497705004,0.929075809388462,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1599,NCT00734474,Adverse Event,Overall Study,FG008,0.0722887448567162,0.929031398498912,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1600,NCT01560637,Lost to Follow-up,Overall Study,FG000,0.0722877542703075,0.9289869876093618,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1601,NCT02769481,Lost to Follow-up,Overall Study,FG001,0.0722559622626786,0.9289425767198116,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1602,NCT01560637,Protocol Violation,Overall Study,FG000,0.0722544056340575,0.9288981658302616,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1603,NCT02769481,Lost to Follow-up,Overall Study,FG000,0.0722325812885119,0.9288537549407114,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1604,NCT00305604,Withdrawal by Subject,Overall Study,FG000,0.072173917827619,0.9288093440511612,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1605,NCT00174785,Adverse Event,Overall Study,FG001,0.0720689325747322,0.9287649331616112,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1606,NCT00773747,Physician Decision,Overall Study,FG001,0.0720280506828553,0.9287205222720613,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1607,NCT01507831,Poor compliance to protocol,Overall Study,FG001,0.0720127122505654,0.9286761113825108,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1608,NCT01898923,Lack of Efficacy,Overall Study,FG000,0.071982672530873,0.9286317004929608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1609,NCT01849289,Unclassified,Overall Study,FG000,0.0719206306227976,0.9285872896034107,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1610,NCT00732641,Serious Adverse Events,Overall Study,FG000,0.0718688294412499,0.9285428787138608,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1611,NCT02460978,Adverse Event,Overall Study,FG000,0.0717358447764781,0.9284984678243106,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1612,NCT00689936,Death,Active Treatment Phase,FG002,0.0715805054189502,0.9284540569347604,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1613,NCT00545584,Only one reason for discontinuation,Overall Study,FG002,0.0715774689074503,0.9284096460452104,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1614,NCT00124072,Death,Overall Study,FG001,0.0715721359282143,0.9283652351556602,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1615,NCT00507416,Patient declined further treatment,Overall Study,FG000,0.0715557894478273,0.92832082426611,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1616,NCT01999218,Withdrawal by Subject,Overall Study,FG001,0.0715474543301686,0.92827641337656,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1617,NCT00308139,Investigator Decision,Overall Study,FG001,0.0714769315238582,0.9282320024870098,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1618,NCT01568866,Withdrawal by Subject,Overall Study,FG000,0.0714282043317758,0.9281875915974596,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1619,NCT01492361,Other than specified above,Overall Study,FG001,0.0712862766714582,0.9281431807079096,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1620,NCT05963022,Protocol Violation,Overall Study,FG001,0.0712638978300298,0.9280987698183596,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1621,NCT05888103,Participant decision,Overall Study,FG000,0.0712572396027977,0.9280543589288094,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1622,NCT00740051,Lost to Follow-up,Overall Study,FG000,0.071246654951369,0.9280099480392592,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1623,NCT00660907,Subject No Longer Meets Study Criteria,Overall Study,FG001,0.0711704337745734,0.9279655371497092,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1624,NCT05888103,Participant decision,Overall Study,FG001,0.0711596734397917,0.927921126260159,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1625,NCT02419612,Withdrawal by Subject,Short-term Treatment Period,FG000,0.0710600324487796,0.9278767153706088,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1626,NCT00291330,Withdrawal by Subject,Overall Study,FG001,0.0710402303723016,0.9278323044810588,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1627,NCT02419612,Withdrawal by Subject,Short-term Treatment Period,FG001,0.0710390430448511,0.9277878935915086,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1628,NCT01999218,Withdrawal by Subject,Overall Study,FG000,0.0709771024060317,0.9277434827019584,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1629,NCT04017832,Withdrawal by Subject,Overall Study,FG002,0.0709640875257837,0.9276990718124084,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1630,NCT00439725,Clinical endpoint reached,Treatment Period,FG001,0.0709441367300694,0.9276546609228584,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1631,NCT00095238,Death,Overall Study,FG001,0.0709005531628571,0.9276102500333082,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1632,NCT00124072,Death,Overall Study,FG003,0.0708947497022024,0.927565839143758,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1633,NCT01217463,Adverse Event,Overall Study,FG000,0.0708648319822023,0.927521428254208,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1634,NCT00707993,Adverse Event,Overall Study,FG001,0.0708640087625,0.9274770173646578,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1635,NCT03325556,Not otherwise specified,Open-label Period,FG000,0.0707397026430753,0.9274326064751076,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1636,NCT00179647,Withdrawal by Subject,Overall Study,FG000,0.0707254413879761,0.9273881955855576,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1637,NCT00509262,Adverse Event,Overall Study,FG001,0.07071974509625,0.9273437846960074,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1638,NCT01954394,Other than specified above,Overall Study,FG001,0.0706487481939285,0.9272993738064572,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1639,NCT03180736,Physician Decision,Overall Study,FG000,0.0706083997421032,0.9272549629169072,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1640,NCT02555878,Other,Overall Study,FG000,0.0705911406141567,0.9272105520273572,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1641,NCT03180736,Adverse Event,Overall Study,FG001,0.0705796145119246,0.927166141137807,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1642,NCT04576988,Death,Double Blind Placebo Controlled (DBPC),FG001,0.0705129892835677,0.9271217302482568,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1643,NCT00657150,Withdrawal by Subject,Treatment,FG001,0.0704914483429067,0.9270773193587069,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1644,NCT02555878,Other,Overall Study,FG001,0.0704493348804662,0.9270329084691566,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1645,NCT02900378,Adverse Event,Randomization (Visit 2),FG000,0.0703490020625595,0.9269884975796066,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1646,NCT01084005,Protocol Violation,Overall Study,FG000,0.0703402861157142,0.9269440866900563,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1647,NCT02302716,Withdrawal by Subject,Overall Study,FG000,0.0703383009482674,0.9268996758005064,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1648,NCT01791153,Withdrawal by Subject,Part 1: Blinded Period,FG000,0.0702822725783532,0.9268552649109562,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1649,NCT04184622,Withdrawal by Subject,Primary Treatment Period,FG001,0.0702785869495833,0.926810854021406,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1650,NCT00124072,Death,Overall Study,FG002,0.0702764365888095,0.926766443131856,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1651,NCT01106651,Adverse Event,Overall Study,FG002,0.0702574125738194,0.9267220322423058,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1652,NCT02100514,Lost to Follow-up,Treatment Period,FG001,0.070235423938648,0.9266776213527556,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1653,NCT01087502,Withdrawal by Subject,Up to Final Analysis (Week 52),FG000,0.0702074276945237,0.9266332104632056,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1654,NCT00839527,Adverse Event,Treatment Period (TP) (156 Weeks),FG002,0.0701694515013492,0.9265887995736556,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1655,NCT01814748,Withdrawal by Subject,Overall Study,FG000,0.0701523122484721,0.9265443886841054,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1656,NCT01345019,Administrative Decision,Open Label Treatment Phase,FG000,0.0700807435752877,0.9264999777945552,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1657,NCT01345019,Adverse Event,Open Label Treatment Phase,FG000,0.0700529852857044,0.9264555669050052,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1658,NCT00282984,Withdrawal by Participant,Overall Study,FG001,0.0699749029491171,0.926411156015455,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1659,NCT01499095,Diverse Reasons,Overall Study,FG001,0.0699638431234127,0.9263667451259048,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1660,NCT00232180,Adverse Event,Double-blind (DB) Phase,FG000,0.0699531532894246,0.9263223342363548,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1661,NCT00765817,Adverse Event,Overall Study,FG000,0.0699032494647024,0.9262779233468046,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1662,NCT02273050,Withdrawal by Subject,Overall Study,FG002,0.0698973870028002,0.9262335124572544,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1663,NCT01137812,Other,Overall Study,FG001,0.0698969864339384,0.9261891015677044,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1664,NCT03882970,Withdrawal by Subject,Overall Study,FG003,0.0698878586325694,0.9261446906781544,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1665,NCT00571649,Withdrawal by Subject,Treatment Period,FG001,0.069856680593244,0.9261002797886042,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1666,NCT00518882,Adverse Event,"Double-Blind, Week 0-26",FG000,0.0698343991953968,0.926055868899054,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1667,NCT02851407,"Adverse event, non-fatal",Overall Study,FG000,0.069760928274742,0.926011458009504,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1668,NCT02851407,Physician Decision,Overall Study,FG000,0.069747764819742,0.9259670471199538,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1669,NCT01885559,Lost to Follow-up,Overall Study,FG000,0.0697244873348051,0.9259226362304036,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1670,NCT01524289,Withdrawal by Subject,Overall Study,FG001,0.0696819292099801,0.9258782253408536,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1671,NCT02851407,Withdrawal by parent/guardian,Overall Study,FG001,0.0696796490483135,0.9258338144513034,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1672,NCT00424047,Adverse Event,On Study at Time of Unblinding,FG001,0.0696633949466568,0.9257671981169784,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1673,NCT00424047,Adverse Event,Blinded Treatment (Up to 03 Aug 2005),FG001,0.0696633949466568,0.9257671981169784,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1674,NCT01272219,Adverse Event,Main Period: Week 0 to Week 56,FG000,0.0696245749955654,0.9257005817826532,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1675,NCT00617123,Withdrawal by Subject,Study Treatment Period,FG001,0.0695782363516369,0.925656170893103,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1676,NCT02674854,Adverse Event,Overall Study,FG000,0.0695692769584613,0.9256117600035528,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1677,NCT01652716,Lost to Follow-up,Overall Study,FG000,0.0694713726854257,0.9255673491140028,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1678,NCT00086515,Protocol-Specific lab discon criteria,Phase B (Weeks 24-104),FG000,0.0694447374039583,0.9255229382244526,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1679,NCT00121641,Lack of Efficacy,24-week Short-term Treatment Period,FG001,0.0692347117364583,0.9254785273349024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1680,NCT00819091,Adverse Event,Overall Study,FG000,0.0692101915055952,0.9254341164453525,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1681,NCT00424047,Other,Long Term Extension (Up to 25 Jun 2013),FG000,0.0692077430742461,0.9253897055558022,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1682,NCT01375647,Withdrawal by Subject,Overall Study,FG001,0.0692025724773259,0.925345294666252,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1683,NCT01621178,Withdrawal by Subject,Overall Study,FG000,0.0691943272614041,0.925300883776702,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1684,NCT04429503,Withdrawal by Subject,Main Study (Up to Wk 96),FG002,0.0691732712897221,0.925256472887152,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1685,NCT00121641,Lack of Efficacy,48-month Short Term + Long Term Period,FG002,0.0691414094036012,0.925212061997602,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1686,NCT00202878,Only Vital Status Known,Overall Study,FG000,0.069133159208869,0.9251676511080515,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1687,NCT05362058,Withdrawal by Subject,Treatment Period,FG001,0.06911621656749,0.9251232402185016,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1688,NCT00489541,No 9-Month Angiography Performed,9-Month Angiographic Follow-up,FG001,0.069113783146746,0.9250788293289516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1689,NCT02110901,Withdrawal by Subject,Overall Study,FG000,0.0690577547409722,0.9250344184394014,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1690,NCT01676116,Withdrawal criteria,Overall Study,FG001,0.0690568961976578,0.9249900075498512,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1691,NCT02924064,Protocol Violation,Overall Study,FG001,0.0688652042703274,0.9249455966603012,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1692,NCT03548935,Lost to Follow-up,Overall Study,FG001,0.0688629534714087,0.924901185770751,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1693,NCT02558231,Physician Decision,Overall Study,FG001,0.0688581661117063,0.9248567748812008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1694,NCT00252694,Withdrawal by Subject,Overall Study,FG000,0.0688328359259027,0.9248123639916508,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1695,NCT01590771,Withdrawal by Subject,Overall Study,FG001,0.0687350570864719,0.9247679531021006,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1696,NCT00877890,Withdrawal of Consent,Overall Study,FG001,0.0686849825068155,0.9247235422125504,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1697,NCT00501059,Lost to Follow-up,Overall Study,FG000,0.0686580060006645,0.9246791313230004,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1698,NCT02073682,PD: Inconvenience of Dosing,Overall Study,FG000,0.0686096022609614,0.9246347204334504,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1699,NCT00789737,Lost to Follow-up,Overall Study,FG001,0.0685924835076749,0.9245903095439002,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1700,NCT00202878,Only Vital Status Known,Overall Study,FG001,0.0685266954535119,0.92454589865435,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1701,NCT03376789,Withdrawal by Subject,Overall Study,FG001,0.0685099305426389,0.9245014877648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1702,NCT01472185,Subject Noncompliance,Overall Study,FG001,0.0683816324593344,0.9244570768752498,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1703,NCT00910429,Adverse Event,Overall Study,FG001,0.0682921066315576,0.9244126659856996,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1704,NCT02164864,Other Adverse Event (AE),Overall Study,FG000,0.0682280811633431,0.9243682550961496,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1705,NCT00097786,lost to follow-up for all-cause death,Overall Study,FG002,0.0682087759081745,0.9243238442065994,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1706,NCT00536744,Adverse Event,Overall Study,FG001,0.0681892740745238,0.9242794333170492,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1707,NCT00849017,Withdrawal by Subject,Treatment Period (156 Weeks),FG002,0.0681820520247916,0.9242350224274992,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1708,NCT01392573,Withdrawal Criteria,Overall Study,FG001,0.0681283988513392,0.9241906115379492,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1709,NCT00661999,Withdrawal by Subject,Overall Study,FG001,0.0681148402222718,0.924146200648399,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1710,NCT02926937,At the Participant's own Request,Overall Study,FG002,0.0681047840041369,0.9241017897588488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1711,NCT02546323,Adverse Event,Overall Study,FG001,0.0680735246142163,0.9240573788692988,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1712,NCT00782340,Adverse Event,Open Label Titration,FG000,0.0680643487073809,0.9240129679797486,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1713,NCT00097786,lost to follow-up for all-cause death,Overall Study,FG003,0.0680519235699603,0.9239685570901984,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1714,NCT00358215,Adverse Event,Overall Study,FG001,0.0680478814471131,0.9239241462006484,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1715,NCT00661999,Other Reasons,Overall Study,FG002,0.068042007217748,0.9238797353110982,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1716,NCT02412878,Withdrawal by Subject,Overall Study,FG001,0.0680395349049207,0.923835324421548,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1717,NCT00866658,Adverse Event,Overall Study,FG001,0.0679583527663392,0.923790913531998,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1718,NCT02229396,Other,Overall Study,FG002,0.0679546607171329,0.923746502642448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1719,NCT01131676,Other than those specified,Discontinuation From Treatment,FG001,0.06795281493248,0.923702091752898,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1720,NCT04760626,Lost to Follow-up,Overall Study,FG000,0.0679472803671428,0.9236576808633477,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1721,NCT00358215,Participant request,Overall Study,FG000,0.0679143178124702,0.9236132699737976,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1722,NCT01045707,Withdrawal Criteria,Main: Week 0 to 26 (NN5401-3590),FG000,0.0678562552583432,0.9235688590842476,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1723,NCT00781937,Adverse Event,Main Trial Period Through Week 56,FG001,0.067816178218234,0.9235244481946974,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1724,NCT03682185,Lost to Follow-up,Overall Study,FG003,0.0678031795191072,0.9234800373051472,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1725,NCT02666664,Withdrawal by participant,Overall Study,FG001,0.0678011809314582,0.9234356264155972,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1726,NCT01976312,Withdrawal by Subject,Overall Study,FG000,0.0678005574727777,0.923391215526047,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1727,NCT03682185,Lost to Follow-up,Overall Study,FG001,0.0677905333995239,0.9233468046364968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1728,NCT01952145,Withdrawal Criteria,Overall Study,FG000,0.0677900921732088,0.9233023937469468,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1729,NCT03682185,Withdrawal by Subject,Overall Study,FG000,0.0677835072374405,0.9232579828573968,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1730,NCT02017171,Death,Overall Study,FG000,0.0677655314363095,0.9232135719678464,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1731,NCT02943785,Did not receive any study medication,Overall Study,FG000,0.0677413908279265,0.9231691610782964,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1732,NCT00781937,Adverse Event,Main Trial Period Through Week 56,FG000,0.0676929655905554,0.9231247501887464,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1733,NCT01618162,Unclassified,Overall Study,FG000,0.067677440100763,0.9230803392991962,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1734,NCT01557166,Withdrawn consent,Overall Study,FG000,0.0676605919101479,0.923035928409646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1735,NCT00044213,Withdrawal by Subject,Overall Study,FG000,0.0676599708922321,0.922991517520096,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1736,NCT03682185,Withdrawal by Subject,Overall Study,FG002,0.0676545327878571,0.9229471066305458,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1737,NCT00309244,Withdrawal by Subject,Overall Study,FG001,0.0676198239432638,0.9229026957409956,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1738,NCT01890421,Other reason,Overall Study,FG000,0.0676033484330555,0.9228582848514456,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1739,NCT03551496,Withdrawal by Subject,Overall Study,FG001,0.0675380863088393,0.9228138739618954,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1740,NCT00708435,Death / Serious Adverse Event,Overall Study,FG000,0.0675333182576191,0.9227694630723452,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1741,NCT00849056,Adverse Event,Treatment Period (TP) (156 Weeks),FG001,0.0674782028362202,0.9227250521827952,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1742,NCT01623115,Last visit outside protocol visit window,Overall Study,FG000,0.067404418601304,0.9226806412932452,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1743,NCT00553267,Adverse Event,Overall Study,FG001,0.0673680428400469,0.922636230403695,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1744,NCT00712673,Adverse Event,Overall Study,FG003,0.0672409138616369,0.9225918195141448,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1745,NCT04707469,Lost to Follow-up,Overall Study,FG001,0.0672333499653075,0.9225474086245948,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1746,NCT00116831,Withdrawal by Subject,Overall Study,FG001,0.0672271059701488,0.9225029977350446,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1747,NCT01631227,withdrawn consent,Overall Study,FG001,0.0671986166531646,0.9224585868454944,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1748,NCT00168818,Adverse Event,Overall Study,FG002,0.0671923565479735,0.9224141759559444,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1749,NCT00168818,Other,Treatment,FG002,0.0671724203342632,0.9223697650663942,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1750,NCT00056160,Adverse Event,Up to Unblinding (07 Jun 2005),FG001,0.0671590136150496,0.922325354176844,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1751,NCT02161562,Withdrawal by Subject,Overall Study,FG001,0.0671365567678489,0.922280943287294,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1752,NCT00116831,Withdrawal by Subject,Overall Study,FG000,0.0670858925942261,0.922236532397744,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1753,NCT01850524,Lost to Follow-up,Overall Study,FG001,0.0670071494981845,0.922192121508194,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1754,NCT00479882,Clinical Adverse Event,Precrossover: Periods I/II (Weeks 1-12),FG001,0.0669881189327679,0.9221477106186436,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1755,NCT02833948,scans could not be evaluated,Overall Study,FG000,0.066958152115883,0.9221032997290936,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1756,NCT00657150,Adverse Event,Overall Study,FG000,0.0669508315179734,0.9220588888395436,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1757,NCT00082381,Adverse Event,Overall Study,FG000,0.0669197815822618,0.9220144779499934,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1758,NCT01364428,Withdrawal Criteria,Overall Study,FG000,0.0668508856792126,0.9219700670604432,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1759,NCT00839527,Withdrawal by Subject,Follow-up Period (FUP) (8 Weeks),FG001,0.0668329246600396,0.9219256561708932,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1760,NCT04660643,Lost to Follow-up,Double-blind Study Period (Week 36 - 92),FG001,0.066823570815248,0.921881245281343,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1761,NCT02884206,Patient/guardian decision,Double-Blind Period,FG001,0.0667980024945536,0.9218368343917928,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1762,NCT00809965,Withdrawal by Subject,Overall Study,FG000,0.0667796526362203,0.9217924235022428,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1763,NCT00856284,Adverse Event,Overall Study,FG001,0.0667354544051487,0.9217480126126928,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1764,NCT02561078,Withdrawal by Subject,Overall Study,FG001,0.0666683222841071,0.9217036017231424,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1765,NCT04660643,Protocol deviation,Open-label Lead-in Period (Week 0 - 36),FG000,0.0666431741929266,0.9216591908335924,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1766,NCT00044213,Death,Overall Study,FG003,0.0665842570360714,0.9216147799440424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1767,NCT00097786,lost to follow-up for all-cause death,Overall Study,FG000,0.0665838970164582,0.9215703690544922,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1768,NCT02733185,Withdrawal by Subject,Overall Study,FG000,0.0665736019965971,0.921525958164942,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1769,NCT03988634,Lost to Follow-up,Double-Blind,FG001,0.0665674296523214,0.921481547275392,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1770,NCT00622284,Lack of Efficacy,Overall Study,FG001,0.0665559929853941,0.9214371363858418,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1771,NCT01624259,Adverse Event,Overall Study,FG001,0.0665337216307134,0.9213927254962916,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1772,NCT02226120,Withdrawal by parent/guardian,Overall Study,FG000,0.066459314242251,0.9213483146067416,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1773,NCT01624259,Adverse Event,Overall Study,FG000,0.0664084936694931,0.9213039037171916,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1774,NCT03439254,Withdrawal by Subject,Double-blind Phase (18 Months),FG000,0.0663831268533829,0.9212594928276412,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1775,NCT03439254,Adverse Event,Double-blind Phase (18 Months),FG001,0.066363597464752,0.9212150819380912,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1776,NCT03988634,Adverse Event,Open-Label,FG002,0.0663434336323611,0.9211706710485412,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1777,NCT00695955,Other,Cohort 1,FG000,0.0663342119559424,0.921126260158991,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1778,NCT00479882,Clinical Adverse Event,Precrossover: Periods I/II (Weeks 1-12),FG002,0.0663040866172321,0.9210818492694408,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1779,NCT01555164,Subject Non-compliance,Overall Study,FG000,0.0662768357823403,0.9210374383798908,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1780,NCT04929249,Subject decision,Overall Study,FG000,0.0662748447867361,0.9209930274903406,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1781,NCT03888066,AE (Adverse Event),Run-in Phase,FG000,0.0662677782242559,0.9209486166007904,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1782,NCT03332771,Reason Not Specified,Overall Study,FG002,0.0662511665606151,0.9209042057112404,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1783,NCT00439777,Study terminated by sponsor,Treatment Period,FG001,0.0662474368316965,0.9208597948216902,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1784,NCT00797862,Adverse Event,Overall Study,FG001,0.0662102587110299,0.92081538393214,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1785,NCT02164864,Other Adverse Event (AE),Overall Study,FG002,0.0660674073834027,0.92077097304259,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1786,NCT02307513,Adverse Event,Active Treatment Phase (Weeks 13-64),FG000,0.0660494253980356,0.9207043567082648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1787,NCT02307513,Adverse Event,Placebo Controlled Phase (Weeks 0-12),FG000,0.0660494253980356,0.9207043567082648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1788,NCT00689936,Miscellaneous,Active Treatment Phase,FG001,0.0659869624382061,0.9206377403739396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1789,NCT00097786,lost to follow-up for all-cause death,Overall Study,FG001,0.0659577726813987,0.9205933294843897,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1790,NCT02307513,Withdrawal by Subject,Placebo Controlled Phase (Weeks 0-12),FG001,0.0658739457350595,0.9205489185948394,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1791,NCT02892149,Withdrawal by Subject,Overall Study,FG000,0.0658645241890773,0.9205045077052894,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1792,NCT01539083,Death,Before Randomization (VCD Induction),FG000,0.0658531677870536,0.9204600968157391,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1793,NCT01644175,Poor compliance to protocol,Overall Study,FG001,0.0658325541908919,0.920415685926189,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1794,NCT00763451,Adverse Event,Overall Study,FG002,0.0658172798023737,0.920371275036639,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1795,NCT00358215,Participant request,Overall Study,FG001,0.0657679947710416,0.9203268641470888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1796,NCT03585270,Withdrawal by Subject,Overall Study,FG001,0.0657444458675001,0.9202824532575388,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1797,NCT01984424,Withdrawal by Subject,Overall Study,FG001,0.0657119646481944,0.9202380423679888,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1798,NCT00295633,Withdrawal of consent by subject,Overall Study,FG002,0.0657075308343352,0.9201936314784384,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1799,NCT02916706,Protocol Violation,Overall Study,FG000,0.0657003025389205,0.9201492205888884,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1800,NCT00174785,Withdrawal by Subject,Overall Study,FG000,0.0656985885822519,0.9201048096993384,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1801,NCT04740931,Lost to Follow-up,Part 2 (Week 24 to Week 72),FG001,0.0656922088401289,0.9200603988097882,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1802,NCT00174785,Withdrawal by Subject,Overall Study,FG001,0.0656660934128851,0.920015987920238,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1803,NCT00358215,Protocol Violation,Overall Study,FG000,0.0656621077192559,0.919971577030688,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1804,NCT00332488,Adverse Event,Initial Treatment Phase (Weeks 0 - 12),FG002,0.0656521088621943,0.9199271661411378,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1805,NCT00121667,Subject Withdrew Consent,Short Term (ST) + Long Term (LT) Period,FG003,0.0655473269086903,0.9198827552515876,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1806,NCT00429364,Underwent aortic root surgery,Overall Study,FG001,0.0655432258122024,0.9198383443620376,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1807,NCT01568866,Death,Overall Study,FG001,0.0655351250719336,0.9197939334724876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1808,NCT00507416,Other,Overall Study,FG001,0.0655149163654265,0.9197495225829372,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1809,NCT00433966,Lost to Follow-up,Stent Intervention/Randomization,FG002,0.0654993647654464,0.9197051116933872,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1810,NCT00558259,Withdrawal by Subject,Overall Study,FG001,0.065497003180652,0.9196607008038372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1811,NCT01539083,Death,After Randomization (TP and VTP),FG001,0.0653974556820734,0.919616289914287,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1812,NCT01539083,Progressive Disease,After Randomization (TP and VTP),FG001,0.0653905220641567,0.9195718790247368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1813,NCT00734474,Withdrawal by Subject,Overall Study,FG007,0.0653730458209027,0.9195274681351868,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1814,NCT03683030,Lost to Follow-up,Overall Study,FG001,0.0653567413871312,0.9194830572456366,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1815,NCT00434954,Subject decision,Overall Study,FG001,0.0653457717115376,0.9194386463560864,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1816,NCT00168818,Other,Overall Study,FG002,0.065345230638787,0.9193942354665364,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1817,NCT02586155,Withdrawal by Subject,Overall Study,FG000,0.0653418778221725,0.9193498245769864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1818,NCT02324569,Voluntary Withdrawal,Overall Study,FG001,0.0653075824112219,0.919305413687436,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1819,NCT04788511,Lost to Follow-up,Overall Study,FG001,0.0652982473588988,0.919261002797886,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1820,NCT01698775,Withdrawal by Subject,Phase B,FG000,0.0652842808932936,0.919216591908336,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1821,NCT01798706,Adverse Event,Overall Study,FG001,0.0652837421522718,0.9191721810187858,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1822,NCT01032629,Lost to Follow-up,Overall Study,FG000,0.0652823552501487,0.9191277701292356,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1823,NCT00090519,Lost to Follow-up,Overall Study,FG001,0.0652510817474332,0.9190833592396856,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1824,NCT00090519,Withdrawal by Subject,Overall Study,FG001,0.0652161750437923,0.9190389483501354,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1825,NCT03285594,At the Participant's Own Request,Overall Study,FG000,0.0652050681697321,0.9189945374605852,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1826,NCT02419612,Withdrawal by Subject,Long-term Treatment Period,FG000,0.0651974765420535,0.9189501265710353,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1827,NCT01818752,Non-compliance,Overall Study,FG001,0.0651805144265593,0.918905715681485,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1828,NCT02033889,Withdrawal by Subject,Overall Study,FG002,0.0651336075214286,0.918861304791935,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1829,NCT00860262,Adverse Event,Overall Study,FG000,0.0651335550003842,0.9188168939023847,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1830,NCT02963935,Lost to Follow-up,Overall Study,FG001,0.0651286958499108,0.9187724830128348,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1831,NCT00129545,Lost to Follow-up,Overall Study,FG001,0.0650884066696663,0.9187280721232848,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1832,NCT00305604,Lack of Efficacy,Overall Study,FG000,0.0650236181770309,0.9186836612337343,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1833,NCT01102426,Physician Decision,Overall Study,FG001,0.0650165997815971,0.9186392503441844,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1834,NCT01698775,Adverse Event,Phase B,FG000,0.0650115977375198,0.9185948394546344,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1835,NCT02963922,Other,Overall Study,FG000,0.064937355408512,0.9185504285650842,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1836,NCT00838916,Lost to Follow-up,Follow-up Period (8 Weeks),FG001,0.0648672124678273,0.918506017675534,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1837,NCT02918279,Withdrawal by Subject,Overall Study,FG000,0.0648563028778572,0.918461606785984,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1838,NCT00839527,Lost to Follow-up,Follow-up Period (FUP) (8 Weeks),FG001,0.0648402314934523,0.9184171958964338,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1839,NCT02463071,Reason not specified,Overall Study,FG001,0.0648232829886507,0.9183727850068836,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1840,NCT02104804,Withdrawal by Subject,Overall Study,FG001,0.0647832208851587,0.9183283741173336,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1841,NCT00393718,Adverse Event,Overall Study,FG000,0.0647510122532142,0.9182839632277836,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1842,NCT00497146,Withdrawal by Subject,Treatment Period,FG001,0.0647097438766468,0.9182395523382332,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1843,NCT01137812,Physician Decision,Overall Study,FG000,0.0646538395293714,0.9181951414486832,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1844,NCT00479882,Clinical Adverse Event,Precrossover: Periods I/II (Weeks 1-12),FG000,0.0645910743373908,0.9181507305591332,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1845,NCT02963935,Adverse Event,Overall Study,FG001,0.0645846677246429,0.918106319669583,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1846,NCT01958671,Lost to Follow-up,Overall Study,FG001,0.0645650035658946,0.9180619087800328,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1847,NCT01652716,Lost to Follow-up,Overall Study,FG001,0.0645627964643155,0.9180174978904828,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1848,NCT03548935,Withdrawal by Subject,Overall Study,FG000,0.0645316221620832,0.9179730870009326,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1849,NCT02229396,Lost to Follow-up,Overall Study,FG000,0.064527732449881,0.9179286761113824,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1850,NCT02468232,Adverse Event,OLE Part of Study,FG002,0.0644889812896131,0.9178842652218324,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1851,NCT03730662,Death,Variable Treatment Period,FG003,0.0644788301994939,0.9178398543322824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1852,NCT02468232,Death,OLE Part of Study,FG002,0.0644746826315576,0.917795443442732,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1853,NCT00424047,Death,On Study at Time of Unblinding,FG001,0.0644629947250387,0.917751032553182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1854,NCT00915772,Refused to continue trial medication,Overall Study,FG000,0.064433533320129,0.917706621663632,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1855,NCT02468232,Physician Decision,OLE Part of Study,FG002,0.0644272907882242,0.9176622107740818,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1856,NCT00095238,Death,Overall Study,FG000,0.0643294029888988,0.9176177998845316,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1857,NCT02229396,Lost to Follow-up,Overall Study,FG001,0.0642970668852381,0.9175733889949816,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1858,NCT02505334,Unclassified,Main Treatment Period,FG001,0.0642921379044544,0.9175289781054314,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1859,NCT01485614,Lost to Follow-up,Weeks 20-54,FG000,0.0641482173514781,0.9174845672158812,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1860,NCT00424047,Death,On Study at Time of Unblinding,FG000,0.0641408061135804,0.9174401563263312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1861,NCT00424047,Death,Blinded Treatment (Up to 03 Aug 2005),FG000,0.0641304164594138,0.9173957454367812,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1862,NCT00976391,Withdrawal by Subject,Treatment Period (52 Weeks),FG001,0.0641172435188257,0.917351334547231,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1863,NCT01181102,Adverse Event,Overall Study,FG000,0.0640874086551785,0.9173069236576809,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1864,NCT03242018,At the Participant's Own Request,Overall Study,FG000,0.0640279481236805,0.9172625127681308,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1865,NCT01068678,Unclassified,Overall Study,FG000,0.0640238088121554,0.9172181018785808,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1866,NCT00781937,Withdrawal by Subject,Main Trial Period Through Week 56,FG000,0.0640149615177579,0.9171736909890306,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1867,NCT05040971,Lost to Follow-up,Overall Study,FG001,0.0639870792318155,0.9171292800994804,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1868,NCT02181413,Lost to Follow-up,Overall Study,FG000,0.0639843245801984,0.9170848692099304,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1869,NCT01106651,Other,Overall Study,FG002,0.0639419031606844,0.9170404583203802,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1870,NCT00308737,Lost to Follow-up,Overall Study,FG001,0.0639288526817261,0.91699604743083,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1871,NCT01413204,Fasting plasma glucose level increased,Overall Study,FG002,0.0639183471824305,0.91695163654128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1872,NCT00474630,Lost to Follow-up,Overall Study,FG000,0.0639125038103868,0.9169072256517298,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1873,NCT02666664,Adverse Event,Overall Study,FG001,0.0638558623494236,0.9168628147621796,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1874,NCT01028053,Patient Request,Overall Study,FG000,0.0638128634909613,0.9168184038726296,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1875,NCT00306384,Voluntary withdrawal,Overall Study,FG002,0.0637710650032837,0.9167739929830796,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1876,NCT00291330,Withdrawal by Subject,Overall Study,FG000,0.0637602588911282,0.9167295820935292,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1877,NCT01674647,Protocol Violation,30-day Safety Follow-up Period,FG000,0.0637446940627381,0.9166851712039792,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1878,NCT02867813,Withdrawal by Subject,Overall Study,FG001,0.0637396114805158,0.9166407603144292,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1879,NCT00532779,Lost to Follow-up,Overall Study,FG002,0.0637370513602678,0.916596349424879,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1880,NCT02867813,Withdrawal by Subject,Overall Study,FG000,0.0637233268513492,0.9165519385353288,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1881,NCT00849017,Lost to Follow-up,Treatment Period (156 Weeks),FG000,0.0637165747369147,0.9165075276457788,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1882,NCT00087516,Protocol specified discontinuation,Overall Study,FG000,0.0637121764536507,0.9164631167562286,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1883,NCT01590771,Other Protocol Specified Criteria,Overall Study,FG001,0.0636575080172565,0.9164187058666784,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1884,NCT03725202,Withdrew consent,Period 1 (Baseline - Week 52),FG000,0.0636508950669264,0.9163520895323534,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1885,NCT03725202,"Other, not specified",Period 1 (Baseline - Week 52),FG000,0.0636508950669264,0.9163520895323534,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1886,NCT01272219,Protocol Violation,Main + Extension Period: Week 0-172,FG004,0.0636154985641964,0.916285473198028,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1887,NCT03768427,Withdrawal by Subject,Overall Study,FG003,0.0635631649094544,0.916241062308478,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1888,NCT03768427,Withdrawal by Subject,Overall Study,FG000,0.0634981331698413,0.916196651418928,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1889,NCT00090519,Withdrawal by Subject,Overall Study,FG000,0.0634943327130879,0.9161522405293778,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1890,NCT02030600,Protocol Violation,Treatment Period 1,FG001,0.0634191078805455,0.9161078296398276,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1891,NCT00300274,Death,Overall Study,FG002,0.0634048359361967,0.9160634187502776,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1892,NCT00168818,Adverse Event,Overall Study,FG001,0.0633690894554536,0.9160190078607274,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1893,NCT01717313,Withdrawal by Subject,Phase B (Weeks 24 to 54),FG001,0.0633664880236805,0.9159745969711772,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1894,NCT00168818,Other,Treatment,FG001,0.0633594559395409,0.9159301860816272,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1895,NCT02990338,Randomized and not treated,Overall Study,FG000,0.0633335863380754,0.9158857751920771,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1896,NCT02030600,Withdrawal by Subject,Treatment Period 1,FG001,0.0633295073517063,0.9158413643025268,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1897,NCT00532779,Lost to Follow-up,Overall Study,FG001,0.0633265084415557,0.9157969534129768,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1898,NCT02943785,Other,Overall Study,FG001,0.0633253807660415,0.9157525425234267,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1899,NCT03110562,Withdrawal by Subject,Crossover Period,FG003,0.063265941721756,0.9157081316338768,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1900,NCT00789737,Withdrawal by Subject,Overall Study,FG000,0.0632531973890141,0.9156637207443266,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1901,NCT00139659,Withdrawal by Subject,Overall Study,FG000,0.0632382115468154,0.9156193098547764,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1902,NCT00894387,Adverse Event,Overall Study,FG001,0.0632367219359028,0.9155748989652264,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1903,NCT00103506,Withdrawal by Subject,Overall Study,FG000,0.0632116397136652,0.9155304880756762,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1904,NCT04740905,Lost to Follow-up,Part 2 (Week 24 to Week 72),FG000,0.0631589381025992,0.915486077186126,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1905,NCT01618162,Unclassified,Overall Study,FG001,0.0631449382624594,0.915441666296576,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1906,NCT01023308,Withdrawal by Subject,Overall Study,FG001,0.0631377592456845,0.9153972554070258,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1907,NCT01703221,Lack of Efficacy,Phase B - (Week 25 to 52),FG000,0.0631368098144183,0.9153528445174756,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1908,NCT00509262,Adverse Event,Overall Study,FG000,0.0631277551673115,0.9153084336279256,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1909,NCT01435616,Adverse Event,Overall Study,FG000,0.0630738154685714,0.9152640227383756,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1910,NCT02994927,Withdrawal by Subject,Overall Study,FG001,0.0630583671259325,0.9152196118488254,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1911,NCT01618162,Protocol Violation,Overall Study,FG000,0.0630486716328165,0.9151752009592752,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1912,NCT00968812,Other,Overall Study,FG002,0.0630426596650432,0.9151307900697252,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1913,NCT00567255,Withdrawal by Subject,Overall Study,FG001,0.0629686504260912,0.915086379180175,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1914,NCT00232180,Other,Double-blind (DB) Phase,FG001,0.062961370691498,0.9150419682906248,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1915,NCT02892149,Withdrawal by Subject,Overall Study,FG001,0.0629549803410713,0.9149975574010748,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1916,NCT03725202,"Other, not specified",Period 1 (Baseline - Week 52),FG002,0.0629427642997836,0.9149531465115246,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1917,NCT00618774,Adverse Event,Overall Study,FG001,0.0629267110629582,0.9149087356219744,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1918,NCT01813435,Lost to Follow-up,Overall Study,FG001,0.062905830191369,0.9148643247324244,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1919,NCT00439777,Study terminated by sponsor,Treatment Period,FG000,0.0628919361250496,0.9148199138428744,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1920,NCT00151775,Lost to Follow-up,Period 4: Open Label,FG004,0.0628735910710317,0.914775502953324,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1921,NCT03725202,"Other, not specified",Period 1 (Baseline - Week 52),FG001,0.0628445351397836,0.914731092063774,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1922,NCT01730053,Other than specified,Overall Study,FG005,0.0627429857521725,0.914686681174224,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1923,NCT02741596,Subject withdrawn-Other,Overall Study,FG001,0.0627205845718551,0.9146422702846738,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1924,NCT00168805,Withdrawal by Subject,Overall Study,FG001,0.0626803977173097,0.9145978593951236,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1925,NCT00168805,Other,Treatment,FG001,0.0626667881568733,0.9145534485055736,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1926,NCT00174785,Atrial Fibrillation/Flutter recurrence,Overall Study,FG001,0.0626557112778256,0.9145090376160234,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1927,NCT00501059,Lost to Follow-up,Overall Study,FG001,0.0626184908383531,0.9144646267264732,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1928,NCT00633893,Adverse Event,Overall Study,FG000,0.0625908475610218,0.9144202158369232,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1929,NCT00168805,Other,Treatment,FG000,0.0625691888302751,0.9143758049473732,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1930,NCT01177384,Withdrawal by Subject,Overall Study,FG001,0.0625620649892063,0.9143313940578228,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1931,NCT02787551,Adverse Event,Core Period: 26 Weeks,FG000,0.0625471290677678,0.9142869831682728,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1932,NCT00641056,Subject Decision,Overall Study,FG001,0.0624978449537797,0.9142425722787229,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1933,NCT00262600,Withdrawal by Subject,Overall Study,FG002,0.0624691679570833,0.9141981613891726,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1934,NCT00108082,Adverse Event,Overall Study,FG000,0.0624355259226488,0.9141537504996226,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1935,NCT01355159,Withdrew consent,Overall Study,FG001,0.0623936878561426,0.9141093396100723,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1936,NCT00532779,Withdrawal by Subject,Overall Study,FG000,0.0623160332326983,0.9140649287205224,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1937,NCT00838903,Lost to Follow-up,Follow-up Period (8 Weeks),FG001,0.0622981562168722,0.9140205178309722,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1938,NCT01370616,Adverse Event,Overall Study,FG001,0.062250452621075,0.913976106941422,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1939,NCT00698932,Withdrawal by Subject,Overall Study,FG001,0.0622186383737499,0.913931696051872,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1940,NCT01709513,Other,Overall Study,FG002,0.0622017713861607,0.9138872851623218,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1941,NCT00262600,Withdrawal by Subject,Overall Study,FG001,0.0621909388231547,0.9138428742727716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1942,NCT00575588,Withdrawal by Subject,Overall Study,FG001,0.0621191336635542,0.9137984633832216,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1943,NCT03814187,Other reasons,Overall Study,FG000,0.0621149808474603,0.9137540524936716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1944,NCT00184600,Withdrawal by Subject,Overall Study,FG001,0.0621089351824007,0.9137096416041214,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1945,NCT00996658,Non-compliance issues,Overall Study,FG000,0.0620978505157937,0.9136652307145712,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1946,NCT05362058,Withdrawal by Subject,Treatment Period,FG000,0.0620786674261138,0.9136208198250212,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1947,NCT00368836,unable to collect blood and/or breath,Phase II,FG000,0.0620548780243155,0.913576408935471,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1948,NCT01512108,Unclassified,Overall Study,FG000,0.0620413636145833,0.9135319980459208,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1949,NCT00661362,Withdrawal by Subject,Overall Study,FG001,0.0619605216728571,0.9134875871563708,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1950,NCT02866175,Death,Overall Study,FG001,0.0618892554762202,0.9134431762668206,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1951,NCT03136484,Withdrawal by Subject,Overall Study,FG001,0.0618844786443154,0.9133987653772704,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1952,NCT00708435,Lost to Follow-up,Overall Study,FG000,0.0618629731777182,0.9133543544877204,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1953,NCT01507831,Last visit outside protocol visit window,Overall Study,FG000,0.0618569704321131,0.9133099435981704,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1954,NCT00765817,Subject decision,Overall Study,FG001,0.0618472013944642,0.9132655327086202,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1955,NCT03439254,Adverse Event,Double-blind Phase (18 Months),FG000,0.0617029498827182,0.91322112181907,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1956,NCT02294474,Other than specified above,Overall Study,FG001,0.0616976064315475,0.91317671092952,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1957,NCT02558296,Death,Completed the Study,FG001,0.0616974405330951,0.9131323000399698,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1958,NCT01189890,Withdrawal by Subject,Overall Study,FG000,0.0616922850581646,0.9130878891504196,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1959,NCT02294474,Other than specified above,Overall Study,FG000,0.0616800384540475,0.9130434782608696,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1960,NCT04847557,Withdrawal by Subject,Overall Study,FG000,0.0615935693134622,0.9129990673713194,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1961,NCT00474630,Withdrawal by Subject,Overall Study,FG000,0.0615801435395832,0.9129546564817692,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1962,NCT01194830,Lost to Follow-up,Overall Study,FG000,0.0615563582193849,0.9129102455922192,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1963,NCT01594333,Withdrawal by Subject,Overall Study,FG001,0.0615480596825594,0.9128658347026692,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1964,NCT02884206,Patient/guardian decision,Valsartan Run-in Period,FG000,0.0615240642983929,0.9128214238131188,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1965,NCT00736099,Adverse Event,Overall Study,FG001,0.061515769138143,0.9127770129235688,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1966,NCT01623115,Adverse Event,Overall Study,FG001,0.0615151599306052,0.9127326020340188,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1967,NCT00641043,Withdrawal by Subject,Overall Study,FG000,0.0614949215956547,0.9126881911444686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1968,NCT02273050,Withdrawal by Subject,Overall Study,FG001,0.0614848229885615,0.9126437802549184,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1969,NCT01624142,Death,Overall Study,FG001,0.0614829595896229,0.9125993693653685,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1970,NCT01624142,Study Closure,Overall Study,FG001,0.0614804224042063,0.9125549584758182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1971,NCT00358215,Protocol Violation,Overall Study,FG001,0.0614173530268452,0.9125105475862682,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1972,NCT05024032,Withdrawal by Subject,Overall Study,FG001,0.0614111903799404,0.912466136696718,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1973,NCT00641043,Other incl. lack of efficacy,Overall Study,FG000,0.0614013312407539,0.912421725807168,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1974,NCT00996658,Non-compliance issues,Overall Study,FG001,0.0613582776621925,0.9123773149176178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1975,NCT00306384,Adverse Event,Overall Study,FG001,0.061321453978611,0.9123329040280675,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1976,NCT01729871,Adverse Event,Overall Study,FG000,0.0613175662822321,0.9122884931385176,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1977,NCT01729871,Adverse Event,Overall Study,FG001,0.0612969563715774,0.9122440822489676,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1978,NCT04520256,Lost to Follow-up,Overall Study,FG012,0.061274543192877,0.9121774659146422,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1979,NCT04520256,Lost to Follow-up,Overall Study,FG024,0.061274543192877,0.9121774659146422,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1980,NCT00345839,Withdrawal by Subject,Overall Study,FG001,0.0612576964348214,0.9121108495803172,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1981,NCT02064439,Efficacy outcome reached,Overall Study,FG002,0.0612301658543253,0.912066438690767,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1982,NCT00838916,Noncompliance,Treatment Period (156 Weeks),FG000,0.0611696075330194,0.9120220278012168,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1983,NCT03481634,Death,Overall Study,FG001,0.0611642863330456,0.9119776169116668,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1984,NCT01499095,Diverse Reasons,Overall Study,FG000,0.0611412992547122,0.9119332060221166,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1985,NCT03988634,Lost to Follow-up,Double-Blind,FG000,0.061096643618254,0.9118887951325664,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1986,NCT00508820,Requirement for alternative therapy,Overall Study,FG001,0.061092701151736,0.9118443842430164,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1987,NCT00479882,Clinical Adverse Event,Precrossover: Periods I/II (Weeks 1-12),FG003,0.0610819237238591,0.9117999733534664,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1988,NCT01031680,Subject No Longer Meets Study Criteria,Overall Study,FG000,0.0610638800011146,0.9117555624639162,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1989,NCT00696384,Protocol Violation,Open Label Phase,FG000,0.0610402640987995,0.911711151574366,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
1990,NCT00309244,Adverse Event,Overall Study,FG000,0.0610258818195138,0.911666740684816,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1991,NCT00839527,Withdrawal by Subject,Follow-up Period (FUP) (8 Weeks),FG002,0.0609667041354167,0.9116223297952658,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1992,NCT01009580,Unclassified,Overall Study,FG000,0.0609525944540674,0.9115779189057156,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1993,NCT02427802,Lost to Follow-up,Overall Study,FG000,0.0609348008077877,0.9115335080161656,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
1994,NCT00641043,Withdrawal by Subject,Overall Study,FG001,0.0608944421188591,0.9114890971266154,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1995,NCT01068665,Other,Overall Study,FG000,0.0608627657894047,0.9114446862370652,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
1996,NCT00641043,Adverse Event,Overall Study,FG001,0.0607609241796527,0.9114002753475152,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
1997,NCT00032487,Withdrawal by Subject,Overall Study,FG000,0.060738221248492,0.9113558644579652,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1998,NCT00853827,Withdrawal by Subject,Double Blind Period (103 Weeks),FG000,0.0606886507815277,0.911311453568415,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
1999,NCT04707469,Withdrawal by Subject,Overall Study,FG000,0.0606823650364781,0.9112670426788648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2000,NCT00385697,Withdrawal by Subject,Open-label Segment 1,FG000,0.0606805105027649,0.9112226317893148,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2001,NCT02110901,Death,Overall Study,FG000,0.0606692602943452,0.9111782208997646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2002,NCT01582854,Recurrent Stroke,Overall Study,FG000,0.0606465024772024,0.9111338100102144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2003,NCT01841697,Withdrawal by Subject,Overall Study,FG000,0.0606232859147421,0.9110893991206644,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2004,NCT01115855,Death,Overall Study,FG000,0.0606116254570138,0.9110449882311142,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2005,NCT01841697,Withdrawal by Subject,Overall Study,FG001,0.0605940230810119,0.911000577341564,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2006,NCT02023879,Adverse Event,Period 1: 24-Week Double-blind Treatment,FG002,0.0605889618516071,0.910956166452014,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2007,NCT00097981,Withdrawal by Subject,Overall Study,FG000,0.0605822416586805,0.910911755562464,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2008,NCT01115855,Other,Overall Study,FG001,0.0605525422370734,0.9108673446729136,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2009,NCT00558259,Withdrawal by Subject,Overall Study,FG000,0.0605273713497817,0.9108229337833637,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2010,NCT00894387,Adverse Event,Overall Study,FG000,0.0605265915603373,0.9107785228938136,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2011,NCT00960661,Withdrawal by Subject,Interventional Phase,FG002,0.0604822443138527,0.9107341120042636,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2012,NCT01475825,Withdrawal by Subject,Overall Study,FG000,0.0604683570127976,0.9106897011147134,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2013,NCT02674854,Adverse Event,Overall Study,FG001,0.0604564020435614,0.9106452902251632,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2014,NCT00660907,Withdrawal by Subject,Overall Study,FG000,0.0604139541159821,0.9106008793356132,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2015,NCT02715726,Other than specified above,Overall Study,FG000,0.0603699000840872,0.910556468446063,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2016,NCT01582451,Withdrawal by Subject,Overall Study,FG000,0.0603571007377382,0.9105120575565128,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2017,NCT01181102,Adverse Event,Overall Study,FG001,0.0603148723285217,0.9104676466669628,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2018,NCT00385697,Withdrawal by Subject,Double-blind Segment 2,FG004,0.0602222896856815,0.9104232357774126,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2019,NCT00385697,Other,Double-blind Segment 2,FG001,0.0601912010565149,0.9103788248878624,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2020,NCT00385697,Lost to Follow-up,Double-blind Segment 2,FG003,0.0601708709529434,0.9103344139983124,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2021,NCT00970489,Death/Withdrew/Criteria Violation,Overall Study,FG001,0.0601393890310515,0.9102900031087624,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2022,NCT01191268,Withdrawal by Subject,Overall Study,FG001,0.060132512750119,0.9102455922192122,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2023,NCT00433966,Lost to Follow-up,Pharmacology Intervention/Randomization,FG001,0.0601245897463194,0.910201181329662,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2024,NCT02203916,Voluntary Withdrawal,Overall Study,FG002,0.0601087876918155,0.910156770440112,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2025,NCT01507831,Adverse Event,Overall Study,FG000,0.0601036331558135,0.9101123595505618,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2026,NCT00860262,Withdrawal by Subject,Overall Study,FG001,0.0600957029966865,0.9100679486610116,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2027,NCT00479388,Adverse Event,Overall Study,FG001,0.0600868960819822,0.9100235377714616,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2028,NCT01644175,Poor compliance to protocol,Overall Study,FG000,0.0600823233215476,0.9099791268819114,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2029,NCT02304484,Withdrawal by Subject,Overall Study,FG000,0.0600713521443452,0.9099347159923612,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2030,NCT00922480,Withdrawal by Subject,Main Study,FG000,0.0600693828557142,0.9098903051028112,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2031,NCT03354273,COVID-19 Restrictions,Overall Study,FG000,0.0600644038163988,0.9098458942132612,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2032,NCT01375647,Withdrawal by Subject,Overall Study,FG000,0.0600157389640873,0.909801483323711,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2033,NCT03541174,Other reasons,Part 3 Double-Blind Withdrawal,FG004,0.0599623254810119,0.9097570724341608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2034,NCT01392573,Withdrawal Criteria,Overall Study,FG000,0.0599297394144146,0.9097126615446108,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2035,NCT04592419,Withdrawal by Subject,Open-Label Extension Period,FG001,0.0599000134819147,0.9096682506550606,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2036,NCT02733185,Lost to Follow-up,Overall Study,FG003,0.0598690858295534,0.9096238397655104,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2037,NCT01045447,Unclassified,Overall Study,FG000,0.0598356225869047,0.9095794288759604,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2038,NCT02284893,Withrawal of the consent by the subject,26 Week (Short Term),FG001,0.0598030763545437,0.9095350179864102,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2039,NCT00262600,Withdrawal by Subject,Overall Study,FG000,0.0597702962905356,0.90949060709686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2040,NCT01335399,Consent withdrawal,Treatment Period,FG000,0.0597647993405456,0.90944619620731,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2041,NCT04592419,Withdrawal by Subject,Primary Study (Through Year 1),FG000,0.0597455156139385,0.90940178531776,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2042,NCT04848480,Withdrawal by Subject,Main Phase (26 Weeks),FG001,0.0597105108985714,0.90935737442821,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2043,NCT00090519,Lost to Follow-up,Overall Study,FG000,0.0597090559596653,0.9093129635386596,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2044,NCT02926950,Reason not Specified,Overall Study,FG001,0.0596995269695535,0.9092685526491096,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2045,NCT02851407,Physician Decision,Overall Study,FG001,0.0596600798801388,0.9092241417595596,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2046,NCT02851407,Disease relapse,Overall Study,FG001,0.0596483099834721,0.9091797308700094,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2047,NCT02851407,"Adverse event, serious fatal",Overall Study,FG000,0.0596476837234721,0.9091353199804592,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2048,NCT00121667,Lack of Efficacy,Short Term (ST) Period,FG002,0.0596322038145435,0.9090909090909092,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2049,NCT01958671,Withdrawal by Subject,Overall Study,FG001,0.0596241017064881,0.909046498201359,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2050,NCT00313313,Withdrawal of consent by subject,Overall Study,FG002,0.0596161953283531,0.9090020873118088,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2051,NCT01676220,Received Rescue Therapy,Overall Study,FG001,0.059599077156746,0.9089576764222588,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2052,NCT02227875,Withdrawal by Subject,Overall Study,FG001,0.0595725526831384,0.9089132655327086,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2053,NCT04560998,Lost to Follow-up,Overall Study,FG000,0.0594971273997817,0.9088688546431584,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2054,NCT00126438,Lost to Follow-up,Overall Study,FG000,0.0594849739227479,0.9088244437536084,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2055,NCT00377676,Lost to Follow-up,Overall Study,FG000,0.0594206646684028,0.9087800328640584,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2056,NCT00576693,Withdrawal by Subject,Overall Study,FG001,0.0594202180479166,0.9087356219745082,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2057,NCT01908816,Death,Overall Study,FG002,0.0593917258361904,0.908691211084958,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2058,NCT00232180,Other,Double-blind (DB) Phase,FG000,0.0593727282300992,0.908646800195408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2059,NCT00142584,"Sponsor Termination of Study, etc.",Overall Study,FG001,0.0593566739476686,0.9086023893058578,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2060,NCT00286442,Hyperglycemic Rescue,Overall Study,FG002,0.0593307064872321,0.9085579784163076,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2061,NCT01210001,Adverse Event,Overall Study,FG002,0.0593258228623412,0.9085135675267576,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2062,NCT00142584,Withdrawal by Subject,Overall Study,FG001,0.0593257709518353,0.9084691566372074,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2063,NCT00553787,Withdrawal by Subject,Overall Study,FG002,0.0593127359694046,0.9084247457476572,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2064,NCT01131676,Other than those specified,Discontinuation From Treatment,FG002,0.0592957218534822,0.9083803348581072,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2065,NCT01306214,Withdrawal by Subject,Overall Study,FG002,0.0592883089284027,0.9083359239685572,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2066,NCT00424047,Death,Blinded Treatment (Up to 03 Aug 2005),FG001,0.0592485953033929,0.908291513079007,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2067,NCT01674647,Protocol Violation,Treatment Period,FG001,0.0591903307059225,0.9082471021894568,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2068,NCT00621140,Other incl. lack of efficacy,Overall Study,FG001,0.0591807199324107,0.9082026912999068,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2069,NCT00621140,Adverse Event,Overall Study,FG001,0.0591775575751885,0.9081582804103566,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2070,NCT04429503,Death,Extension Phase (Wk 96 to Wk 156),FG004,0.0591433199140206,0.9081138695208064,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2071,NCT02558296,Lost to Follow-up,Completed the Study,FG001,0.0591226132566368,0.9080694586312564,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2072,NCT00440193,Study terminated by sponsor,Treatment Period,FG000,0.0591007006627976,0.9080250477417062,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2073,NCT00417963,Withdrawal by Subject,Overall Study,FG000,0.0590777776232737,0.907980636852156,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2074,NCT04429503,Lost to Follow-up,Main Study (Up to Wk 96),FG002,0.0590693323622051,0.907936225962606,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2075,NCT05763875,Lost to Follow-up,Overall Study,FG000,0.059039340800377,0.907891815073056,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2076,NCT00485758,Withdrawal by Subject,Overall Study,FG000,0.0590022017112202,0.9078474041835058,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2077,NCT03199053,Withdrawal by Subject,LT Period,FG001,0.0589768267101487,0.9078029932939556,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2078,NCT01167881,Other not defined above,Overall Study,FG000,0.0589375636182242,0.9077585824044055,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2079,NCT01296412,Other reason not specified,Overall Study,FG000,0.0589332968739086,0.9077141715148556,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2080,NCT00439777,Withdrawal by Subject,Treatment Period,FG001,0.0589325365024008,0.9076697606253054,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2081,NCT00318461,Lack of Efficacy,"Open-Label Extension, 18 Months",FG000,0.0589311751062896,0.9076253497357551,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2082,NCT00380068,Withdrawal by Subject,Overall Study,FG000,0.0588981538268353,0.907580938846205,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2083,NCT03495102,Withdrawal by Subject,Overall Study,FG000,0.058890748010863,0.907536527956655,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2084,NCT00600483,Lost to Follow-up,Overall Study,FG001,0.0588784884174404,0.9074921170671048,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2085,NCT03199053,Lost to Follow-up,Non-treatment Follow-up Period,FG000,0.0588709638044642,0.9074477061775548,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2086,NCT03199053,Withdrawal by parent/guardian,Non-treatment Follow-up Period,FG001,0.058862082317232,0.9074032952880046,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2087,NCT00377676,Other,Overall Study,FG000,0.0588392359568551,0.9073588843984544,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2088,NCT00622284,Lost to Follow-up,Overall Study,FG001,0.0588364766128048,0.9073144735089044,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2089,NCT03199053,Withdrawal by Subject,LT Period,FG002,0.0588092245213392,0.9072700626193544,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2090,NCT01214239,Adverse Event,Overall Study,FG000,0.0587778916,0.9072256517298042,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2091,NCT02447172,Adverse Event,Overall Study,FG000,0.058757361417371,0.907181240840254,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2092,NCT02993406,Unclassifiable Response,Overall Study,FG001,0.0587009696171329,0.907136829950704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2093,NCT00271817,LDL < 50 mg/dL,Part 1,FG002,0.0586849853170635,0.9070924190611538,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2094,NCT01131676,"Refusal to continue, not due to AE",Discontinuation From Treatment,FG002,0.0586677425430059,0.9070480081716036,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2095,NCT02787551,Withdrawal by Subject,Core Period: 26 Weeks,FG000,0.0586184253925892,0.9070035972820536,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2096,NCT00770653,Adverse Event,Overall Study,FG000,0.058615670708621,0.9069591863925034,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2097,NCT02592824,Protocol Violation,Overall Study,FG000,0.0585947605130456,0.9069147755029532,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2098,NCT00168805,Other,Treatment,FG002,0.0585731666653174,0.9068703646134032,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2099,NCT00968812,Other,Overall Study,FG001,0.0585700412699702,0.9068259537238532,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2100,NCT05662332,Lost to Follow-up,Overall Study,FG001,0.0585690745099801,0.906781542834303,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2101,NCT00168805,Lost to Follow-up,Overall Study,FG001,0.0584817643751388,0.9067371319447528,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2102,NCT00329238,Protocol Violation,Overall Study,FG000,0.0584779491506944,0.9066927210552028,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2103,NCT01898923,Withdrawal by Subject,Overall Study,FG000,0.0584510422861905,0.9066483101656526,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2104,NCT02787551,Withdrawal by Subject,Core Period: 26 Weeks,FG001,0.0584085496456845,0.9066038992761024,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2105,NCT01898923,Physician Decision,Overall Study,FG001,0.058405577497877,0.9065594883865524,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2106,NCT05691712,Withdrawal by Subject,Overall Study,FG002,0.0583818016089584,0.9065150774970022,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2107,NCT03759392,Adverse Event,Overall Study,FG001,0.0583640408526984,0.906470666607452,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2108,NCT05691712,Withdrawal by Subject,Overall Study,FG001,0.0583529772574108,0.906426255717902,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2109,NCT01976312,Adverse Event,Overall Study,FG000,0.0583149436501786,0.906381844828352,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2110,NCT04462536,Withdrawal by Subject,Overall Study,FG001,0.0583012223633828,0.9063374339388018,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2111,NCT01976312,Adverse Event,Overall Study,FG001,0.0582755731060119,0.9062930230492516,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2112,NCT00707993,Adverse Event,Overall Study,FG000,0.0582617330238094,0.9062486121597016,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2113,NCT04591626,Adverse Event,Overall Study,FG000,0.0582411813850893,0.9062042012701514,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2114,NCT01798706,Other than specified above,Overall Study,FG001,0.0582237826976488,0.9061597903806012,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2115,NCT01023308,Death,Overall Study,FG001,0.058215281755992,0.9061153794910513,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2116,NCT00707993,Withdrawal by Subject,Overall Study,FG001,0.0581901477985217,0.906070968601501,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2117,NCT02320721,Other than specified above,Overall Study,FG001,0.0580856127906844,0.906026557711951,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2118,NCT01599650,Withdrawal by Subject,Overall Study,FG001,0.0580400767355952,0.9059821468224007,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2119,NCT01599650,Withdrawal by Subject,Overall Study,FG000,0.0580230406692857,0.9059377359328508,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2120,NCT04518306,Participant moved to open-label extension (OLE) study,Double-Blind Period,FG002,0.0580064891149034,0.9058933250433008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2121,NCT00553267,Adverse Event,Overall Study,FG000,0.0579210780518948,0.9058489141537504,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2122,NCT01164501,Adverse Event,Overall Study,FG002,0.0579017459735217,0.9058045032642004,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2123,NCT01818752,Death,Overall Study,FG001,0.0578985041198132,0.9057600923746504,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2124,NCT00106704,Patient Received Glycemic Medication,Overall Study,FG000,0.0578738464986507,0.9057156814851002,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2125,NCT01594333,Withdrawal by Subject,Overall Study,FG000,0.057834331761994,0.90567127059555,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2126,NCT00532779,Withdrawal by Subject,Overall Study,FG001,0.0578247792177091,0.905626859706,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2127,NCT02900378,Adverse Event,Randomization (Visit 2),FG001,0.0577762718379266,0.9055824488164498,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2128,NCT00739973,Patient withdrew consent,Single-blind Period (2 to 4 Weeks),FG000,0.057728848164861,0.9055380379268996,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2129,NCT01508910,Death,Treatment,FG001,0.0576929732225,0.9054936270373496,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2130,NCT02460978,Withdrawal by Subject,Overall Study,FG002,0.0576726421438591,0.9054492161477994,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2131,NCT00291330,Protocol Violation,Overall Study,FG001,0.0576522707870039,0.9054048052582492,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2132,NCT00853827,Withdrawal by Subject,Double Blind Period (103 Weeks),FG001,0.0576085013672781,0.9053603943686992,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2133,NCT01442038,Lost to Follow-up,Overall Study,FG001,0.057569968502629,0.9053159834791492,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2134,NCT01001572,Withdrawal by Subject,Single-Blind Valsartan 160 mg,FG000,0.0575656581239384,0.905271572589599,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2135,NCT04074161,Lost to Follow-up,Overall Study,FG001,0.0574937972174603,0.9052271617000488,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2136,NCT00568178,Lost to Follow-up,Open Label Extension,FG005,0.0574803152012797,0.9051827508104988,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2137,NCT01182441,Lost to Follow-up,Overall Study,FG001,0.0574666753170833,0.9051383399209486,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2138,NCT00763815,Familial and Personal Reasons,Overall Study,FG001,0.0574573453975459,0.9050939290313984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2139,NCT01299376,Blood Pressure/Potassium Criteria Met,Extension (Weeks 9 to 52),FG001,0.0574545586414086,0.9050495181418484,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2140,NCT03472040,Subject Non-compliance,Overall Study,FG001,0.0574280191787301,0.9050051072522982,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2141,NCT00553787,Lost to Follow-up,Overall Study,FG002,0.0574230603407836,0.904960696362748,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2142,NCT03351478,At the subject's own request,Overall Study,FG001,0.0574011931137599,0.904916285473198,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2143,NCT00536744,Withdrawal by Subject,Overall Study,FG001,0.0573904599951984,0.904871874583648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2144,NCT05412004,Assigned Treatment by Mistake,Overall Study,FG000,0.0573836423954663,0.9048274636940978,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2145,NCT00568178,Adverse Event,Open Label Extension,FG004,0.0573832843816964,0.9047830528045476,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2146,NCT01294436,subject no longer meets study criteria,Overall Study,FG001,0.0573672343800433,0.9047386419149976,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2147,NCT03548987,Adverse Event,Maintenance Period (Week 20 to Week 68),FG000,0.0573559426810515,0.9046942310254474,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2148,NCT00485758,Adverse Event,Overall Study,FG001,0.0573058173231646,0.9046498201358972,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2149,NCT03585270,Death,Overall Study,FG000,0.0572737235871825,0.9046054092463472,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2150,NCT01131676,"Refusal to continue, not due to AE",Discontinuation From Treatment,FG001,0.0572458619512698,0.904560998356797,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2151,NCT04657003,Withdrawal by Subject,Overall Study,FG002,0.0572063698581348,0.904516587467247,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2152,NCT01734785,Lost to Follow-up,Open-Label Period,FG003,0.057195844069256,0.9044721765776969,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2153,NCT00961636,Adverse Event,Overall Study,FG000,0.0571786193405456,0.9044277656881468,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2154,NCT01644188,Last visit outside protocol visit window,Overall Study,FG001,0.0571723364004067,0.9043833547985968,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2155,NCT03585270,Adverse Event,Overall Study,FG000,0.0571554846964682,0.9043389439090465,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2156,NCT04657003,Lost to Follow-up,Overall Study,FG002,0.057087835559355,0.9042945330194964,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2157,NCT00121641,Subject Withdrew Consent,48-month Short Term + Long Term Period,FG002,0.0570460285050297,0.9042501221299464,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2158,NCT00143598,Lost to Follow-up,Overall Study,FG000,0.0570424383329265,0.9042057112403962,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2159,NCT02507687,Adverse Event,Overall Study,FG000,0.0570369482584821,0.904161300350846,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2160,NCT01451398,Withdrawal by Subject,Overall Study,FG000,0.0570266102278671,0.904116889461296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2161,NCT02181413,Lost to Follow-up,Overall Study,FG001,0.0570089954489385,0.9040724785717458,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2162,NCT02513303,Lost to Follow-up,Overall Study,FG001,0.0570029572500198,0.9040280676821956,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2163,NCT00168818,Withdrawal by Subject,Treatment,FG000,0.0569991470047619,0.9039836567926456,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2164,NCT00507416,Patient declined further treatment,Overall Study,FG001,0.0569856171783964,0.9039392459030956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2165,NCT00536510,Adverse Event,Overall Study,FG000,0.0569761005793254,0.9038948350135452,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2166,NCT02513303,Death,Overall Study,FG001,0.0569000927559127,0.9038504241239952,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2167,NCT01999218,Lost to Follow-up,Overall Study,FG000,0.0568499947267748,0.9038060132344452,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2168,NCT01027949,Protocol Violation,Overall Study,FG000,0.0568328981237599,0.903761602344895,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2169,NCT00497146,Withdrawal by Subject,Long-term Follow-up Period,FG000,0.0567835678796725,0.9037171914553448,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2170,NCT01763918,Sponsor Decision,Overall Study,FG002,0.0567804294536905,0.9036727805657948,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2171,NCT00330759,Adverse Event,Overall Study,FG000,0.056749371161865,0.9036283696762446,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2172,NCT01926782,Adverse Event,Overall Study,FG002,0.0567199874506646,0.9035839587866944,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2173,NCT05412004,Adverse Event,Overall Study,FG003,0.0566953715857242,0.9035395478971444,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2174,NCT05412004,Assigned Treatment by Mistake,Overall Study,FG003,0.0566881945603075,0.9034951370075942,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2175,NCT00168805,Adverse Event,Overall Study,FG002,0.0566440341674801,0.903450726118044,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2176,NCT01652716,Adverse Event,Overall Study,FG001,0.0566254133081448,0.903406315228494,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2177,NCT00332488,Various,Transfer Treatment Phase (Weeks 12 - 24),FG002,0.0566070189877381,0.903361904338944,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2178,NCT03332771,At the Participant's own request,Overall Study,FG002,0.0565352570393452,0.9033174934493938,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2179,NCT00273052,Lost to Follow-up,Overall Study,FG001,0.0565266391099503,0.9032730825598436,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2180,NCT01890122,Lack of Efficacy,Overall Study,FG000,0.0565000972817361,0.9032286716702936,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2181,NCT03917472,Death,Overall Study,FG000,0.0564889558921726,0.9031842607807434,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2182,NCT00781937,Unclassified,Main Trial Period Through Week 56,FG001,0.0564847745867361,0.9031398498911932,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2183,NCT00759681,Lost to Follow-up,Overall Study,FG000,0.0564846132578868,0.9030954390016432,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2184,NCT00622336,Other,Extension Phase,FG000,0.0564588098528373,0.903051028112093,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2185,NCT00044213,Death,Overall Study,FG001,0.0564581018059226,0.9030066172225428,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2186,NCT00856284,Voluntary withdrawal,Overall Study,FG002,0.0564529660883035,0.9029622063329928,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2187,NCT00518882,Completed extension 1 (weeks 26-40),"Open-Label Extension, Week 26-78",FG000,0.0564516063116666,0.9029177954434427,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2188,NCT01830543,Other,Overall Study,FG002,0.0564276904839303,0.9028733845538928,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2189,NCT00306384,Other,Overall Study,FG000,0.0564026695294146,0.9028289736643424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2190,NCT04233801,Withdrawal by Subject,Overall Study,FG002,0.056371697740119,0.9027845627747924,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2191,NCT00044213,Death,Overall Study,FG002,0.0563336673154861,0.9027401518852424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2192,NCT00168805,Withdrawal by Subject,Overall Study,FG000,0.0563115053878372,0.9026957409956922,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2193,NCT00044213,Death,Overall Study,FG000,0.0562864839206051,0.902651330106142,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2194,NCT02227875,Withdrawal by Subject,Overall Study,FG000,0.0562831964445535,0.902606919216592,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2195,NCT00739674,No follow-up data,Overall Study,FG000,0.0562144272726785,0.9025625083270418,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2196,NCT00106704,Withdrawal by Subject,Overall Study,FG001,0.0561518739759325,0.9025180974374916,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2197,NCT00121667,Subject Withdrew Consent,Short Term (ST) + Long Term (LT) Period,FG002,0.0561098542610019,0.9024736865479416,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2198,NCT04184622,Withdrawal by Subject,Primary Treatment Period,FG003,0.0560836353615972,0.9024292756583916,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2199,NCT04184622,Other - as reported by the investigator,Primary Treatment Period,FG000,0.0560687004039511,0.9023848647688412,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2200,NCT05662332,Assigned Treatment by Mistake,Overall Study,FG001,0.056053423931508,0.9023404538792912,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2201,NCT00271817,Withdrawal by Subject,Part 1,FG002,0.0560504932013988,0.9022960429897412,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2202,NCT00604383,Withdrawal by Subject,Overall Study,FG000,0.0560280185316567,0.902251632100191,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2203,NCT04184622,Withdrawal by Subject,Additional Treatment Period,FG000,0.0560252494439511,0.9022072212106408,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2204,NCT01854918,Lost to Follow-up,All-IP Period (Years 2 and 3),FG001,0.0560165502007539,0.9021628103210908,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2205,NCT00633893,Adverse Event,Overall Study,FG001,0.0559758930097862,0.9021183994315406,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2206,NCT00624052,Adverse Event,Overall Study,FG000,0.0559503178364286,0.9020739885419904,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2207,NCT04445519,Adverse Event,Overall Study,FG001,0.0558639364699503,0.9020295776524404,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2208,NCT00308139,Lost to Follow-up,Overall Study,FG001,0.0558496992930853,0.9019851667628904,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2209,NCT01539083,Other,Before Randomization (VCD Induction),FG000,0.0558480483787202,0.90194075587334,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2210,NCT00433966,Lost to Follow-up,Pharmacology Intervention/Randomization,FG000,0.0558274558912003,0.90189634498379,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2211,NCT03735979,Withdrawal by Subject,Overall Study,FG001,0.0557965119499503,0.90185193409424,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2212,NCT00345839,Withdrawal by Subject,Overall Study,FG000,0.0557941094126731,0.9018075232046898,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2213,NCT00550953,Not able to visit the site,Overall Study,FG001,0.0557755364108433,0.9017631123151396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2214,NCT00554216,Withdrawal by Subject,Overall Study,FG002,0.0557667538023619,0.9017187014255896,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2215,NCT01539083,Withdrawal by Subject,After Randomization (TP and VTP),FG001,0.0557664843291964,0.9016742905360394,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2216,NCT04707469,Withdrawal by Subject,Overall Study,FG001,0.0557406370759524,0.9016298796464892,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2217,NCT00550953,Adverse Event,Overall Study,FG001,0.0557283352877282,0.9015854687569392,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2218,NCT02558231,Lost to Follow-up,Overall Study,FG001,0.0557055863188392,0.901541057867389,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2219,NCT01320722,Adverse Event,Overall Study,FG003,0.0557028635265178,0.9014966469778388,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2220,NCT03730662,Withdrawal by Subject,Treatment Period (52 Weeks),FG003,0.0556892448860119,0.9014522360882888,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2221,NCT02558231,Withdrawal by Subject,Overall Study,FG001,0.0556811856196131,0.9014078251987389,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2222,NCT04873934,Withdrew consent,Overall Study,FG001,0.0556800543732143,0.9013634143091886,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2223,NCT00972283,Adverse Event,Main: Week 0 to 52 (NN1250-3582),FG000,0.0556714450335416,0.9013190034196384,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2224,NCT00910429,Lack of Efficacy,Overall Study,FG000,0.0556613598681051,0.9012745925300883,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2225,NCT00849056,Withdrawal by Subject,Follow-up Period (FUP) (8 Weeks),FG000,0.0556419244696526,0.9012301816405384,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2226,NCT00808067,Adverse Event,Overall Study,FG001,0.0556359388674602,0.9011857707509882,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2227,NCT02648347,Lost to Follow-up,Overall Study,FG001,0.0556184962351983,0.901141359861438,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2228,NCT03110562,Other,Initial Treatment Period,FG000,0.0555993350922619,0.901096948971888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2229,NCT00849056,Lost to Follow-up,Follow-up Period (FUP) (8 Weeks),FG001,0.0555930567429761,0.9010525380823378,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2230,NCT02558231,Death,Overall Study,FG000,0.0555920016442956,0.9010081271927876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2231,NCT00532779,Adverse Event,Overall Study,FG002,0.0555714679237012,0.9009637163032376,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2232,NCT01336023,Withdrawal Criteria,Week 0 to Week 26,FG002,0.0555692979067261,0.9009193054136876,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2233,NCT01648582,Withdrawal by Subject,Overall Study,FG002,0.0555315051361706,0.9008748945241372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2234,NCT00699998,Withdrawal by Subject,Overall Study,FG002,0.0555247252447817,0.9008304836345872,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2235,NCT01648582,Withdrawal by Subject,Overall Study,FG001,0.055524260157748,0.9007860727450372,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2236,NCT00439725,Adverse Event,Treatment Period,FG000,0.055496092609861,0.900741661855487,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2237,NCT02942576,Other,Overall Study,FG000,0.0554757197267063,0.9006972509659369,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2238,NCT00377676,Adverse Event,Overall Study,FG001,0.0554458818984722,0.9006528400763867,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2239,NCT05142722,Withdrawal by Subject,Overall Study,FG000,0.0553899943419272,0.9006084291868366,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2240,NCT01558271,Withdrawal by Subject,Overall Study,FG002,0.0553824710034524,0.9005640182972865,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2241,NCT01363440,Withdrawal by Subject,Overall Study,FG001,0.0553531695169345,0.9005196074077364,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2242,NCT02586155,Other reasons,Overall Study,FG000,0.0553496507795039,0.9004751965181863,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2243,NCT01177813,Adverse Event,Overall Study,FG000,0.0553289203865575,0.9004307856286361,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2244,NCT00838916,Lost to Follow-up,Treatment Period (156 Weeks),FG000,0.0552819725803201,0.900386374739086,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2245,NCT01363440,Withdrawal by Subject,Overall Study,FG002,0.0552609527653869,0.9003419638495359,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2246,NCT01106625,Unable to take rescue therapy,Extension Period: Week 26 to Week 52,FG000,0.055235369888611,0.9002975529599858,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2247,NCT02634333,Missed Visit,Overall Study,FG000,0.0552338209297917,0.9002531420704357,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2248,NCT01617434,Withdrawal Criteria,Overall Study,FG000,0.0552317945869245,0.9002087311808855,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2249,NCT00622284,Protocol Violation,Overall Study,FG000,0.0552274601774206,0.9001643202913354,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2250,NCT00439777,Adverse Event,Treatment Period,FG000,0.0552016228734821,0.9001199094017853,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2251,NCT01617434,Adverse Event,Overall Study,FG000,0.0551908133856745,0.9000754985122352,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2252,NCT00838903,Adverse Event,Treatment Period (156 Weeks),FG003,0.0551684918542064,0.9000310876226851,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2253,NCT02059187,Withdrawal by Subject,Overall Study,FG000,0.0551602047912302,0.8999866767331349,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2254,NCT02733185,Withdrawal by Subject,Overall Study,FG001,0.055102900375744,0.8999422658435848,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2255,NCT02229396,Adverse Event,Overall Study,FG001,0.0550773627810714,0.8998978549540347,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2256,NCT04252287,Lost to Follow-up,Overall Study,FG001,0.0550701935318154,0.8998534440644846,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2257,NCT00699998,Withdrawal by Subject,Overall Study,FG000,0.0550139494786507,0.8998090331749345,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2258,NCT00082407,Adverse Event,Overall Study,FG000,0.0550109539391369,0.8997646222853843,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2259,NCT00689936,Death,Active Treatment Phase,FG001,0.0550085223571049,0.8997202113958342,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2260,NCT00856284,Adverse Event,Overall Study,FG000,0.0550056972280951,0.8996758005062842,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2261,NCT02152371,Withdrawal by Subject,Overall Study,FG001,0.0549906404151488,0.8996313896167341,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2262,NCT02229396,Adverse Event,Overall Study,FG002,0.0549567010130952,0.8995869787271839,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2263,NCT01388361,Withdrawal criteria,Overall Study,FG000,0.0549365915523412,0.8995425678376338,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2264,NCT01475825,Withdrawal by Subject,Overall Study,FG003,0.0549014784245932,0.8994981569480837,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2265,NCT02398188,Withdrawal by Subject,Overall Study,FG001,0.054895128075119,0.8994537460585336,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2266,NCT01819129,Withdrawal by Subject,Overall Study,FG000,0.0548674925490973,0.8994093351689835,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2267,NCT01137812,Adverse Event,Overall Study,FG000,0.0548511796380357,0.8993649242794333,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2268,NCT01734785,Protocol Violation,Open-Label Period,FG003,0.0548302626166766,0.8993205133898832,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2269,NCT01151410,Withdrawal by Subject,Overall Study,FG001,0.0548227549072916,0.8992761025003331,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2270,NCT00440193,Study terminated by sponsor,Treatment Period,FG001,0.054822110657609,0.899231691610783,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2271,NCT00601250,Lost to Follow-up,Overall Study,FG001,0.0547955812882044,0.8991872807212329,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2272,NCT00860262,Adverse Event,Overall Study,FG002,0.0547640548593253,0.8991428698316827,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2273,NCT01819129,Withdrawal by Subject,Overall Study,FG001,0.0547223621336508,0.8990984589421326,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2274,NCT00082628,Subjects Did Not Complete Week 36,Treatment Period II: Week 12 to Week 36,FG004,0.0546933131613591,0.8990540480525825,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2275,NCT00567255,Lost to Follow-up,Overall Study,FG001,0.0546859332593451,0.8990096371630324,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2276,NCT00798161,Other reason (incl. lack of efficacy),Overall Study,FG000,0.0546624429059325,0.8989652262734823,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2277,NCT02229227,Adverse Event,Overall Study,FG000,0.0546475044359821,0.8989208153839321,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2278,NCT00877929,Other reason (not specified),Overall Study,FG001,0.0546455551344445,0.898876404494382,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2279,NCT03768427,Withdrawal by Subject,Overall Study,FG002,0.0546017596649404,0.8988319936048319,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2280,NCT03819153,Lost to Follow-up,Overall Study,FG001,0.0545898289800523,0.8987875827152818,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2281,NCT02312258,Lost to Follow-up,Overall Study,FG000,0.0545799145181745,0.8987431718257317,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2282,NCT01819129,Withdrawal Criteria,Overall Study,FG001,0.0545604759504365,0.8986987609361815,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2283,NCT03481634,Death,Overall Study,FG002,0.0545368010862797,0.8986543500466314,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2284,NCT00976391,Adverse Event,Treatment Period (52 Weeks),FG000,0.0545335714094471,0.8986099391570813,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2285,NCT00311402,IRB's rejection etc.,Overall Study,FG000,0.0545306796760813,0.8985655282675312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2286,NCT02312258,Lost to Follow-up,Overall Study,FG001,0.0545250681193253,0.8985211173779811,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2287,NCT02681094,Study specific discontinuation criteria,2 - Enrolled Participants Set,FG001,0.05449099740125,0.8984767064884309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2288,NCT03481634,Adverse Event,Overall Study,FG002,0.0544901090925297,0.8984322955988808,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2289,NCT02988115,Adverse Event,Overall Study,FG000,0.0544715962201677,0.8983878847093307,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2290,NCT03548987,other,Maintenance Period (Week 20 to Week 68),FG000,0.0544494415946528,0.8983434738197806,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2291,NCT01310777,Adverse Event,Overall Study,FG002,0.0543694139835849,0.8982990629302305,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2292,NCT00657150,Other,Treatment,FG001,0.0543623065759523,0.8982546520406803,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2293,NCT00139659,Adverse Event,Overall Study,FG000,0.054330767775496,0.8982102411511302,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2294,NCT03338010,Withdrawal by Subject,Overall Study,FG001,0.0543147712836111,0.8981658302615801,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2295,NCT01644175,Adverse Event,Overall Study,FG000,0.054246908968869,0.89812141937203,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2296,NCT02683746,Lost to Follow-up,Overall Study,FG001,0.0541567181339583,0.89807700848248,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2297,NCT00168818,Other,Overall Study,FG001,0.0541130890605952,0.8980325975929297,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2298,NCT00266695,Death,Overall Study,FG000,0.0540295953846329,0.8979881867033797,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2299,NCT02683746,Withdrawal by Subject,Overall Study,FG000,0.0540083356243154,0.8979437758138296,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2300,NCT01763905,Decision by sponsor,Overall Study,FG002,0.0539861672805357,0.8978993649242795,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2301,NCT00549302,Adverse Event,Open-Label,FG002,0.0539728554051288,0.8978549540347294,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2302,NCT04660643,Lost to Follow-up,Double-blind Study Period (Week 36 - 92),FG002,0.0539658528382836,0.8978105431451792,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2303,NCT00417963,Death,Overall Study,FG000,0.0539656444488392,0.8977661322556291,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2304,NCT01217476,Adverse Event,Overall Study,FG000,0.0539629950007737,0.897721721366079,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2305,NCT01330628,Lost to Follow-up,Overall Study,FG001,0.0539405395554762,0.8976773104765289,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2306,NCT01330628,Withdrawn,Overall Study,FG001,0.0539381639908929,0.8976328995869787,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2307,NCT04660643,Other - as reported by the investigator,Double-blind Study Period (Week 36 - 92),FG001,0.0539226260589086,0.8975884886974286,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2308,NCT02344290,Unable to get to clinic,Overall Study,FG000,0.0539171445884948,0.8975440778078785,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2309,NCT03180736,Adverse Event,Overall Study,FG000,0.053870687300873,0.8974996669183284,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2310,NCT00575588,Withdrawal by Subject,Overall Study,FG000,0.0538662596059325,0.8974552560287783,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2311,NCT01181167,Adverse Event,Overall Study,FG001,0.0538294878938293,0.8974108451392281,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2312,NCT02064439,Adverse Event,Overall Study,FG000,0.0538275673090376,0.897366434249678,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2313,NCT01194830,Other Reason,Overall Study,FG001,0.0538232251535758,0.8973220233601279,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2314,NCT00159861,Adverse Event,Extension Study - up to 3 Years,FG001,0.0538191394292758,0.8972776124705778,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2315,NCT02096705,Adverse Event,Treatment,FG000,0.0538166361059919,0.8972332015810277,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2316,NCT00643201,Other,"Randomized, Completed 6 Months of Study",FG000,0.0537885439158531,0.8971887906914775,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2317,NCT00159861,Adverse Event,Extension Study - up to 3 Years,FG000,0.0537818358010615,0.8971443798019274,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2318,NCT00643201,Other,"Randomized, Completed 6 Months of Study",FG001,0.0537817009619841,0.8970999689123773,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2319,NCT01778049,Adverse Event,Open Label Treatment Period,FG001,0.0537337247414186,0.8970555580228272,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2320,NCT00121667,Lack of Efficacy,Short Term (ST) Period,FG000,0.0537328476889187,0.8970111471332771,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2321,NCT01560637,Other Reason Not Specified,Overall Study,FG000,0.0537212540229762,0.8969667362437269,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2322,NCT01176240,Lack of Efficacy,Study 306A,FG000,0.0537030827926387,0.8969223253541768,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2323,NCT03180736,randomized but not treated,Overall Study,FG001,0.0536158702243056,0.8968779144646267,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2324,NCT01387737,Withdrawal by Subject,Overall Study,FG001,0.0535884426169841,0.8968335035750766,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2325,NCT03214380,Withdrawal by Subject,Lead-in,FG003,0.0535840125346825,0.8967890926855265,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2326,NCT01289990,did not continue in extension,Overall Study,FG012,0.0535782031736607,0.8967446817959763,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2327,NCT05478252,Lost to Follow-up,Overall Study,FG000,0.0534852720756771,0.8967002709064262,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2328,NCT01599650,Withdrawal by Subject,Overall Study,FG002,0.0534814392781349,0.8966558600168761,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2329,NCT01492361,Other than specified above,Overall Study,FG000,0.0534754800539718,0.896611449127326,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2330,NCT03693430,Withdrawal by Subject,Overall Study,FG001,0.0534310391083036,0.896567038237776,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2331,NCT01106690,Other,Core Period: Baseline to Week 26,FG000,0.0534284638176785,0.8965226273482257,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2332,NCT00712673,Adverse Event,Overall Study,FG002,0.0533997628798511,0.8964782164586756,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2333,NCT00386607,Lost to Follow-up,Core,FG000,0.0533968540585912,0.8964338055691256,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2334,NCT00386607,Unsatisfactory therapeutic effect,Core,FG000,0.0533941217427579,0.8963893946795755,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2335,NCT03882970,Withdrawal by Subject,Overall Study,FG001,0.0533837238174801,0.8963449837900254,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2336,NCT01406717,Lost to Follow-up,Overall Study,FG001,0.0533772908071825,0.8963005729004752,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2337,NCT00736099,Lack of Efficacy,Overall Study,FG000,0.0532826829931547,0.8962561620109251,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2338,NCT01176240,Supine Hypertension,Study 306B,FG001,0.0532618154062498,0.896211751121375,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2339,NCT02104817,Other reasons,Overall Study,FG001,0.0531937835333035,0.8961673402318249,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2340,NCT00108082,Adverse Event,Overall Study,FG001,0.0531638987085912,0.8961229293422748,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2341,NCT04740905,Lost to Follow-up,Part 2 (Week 24 to Week 72),FG001,0.053162866234668,0.8960785184527246,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2342,NCT01176240,Protocol Violation,Study 306B,FG000,0.0531372521636506,0.8959896966736244,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2343,NCT01176240,Physician Decision,Study 306B,FG000,0.0531372521636506,0.8959896966736244,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2344,NCT01176240,withdrew prior to dosing,Study 306B,FG000,0.0531372521636506,0.8959896966736244,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2345,NCT01178073,Physician Decision,Overall Study,FG000,0.0531206006310615,0.8959008748945242,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2346,NCT00330759,Other,Overall Study,FG001,0.0530925671124305,0.895856464004974,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2347,NCT00113087,Family or MD withdrew subject,Overall Study,FG000,0.0530788310237401,0.8958120531154239,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2348,NCT02207634,Withdrawal by Subject,Overall Study,FG001,0.0530765287738095,0.8957676422258738,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2349,NCT00087516,Protocol specified discontinuation,Overall Study,FG002,0.0530679692129265,0.8957232313363237,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2350,NCT00424047,Withdrawal by Subject,On Study at Time of Unblinding,FG001,0.0530135100802976,0.8956788204467735,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2351,NCT00982644,Unclassified,Main: Week 0 to 52 (NN1250-3579),FG001,0.0530078623557738,0.8956344095572234,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2352,NCT00087516,Protocol specified discontinuation,Overall Study,FG001,0.053000496403492,0.8955899986676733,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2353,NCT00830960,Withdrawal by Subject,Overall Study,FG003,0.0529820778686904,0.8955455877781232,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2354,NCT01059812,Unclassified,Overall Study,FG000,0.0529452224224404,0.8955011768885731,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2355,NCT00032487,Lost to Follow-up,Overall Study,FG001,0.0529244419977092,0.8954567659990229,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2356,NCT00789737,Other,Overall Study,FG000,0.0528962275195679,0.8954123551094728,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2357,NCT02505334,Withdrawal by Subject,Main Treatment Period,FG001,0.0528662293035119,0.8953679442199227,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2358,NCT00289848,Lack of Efficacy,Overall Study,FG001,0.0528623652043452,0.8953235333303726,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2359,NCT01703221,Lack of Efficacy,Phase B - (Week 25 to 52),FG001,0.0528459665723908,0.8952791224408225,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2360,NCT01854918,Withdrawal by Subject,SOC-controlled Period (Year 1),FG001,0.0528450590585714,0.8952347115512723,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2361,NCT00838916,Lost to Follow-up,Treatment Period (156 Weeks),FG001,0.0527980355560542,0.8951903006617222,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2362,NCT00507416,Progressive Disease,Overall Study,FG002,0.0527940645336805,0.8951458897721721,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2363,NCT04807400,Withdrawal by Subject,Overall Study,FG001,0.0527805645641071,0.895101478882622,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2364,NCT00838903,Lost to Follow-up,Follow-up Period (8 Weeks),FG003,0.0527797702853301,0.8950570679930719,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2365,NCT00507416,Other,Overall Study,FG002,0.0527758111753472,0.8950126571035217,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2366,NCT00602472,Withdrawal by Subject,Overall Study,FG000,0.0527202951812102,0.8949682462139716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2367,NCT00129545,Withdrawal by Subject,Overall Study,FG001,0.0526594554153598,0.8949238353244215,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2368,NCT03819153,Withdrawal by Subject,Overall Study,FG001,0.0526573085711607,0.8948794244348715,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2369,NCT01068678,Unclassified,Overall Study,FG001,0.0526565397352976,0.8948350135453214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2370,NCT00368277,Adverse Event,Overall Study,FG000,0.0526353857071924,0.8947906026557712,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2371,NCT02314637,Adverse Event,Overall Study,FG001,0.0525814248926532,0.894746191766221,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2372,NCT02463071,Reason not specified,Overall Study,FG000,0.0525359895602868,0.894701780876671,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2373,NCT00142584,Adverse Event,Overall Study,FG000,0.0525040609952579,0.8946573699871209,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2374,NCT02555878,Physician Decision,Overall Study,FG001,0.0524626043763095,0.8946129590975708,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2375,NCT01179048,Alive,Overall Study,FG001,0.0524574268228174,0.8945685482080206,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2376,NCT02284893,Adverse Event,26 Week (Short Term),FG001,0.052450080730744,0.8945241373184705,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2377,NCT01764386,"Withdrawal of Consent,Protocol Deviation",Controlled Treatment Period (CTP),FG000,0.052442993667242,0.8944797264289204,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2378,NCT00968708,Voluntary Withdrawal,Overall Study,FG000,0.0524291614252579,0.8944353155393703,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2379,NCT03325556,Withdrawal by Subject,Double-blind Period,FG001,0.0524251685971924,0.8943909046498202,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2380,NCT01355159,Withdrew consent,Overall Study,FG000,0.0523990029425099,0.89434649376027,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2381,NCT01818752,Non-compliance,Overall Study,FG000,0.0523823357251388,0.8943020828707199,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2382,NCT00318461,Lack of Efficacy,"Open-Label Extension, 18 Months",FG002,0.0523349434644155,0.8942576719811698,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2383,NCT03725202,Adverse Event,Period 2 (Week 52 - Week 104),FG006,0.0523197352501786,0.8942132610916197,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2384,NCT04844918,Withdrawal by Subject,Overall Study,FG001,0.052275633221801,0.8941688502020696,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2385,NCT04844918,Withdrawal by Subject,Overall Study,FG002,0.0522605130785867,0.8941244393125194,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2386,NCT01115855,Withdrawal by Subject,Overall Study,FG001,0.0522558541799206,0.8940800284229693,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2387,NCT05963022,Withdrawal by Subject,Overall Study,FG002,0.0522391114483433,0.8940356175334192,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2388,NCT02025621,No longer eligible,Overall Study,FG001,0.0522300530925694,0.8939912066438691,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2389,NCT00143598,Lost to Follow-up,Overall Study,FG001,0.0522262000364619,0.893946795754319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2390,NCT01115855,Death,Overall Study,FG001,0.0522082300168849,0.8939023848647688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2391,NCT01656889,Adverse Event,"Treatment Period, 12 Weeks",FG000,0.052196841558492,0.8938579739752187,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2392,NCT00484198,Participant Withdrew Consent,Overall Study,FG003,0.0521721266760515,0.8938135630856686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2393,NCT02277691,Voluntary Withdrawal,Overall Study,FG000,0.0521239602764782,0.8937691521961185,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2394,NCT00032487,Lost to Follow-up,Overall Study,FG000,0.0521174254189394,0.8937247413065683,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2395,NCT01115855,Withdrawal by Subject,Overall Study,FG000,0.0521139439943254,0.8936803304170182,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2396,NCT00839527,Noncompliance,Treatment Period (TP) (156 Weeks),FG002,0.0520976114686011,0.8936359195274681,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2397,NCT01582854,Withdrawal by Participant,Overall Study,FG001,0.0520938759475397,0.893591508637918,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2398,NCT00796367,Lost to Follow-up,Overall Study,FG002,0.0520913852983928,0.8935470977483679,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2399,NCT03888066,Physician Decision,Treatment Phase (Overall Study),FG001,0.0520741798937698,0.8935026868588177,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2400,NCT03888066,Protocol Violation,Run-in Phase,FG000,0.0520333701479365,0.8934582759692676,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2401,NCT02943785,Other,Overall Study,FG000,0.0520306818759623,0.8934138650797175,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2402,NCT02427802,protocol specific treatment unrelated,Overall Study,FG001,0.0519886753008522,0.8933694541901674,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2403,NCT02926950,Lost to Follow-up,Overall Study,FG001,0.051958386766498,0.8933250433006173,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2404,NCT04072835,Death,Overall Study,FG000,0.0519460702900063,0.8932806324110671,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2405,NCT03351478,At the subject's own request,Overall Study,FG000,0.0519135739020535,0.893236221521517,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2406,NCT00902174,Adverse Event,Overall Study,FG001,0.0519070937719092,0.893191810631967,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2407,NCT00637273,Withdrawal of Consent,Overall Study,FG000,0.0519069556719344,0.8931473997424169,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2408,NCT01106651,Adverse Event,Overall Study,FG000,0.0518691365136408,0.8931029888528668,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2409,NCT00637273,Withdrawal of Consent,Overall Study,FG002,0.0518638683660415,0.8930585779633166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2410,NCT00306384,Other,Overall Study,FG001,0.0518232825441612,0.8930141670737665,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2411,NCT03541174,Lost to Follow-up,Part 2 Single-Blind,FG003,0.0518166736642559,0.8929697561842164,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2412,NCT00739674,Lost to Follow-up,Overall Study,FG001,0.0518042023719742,0.8929253452946663,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2413,NCT03541174,Adverse Event,Part 3 Double-Blind Withdrawal,FG004,0.0518029461210615,0.8928809344051162,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2414,NCT02427802,Withdrawal by Subject,Overall Study,FG002,0.0517919880678869,0.892836523515566,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2415,NCT02427802,protocol specific treatment unrelated,Overall Study,FG002,0.0517909077658522,0.8927921126260159,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2416,NCT00168818,Other,Treatment,FG000,0.051782371191756,0.8927477017364658,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2417,NCT02585778,Participant did not wish to continue,Overall Study,FG000,0.0517366266865368,0.8927032908469157,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2418,NCT02501161,Withdrawal by Subject,Overall Study,FG001,0.0517321045943651,0.8926588799573656,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2419,NCT00097981,Disease Progression,Overall Study,FG000,0.0516917200142558,0.8926144690678154,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2420,NCT01535261,Lost to Follow-up,Overall Study,FG000,0.0516802409128769,0.8925700581782653,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2421,NCT02427802,Adverse Event,Overall Study,FG000,0.0516725843333522,0.8925256472887152,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2422,NCT01535261,Physician Decision,Overall Study,FG000,0.0516356916232936,0.8924812363991651,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2423,NCT01582451,Protocol Violation,Overall Study,FG000,0.0516187399479463,0.892436825509615,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2424,NCT00630877,Adverse Event,Overall Study,FG000,0.0516052211325198,0.8923924146200648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2425,NCT02058147,Adverse Event,Overall Study,FG002,0.0516027477675396,0.8923480037305147,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2426,NCT00622284,Lost to Follow-up,Overall Study,FG000,0.0515420537041666,0.8923035928409646,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2427,NCT01387737,Adverse Event,Overall Study,FG001,0.0515151782485416,0.8922591819514145,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2428,NCT00168818,Adverse Event,Overall Study,FG000,0.0515143084901488,0.8922147710618644,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2429,NCT01326026,Withdrawal Criteria,Overall Study,FG001,0.0515073351828318,0.8921703601723142,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2430,NCT00604383,Withdrawal by Subject,Overall Study,FG001,0.0514178503194147,0.8921259492827641,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2431,NCT04657016,Other - as reported by the investigator,Overall Study,FG000,0.051395981039547,0.892081538393214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2432,NCT02344290,Unable to get to clinic,Overall Study,FG001,0.0513385360955258,0.8920371275036639,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2433,NCT00093015,Lost to Follow-up,Overall Study,FG001,0.0513268885659325,0.8919927166141138,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2434,NCT00712673,Withdrawal by Subject,Overall Study,FG003,0.0513183222685516,0.8919483057245636,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2435,NCT03988634,Physician Decision,Double-Blind,FG001,0.0513156148258405,0.8919038948350135,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2436,NCT01849289,Unclassified,Overall Study,FG001,0.0513150405377705,0.8918594839454634,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2437,NCT01555164,Subject Withdrew Consent,Overall Study,FG001,0.0513071288213987,0.8918150730559133,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2438,NCT00984867,Withdrawal by Subject,Overall Study,FG000,0.0511929804850045,0.8917706621663631,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2439,NCT04058067,Physician Decision,Overall Study,FG000,0.0511720249698791,0.891726251276813,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2440,NCT00097981,Withdrawal by Subject,Overall Study,FG001,0.0511704358755654,0.891681840387263,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2441,NCT00827606,Withdrawal by Subject,Overall Study,FG000,0.0511277422669047,0.8916374294977129,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2442,NCT00863681,Death,Overall Study,FG002,0.051093103573492,0.8915930186081628,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2443,NCT00403767,Clinical efficacy endpoint reached,Overall Study,FG001,0.0510822334814385,0.8915486077186126,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2444,NCT00863681,Adverse Event,Overall Study,FG002,0.051058547749742,0.8915041968290625,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2445,NCT00368277,Patient withdrew consent,Overall Study,FG000,0.051045165349485,0.8914597859395124,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2446,NCT01289990,did not continue in extension,Overall Study,FG006,0.0510358926433532,0.8914153750499623,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2447,NCT00968812,Adverse Event,Overall Study,FG002,0.0509878623921725,0.8913709641604122,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2448,NCT03172494,Withdrawal by Subject,Overall Study,FG000,0.0509601424568254,0.891326553270862,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2449,NCT00968708,Voluntary Withdrawal,Overall Study,FG001,0.0509169452141368,0.8912821423813119,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2450,NCT01717313,Withdrawal by Subject,Phase B (Weeks 24 to 54),FG000,0.0508479032123511,0.8912377314917618,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2451,NCT02681094,Lack of therapeutic response,2 - Enrolled Participants Set,FG002,0.0508393069224404,0.8911933206022117,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2452,NCT01029886,Adverse Event,Overall Study,FG001,0.0508246852089087,0.8911489097126616,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2453,NCT02681094,Lack of therapeutic response,1 -Modified Enrolled Participants Set,FG002,0.0508158911557737,0.8911044988231114,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2454,NCT02681094,Study specific discontinuation criteria,2 - Enrolled Participants Set,FG000,0.0507517604852975,0.8910600879335613,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2455,NCT01524289,Adverse Event,Overall Study,FG001,0.0506973010771528,0.8910156770440112,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2456,NCT01365507,Withdrawal Criteria,Overall Study,FG000,0.0506958362053273,0.8909712661544611,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2457,NCT01524289,Protocol Violation,Overall Study,FG000,0.0506936368867361,0.890926855264911,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2458,NCT00300274,Death,Overall Study,FG001,0.0505403487954266,0.8908824443753608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2459,NCT00707031,Lack of Efficacy,Overall Study,FG000,0.0505291994625099,0.8908380334858107,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2460,NCT02036515,Withdrawal by Subject,Overall Study,FG002,0.050507629542748,0.8907936225962606,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2461,NCT02110901,received a kidney transplant,Overall Study,FG000,0.0504767330323909,0.8907492117067105,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2462,NCT02586155,Withdrawal by Subject,Overall Study,FG001,0.0504749831625297,0.8907048008171604,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2463,NCT01191268,Adverse Event,Overall Study,FG000,0.0504664685478274,0.8906603899276102,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2464,NCT04429503,Lost to Follow-up,Extension Phase (Wk 96 to Wk 156),FG005,0.0504593218116802,0.8906159790380601,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2465,NCT01451398,Adverse Event,Overall Study,FG001,0.0504527467578769,0.89057156814851,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2466,NCT04520256,Lost to Follow-up,Overall Study,FG025,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2467,NCT04520256,Lost to Follow-up,Overall Study,FG030,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2468,NCT04520256,Lost to Follow-up,Overall Study,FG006,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2469,NCT04520256,Lost to Follow-up,Overall Study,FG031,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2470,NCT04520256,Lost to Follow-up,Overall Study,FG017,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2471,NCT04520256,Lost to Follow-up,Overall Study,FG029,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2472,NCT04520256,Lost to Follow-up,Overall Study,FG027,0.0504398676488967,0.8903939245903095,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2473,NCT00614120,Adverse Event,Overall Study,FG002,0.0504389872822429,0.890216281032109,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2474,NCT01347710,Angio or SPECT not completed,Overall Study,FG000,0.0504344694091991,0.8901718701425589,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2475,NCT04429503,Lost to Follow-up,Extension Phase (Wk 96 to Wk 156),FG004,0.0504240223700136,0.8901274592530088,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2476,NCT04520256,Lost to Follow-up,Overall Study,FG001,0.0503992651726566,0.8900830483634588,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2477,NCT04620135,Adverse Event,Study Completion,FG001,0.0503730432826488,0.8900386374739087,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2478,NCT01191268,Withdrawal by Subject,Overall Study,FG002,0.050372361380836,0.8899942265843584,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2479,NCT01841762,Withdrawal by Subject,Post-Treatment Safety Follow-Up Period,FG000,0.0503571938695733,0.8899498156948084,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2480,NCT01841762,Withdrawal by Subject,Treatment Period,FG000,0.0503497806154067,0.8899054048052583,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2481,NCT02270736,Adverse Event,OLEX Period (up to 48 Weeks),FG003,0.0503495963105952,0.8898609939157082,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2482,NCT02489968,Adverse Event,Open-label Treatment Period,FG000,0.0503064761230059,0.889816583026158,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2483,NCT00542178,did not complete year 4 follow-up,Overall Study,FG005,0.0502997792165376,0.8897721721366079,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2484,NCT03548987,Withdrawal by Subject,Run-in Period (Week 0 to Week 20),FG000,0.0502798139779564,0.8897277612470578,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2485,NCT00858637,Adverse Event,Active Comparison Phase,FG003,0.0502738134461608,0.8896833503575077,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2486,NCT00713830,Lack of Efficacy,Overall Study,FG000,0.0502525469380456,0.8896389394679576,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2487,NCT01137812,Other,Overall Study,FG000,0.050220038508879,0.8895945285784074,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2488,NCT01177813,Withdrawal by Subject,Overall Study,FG001,0.0501959633168154,0.8895501176888573,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2489,NCT01442038,Investigator-Initiated Early Closure,Overall Study,FG000,0.0501956485181349,0.8895057067993072,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2490,NCT02480764,Voluntary Withdrawal,Overall Study,FG002,0.0501828881549107,0.8894612959097571,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2491,NCT01644188,Poor compliance to protocol,Overall Study,FG001,0.0501562895548214,0.889416885020207,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2492,NCT00660907,Adverse Event,Overall Study,FG001,0.0501366286041766,0.8893724741306568,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2493,NCT01968967,Lost to Follow-up,Treatment Period,FG001,0.0501027521432142,0.8893280632411067,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2494,NCT02851407,"Adverse event, non-fatal",Overall Study,FG001,0.0500691900537797,0.8892836523515566,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2495,NCT02851407,Consent withdrawn by participant,Overall Study,FG000,0.0500615589815774,0.8892392414620065,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2496,NCT00528879,Lack of Efficacy,Long-term Period (Weeks 24 to 102),FG002,0.0500480902376686,0.8891948305724564,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2497,NCT01194830,Lost to Follow-up,Overall Study,FG001,0.0500117798392802,0.8891504196829062,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2498,NCT00434954,Adverse Event,Overall Study,FG000,0.0499866063254761,0.8891060087933561,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2499,NCT01644188,Consent withdrawn by participant,Overall Study,FG000,0.0499743786732738,0.889039392459031,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2500,NCT01644188,Last visit outside protocol visit window,Overall Study,FG000,0.0499743786732738,0.889039392459031,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2501,NCT02892149,Lost to Follow-up,Overall Study,FG000,0.0499421809640178,0.8889727761247058,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2502,NCT00608023,Withdrawal by Subject,Overall Study,FG001,0.0499022870368253,0.8889283652351556,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2503,NCT02033889,Withdrawal by Subject,Overall Study,FG001,0.0498995022352381,0.8888839543456055,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2504,NCT00846365,Adverse Event,Overall Study,FG001,0.0498780700048016,0.8888395434560554,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2505,NCT00830960,Withdrawal by Subject,Overall Study,FG005,0.0498683587194642,0.8887951325665053,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2506,NCT04109547,Withdrawal by Subject,Overall Study,FG002,0.0498580274319941,0.8887507216769552,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2507,NCT01128153,Condition under investigation worsened,Overall Study,FG000,0.0498397323983576,0.888706310787405,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2508,NCT03514641,Lost to Follow-up,603A: 0-12 Week Study Period,FG000,0.049831577873869,0.8886618998978549,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2509,NCT04109547,Withdrawal by Subject,Overall Study,FG003,0.0498273492003274,0.8886174890083048,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2510,NCT00763815,Adverse Event,Overall Study,FG000,0.0498262359628219,0.8885730781187547,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2511,NCT03436693,Withdrawal by Subject,Overall Study,FG000,0.0497934021659821,0.8885286672292046,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2512,NCT00841672,Adverse Event,Overall Study,FG001,0.0497804595250595,0.8884842563396544,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2513,NCT00689936,Study Close Out,Active Treatment Phase,FG001,0.0497699337414583,0.8884398454501043,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2514,NCT03285594,Reason Not Specified,Overall Study,FG002,0.0497518959271527,0.8883954345605543,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2515,NCT01335399,Administrative reasons by Sponsor,Treatment Period,FG000,0.0497432164593154,0.8883510236710042,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2516,NCT01169779,Adverse Event,Overall Study,FG001,0.0497364712815773,0.8883066127814541,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2517,NCT01164501,Adverse Event,Overall Study,FG000,0.049725133245873,0.8882622018919039,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2518,NCT00087516,Lack of Efficacy,Overall Study,FG003,0.0497111363392857,0.8882177910023538,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2519,NCT02104817,Other reasons,Overall Study,FG000,0.0496828031550198,0.8881733801128037,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2520,NCT03439254,Withdrawal by Subject,Double-blind Phase (18 Months),FG002,0.0496445743562004,0.8881289692232536,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2521,NCT00808067,Adverse Event,Overall Study,FG000,0.0495755080651488,0.8880845583337035,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2522,NCT01272219,Unclassified,Main + Extension Period: Week 0-172,FG004,0.0495650662306845,0.8880401474441533,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2523,NCT02735044,Poor compliance to protocol,Overall Study,FG000,0.0495524498358333,0.8879957365546032,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2524,NCT01517412,Adverse Event,Overall Study,FG001,0.0495501920160415,0.8879513256650531,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2525,NCT01375647,Withdrawal by Subject,Overall Study,FG003,0.0495458395081547,0.887906914775503,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2526,NCT00818883,Adverse Event,Overall Study,FG001,0.0495137265975793,0.8878625038859528,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2527,NCT00549302,New Drug Pulmonary Atrial Hypertension,Double-Blind,FG001,0.0495100695083035,0.8878180929964027,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2528,NCT00849017,Lost to Follow-up,Treatment Period (156 Weeks),FG002,0.0495060688049504,0.8877736821068526,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2529,NCT02735044,Poor compliance to protocol,Overall Study,FG001,0.0494922196698214,0.8877292712173025,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2530,NCT01676220,Lost to Follow-up,Overall Study,FG001,0.0494866056702805,0.8876848603277524,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2531,NCT02100514,Withdrawal by Subject,Treatment Period,FG000,0.049478456060744,0.8876404494382022,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2532,NCT00594100,Technical Failure,Procedure,FG000,0.0494743540469344,0.8875960385486521,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2533,NCT00576693,Lost to Follow-up,Overall Study,FG001,0.0494609726070237,0.887551627659102,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2534,NCT01676116,Unclassified,Overall Study,FG001,0.0494550258750992,0.8875072167695519,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2535,NCT00308139,Loss of Glucose Control,Overall Study,FG001,0.0494315709971527,0.8874628058800018,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2536,NCT00283686,Less than full participation,Overall Study,FG003,0.0494294888332936,0.8874183949904516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2537,NCT00740051,Lack of Efficacy,Overall Study,FG000,0.0493996005638591,0.8873739841009015,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2538,NCT02064439,Adverse Event,Overall Study,FG001,0.0493770563745833,0.8873295732113514,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2539,NCT01059799,Withdrawal criteria,Overall Study,FG000,0.0493208302283929,0.8872851623218013,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2540,NCT00620542,Withdrawal by Subject,Part B (2 Year Core Study),FG002,0.0493089075925423,0.8872407514322512,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2541,NCT01345019,Completed Survival Follow-up,Blinded Treatment Phase,FG000,0.0492979396921329,0.887196340542701,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2542,NCT00740051,Protocol Violation,Overall Study,FG000,0.0492934290926091,0.8871519296531509,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2543,NCT01297920,Inadequate Control of IOP,Overall Study,FG002,0.0492751351866865,0.8871075187636008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2544,NCT05822830,Adverse Event,Overall Study,FG000,0.0492710099326786,0.8870631078740507,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2545,NCT00358215,Physician Decision,Overall Study,FG000,0.0492272759335146,0.8870186969845006,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2546,NCT00152971,Lost to Follow-up,Overall Study,FG000,0.0492246679459821,0.8869742860949504,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2547,NCT05822830,Adverse Event,Overall Study,FG001,0.0491870396110714,0.8869298752054003,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2548,NCT02555878,Physician Decision,Overall Study,FG000,0.0491858004294345,0.8868854643158502,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2549,NCT01499082,Diverse Reasons,Overall Study,FG000,0.0491795119117785,0.8868410534263002,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2550,NCT00432276,Protocol Violation,Overall Study,FG000,0.0491724438409028,0.8867966425367501,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2551,NCT02555878,Adverse Event,Overall Study,FG000,0.0491550017027678,0.8867522316471999,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2552,NCT00536744,Withdrawal by Subject,Overall Study,FG000,0.0491394590365179,0.8867078207576498,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2553,NCT00485758,Withdrawal by Subject,Overall Study,FG001,0.0491245247134036,0.8866634098680997,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2554,NCT03389555,Protocol Violation,Overall Study,FG001,0.0491126094021626,0.8866189989785496,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2555,NCT04251156,Withdrawal by Subject,Overall Study,FG001,0.0490757605339538,0.8865745880889995,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2556,NCT04251156,Withdrawal by Subject,Overall Study,FG000,0.0490210701577679,0.8865301771994493,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2557,NCT00432276,Withdrawal by Subject,Overall Study,FG000,0.0490181405621528,0.8864857663098992,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2558,NCT01890434,Adverse Event,Overall Study,FG000,0.0489976631804662,0.8864413554203491,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2559,NCT00121641,Lack of Efficacy,24-week Short-term Treatment Period,FG000,0.0489919130693452,0.886396944530799,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2560,NCT02307513,Adverse Event,Placebo Controlled Phase (Weeks 0-12),FG001,0.0489665194495436,0.8863525336412489,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2561,NCT00621140,Withdrawal by Subject,Overall Study,FG000,0.0489618254763889,0.8863081227516987,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2562,NCT00542178,did not complete year 4 follow-up,Overall Study,FG006,0.048954060848373,0.8862637118621486,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2563,NCT00621140,Adverse Event,Overall Study,FG000,0.0489483477451984,0.8862193009725985,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2564,NCT00789737,Lost to Follow-up,Overall Study,FG000,0.0489228946433035,0.8861748900830484,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2565,NCT01468987,Withdrawal by Subject,Overall Study,FG001,0.0489107434601091,0.8861304791934983,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2566,NCT00494871,Withdrawal by Subject,Double-blind (DB) Treatment Period,FG001,0.0489031396958035,0.8860860683039481,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2567,NCT00368277,Unsatisfactory therapeutic effect,Overall Study,FG000,0.0488892417487211,0.886041657414398,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2568,NCT01648582,Withdrawal by Subject,Overall Study,FG000,0.0488885730703274,0.8859972465248479,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2569,NCT04847557,Lost to Follow-up,Overall Study,FG001,0.0488866445501001,0.8859528356352978,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2570,NCT00838903,Lost to Follow-up,Follow-up Period (8 Weeks),FG002,0.0488787537523836,0.8859084247457476,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2571,NCT03772041,Protocol Violation,Overall Study,FG000,0.0488755287486012,0.8858640138561975,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2572,NCT00508820,Protocol-specified Criteria,Overall Study,FG001,0.0488574201914285,0.8858196029666474,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2573,NCT00456521,"Drug non-compliance, moved, other",Overall Study,FG000,0.0488570528754464,0.8857751920770973,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2574,NCT01818752,Withdrawal by Subject,Overall Study,FG000,0.0488518895581845,0.8857307811875472,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2575,NCT01468987,Withdrawal by Subject,Overall Study,FG000,0.0488412262984424,0.885686370297997,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2576,NCT02551874,Reason not reported,Overall Study,FG000,0.0487657369192857,0.8856419594084469,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2577,NCT00666718,Withdrawal by Subject,Overall Study,FG001,0.0487649172834028,0.8855975485188968,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2578,NCT00168818,Withdrawal by Subject,Treatment,FG002,0.0487215955533631,0.8855531376293467,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2579,NCT00168818,Other,Overall Study,FG000,0.0487084759336012,0.8855087267397966,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2580,NCT01734785,Withdrawal by Subject,Open-Label Period,FG003,0.0487076221634523,0.8854643158502464,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2581,NCT01512108,Adverse Event,Overall Study,FG000,0.0486940056218352,0.8854199049606963,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2582,NCT02030600,Withdrawal by Subject,Treatment Period 2,FG000,0.0486671494174305,0.8853532886263712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2583,NCT02030600,Withdrawal by Subject,Treatment Period 1,FG000,0.0486671494174305,0.8853532886263712,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2584,NCT00508820,Withdrawal by Subject,Overall Study,FG001,0.0486552026900893,0.885286672292046,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2585,NCT01788358,Other,Overall Study,FG000,0.0486444073500054,0.8852422614024958,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2586,NCT02963922,Protocol deviation,Overall Study,FG000,0.0486416657750596,0.8851978505129457,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2587,NCT00763451,Adverse Event,Overall Study,FG003,0.0486415023323214,0.8851534396233957,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2588,NCT00273052,Adverse Event,Overall Study,FG000,0.0486288435297123,0.8851090287338456,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2589,NCT01623115,Adverse Event,Overall Study,FG000,0.0486115096919543,0.8850646178442955,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2590,NCT01623115,Poor compliance to protocol,Overall Study,FG001,0.0485993166846924,0.8850202069547453,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2591,NCT02963922,Protocol deviation,Overall Study,FG001,0.0485948029675596,0.8849757960651952,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2592,NCT02963922,Adverse Event,Overall Study,FG001,0.0485788708228572,0.8849313851756451,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2593,NCT02064439,Adverse Event,Overall Study,FG002,0.0485568339593353,0.884886974286095,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2594,NCT00121667,Lack of Efficacy,Short Term (ST) Period,FG001,0.0485285420750198,0.8848425633965449,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2595,NCT00620542,Withdrawal by Subject,Part B (2 Year Core Study),FG003,0.0484915559561435,0.8847981525069947,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2596,NCT01730053,Other than specified,Overall Study,FG004,0.0484683385193947,0.8847537416174446,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2597,NCT03242018,At the Participant's Own Request,Overall Study,FG002,0.0484603239026488,0.8847093307278945,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2598,NCT03242018,Reason Not Specified,Overall Study,FG001,0.04842953051624,0.8846649198383444,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2599,NCT04707469,Lost to Follow-up,Overall Study,FG002,0.0484131039816567,0.8846205089487943,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2600,NCT01618162,Protocol Violation,Overall Study,FG001,0.0484022983488194,0.8845760980592441,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2601,NCT01618162,Withdrawal Criteria,Overall Study,FG001,0.0483961356188194,0.884531687169694,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2602,NCT00856284,Voluntary withdrawal,Overall Study,FG001,0.048376328837242,0.8844872762801439,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2603,NCT03242252,At the Participant's own Request,Overall Study,FG001,0.0483551514933318,0.8844428653905938,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2604,NCT01076088,Withdrawal by Subject,Overall Study,FG005,0.0483047671874901,0.8843984545010437,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2605,NCT02769481,Adverse Event,Overall Study,FG001,0.0482801746683035,0.8843540436114935,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2606,NCT02284893,Subject no longer meets study criteria,26 Week (Short Term),FG001,0.0482751573361111,0.8843096327219434,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2607,NCT01294436,Adverse Event,Overall Study,FG001,0.048247195061627,0.8842652218323933,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2608,NCT01986855,Withdrawal by Subject,Overall Study,FG001,0.048238463831617,0.8842208109428432,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2609,NCT01513590,Unclassified,Overall Study,FG001,0.0482323289039682,0.8841764000532931,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2610,NCT01098539,Withdrawal by Subject,Overall Study,FG000,0.0481789326996032,0.8841319891637429,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2611,NCT05142722,Death,Overall Study,FG001,0.0481420419324702,0.8840875782741928,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2612,NCT00996281,Withdrawal by Subject,Overall Study,FG001,0.0481137639122349,0.8840431673846427,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2613,NCT00553787,Adverse Event,Overall Study,FG002,0.0481022002949008,0.8839987564950926,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2614,NCT00713830,Withdrawal by Subject,Overall Study,FG001,0.0480910315535813,0.8839543456055424,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2615,NCT00420849,Death,Overall Study,FG000,0.0480883747165575,0.8839099347159923,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2616,NCT00713830,Adverse Event,Overall Study,FG000,0.0480871386489087,0.8838655238264422,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2617,NCT03481634,Adverse Event,Overall Study,FG000,0.0480708286403472,0.8838211129368921,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2618,NCT00542178,did not complete year 4 follow-up,Overall Study,FG007,0.0480684347487301,0.883776702047342,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2619,NCT00708435,Withdrawal by Subject,Overall Study,FG001,0.0480682780803174,0.8837322911577918,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2620,NCT00091949,Lost to Follow-up,Overall Study,FG000,0.0480417227006042,0.8836878802682417,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2621,NCT02252172,Lost to Follow-up,Overall Study,FG001,0.0480380351364682,0.8836434693786916,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2622,NCT00968812,Adverse Event,Overall Study,FG000,0.0480050070496428,0.8835990584891416,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2623,NCT01336023,Withdrawal Criteria,Week 0 to Week 26,FG000,0.0480032860611606,0.8835546475995915,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2624,NCT02648347,Lost to Follow-up,Overall Study,FG000,0.0479965018195634,0.8835102367100413,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2625,NCT02849080,Lost to Follow-up,Main Phase: 0 - 52 Weeks,FG000,0.0479939228370237,0.8834658258204912,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2626,NCT01387737,Withdrawal by Subject,Overall Study,FG000,0.0479390021000892,0.8834214149309411,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2627,NCT01790438,Withdrawal by Subject,Overall Study,FG000,0.0479067847118903,0.883377004041391,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2628,NCT01126580,Withdrawal by Subject,Overall Study,FG001,0.0479014541053644,0.8833325931518409,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2629,NCT04880850,Lost to Follow-up,Overall Study,FG001,0.0478749182829175,0.8832881822622907,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2630,NCT02132767,Withdrawal by Subject,Overall Study,FG000,0.0478640570290079,0.8832437713727406,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2631,NCT01033071,Adverse Event,Overall Study,FG000,0.047860397038998,0.8831993604831905,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2632,NCT02863328,Withdrawal by Subject,Overall Study,FG001,0.047841463551994,0.8831549495936404,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2633,NCT00129545,Device not implanted,Overall Study,FG000,0.0478372847765728,0.8831105387040903,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2634,NCT01289990,did not continue in extension,Overall Study,FG003,0.0478206481710119,0.8830661278145401,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2635,NCT01289990,did not continue in extension,Overall Study,FG002,0.0478151234685119,0.88302171692499,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2636,NCT01494987,Subject Non-Compliance,Overall Study,FG001,0.0478105730296924,0.8829773060354399,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2637,NCT01442038,Investigator-Initiated Early Closure,Overall Study,FG001,0.0477951831863987,0.8829328951458898,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2638,NCT00434954,Entry criteria not met,Overall Study,FG001,0.0477834576225297,0.8828884842563397,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2639,NCT01210001,Adverse Event,Overall Study,FG000,0.0477597283155555,0.8828440733667895,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2640,NCT00961636,Flushing Symptoms,Overall Study,FG000,0.0477420600945932,0.8827996624772394,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2641,NCT00976391,Lost to Follow-up,Follow-up Period (8 Weeks),FG000,0.0477381617794444,0.8827552515876893,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2642,NCT00961636,Withdrawal by Subject,Overall Study,FG000,0.0477296522531051,0.8827108406981392,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2643,NCT03954834,Withdrawal by Subject,Overall Study,FG003,0.0477189756416071,0.8826664298085891,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2644,NCT02229383,Other,Overall Study,FG001,0.0476652872520238,0.8826220189190389,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2645,NCT00082628,Did not continue to Period II,Treatment Period I (Week 1 to Week 12),FG001,0.0476636709572222,0.8825776080294888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2646,NCT01730040,Other than specified,Overall Study,FG001,0.0476568034808829,0.8825331971399387,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2647,NCT02648217,Unclassified,Overall Study,FG000,0.0476114059336796,0.8824887862503886,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2648,NCT01210001,Lost to Follow-up,Overall Study,FG000,0.0475888998880952,0.8824443753608385,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2649,NCT02419612,Lost to Follow-up,Long-term Treatment Period,FG000,0.0475719999399404,0.8823999644712883,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2650,NCT00624052,Adverse Event,Overall Study,FG001,0.0475532091796428,0.8823555535817382,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2651,NCT00082628,Subjects Did Not Complete Week 36,Treatment Period II: Week 12 to Week 36,FG002,0.0475465830858531,0.8823111426921881,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2652,NCT02419612,Lost to Follow-up,Short-term Treatment Period,FG001,0.0475462313587499,0.882266731802638,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2653,NCT02419612,Lost to Follow-up,Short-term Treatment Period,FG000,0.047540779894107,0.8822223209130879,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2654,NCT00082628,Subjects Did Not Complete Week 36,Treatment Period II: Week 12 to Week 36,FG003,0.0475002463050198,0.8821779100235377,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2655,NCT04157751,Lost to Follow-up,Overall Study,FG000,0.0474898767579545,0.8821334991339876,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2656,NCT02152371,Adverse Event,Overall Study,FG000,0.047486318412738,0.8820890882444375,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2657,NCT01958671,Withdrawal by Subject,Overall Study,FG000,0.0474756594321627,0.8820446773548875,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2658,NCT02073682,Cancer Cured,Overall Study,FG001,0.0474555098063294,0.8820002664653372,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2659,NCT01485614,Withdrawal by Subject,Weeks 20-54,FG001,0.0474496464272122,0.8819558555757872,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2660,NCT01396057,Adverse Event,Overall Study,FG001,0.0474271401935217,0.8819114446862371,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2661,NCT01485614,Withdrawal by Subject,Weeks 0-20,FG000,0.0474055649326289,0.881867033796687,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2662,NCT01952145,Withdrawal Criteria,Overall Study,FG001,0.0473972183290972,0.8818226229071369,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2663,NCT00286494,Hyperglycemic rescue,Overall Study,FG001,0.0473807788292361,0.8817782120175867,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2664,NCT00528879,Lack of Efficacy,Long-term Period (Weeks 24 to 102),FG001,0.0473791728845238,0.8817338011280366,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2665,NCT01396057,Unsatisfactory therapeutic effect,Overall Study,FG001,0.0473780236810813,0.8816893902384865,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2666,NCT00657150,Other,Treatment,FG000,0.0473715014153274,0.8816449793489364,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2667,NCT00667719,Withdrawal by Subject,Overall Study,FG000,0.0473589105476289,0.8816005684593863,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2668,NCT01485614,Lost to Follow-up,Weeks 20-54,FG001,0.0473418402163789,0.8815561575698361,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2669,NCT01239797,Participant withdrew consent,Randomized Participants,FG001,0.0473401515987301,0.881511746680286,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2670,NCT02681094,Study-specific discontinuation criteria,1 -Modified Enrolled Participants Set,FG001,0.0473309142054067,0.8814673357907359,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2671,NCT03080883,Alternative Therapy,Overall Study,FG001,0.0473094493725992,0.8814229249011858,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2672,NCT00554216,Adverse Event,Overall Study,FG002,0.0472774876035813,0.8813785140116357,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2673,NCT00103506,Lost to Follow-up,Overall Study,FG001,0.0472464148995733,0.8813341031220855,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2674,NCT00103506,Lost to Follow-up,Overall Study,FG000,0.04722929691124,0.8812896922325354,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2675,NCT00087516,Withdrawal by Subject,Overall Study,FG001,0.0472195620583432,0.8812452813429853,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2676,NCT00424047,Withdrawal by Subject,Blinded Treatment (Up to 03 Aug 2005),FG001,0.0472163552225495,0.8812008704534352,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2677,NCT00558259,Protocol Violation,Overall Study,FG000,0.0472076081947916,0.8811564595638851,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2678,NCT01786993,Death,Overall Study,FG001,0.0471824411956845,0.8811120486743349,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2679,NCT00484315,No 9-Month Angiography Performed,9-Month Angiographic Follow-up,FG000,0.047165219610377,0.8810676377847848,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2680,NCT02234843,Withdrawal by Subject,Overall Study,FG005,0.0471484560532242,0.8810232268952347,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2681,NCT02926950,Lost to Follow-up,Overall Study,FG000,0.0470877648183035,0.8809788160056846,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2682,NCT00798161,Adverse Event,Overall Study,FG003,0.0470472696381547,0.8809344051161345,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2683,NCT00798161,Adverse Event,Overall Study,FG002,0.047042973233869,0.8808899942265843,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2684,NCT00860262,Adverse Event,Overall Study,FG001,0.047003029477857,0.8808455833370342,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2685,NCT02427802,Withdrawal by Subject,Overall Study,FG000,0.0469994950727678,0.8808011724474841,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2686,NCT02229227,Physician Decision,Overall Study,FG001,0.0469674059264584,0.880756761557934,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2687,NCT00617123,Withdrawal by Subject,Study Treatment Period,FG000,0.0469655259305556,0.8807123506683839,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2688,NCT00860262,Withdrawal by Subject,Overall Study,FG002,0.0469561082370833,0.8806679397788337,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2689,NCT02229227,Withdrawal by Subject,Overall Study,FG001,0.046910066446875,0.8806235288892836,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2690,NCT03021187,Lost to Follow-up,Overall Study,FG000,0.0468974113847023,0.8805791179997335,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2691,NCT04074161,Withdrawal by Subject,Overall Study,FG001,0.046894045680625,0.8805347071101834,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2692,NCT04074161,Lost to Follow-up,Overall Study,FG000,0.0468908085830438,0.8804902962206334,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2693,NCT00289887,Lack of Efficacy,Overall Study,FG001,0.0468567220290476,0.8804458853310831,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2694,NCT02227875,Lost to Follow-up,Overall Study,FG001,0.0468379540672321,0.880401474441533,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2695,NCT00786474,Withdrawal by Subject,Overall Study,FG001,0.0468234972301786,0.880357063551983,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2696,NCT03067441,Withdrawal by Subject,Overall Study,FG000,0.0468187474794841,0.8803126526624329,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2697,NCT01289990,did not continue in extension,Overall Study,FG005,0.0468070490003571,0.8802682417728828,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2698,NCT02227875,Protocol Violation,Overall Study,FG000,0.0468007164155455,0.8802238308833326,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2699,NCT00142584,Lost to Follow-up,Overall Study,FG001,0.0467755050804761,0.8801794199937825,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2700,NCT04184622,Lost to Follow-up,Primary Treatment Period,FG001,0.0467669389964285,0.8801350091042324,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2701,NCT02741596,Other (Unspecified),Overall Study,FG001,0.0467500314759126,0.8800905982146823,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2702,NCT00291330,Lost to Follow-up,Overall Study,FG000,0.0467461513640377,0.8800461873251321,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2703,NCT00286455,Hyperglycemia rescue,Overall Study,FG001,0.0467457035913591,0.880001776435582,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2704,NCT02227875,Lost to Follow-up,Overall Study,FG000,0.046737242987867,0.8799573655460319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2705,NCT02683746,Withdrawal by Subject,Overall Study,FG001,0.0467239945838095,0.8799129546564818,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2706,NCT01272232,Adverse Event,Weeks 0-56,FG001,0.0467233416975595,0.8798685437669317,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2707,NCT00568178,Physician Decision,Open Label Extension,FG004,0.046710631881875,0.8798241328773815,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2708,NCT04915729,Withdrawal by Subject,Overall Study,FG000,0.0467102049028571,0.8797797219878314,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2709,NCT04252287,Death,Overall Study,FG000,0.0467037926846329,0.8797353110982813,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2710,NCT01558271,Withdrawal by Subject,Overall Study,FG000,0.0466696583422177,0.8796909002087312,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2711,NCT03860935,Withdrawal of Consent,Overall Study,FG001,0.0466673725272033,0.8796464893191811,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2712,NCT02741596,Pregnancy,Overall Study,FG000,0.0466336730770238,0.8796020784296309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2713,NCT02683746,Lost to Follow-up,Overall Study,FG000,0.0466282278480357,0.8795576675400808,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2714,NCT01087502,Lack of Efficacy,Up to Final Analysis (Week 52),FG001,0.0466043811172421,0.8795132566505307,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2715,NCT01179048,Alive,Overall Study,FG000,0.0465484676949206,0.8794688457609806,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2716,NCT01087502,Other reason not described above,Up to Interim Analysis (Week 12),FG001,0.046515416878492,0.8794244348714305,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2717,NCT01087502,Withdrawal by Subject,Up to Final Analysis (Week 52),FG001,0.0464913034351587,0.8793800239818803,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2718,NCT01064414,Other,Core Period: Baseline to Week 26,FG001,0.0464745057401289,0.8793356130923302,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2719,NCT00295633,Lack of Efficacy,Overall Study,FG000,0.046473129362371,0.8792912022027801,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2720,NCT00366249,Most due to osteomylitis status,Overall Study,FG000,0.0464696123000396,0.87924679131323,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2721,NCT01307033,Potassium Withdrawal Criteria Met,44-week Open-label Extension,FG003,0.0463560293070932,0.8792023804236799,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2722,NCT02993406,Unclassifiable Response,Overall Study,FG000,0.0463072010989583,0.8791579695341297,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2723,NCT00309244,Lost to Follow-up,Overall Study,FG001,0.0463070537864186,0.8791135586445796,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2724,NCT01087502,Lost to Follow-up,Up to Final Analysis (Week 52),FG000,0.046303294919623,0.8790691477550295,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2725,NCT03989232,Lost to Follow-up,Overall Study,FG001,0.0462788159571328,0.8790247368654794,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2726,NCT00439777,Adverse Event,Treatment Period,FG001,0.0462772436828814,0.8789803259759293,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2727,NCT02229396,Other,Overall Study,FG000,0.0462555554717658,0.8789359150863791,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2728,NCT00094757,Withdrawal by Subject,Overall Study,FG001,0.0462399449609225,0.878891504196829,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2729,NCT00121641,Lack of Efficacy,24-week Short-term Treatment Period,FG002,0.0462325754351785,0.878847093307279,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2730,NCT01926782,Adverse Event,Overall Study,FG005,0.0462222818559424,0.8788026824177289,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2731,NCT01364428,Withdrawal Criteria,Overall Study,FG001,0.0461125406052877,0.8787582715281788,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2732,NCT03514641,Lost to Follow-up,603A: 0-12 Week Study Period,FG001,0.0460973874070024,0.8787138606386286,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2733,NCT00289848,Lack of Efficacy,Overall Study,FG000,0.0460934412055357,0.8786694497490785,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2734,NCT00093015,Lost to Follow-up,Overall Study,FG000,0.0460596520596428,0.8786250388595284,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2735,NCT00286494,Hyperglycemic rescue,Overall Study,FG002,0.0460561666691765,0.8785806279699783,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2736,NCT00819091,Other,Overall Study,FG001,0.0460217527940773,0.8785362170804282,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2737,NCT02460978,Adverse Event,Overall Study,FG001,0.0460020598406249,0.878491806190878,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2738,NCT02460978,Adverse Event,Overall Study,FG002,0.0460000833545535,0.8784473953013279,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2739,NCT00819091,Withdrawal by Subject,Overall Study,FG001,0.045997639350744,0.8784029844117778,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2740,NCT00094770,Withdrawal by Subject,Year 2 (Week 0 to Week 104),FG001,0.0459731657201289,0.8783585735222277,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2741,NCT00641043,Protocol Violation,Overall Study,FG001,0.0459705414648015,0.8783141626326776,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2742,NCT00308737,Lost to Follow-up,Overall Study,FG000,0.0459652356974305,0.8782697517431274,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2743,NCT03259789,Lost to Follow-up,Overall Study,FG000,0.0459598184463094,0.8782253408535773,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2744,NCT00456521,Adverse Event,Overall Study,FG001,0.0459442169390674,0.8781809299640272,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2745,NCT02100514,Other,Treatment Period,FG001,0.0459380531693452,0.8781365190744771,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2746,NCT00318461,Lack of Efficacy,"Open-Label Extension, 18 Months",FG001,0.0459358833991468,0.8780921081849269,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2747,NCT03877224,Withdrawal by Subject,Overall Study,FG001,0.0458747628735317,0.8780476972953768,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2748,NCT04657003,Lost to Follow-up,Overall Study,FG000,0.0458732299743055,0.8780032864058267,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2749,NCT03259789,Withdrawal by Subject,Overall Study,FG001,0.0458694342817063,0.8779588755162766,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2750,NCT00819091,Lost to Follow-up,Overall Study,FG000,0.0458480430889384,0.8779144646267265,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2751,NCT01191268,Withdrawal by Subject,Overall Study,FG000,0.0458333906083757,0.8778700537371763,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2752,NCT02924064,Physician Decision,Overall Study,FG001,0.045829706592113,0.8778256428476262,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2753,NCT03211858,Adverse Event,Overall Study,FG000,0.045802178710792,0.8777812319580761,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2754,NCT02924064,Adverse Event,Overall Study,FG001,0.045783935578482,0.877736821068526,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2755,NCT02596126,Lost to Follow-up,Overall Study,FG001,0.0457750146632639,0.8776924101789759,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2756,NCT02924064,Adverse Event,Overall Study,FG000,0.0457738849150297,0.8776479992894257,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2757,NCT00838903,Withdrawal by Subject,Treatment Period (156 Weeks),FG000,0.0457696254259127,0.8776035883998756,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2758,NCT01507831,Poor compliance to protocol,Overall Study,FG000,0.0457198988555952,0.8775591775103255,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2759,NCT00641043,Lost to Follow-up,Overall Study,FG000,0.0457087401947222,0.8775147666207754,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2760,NCT02680574,Withdrawal by Subject,Overall Study,FG000,0.0456972367959126,0.8774703557312253,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2761,NCT01095653,"non-compliance, not met criteria, etc.",Overall Study,FG000,0.0456267603835912,0.8774259448416751,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2762,NCT02924064,Lost to Follow-up,Overall Study,FG001,0.0456234630808431,0.877381533952125,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2763,NCT04401293,Withdrawal by Subject,Overall Study,FG001,0.0455845939328571,0.8773371230625749,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2764,NCT01388361,Withdrawal criteria,Overall Study,FG002,0.0455688170247222,0.8772927121730248,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2765,NCT00159861,Adverse Event,Core Study - 16 Weeks,FG000,0.0455404043468453,0.8772483012834748,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2766,NCT00532935,Protocol Specific Criteria,Overall Study,FG001,0.0454877759375595,0.8772038903939245,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2767,NCT01472185,Adverse Event Other than Hyperglycemia,Overall Study,FG001,0.0454669975610173,0.8771594795043745,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2768,NCT01908699,Lost to Follow-up,Overall Study,FG001,0.045422278607619,0.8771150686148244,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2769,NCT02505334,Lack of Efficacy,Main Treatment Period,FG000,0.04541234371125,0.8770706577252743,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2770,NCT01999218,Hyperglycemia,Overall Study,FG000,0.045411395829503,0.8770262468357242,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2771,NCT01217463,Adverse Event,Overall Study,FG001,0.0454084814111408,0.876981835946174,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2772,NCT01999218,Lost to Follow-up,Overall Study,FG002,0.0454000485993948,0.8769374250566239,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2773,NCT01818752,Death,Overall Study,FG000,0.0453859749194137,0.8768930141670738,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2774,NCT02755597,"Other, not specified",Overall Study,FG001,0.0453799636430555,0.8768486032775237,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2775,NCT00159861,Reason Unspecified,Extension Study - up to 3 Years,FG000,0.0453713107533929,0.8768041923879736,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2776,NCT05412004,Withdrawal by Subject,Overall Study,FG002,0.0453589277444642,0.8767597814984234,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2777,NCT00736099,Withdrawal by Subject,Overall Study,FG001,0.0453448409037995,0.8767153706088733,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2778,NCT02229227,Study terminated by sponsor,Overall Study,FG000,0.0453362092461011,0.8766709597193232,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2779,NCT01818752,Withdrawal by Subject,Overall Study,FG001,0.0453288196916567,0.8766265488297731,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2780,NCT01189890,Withdrawal by Subject,Overall Study,FG001,0.0453212610088491,0.876582137940223,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2781,NCT05412004,Withdrawal by Subject,Overall Study,FG000,0.0453046998129166,0.8765377270506728,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2782,NCT02229227,Study terminated by sponsor,Overall Study,FG001,0.0453021785165178,0.8764933161611227,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2783,NCT04807400,Lost to Follow-up,Overall Study,FG000,0.045296407941994,0.8764489052715726,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2784,NCT03861039,Adverse Event,Overall Study,FG001,0.0452947373465178,0.8764044943820225,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2785,NCT00286442,Hyperglycemic Rescue,Overall Study,FG000,0.0452826895872619,0.8763600834924724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2786,NCT03472040,Other - Not Otherwise Specified (NOS),Overall Study,FG000,0.0452781487513888,0.8763156726029222,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2787,NCT04964544,Screen failure or other uncategorised,Overall Study,FG000,0.0452289856042757,0.8762712617133721,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2788,NCT00139659,Withdrawal by Subject,Overall Study,FG001,0.045227825161865,0.876226850823822,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2789,NCT01147250,Withdrawal by Subject,Overall Study,FG001,0.0452238639447321,0.8761824399342719,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2790,NCT01564537,Lost to Follow-up,Overall Study,FG000,0.0452168748017162,0.8761380290447217,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2791,NCT01539083,Withdrawal by Subject,After Randomization (TP and VTP),FG002,0.0452082093705555,0.8760936181551716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2792,NCT00403767,Clinical efficacy endpoint reached,Overall Study,FG000,0.0451911847330357,0.8760492072656215,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2793,NCT01363440,Withdrawal by Subject,Overall Study,FG000,0.0451868915714583,0.8760047963760714,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2794,NCT01539083,Withdrawal by Subject,Before Randomization (VCD Induction),FG000,0.0451839222472222,0.8759603854865213,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2795,NCT01517412,Adverse Event,Overall Study,FG000,0.0451045363293902,0.8759159745969711,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2796,NCT03611582,Lost to Follow-up,Overall Study,FG001,0.0451011736528769,0.875871563707421,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2797,NCT01517412,Lack of Efficacy,Overall Study,FG000,0.0450655127067117,0.8758271528178709,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2798,NCT01499082,Adverse Event,Overall Study,FG001,0.0450467906558089,0.8757827419283208,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2799,NCT00097981,Physician Decision,Overall Study,FG000,0.0450302302184027,0.8757383310387707,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2800,NCT02239120,Death,Overall Study,FG001,0.0450233275129103,0.8756939201492205,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2801,NCT05142722,Lost to Follow-up,Overall Study,FG000,0.0450087380020932,0.8756495092596704,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2802,NCT01676116,Protocol Violation,Overall Study,FG000,0.0449950437756006,0.8756050983701203,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2803,NCT01033071,Adverse Event,Overall Study,FG002,0.0449772803070634,0.8755606874805703,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2804,NCT00087516,Protocol specified discontinuation,Overall Study,FG003,0.0449700882485218,0.8755162765910202,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2805,NCT00734474,"Sponsor Decision, Arm Discontinued",Overall Study,FG001,0.0449594992338762,0.87547186570147,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2806,NCT03585270,Lost to Follow-up,Overall Study,FG001,0.0449579538297908,0.8754274548119199,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2807,NCT00853827,Adverse Event,Double Blind Period (103 Weeks),FG001,0.0449556673307097,0.8753830439223698,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2808,NCT01299376,Blood Pressure/Potassium Criteria Met,Double-blind Treatment (Weeks 1 to 8),FG001,0.0449516286754166,0.8753386330328197,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2809,NCT00542178,did not complete year 4 follow-up,Overall Study,FG001,0.0449510184639384,0.8752942221432696,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2810,NCT00662831,Protocol Violation,Overall Study,FG000,0.0449307372826289,0.8752498112537194,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2811,NCT01330628,Lost to Follow-up,Overall Study,FG000,0.044929037136617,0.8752054003641693,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2812,NCT01059799,Other,Overall Study,FG000,0.0448996232398214,0.8751609894746192,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2813,NCT00282984,Withdrawal by Participant,Overall Study,FG000,0.0448919364233928,0.8751165785850691,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2814,NCT00368277,Patient withdrew consent,Overall Study,FG001,0.0448726268236904,0.875072167695519,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2815,NCT00507416,Patient declined further treatment,Overall Study,FG002,0.044851480592297,0.8750277568059688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2816,NCT01045447,Unclassified,Overall Study,FG001,0.0448465939731051,0.8749833459164187,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2817,NCT00922480,Withdrawal by Subject,Main Study,FG001,0.0448445549271626,0.8749389350268686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2818,NCT02161562,Withdrawal by Subject,Overall Study,FG000,0.0448358827125595,0.8748945241373185,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2819,NCT00097591,Withdrawal of consent,Overall Study,FG000,0.0448349109312104,0.8748501132477684,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2820,NCT01760447,Consent withdrawn by Parent/Guardian,Weeks 0-20,FG003,0.0448111667377381,0.8748057023582182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2821,NCT00757588,Withdrawal by Subject,Period 1: Short-term (24-week) Phase,FG000,0.0448065194851587,0.8747612914686681,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2822,NCT01890122,Voluntary Withdrawal,Overall Study,FG003,0.0447805476045138,0.874716880579118,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2823,NCT00507416,Other,Overall Study,FG000,0.0447516728948665,0.8746724696895679,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2824,NCT00412984,Death,Overall Study,FG001,0.04473783849,0.8746280588000178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2825,NCT00917267,Protocol Violation,Overall Study,FG001,0.0447319756129364,0.8745836479104676,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2826,NCT01302392,Withdrawal by Subject,Overall Study,FG000,0.044717079705863,0.8745392370209175,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2827,NCT01102426,Randomized but not treated,Overall Study,FG000,0.0446563591480655,0.8744948261313674,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2828,NCT00184600,Withdrawal by Subject,Overall Study,FG000,0.044612943256379,0.8744504152418173,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2829,NCT02798471,Physician Decision,Overall Study,FG000,0.0446022119566666,0.8744060043522672,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2830,NCT01215253,Other,Overall Study,FG000,0.0445979591879752,0.874361593462717,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2831,NCT01289990,did not continue in extension,Overall Study,FG004,0.0445916465651487,0.8743171825731669,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2832,NCT00986154,Death,Overall Study,FG000,0.0445903859614881,0.8742727716836168,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2833,NCT01712789,Transition to Commercial Treatment,Overall Study,FG000,0.0445840789517047,0.8742283607940667,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2834,NCT01289990,did not continue in extension,Overall Study,FG009,0.044583211673482,0.8741839499045165,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2835,NCT02305381,Unclassified,Overall Study,FG002,0.0445830937744444,0.8741395390149664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2836,NCT03284853,Withdrawal by Subject,Overall Study,FG000,0.0445813187609226,0.8740951281254163,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2837,NCT00954447,Lost to Follow-up,Overall Study,FG000,0.0445647926976488,0.8740507172358662,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2838,NCT02798471,Other,Overall Study,FG001,0.0445628241534722,0.8739841009015411,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2839,NCT02798471,Death,Overall Study,FG001,0.0445628241534722,0.8739841009015411,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2840,NCT05040971,Death,Overall Study,FG000,0.0445572420447718,0.8739174845672159,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2841,NCT00168818,Withdrawal by Subject,Treatment,FG001,0.0445111672436904,0.8738730736776658,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2842,NCT05040971,Withdrawal by Subject,Overall Study,FG001,0.0445036451913988,0.8738286627881157,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2843,NCT00549302,Death,Double-Blind,FG001,0.0444801063789881,0.8737842518985656,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2844,NCT00620542,Adverse Event,Part B (2 Year Core Study),FG003,0.0444426265472916,0.8737398410090154,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2845,NCT01908816,Lost to Follow-up,Overall Study,FG001,0.0444286232267657,0.8736954301194653,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2846,NCT01682759,Lost to Follow-up,Overall Study,FG001,0.0444271242976785,0.8736510192299152,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2847,NCT02132767,Withdrawal by Subject,Overall Study,FG001,0.0444178344296329,0.8736066083403651,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2848,NCT03064126,Death,Overall Study,FG002,0.0443979734948214,0.873562197450815,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2849,NCT01877915,Withdrawal by Subject,Overall Study,FG001,0.0443867458131484,0.8735177865612648,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2850,NCT03541174,Adverse Event,Part 3 Double-Blind Withdrawal,FG005,0.0443608927286408,0.8734733756717147,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2851,NCT03325556,Not otherwise specified,Double-blind Period,FG002,0.0443578225427975,0.8734289647821646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2852,NCT00456521,Withdrawal by Subject,Overall Study,FG001,0.0443561015611904,0.8733845538926145,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2853,NCT04591626,Withdrawal by Subject,Overall Study,FG001,0.0442986111145833,0.8733401430030644,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2854,NCT00856986,Protocol Violation,"Run-in Period, Weeks -12-0",FG003,0.0442906593111111,0.8732957321135142,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2855,NCT00856986,Unclassified,"Run-in Period, Weeks -12-0",FG003,0.0442705289152182,0.8732513212239641,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2856,NCT00440193,Withdrawal by Subject,Treatment Period,FG001,0.0442595063031051,0.873206910334414,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2857,NCT01272193,Unclassified,Overall Study,FG000,0.0442419670633035,0.8731624994448639,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2858,NCT00849017,Lost to Follow-up,Treatment Period (156 Weeks),FG001,0.0442362215745932,0.8731180885553138,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2859,NCT03325556,Non-compliance with study drug,Open-label Period,FG000,0.0442331936894642,0.8730736776657636,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2860,NCT00830960,Withdrawal by Subject,Overall Study,FG001,0.0442206779840079,0.8730292667762135,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2861,NCT01976338,Withdrawal by Subject,Overall Study,FG000,0.0442145870633828,0.8729848558866634,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2862,NCT05425745,Withdrawal of Consent,Overall Study,FG000,0.0442123967414881,0.8729404449971133,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2863,NCT00830960,Withdrawal by Subject,Overall Study,FG000,0.0442097490762698,0.8728960341075632,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2864,NCT01976338,Adverse Event,Overall Study,FG000,0.0442062573801983,0.872851623218013,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2865,NCT02104817,Withdrawal by Subject,Overall Study,FG000,0.0441977530473114,0.8728072123284629,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2866,NCT05425745,Death,Overall Study,FG001,0.0441724417929167,0.8727628014389128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2867,NCT02239120,Death,Overall Study,FG000,0.0441652917843687,0.8727183905493627,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2868,NCT05425745,Withdrawal of Consent,Overall Study,FG001,0.04415252142125,0.8726739796598126,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2869,NCT00501059,Death,Overall Study,FG000,0.0440609672084424,0.8726295687702624,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2870,NCT00474630,Lost to Follow-up,Overall Study,FG001,0.0440597063818055,0.8725851578807123,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2871,NCT04017832,Withdrawal by Subject,Overall Study,FG000,0.0440460759929662,0.8725407469911622,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2872,NCT00332488,Various,Initial Treatment Phase (Weeks 0 - 12),FG000,0.0440347583856845,0.8724963361016121,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2873,NCT01814748,Withdrawal by Subject,Overall Study,FG001,0.0440318205840674,0.872451925212062,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2874,NCT01421459,Withdrawal by Subject,Overall Study,FG001,0.0440268404780411,0.8724075143225118,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2875,NCT01768559,Adverse Event,Overall Study,FG000,0.0440052444528571,0.8723631034329618,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2876,NCT00474630,Withdrawal by Subject,Overall Study,FG001,0.0439802203196328,0.8723186925434117,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2877,NCT00849056,Withdrawal by Subject,Follow-up Period (FUP) (8 Weeks),FG001,0.0439773397171924,0.8722742816538616,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2878,NCT02054897,Lost to Follow-up,Overall Study,FG002,0.0439620628393452,0.8722298707643114,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2879,NCT02942576,Other,Overall Study,FG001,0.0439483638543833,0.8721854598747613,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2880,NCT00734474,Withdrawal by Subject,Overall Study,FG004,0.0439307560754509,0.8721410489852112,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2881,NCT01618162,Adverse Event,Overall Study,FG000,0.0439213625490232,0.8720966380956611,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2882,NCT01182441,Withdrawal by Subject,Overall Study,FG000,0.0439197941237202,0.872052227206111,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2883,NCT00915772,Any other reason,Overall Study,FG000,0.0439174431692262,0.8720078163165608,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2884,NCT00915772,Refused to continue trial medication,Overall Study,FG002,0.0439095691157738,0.8719634054270107,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2885,NCT00915772,Protocol Violation,Overall Study,FG000,0.0439071490025595,0.8719189945374606,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2886,NCT00849056,Lost to Follow-up,Treatment Period (TP) (156 Weeks),FG000,0.0438979715135317,0.8718745836479105,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2887,NCT02988115,Sponsor Decision,Overall Study,FG000,0.0438519094179266,0.8718301727583604,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2888,NCT00273052,Withdrawal by Subject,Overall Study,FG001,0.0438219231704762,0.8717857618688102,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2889,NCT01898923,Adverse Event,Overall Study,FG000,0.0438213734686309,0.8717413509792601,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2890,NCT01898923,Physician Decision,Overall Study,FG000,0.0437861097990476,0.87169694008971,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2891,NCT00273052,Adverse Event,Overall Study,FG001,0.0437424554204762,0.8716525292001599,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2892,NCT01296412,Other reason not specified,Overall Study,FG001,0.0437401635876587,0.8716081183106098,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2893,NCT01557166,Protocol Violation,Overall Study,FG000,0.0437161012841026,0.8715637074210596,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2894,NCT03078478,Withdrawal by Subject,Maintencance Period 2 (36 Weeks),FG000,0.0437028760906448,0.8715192965315095,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2895,NCT00508820,Other,Overall Study,FG000,0.0436838284036011,0.8714748856419594,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2896,NCT00591578,Adverse Event,Double-Blind Treatment Phase,FG001,0.0436642343708234,0.8714304747524093,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2897,NCT02897349,Adverse Event,Overall Study,FG001,0.0436386614075397,0.8713860638628592,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2898,NCT00501059,Death,Overall Study,FG001,0.0436266986616865,0.871341652973309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2899,NCT00497146,Adverse Event,Treatment Period,FG000,0.0436242192741666,0.8712972420837589,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2900,NCT01717313,Withdrawal by Subject,Phase A (Weeks 0 to 24),FG001,0.0436206245097618,0.8712528311942088,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2901,NCT01841762,Lost to Follow-up,Post-Treatment Safety Follow-Up Period,FG000,0.0435913031156944,0.8712084203046587,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2902,NCT02897349,Adverse Event,Overall Study,FG000,0.043585372659623,0.8711640094151086,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2903,NCT04184622,Adverse Event,Safety Follow-up Period,FG003,0.0435481179671626,0.8711195985255584,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2904,NCT03242252,Adverse Event,Overall Study,FG002,0.043544315796804,0.8710751876360083,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2905,NCT00330759,Adverse Event,Overall Study,FG001,0.0435309842516414,0.8710307767464582,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2906,NCT02630706,Withdrawal by Subject,Overall Study,FG002,0.0435282711047122,0.8709863658569081,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2907,NCT00330759,Other,Overall Study,FG000,0.0435207502056295,0.870941954967358,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2908,NCT05275400,Adverse Event,Treatment Period,FG000,0.0435030959450892,0.8708975440778078,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2909,NCT01764386,"Withdrawal of Consent,Protocol Deviation",Uncontrolled Treatment Period (UTP),FG000,0.0434993747657539,0.8708531331882577,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2910,NCT01764386,"Withdrawal of Consent,Protocol Deviation",Uncontrolled Treatment Period (UTP),FG001,0.0434907678265475,0.8708087222987076,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2911,NCT01764386,Lost to Follow-up,Controlled Treatment Period (CTP),FG001,0.0434857626099999,0.8707643114091576,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2912,NCT03819153,Lost to Follow-up,Overall Study,FG000,0.0434836015381448,0.8707199005196075,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2913,NCT00856284,Voluntary withdrawal,Overall Study,FG000,0.0434625299305158,0.8706754896300573,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2914,NCT00412984,Death,Overall Study,FG000,0.0434521504126884,0.8706310787405072,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2915,NCT03439254,Adverse Event,Open Label Extension Phase (12 Months),FG003,0.0434452540880257,0.8705866678509571,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2916,NCT01599650,Adverse Event,Overall Study,FG001,0.0434093957154761,0.870542256961407,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2917,NCT00321919,Refused Treatment,Overall Study,FG000,0.0433892616848214,0.8704978460718569,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2918,NCT01147250,Withdrawal by Subject,Overall Study,FG000,0.0433830316712103,0.8704534351823067,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2919,NCT01468181,Adverse Event,Overall Study,FG000,0.0433481370324161,0.8704090242927566,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2920,NCT01555164,Protocol Violation,Overall Study,FG000,0.0433462176621185,0.8703646134032065,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2921,NCT01003184,Withdrawal by Subject,Overall Study,FG001,0.0433306885210119,0.8703202025136564,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2922,NCT03066804,Withdrawal by Subject,Overall Study,FG001,0.0433269926086904,0.8702757916241062,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2923,NCT03888066,Randomization Criterion #3,Run-in Phase,FG000,0.0433150533683928,0.8702313807345561,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2924,NCT00402727,Lost to Follow-up,Overall Study,FG000,0.0432848801440376,0.870186969845006,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2925,NCT00663260,Adverse Event,Overall Study,FG001,0.0432797501298214,0.8701425589554559,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2926,NCT01494987,Subject Non-Compliance,Overall Study,FG000,0.0432572947653129,0.8700981480659058,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2927,NCT00902538,Adverse Event,"1-Single-blind, Run-in, Single-Treatment",FG000,0.0432448460488491,0.8700537371763556,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2928,NCT00935532,Adverse Event,Overall Study,FG000,0.043209814059246,0.8700093262868055,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2929,NCT01137812,Physician Decision,Overall Study,FG001,0.0431813034013194,0.8699649153972554,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2930,NCT04809220,Withdrawal by Subject,Overall Study,FG001,0.0431745181999621,0.8699205045077053,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2931,NCT04039503,Withdrawal by Subject,Overall Study,FG002,0.043171230482738,0.8698760936181552,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2932,NCT00482729,Adverse Event,Overall Study,FG001,0.043160199935119,0.869831682728605,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2933,NCT00827606,Withdrawal by Subject,Overall Study,FG001,0.0431098299855555,0.8697872718390549,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2934,NCT03814187,Adverse Event,Overall Study,FG001,0.0430741186933631,0.8697428609495048,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2935,NCT04592419,Lost to Follow-up,Primary Study (Through Year 1),FG001,0.0430378152293154,0.8696984500599547,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2936,NCT04592419,Lost to Follow-up,Primary Study (Through Year 1),FG000,0.0430314993366368,0.8696540391704046,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2937,NCT03552757,Withdrawal by Subject,Overall Study,FG002,0.0430276382416368,0.8696096282808544,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2938,NCT00707993,Withdrawal by Subject,Overall Study,FG000,0.0430209300056547,0.8695652173913043,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2939,NCT04592419,Lost to Follow-up,Open-Label Extension Period,FG001,0.0430165306255654,0.8695208065017542,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2940,NCT03730662,Withdrawal by Subject,Variable Treatment Period,FG003,0.0429811373049305,0.8694763956122041,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2941,NCT00327015,Lack of Efficacy,Overall Study,FG002,0.0429717073455059,0.869431984722654,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2942,NCT00715624,Poor compliance,Overall Study,FG001,0.0429671170378868,0.8693875738331038,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2943,NCT00440193,Adverse Event,Treatment Period,FG000,0.0429628979395237,0.8693431629435537,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2944,NCT01698775,Withdrawal by Subject,Phase A,FG001,0.0429551371882439,0.8692987520540036,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2945,NCT01032629,Withdrawal by Subject,Overall Study,FG000,0.0429527519961399,0.8692543411644535,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2946,NCT03548935,Withdrawal by Subject,Overall Study,FG001,0.0429380797488293,0.8692099302749035,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2947,NCT00168805,Protocol Violation,Overall Study,FG000,0.0428829281742063,0.8691655193853532,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2948,NCT00094770,Adverse Event,Year 2 (Week 0 to Week 104),FG001,0.0428775279090575,0.8691211084958032,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2949,NCT00168805,Lost to Follow-up,Overall Study,FG000,0.0428483165445039,0.8690766976062531,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2950,NCT00509262,Withdrawal by Subject,Overall Study,FG001,0.0428480662699701,0.869032286716703,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2951,NCT01068665,Other,Overall Study,FG001,0.0428363662612202,0.8689878758271529,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2952,NCT01370616,Adverse Event,Overall Study,FG000,0.0428360990855114,0.8689434649376027,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2953,NCT03214380,Withdrawal by Subject,Treatment Period,FG005,0.0428090772835317,0.8688990540480526,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2954,NCT04592419,Sponsor Request,Primary Study (Through Year 1),FG001,0.0428090060769344,0.8688546431585025,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2955,NCT01106690,Other,Extension Period: Week 26 to Week 52,FG000,0.0427842271965873,0.8688102322689524,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2956,NCT01243424,Lack of Efficacy,Discontinuation From Treatment,FG000,0.0427699762717658,0.8687658213794023,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2957,NCT01068678,Withdrawal criteria,Overall Study,FG000,0.042758700151488,0.8687214104898521,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2958,NCT04445519,Adverse Event,Overall Study,FG002,0.0427521632185019,0.868676999600302,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2959,NCT00350779,Withdrawal by Subject,Overall Study,FG000,0.0427514631686508,0.8686325887107519,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2960,NCT01046110,Protocol Violation,Overall Study,FG001,0.0427347863491963,0.8685881778212018,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
2961,NCT04592419,Withdrawal by Subject,Open-Label Extension Period,FG000,0.0427266565204463,0.8685437669316517,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2962,NCT01813422,Withdrawal by Subject,Overall Study,FG000,0.0426877137237589,0.8684993560421015,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2963,NCT00546052,Adverse Event,Overall Study,FG000,0.0426807502291865,0.8684549451525514,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2964,NCT01128153,Condition under investigation worsened,Overall Study,FG001,0.0426434544220535,0.8684105342630013,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2965,NCT03859427,Withdrawal by Subject,Overall Study,FG000,0.0426327058940178,0.8683661233734512,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2966,NCT00591578,Lack of Efficacy,Double-Blind Treatment Phase,FG002,0.0426209096913392,0.868321712483901,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2967,NCT03785405,Participant decision,Overall Study,FG000,0.0425769601499405,0.8682773015943509,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2968,NCT01730040,Other than specified,Overall Study,FG000,0.0425769511394147,0.8682328907048008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2969,NCT02059187,Lost to Follow-up,Overall Study,FG000,0.0425347286819047,0.8681884798152507,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2970,NCT01076647,Unclassified,Overall Study,FG000,0.0425216587174701,0.8681440689257006,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2971,NCT01289990,did not continue in extension,Overall Study,FG010,0.0425205324453868,0.8680996580361504,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2972,NCT00523978,Withdrawal by Subject,Overall Study,FG001,0.0425126398892559,0.8680552471466003,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2973,NCT00494013,Withdrawal by Subject,Overall Study,FG001,0.0424995061898016,0.8680108362570502,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2974,NCT00542178,did not complete year 4 follow-up,Overall Study,FG000,0.0424968017887896,0.8679664253675001,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2975,NCT04707469,Withdrawal by Subject,Overall Study,FG002,0.0424888512807738,0.86792201447795,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2976,NCT03954834,Lost to Follow-up,Overall Study,FG003,0.042473072247389,0.8678776035883998,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2977,NCT01289990,did not continue in extension,Overall Study,FG001,0.0424564257024106,0.8678331926988497,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2978,NCT01237223,Adverse Event,"Single Blind(Run-in Period, 4 Weeks)",FG000,0.0424552926485417,0.8677887818092996,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2979,NCT02320721,Other than specified above,Overall Study,FG000,0.042439591135138,0.8677443709197495,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2980,NCT01076647,Unclassified,Overall Study,FG001,0.0424348280626784,0.8676999600301994,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2981,NCT02284893,Withrawal of the consent by the subject,26 Week (Short Term),FG000,0.0424234890847222,0.8676555491406492,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2982,NCT00249795,Other adverse events (non-serious),Overall Study,FG000,0.0423789506208432,0.8676111382510991,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2983,NCT00863681,Withdrawal by Subject,Overall Study,FG001,0.0423736842286905,0.867566727361549,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2984,NCT02558296,Withdrawal by Subject,Completed the Study Through Week 24,FG000,0.0423726836397618,0.867522316471999,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2985,NCT01106651,Withdrawal by Subject,Overall Study,FG000,0.0423716348771284,0.8674779055824489,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2986,NCT01151410,Lost to Follow-up,Overall Study,FG001,0.042364969958244,0.8674334946928987,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2987,NCT04537923,Death,Overall Study,FG003,0.0423433841923511,0.8673890838033486,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2988,NCT01396083,Consent withdrawn,Overall Study,FG001,0.0423321324860714,0.8673446729137985,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2989,NCT02447172,Adverse Event,Overall Study,FG001,0.0423148212588987,0.8673002620242484,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2990,NCT01999218,Hyperglycemia,Overall Study,FG002,0.042311916781637,0.8672558511346983,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2991,NCT04429503,Withdrawal by Subject,Extension Phase (Wk 96 to Wk 156),FG005,0.0422903790580851,0.8672114402451481,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2992,NCT01999218,Hyperglycemia,Overall Study,FG001,0.0422780828797917,0.867167029355598,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2993,NCT04429503,Withdrawal by Subject,Extension Phase (Wk 96 to Wk 156),FG003,0.0422699013680851,0.8671226184660479,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2994,NCT00295633,Adverse Event,Overall Study,FG001,0.0422614063050198,0.8670782075764978,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
2995,NCT01999218,Lost to Follow-up,Overall Study,FG001,0.0422471396858631,0.8670337966869477,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2996,NCT02892149,Lost to Follow-up,Overall Study,FG001,0.0422456139028868,0.8669893857973975,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
2997,NCT00763815,Withdrawal by Subject,Overall Study,FG001,0.0422372582585912,0.8669449749078474,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
2998,NCT01345019,Disease Progression,Open Label Treatment Phase,FG001,0.0422323771695535,0.8669005640182973,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
2999,NCT01154036,Withdrawal by Subject,Phase I,FG002,0.0422252977159325,0.8668561531287472,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3000,NCT00536510,Flushing with Product,Overall Study,FG000,0.0422228096848214,0.8668117422391971,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3001,NCT04429503,Death,Main Study (Up to Wk 96),FG002,0.0422125196137994,0.8667673313496469,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3002,NCT04429503,Lost to Follow-up,Main Study (Up to Wk 96),FG000,0.0422111221174006,0.8667229204600968,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3003,NCT02058160,Other than specified above,Overall Study,FG000,0.0421918795942758,0.8666785095705467,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3004,NCT00507416,Progressive Disease,Overall Study,FG001,0.0421860283253824,0.8666340986809966,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3005,NCT01006291,Other,Overall Study,FG002,0.0421782851510118,0.8665896877914465,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3006,NCT02111564,Death,Overall Study,FG001,0.0421724548296031,0.8665452769018963,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3007,NCT00094770,Adverse Event,Year 2 (Week 0 to Week 104),FG000,0.0421590655665178,0.8665008660123462,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3008,NCT00366249,Adverse Event,Overall Study,FG001,0.0421555114058134,0.8664564551227961,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3009,NCT00306384,Lost to Follow-up,Overall Study,FG000,0.0421383241063591,0.866412044233246,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3010,NCT02648347,Withdrawal by Subject,Overall Study,FG000,0.0421298588881448,0.8663676333436958,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3011,NCT00830960,Withdrawal by Subject,Overall Study,FG002,0.0421228374190178,0.8663232224541457,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3012,NCT00620542,Adverse Event,Part B (2 Year Core Study),FG002,0.0421176420539087,0.8662788115645956,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3013,NCT04017832,Withdrawal by Subject,Overall Study,FG001,0.0421052407746726,0.8662344006750455,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3014,NCT04093752,Withdrawal by Subject,Overall Study,FG002,0.0420974395491864,0.8661899897854954,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3015,NCT03110562,Other,Initial Treatment Period,FG001,0.0420737830163122,0.8661455788959452,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3016,NCT02926937,At the Participant's own Request,Overall Study,FG001,0.0420578926252778,0.8661011680063951,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3017,NCT02926937,Lost to Follow-up,Overall Study,FG001,0.0420561919869445,0.866056757116845,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3018,NCT03444324,Lost to Follow-up,Overall Study,FG001,0.0420555060697023,0.866012346227295,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3019,NCT02058160,Adverse Event,Overall Study,FG000,0.0420522840737401,0.8659679353377449,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3020,NCT00614380,Lost to Follow-up,Overall Study,FG000,0.0420307415590673,0.8659235244481946,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3021,NCT00996658,Adverse Event,Overall Study,FG000,0.0420261291094544,0.8658791135586446,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3022,NCT01926782,Adverse Event,Overall Study,FG000,0.042023112092867,0.8658347026690945,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3023,NCT00542178,did not complete year 4 follow-up,Overall Study,FG002,0.042011750126617,0.8657902917795444,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3024,NCT01272219,Unclassified,Main + Extension Period: Week 0-172,FG005,0.0420093544712698,0.8657458808899943,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3025,NCT03376789,Withdrawal by Subject,Overall Study,FG000,0.0419762358326885,0.8657014700004441,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3026,NCT01885559,Less than full participation,Overall Study,FG000,0.0419696766283631,0.865657059110894,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3027,NCT04460885,Withdrawal by Subject,Overall Study,FG001,0.04196646301125,0.8656126482213439,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3028,NCT01730053,Other than specified,Overall Study,FG001,0.0419417654024504,0.8655682373317938,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3029,NCT01335399,Death,Treatment Period,FG000,0.0419381369760118,0.8655238264422437,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3030,NCT00097591,Withdrawal of consent,Overall Study,FG001,0.0419345460204067,0.8654794155526935,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3031,NCT01078675,Withdrawal by Subject,Overall Study,FG000,0.0419318299748908,0.8654350046631434,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3032,NCT01081834,Withdrawal by Subject,Core Period: Baseline to Week 26,FG000,0.0419285945647023,0.8653905937735933,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3033,NCT00484198,Participant Withdrew Consent,Overall Study,FG002,0.0419200770927083,0.8653461828840432,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3034,NCT02229383,Adverse Event,Overall Study,FG000,0.0418755752474404,0.8653017719944931,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3035,NCT01335399,Consent withdrawal,Treatment Period,FG001,0.0418711247143353,0.8652573611049429,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3036,NCT00423319,Adverse Event,Overall Study,FG001,0.0418521010326586,0.8652129502153928,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3037,NCT01730053,Adverse Event,Overall Study,FG001,0.0418449856497718,0.8651685393258427,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3038,NCT00719563,Personal reasons,Overall Study,FG001,0.0418416740445535,0.8651019229915176,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3039,NCT00719563,Lack of Efficacy,Overall Study,FG001,0.0418416740445535,0.8651019229915176,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3040,NCT00972283,Protocol Violation,Main: Week 0 to 52 (NN1250-3582),FG000,0.0418310588212797,0.8650353066571923,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3041,NCT02994927,Death,Overall Study,FG000,0.0417900121606944,0.8649908957676422,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3042,NCT02994927,Physician Decision,Overall Study,FG000,0.0417704687156944,0.8649464848780921,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3043,NCT00736099,Lost to Follow-up,Overall Study,FG000,0.0417689502011706,0.864902073988542,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3044,NCT02164864,Other Adverse Event (AE),Overall Study,FG001,0.041768718268502,0.8648576630989919,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3045,NCT00174785,Atrial Fibrillation/Flutter recurrence,Overall Study,FG000,0.0417458818379662,0.8648132522094417,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3046,NCT02107898,Adverse Event,Overall Study,FG000,0.0417445159417955,0.8647688413198916,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3047,NCT00996658,Lost to Follow-up,Overall Study,FG000,0.0417359426078473,0.8647244304303415,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3048,NCT01958671,Lost to Follow-up,Overall Study,FG000,0.0417190521478968,0.8646800195407914,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3049,NCT00126425,Withdrawal by Subject,Overall Study,FG000,0.0417103856157241,0.8646356086512413,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3050,NCT00360334,Subject decision,Overall Study,FG000,0.0416839708031547,0.8645911977616911,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3051,NCT01392573,Unclassified,Overall Study,FG000,0.0416799307626244,0.864546786872141,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3052,NCT03053440,Physician Decision,Overall Study,FG000,0.0416774962998413,0.8645023759825909,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3053,NCT00434954,Entry criteria not met,Overall Study,FG000,0.0416625046905555,0.8644579650930408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3054,NCT00909870,Adverse Event,Overall Study,FG000,0.0416605024604473,0.8644135542034906,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3055,NCT00086515,Patient received Phase A rescue therapy,Phase A to Phase B Transition Period,FG001,0.0416576663423313,0.8643691433139405,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3056,NCT02076009,Lost to Follow-up,Overall Study,FG000,0.0416568771680952,0.8643247324243905,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3057,NCT01958671,Lost to Follow-up,Overall Study,FG002,0.0416520307461904,0.8642803215348404,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3058,NCT04964544,Lost to Follow-up,Overall Study,FG000,0.0416311934188392,0.8642359106452903,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3059,NCT01652716,Adverse Event,Overall Study,FG000,0.0416299422002381,0.8641914997557401,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3060,NCT00424047,Progression of Disease,Long Term Extension (Up to 25 Jun 2013),FG000,0.0416254492489881,0.86414708886619,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3061,NCT01986855,Withdrawal by Subject,Overall Study,FG000,0.0416090537233035,0.8641026779766399,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3062,NCT02561078,Non-Compliance with Study Drug,Overall Study,FG000,0.0415540681268452,0.8640582670870898,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3063,NCT01237223,Subject withdrew consent,"Single Blind(Run-in Period, 4 Weeks)",FG000,0.0415370727431872,0.8640138561975397,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3064,NCT03888066,"1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L",Run-in Phase,FG000,0.041527962403621,0.8639694453079895,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3065,NCT00986154,Death,Overall Study,FG001,0.041524453033998,0.8639250344184394,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3066,NCT00976391,Lost to Follow-up,Follow-up Period (8 Weeks),FG001,0.041514341139871,0.8638806235288893,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3067,NCT02561078,Lost to Follow-up,Overall Study,FG001,0.0414967165629662,0.8638362126393392,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3068,NCT00273052,Protocol Violation,Overall Study,FG001,0.0414841436112797,0.8637918017497891,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3069,NCT01652729,Withdrawal by Subject,Overall Study,FG002,0.0414832159647718,0.8637473908602389,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3070,NCT01652729,Withdrawal by Subject,Overall Study,FG001,0.0414719148406051,0.8637029799706888,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3071,NCT03495102,Withdrawal by Subject,Overall Study,FG002,0.0414693680045734,0.8636585690811387,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3072,NCT00501059,Adverse Event,Overall Study,FG000,0.0414481565020138,0.8636141581915886,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3073,NCT04576988,Withdrawal by Subject,Double Blind Placebo Controlled (DBPC),FG001,0.0414345780011904,0.8635475418572633,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3074,NCT04576988,Withdrawal by Subject,Long Term Double Blind (LTDB),FG001,0.0414345780011904,0.8635475418572633,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3075,NCT00328627,Hyperglycemic Rescue,Overall Study,FG000,0.0414183082493352,0.8634809255229382,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3076,NCT01582451,Withdrawal by Subject,Overall Study,FG001,0.0414118412127083,0.8634365146333881,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3077,NCT00614939,Adverse Event,Overall Study,FG001,0.0414034191966865,0.863392103743838,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3078,NCT00479388,Withdrawal by Subject,Overall Study,FG000,0.0413832441991467,0.8633476928542879,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3079,NCT03814187,Adverse Event,Overall Study,FG000,0.0413728182846031,0.8633032819647377,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3080,NCT01289990,did not continue in extension,Overall Study,FG008,0.0413437342637202,0.8632588710751876,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3081,NCT03548987,Other,Run-in Period (Week 0 to Week 20),FG000,0.0413127456885019,0.8632144601856375,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3082,NCT00894387,Patient's request,Overall Study,FG001,0.0413123967689195,0.8631700492960874,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3083,NCT03115112,Adverse Event,Overall Study,FG000,0.0413105399203174,0.8631256384065373,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3084,NCT00568178,Adverse Event,Open Label Extension,FG005,0.0412689899993749,0.8630812275169871,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3085,NCT00568178,Physician Decision,Open Label Extension,FG005,0.0412639856008233,0.863036816627437,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3086,NCT01442038,Lost to Follow-up,Overall Study,FG000,0.0412531807115674,0.8629924057378869,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3087,NCT00766493,Discontinued,30 Days Post-Procedure,FG000,0.0412376382636408,0.8629479948483368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3088,NCT01032629,Lost to Follow-up,Overall Study,FG001,0.0412370309981151,0.8629035839587867,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3089,NCT00456521,Lost to Follow-up,Overall Study,FG000,0.0412154085326785,0.8628591730692365,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3090,NCT01177813,Withdrawal by Subject,Overall Study,FG002,0.0411982162222618,0.8628147621796864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3091,NCT00429364,Withdrawal by Subject,Overall Study,FG000,0.0411930669920337,0.8627703512901364,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3092,NCT01786993,Death,Overall Study,FG000,0.0411664415355158,0.8627259404005863,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3093,NCT00152971,Withdrawal by Subject,Overall Study,FG002,0.041140215505238,0.8626815295110362,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3094,NCT01177813,Lost to Follow-up,Overall Study,FG002,0.041136005349226,0.862637118621486,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3095,NCT01177813,Adverse Event,Overall Study,FG003,0.0411086462663094,0.8625927077319359,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3096,NCT00152971,Lost to Follow-up,Overall Study,FG001,0.0410977041865475,0.8625482968423858,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3097,NCT02884206,Protocol deviation,LCZ696 Run-in Period,FG000,0.0410962946766964,0.8625038859528357,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3098,NCT00286442,Hyperglycemic Rescue,Overall Study,FG001,0.0410953007979563,0.8624594750632855,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3099,NCT00982644,Unclassified,Extension: Week 53 to 104 (NN1250-3643),FG000,0.0410886973293452,0.8624150641737354,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3100,NCT04807400,Protocol Violation,Overall Study,FG002,0.0410172651557455,0.8623706532841853,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3101,NCT00838916,Noncompliance,Treatment Period (156 Weeks),FG001,0.0409914625355357,0.8623262423946352,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3102,NCT00318461,Adverse Event,"Double-Blind, 6 Months",FG002,0.0409818801683134,0.8622818315050851,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3103,NCT01968967,Lost to Follow-up,Treatment Period,FG000,0.0409723813347024,0.8622374206155349,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3104,NCT00318461,Lack of Efficacy,"Double-Blind, 6 Months",FG003,0.0409682789531349,0.8621930097259848,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3105,NCT01621178,Adverse Event,Overall Study,FG002,0.0408776457079364,0.8621485988364347,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3106,NCT03172494,Withdrawal by Subject,Overall Study,FG001,0.0408759900625297,0.8621041879468846,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3107,NCT03172494,Withdrawal by Subject,Overall Study,FG002,0.0408568328383333,0.8620597770573345,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3108,NCT00712673,Poor Compliance to Protocol,Overall Study,FG003,0.0408342375019246,0.8620153661677843,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3109,NCT02833948,Death,Overall Study,FG001,0.0408127328417063,0.8619709552782342,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3110,NCT00359762,Physician Decision,Period II,FG004,0.0408012122767261,0.8619265443886841,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3111,NCT04184622,Withdrawal by Subject,Additional Treatment Period,FG001,0.0407901704279166,0.861882133499134,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3112,NCT01272232,Unclassified,Weeks 0-56,FG000,0.0407419185513095,0.8618377226095839,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3113,NCT04102189,Withdrawal by Subject,Overall Study,FG001,0.0407259057373313,0.8617933117200337,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3114,NCT00910429,Withdrawal by Subject,Overall Study,FG000,0.0407231170425595,0.8617489008304836,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3115,NCT03988634,Adverse Event,Double-Blind,FG000,0.0407151727234442,0.8617044899409335,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3116,NCT00617123,Adverse Event,Study Treatment Period,FG000,0.0407071723959821,0.8616600790513834,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3117,NCT02036515,Withdrawal by Subject,Overall Study,FG001,0.0407040953672619,0.8616156681618333,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3118,NCT00715624,Adverse Event,Overall Study,FG000,0.0406990789608495,0.8615712572722831,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3119,NCT00249873,Oral anticoagulant required,Overall Study,FG000,0.0406595942180654,0.861526846382733,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3120,NCT03914326,Lost to Follow-up,Overall Study,FG001,0.0406364108910118,0.8614824354931829,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3121,NCT04184622,Lost to Follow-up,Primary Treatment Period,FG002,0.0406355373886904,0.8614380246036328,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3122,NCT00661999,Withdrawal by Subject,Overall Study,FG002,0.0406287824882936,0.8613936137140827,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3123,NCT00554216,Lost to Follow-up,Overall Study,FG001,0.0405798153730952,0.8613492028245325,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3124,NCT05691712,Withdrawal by Subject,Overall Study,FG000,0.040565653031488,0.8613047919349824,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3125,NCT02072434,Withdrawal by Subject,Overall Study,FG001,0.0405568459876785,0.8612603810454323,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3126,NCT05691712,Adverse Event,Overall Study,FG002,0.0405449395387797,0.8612159701558822,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3127,NCT01507831,Consent withdrawn by participant,Overall Study,FG000,0.040541964977996,0.8611715592663322,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3128,NCT02863328,Lost to Follow-up,Overall Study,FG001,0.0405411785842261,0.861127148376782,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3129,NCT02414841,Withdrawal by Subject,Overall Study,FG000,0.0405405753675198,0.8610827374872319,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3130,NCT00271817,Adverse Event,Part 2,FG002,0.0405399690377777,0.8610383265976818,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3131,NCT02072434,Other,Overall Study,FG001,0.0405397907103571,0.8609939157081317,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3132,NCT00056160,Withdrawal by Subject,Extended Follow-up Cutoff (23 Jul 2008),FG000,0.0404963278150694,0.8609495048185816,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3133,NCT02030600,Lost to Follow-up,Treatment Period 1,FG000,0.0404711128674603,0.8609050939290314,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3134,NCT00554216,Withdrawal by Subject,Overall Study,FG001,0.0404643928048908,0.8608606830394813,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3135,NCT00734474,"Sponsor Decision, Arm Discontinued",Overall Study,FG006,0.0404499599995292,0.8608162721499312,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3136,NCT00818883,Withdrawal by Subject,Overall Study,FG000,0.0404307841869939,0.8607718612603811,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3137,NCT00508820,Withdrawal by Subject,Overall Study,FG000,0.0403961755227543,0.860727450370831,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3138,NCT00358215,Physician Decision,Overall Study,FG001,0.0403437600093253,0.8606830394812808,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3139,NCT01451398,Adverse Event,Overall Study,FG000,0.0403370643185515,0.8606386285917307,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3140,NCT00232180,Death,Open Label Phase,FG002,0.0403091196986516,0.8605942177021806,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3141,NCT02017171,ESKD,Overall Study,FG000,0.0402768486848572,0.8605498068126305,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3142,NCT00689936,Study Close Out,Active Treatment Phase,FG002,0.0402677618020238,0.8605053959230803,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3143,NCT00689936,Withdrawal by Subject,Active Treatment Phase,FG002,0.0402549746661905,0.8604609850335302,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3144,NCT02791490,Withdrawal by Subject,Overall Study,FG001,0.0402419330026388,0.8604165741439801,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3145,NCT04915729,Lost to Follow-up,Overall Study,FG001,0.040230924128363,0.86037216325443,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3146,NCT00508820,Adverse Event,Overall Study,FG001,0.0402223967355519,0.8603277523648799,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3147,NCT02532855,Withdrawal by Subject,Overall Study,FG001,0.040211895990873,0.8602833414753297,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3148,NCT00501059,Clinical endpoint reached,Overall Study,FG001,0.0401780378550595,0.8602389305857796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3149,NCT00487240,Withdrawal by Subject,Overall Study,FG000,0.0401655444876587,0.8601945196962295,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3150,NCT00249873,Oral anticoagulant required,Overall Study,FG001,0.0401643858601686,0.8601501088066794,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3151,NCT00927862,Missing data needed for endpt analyses,Overall Study,FG001,0.0401603546688392,0.8601056979171293,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3152,NCT03067441,Adverse Event,Overall Study,FG001,0.0401215558512202,0.8600612870275791,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3153,NCT03868124,Withdrawal by Subject,Overall Study,FG000,0.040115398790615,0.860016876138029,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3154,NCT01615198,Adverse Event,Overall Study,FG000,0.0401071152350297,0.8599724652484789,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3155,NCT01307033,Potassium Withdrawal Criteria Met,44-week Open-label Extension,FG002,0.0400859405247917,0.8599280543589288,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3156,NCT01307033,Potassium Withdrawal Criteria Met,8-week Double-blind Period,FG000,0.0400634749671131,0.8598836434693787,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3157,NCT03242252,Adverse Event,Overall Study,FG000,0.0400143038341666,0.8598392325798285,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3158,NCT01627327,Adverse Event,Overall Study,FG001,0.0400130946776488,0.8597948216902784,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3159,NCT01345019,Disease Progression,Open Label Treatment Phase,FG000,0.0399745302790376,0.8597504108007283,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3160,NCT01076088,Withdrawal by Subject,Overall Study,FG002,0.0399595154281051,0.8597059999111782,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3161,NCT02866175,Physician Decision,Overall Study,FG001,0.0399534848387103,0.859639383576853,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3162,NCT02866175,Did not receive treatment,Overall Study,FG001,0.0399534848387103,0.859639383576853,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3163,NCT03066804,Death,Overall Study,FG000,0.039950917004613,0.8595727672425278,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3164,NCT01467466,No Endpoint Blood Draw,Overall Study,FG002,0.0399498542768353,0.8595283563529778,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3165,NCT02207374,Withdrawal by Subject,Overall Study,FG001,0.0399101695983631,0.8594839454634277,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3166,NCT01624142,Withdrawal by Subject,Overall Study,FG001,0.0398984911579364,0.8594395345738776,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3167,NCT00494013,Withdrawal by Subject,Overall Study,FG000,0.0398745190947619,0.8593951236843274,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3168,NCT04657003,Withdrawal by Subject,Overall Study,FG001,0.0398367351522817,0.8593507127947773,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3169,NCT00168805,Lost to Follow-up,Overall Study,FG002,0.0398262218245237,0.8593063019052272,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3170,NCT00295633,Withdrawal of consent by subject,Overall Study,FG001,0.0398105227591369,0.8592618910156771,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3171,NCT00604383,Lost to Follow-up,Overall Study,FG000,0.0398050654613095,0.859217480126127,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3172,NCT05259033,Withdrawal by Subject,Overall Study,FG001,0.0398039863791152,0.8591730692365768,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3173,NCT02648217,Withdrawal by Subject,Overall Study,FG000,0.0398033432659325,0.8591286583470267,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3174,NCT00168805,Protocol Violation,Overall Study,FG001,0.0398004400691071,0.8590842474574766,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3175,NCT02926950,Adverse Event,Overall Study,FG001,0.039799650184014,0.8590398365679265,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3176,NCT02911948,Unclassified,Overall Study,FG001,0.0397957415774404,0.8589954256783764,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3177,NCT00295633,Lack of Efficacy,Overall Study,FG002,0.0397886061515774,0.8589510147888262,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3178,NCT02453555,Withdrawal by Subject,24-week Double-blind Treatment Period,FG001,0.0397875731490971,0.8589066038992761,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3179,NCT00168805,Adverse Event,Overall Study,FG001,0.0397560535295237,0.858862193009726,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3180,NCT00295633,Withdrawal of consent by subject,Overall Study,FG000,0.0397558498064584,0.8588177821201759,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3181,NCT02607306,Withdrawal by Subject,Overall Study,FG001,0.0397530363747023,0.8587733712306258,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3182,NCT03242018,Reason Not Specified,Overall Study,FG000,0.0397520671133928,0.8587289603410756,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3183,NCT00501059,Adverse Event,Overall Study,FG001,0.0397014008291369,0.8586845494515255,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3184,NCT01031680,Subject No Longer Meets Study Criteria,Overall Study,FG001,0.0396783858942658,0.8586401385619754,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3185,NCT00707031,Familial or Personal Reasons,Overall Study,FG001,0.0396721710238591,0.8585957276724253,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3186,NCT03214380,Withdrawal by Subject,Treatment Period,FG001,0.0396633137499504,0.8585513167828751,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3187,NCT00968812,Other,Overall Study,FG000,0.0396571146087815,0.858506905893325,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3188,NCT00968812,Withdrawal by Subject,Overall Study,FG002,0.0396451078308549,0.8584624950037749,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3189,NCT02419612,Adverse Event,Long-term Treatment Period,FG001,0.0396211718297321,0.8584180841142248,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3190,NCT01272193,Unclassified,Overall Study,FG001,0.0396198587115476,0.8583736732246747,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3191,NCT00680017,Adverse Event,Overall Study,FG001,0.0395983996049702,0.8583292623351245,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3192,NCT04509674,Lost to Follow-up,Overall Study,FG001,0.0395981789136904,0.8582848514455744,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3193,NCT01644500,Withdrawal by Subject,Overall Study,FG001,0.0395912166893948,0.8582404405560243,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3194,NCT01644500,Withdrawal by Subject,Overall Study,FG002,0.0395871511558234,0.8581960296664742,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3195,NCT03277105,Lost to Follow-up,Overall Study,FG001,0.0395697456493746,0.8581516187769241,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3196,NCT00463606,Adverse Event,Overall Study,FG000,0.0395662819327173,0.8581072078873739,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3197,NCT02181413,Reason Not Specified,Overall Study,FG001,0.0395224244034864,0.8580627969978238,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3198,NCT01895777,Other reasons,Overall Study,FG000,0.0395017616470833,0.8580183861082737,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3199,NCT01568866,Withdrawal by Subject,Overall Study,FG001,0.0394939852529762,0.8579739752187237,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3200,NCT03917472,Lost to Follow-up,Overall Study,FG001,0.0394597404766369,0.8579295643291736,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3201,NCT01183013,Reasons other than stated above,Overall Study,FG002,0.0393916454870634,0.8578851534396233,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3202,NCT01239797,Participant withdrew consent,Treated Participants,FG000,0.0393737770023511,0.8578407425500733,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3203,NCT03061214,Withdrawal by Subject,Overall Study,FG002,0.0393527269791369,0.8577963316605232,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3204,NCT02991118,Lost to Follow-up,Overall Study,FG001,0.0393517340069925,0.8577519207709731,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3205,NCT00954447,Protocol Violation,Overall Study,FG001,0.0393473882770535,0.857707509881423,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3206,NCT03917472,Death,Overall Study,FG001,0.0393219170113988,0.8576630989918728,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3207,NCT00281580,Adverse Event,Overall Study,FG012,0.0393062212074106,0.8576186881023227,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3208,NCT02666664,Withdrawal by participant,Overall Study,FG000,0.0392828602215476,0.8575742772127726,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3209,NCT01159600,Adverse Event,Overall Study,FG004,0.0392757743018749,0.8575298663232225,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3210,NCT02681094,Study-specific discontinuation criteria,1 -Modified Enrolled Participants Set,FG000,0.0392617496417262,0.8574854554336724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3211,NCT01499082,Diverse Reasons,Overall Study,FG001,0.0392615117572122,0.8574410445441222,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3212,NCT00532779,Lack of Efficacy,Overall Study,FG002,0.0392240978916864,0.8573966336545721,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3213,NCT02942576,Withdrawal by Subject,Overall Study,FG000,0.0391937891265079,0.857352222765022,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3214,NCT02033889,Lost to Follow-up,Overall Study,FG000,0.0391908941945634,0.8573078118754719,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3215,NCT00321919,Death,Overall Study,FG000,0.0391609946727381,0.8572634009859218,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3216,NCT01984424,Withdrawal by Subject,Overall Study,FG000,0.0391468827375694,0.8572189900963716,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3217,NCT00121641,Lost to Follow-up,48-month Short Term + Long Term Period,FG002,0.0391359124697808,0.8571745792068215,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3218,NCT00121641,Lost to Follow-up,48-month Short Term + Long Term Period,FG004,0.0391343999656141,0.8571301683172714,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3219,NCT01733758,Adverse Event,Overall Study,FG002,0.0391336818095337,0.8570857574277213,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3220,NCT03285594,Adverse Event,Overall Study,FG002,0.0391056786116132,0.8570413465381712,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3221,NCT00641056,Adverse Event,Overall Study,FG000,0.0390997981547348,0.856996935648621,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3222,NCT00620542,Withdrawal by Subject,Part A (Run-in - 2 Weeks),FG000,0.039094695140137,0.8569525247590709,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3223,NCT00432276,Withdrawal by Subject,Overall Study,FG001,0.0390830350486012,0.8569081138695208,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3224,NCT00549302,Withdrawal by Subject,Double-Blind,FG001,0.0390688597254166,0.8568637029799707,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3225,NCT00432276,Protocol Violation,Overall Study,FG001,0.03906729100624,0.8568192920904206,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3226,NCT01442038,Death,Overall Study,FG000,0.0390475032091666,0.8567748812008704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3227,NCT00494871,Clinical Endpoint Reached,Double-blind (DB) Treatment Period,FG001,0.0390414726287102,0.8567304703113203,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3228,NCT00608023,Withdrawal by Subject,Overall Study,FG000,0.039040870379365,0.8566860594217702,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3229,NCT00452530,Withdrawal by Subject,Overall Study,FG000,0.0390370254930933,0.8566416485322201,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3230,NCT02918279,Other,Overall Study,FG000,0.0390323050009821,0.8565972376426699,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3231,NCT02918279,Lost to Follow-up,Overall Study,FG000,0.0390321526259821,0.8565528267531198,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3232,NCT03495102,Lost to Follow-up,Overall Study,FG002,0.0390092799660019,0.8565084158635697,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3233,NCT00121667,Adverse Event,Short Term (ST) + Long Term (LT) Period,FG001,0.0389883351909126,0.8564640049740196,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3234,NCT00368277,Unsatisfactory therapeutic effect,Overall Study,FG001,0.0389817409509515,0.8564195940844695,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3235,NCT00798161,Withdrawal by Subject,Overall Study,FG002,0.038968305988353,0.8563751831949193,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3236,NCT00798161,Other reason (incl. lack of efficacy),Overall Study,FG003,0.0389436209041863,0.8563307723053692,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3237,NCT00798161,Adverse Event,Overall Study,FG004,0.038927742775853,0.8562863614158192,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3238,NCT00798161,Other reason (incl. lack of efficacy),Overall Study,FG006,0.0389154276904363,0.8562419505262691,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3239,NCT00798161,Other reason (incl. lack of efficacy),Overall Study,FG001,0.0389065728491863,0.856197539636719,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3240,NCT00860262,Other,Overall Study,FG000,0.0388954246529363,0.8561531287471688,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3241,NCT00712673,Withdrawal by Subject,Overall Study,FG002,0.0388508496895436,0.8561087178576187,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3242,NCT00798161,Withdrawal by Subject,Overall Study,FG000,0.0388450497291863,0.8560643069680686,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3243,NCT00489736,Lack of Efficacy,Overall Study,FG001,0.0388376088589186,0.8560198960785185,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3244,NCT03541174,Other reasons,Part 3 Double-Blind Withdrawal,FG005,0.0388315039583333,0.8559754851889684,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3245,NCT01178073,Physician Decision,Overall Study,FG002,0.0388225241823908,0.8559310742994182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3246,NCT01178073,Physician Decision,Overall Study,FG001,0.0388037895074503,0.8558866634098681,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3247,NCT00789737,Adverse Event,Overall Study,FG001,0.038788277880625,0.855842252520318,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3248,NCT01178073,Withdrawal by Subject,Overall Study,FG000,0.0387752214943551,0.8557978416307679,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3249,NCT04072835,Participant felt the drug did not work,Overall Study,FG000,0.0387653496118269,0.8557534307412178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3250,NCT02302716,Withdrawal by Subject,Overall Study,FG001,0.0387546925400595,0.8557090198516676,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3251,NCT02226120,Physician Decision,Overall Study,FG000,0.0387316497453571,0.8556646089621175,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3252,NCT00917267,Adverse Event,Overall Study,FG000,0.0386874261585813,0.8556201980725674,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3253,NCT00839527,Withdrawal by Subject,Follow-up Period (FUP) (8 Weeks),FG000,0.0386850784844345,0.8555757871830173,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3254,NCT00311402,Protocol Violation,Overall Study,FG000,0.0386813549242162,0.8555313762934672,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3255,NCT00789737,Adverse Event,Overall Study,FG000,0.0386813223045833,0.855486965403917,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3256,NCT03541174,Adverse Event,Part 1 Double-Blind,FG000,0.0386807218645238,0.8554425545143669,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3257,NCT03819153,Withdrawal by Subject,Overall Study,FG000,0.0386646792978869,0.8553981436248168,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3258,NCT00839527,Lost to Follow-up,Treatment Period (TP) (156 Weeks),FG001,0.0386397654651488,0.8553537327352667,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3259,NCT01435616,Withdrawal by Subject,Overall Study,FG001,0.0386268445536706,0.8553093218457166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3260,NCT00849017,Adverse Event,Treatment Period (156 Weeks),FG001,0.0386170104205654,0.8552649109561664,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3261,NCT02304484,Death,Overall Study,FG000,0.0386148072663789,0.8552205000666163,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3262,NCT01952145,Adverse Event,Overall Study,FG000,0.0386116073317063,0.8551760891770662,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3263,NCT03611582,Adverse Event,Overall Study,FG001,0.0385893414834981,0.8551316782875161,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3264,NCT00032487,Withdrawal by Subject,Overall Study,FG001,0.0385568877762797,0.855087267397966,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3265,NCT04157751,Not treated,Overall Study,FG001,0.038556562291369,0.8550428565084158,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3266,NCT00858637,Withdrawal by Subject,Active Comparison Phase,FG000,0.0385334955478895,0.8549984456188657,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3267,NCT00482729,Adverse Event,Overall Study,FG000,0.0385326076532936,0.8549540347293156,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3268,NCT03439254,Adverse Event,Open Label Extension Phase (12 Months),FG005,0.0385310030204761,0.8549096238397655,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3269,NCT00129545,Lost to Follow-up,Overall Study,FG002,0.038526168063988,0.8548652129502154,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3270,NCT00318461,Withdrawals between 6 and 24 months,"Open-Label Extension, 18 Months",FG002,0.0384860721068443,0.8548208020606652,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3271,NCT01296412,Withdrawal by Subject,Overall Study,FG001,0.0384853959486805,0.8547763911711151,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3272,NCT00318461,Lack of Efficacy,"Open-Label Extension, 18 Months",FG003,0.0384846873038383,0.854731980281565,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3273,NCT00558428,Adverse Event,Overall Study,FG000,0.0384817372702281,0.854687569392015,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3274,NCT03682185,Lost to Follow-up,Overall Study,FG002,0.0384771353905952,0.8546431585024648,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3275,NCT03682185,Lost to Follow-up,Overall Study,FG000,0.0384640028783928,0.8545987476129147,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3276,NCT01926782,Other than specified,Overall Study,FG003,0.0384596899208432,0.8545543367233646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3277,NCT00643851,Withdrawal by Subject,Overall Study,FG001,0.0384395153903598,0.8545099258338145,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3278,NCT03693430,Lost to Follow-up,Overall Study,FG000,0.0384347941557836,0.8544655149442644,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3279,NCT03175120,Withdrawal by Subject,Overall Study,FG001,0.0384126554330059,0.8544211040547142,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3280,NCT01755156,Withdrawal by Subject,Phase A (Weeks 0-24),FG000,0.0384056018102381,0.8543766931651641,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3281,NCT00591578,Withdrawal by Subject,Double-Blind Treatment Phase,FG001,0.0384039341454463,0.854332282275614,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3282,NCT00414609,Death,Extension Study,FG002,0.0384025480365972,0.8542878713860639,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3283,NCT00591578,Withdrawal by Subject,Double-Blind Treatment Phase,FG000,0.0384008685691963,0.8542434604965138,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3284,NCT00591578,Withdrawal by Subject,Double-Blind Treatment Phase,FG002,0.0383861415131546,0.8541990496069636,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3285,NCT00849056,Protocol Violation,Treatment Period (TP) (156 Weeks),FG001,0.0383615969634226,0.8541546387174135,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3286,NCT00567255,Lack of Efficacy,Overall Study,FG001,0.0383437878801189,0.8541102278278634,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3287,NCT01663402,Other than specified above,Overall Study,FG000,0.0383379349579166,0.8540658169383133,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3288,NCT00853827,Protocol Violation,Single Blind Period (1 Week),FG000,0.0383312472036805,0.8540214060487632,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3289,NCT05478252,Withdrawal by Subject,Overall Study,FG001,0.0383132630598458,0.853976995159213,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3290,NCT01076075,other,Overall Study,FG001,0.0383001704969643,0.8539325842696629,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3291,NCT05822830,Assigned Treatment by Mistake,Overall Study,FG000,0.038280942347738,0.8538881733801128,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3292,NCT01076075,Adverse Event,Overall Study,FG001,0.0382764115713393,0.8538437624905627,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3293,NCT00960076,Adverse Event,Overall Study,FG001,0.038275183372205,0.8537993516010126,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3294,NCT03199053,Lost to Follow-up,ST Period,FG000,0.0382620263923578,0.8537549407114624,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3295,NCT03158688,Lost to Follow-up,Overall Study,FG000,0.0382447883982142,0.8537105298219123,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3296,NCT00291330,Protocol Violation,Overall Study,FG000,0.0382410586761011,0.8536661189323622,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3297,NCT01508910,Lost to Follow-up,Treatment,FG002,0.0382376140449502,0.8536217080428121,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3298,NCT01289990,discontinued in preceding trial,Overall Study,FG002,0.038224116504246,0.853577297153262,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3299,NCT03175120,Protocol Violation,Overall Study,FG000,0.0382236946468155,0.8535328862637118,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3300,NCT00313313,Lack of Efficacy,Overall Study,FG002,0.0382233969826677,0.8534884753741617,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3301,NCT01508910,Death,Treatment,FG000,0.0382213120512697,0.8534440644846116,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3302,NCT03199053,Miscellaneous,LT Period,FG002,0.0382195937981911,0.8533996535950615,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3303,NCT03199053,Withdrawal by parent/guardian,Non-treatment Follow-up Period,FG002,0.0382124742052745,0.8533552427055114,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3304,NCT03199053,Withdrawal by Subject,ST Period,FG000,0.0382105169425364,0.8533108318159612,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3305,NCT03199053,Withdrawal by Subject,Non-treatment Follow-up Period,FG000,0.0382078565237864,0.8532664209264111,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3306,NCT01289990,did not continue in extension,Overall Study,FG000,0.038197813091627,0.853222010036861,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3307,NCT01214239,Lack of Efficacy,Overall Study,FG001,0.0381887484029564,0.853177599147311,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3308,NCT00276380,Withdrawal by Subject,Overall Study,FG001,0.0381884359915178,0.8531331882577609,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3309,NCT01214239,Protocol Violation,Overall Study,FG000,0.0381851286575397,0.8530887773682106,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3310,NCT03811574,Withdrawal by Subject,Overall Study,FG001,0.0381829065986011,0.8530443664786606,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3311,NCT03199053,Withdrawal by parent/guardian,Non-treatment Follow-up Period,FG000,0.0381757053306912,0.8529999555891105,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3312,NCT01031680,Withdrawal by Subject,Overall Study,FG001,0.0381511791784225,0.8529555446995604,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3313,NCT01106677,Other,Core Period: Baseline to Week 26,FG003,0.0381464821449395,0.8529111338100103,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3314,NCT00571649,Patient convenience,Follow-up Period,FG000,0.0381455514512599,0.8528667229204601,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3315,NCT00763815,Lack of Efficacy,Overall Study,FG001,0.03811844396374,0.85282231203091,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3316,NCT02505334,Withdrawal by Subject,Extension Treatment Period,FG000,0.0380786429728571,0.8527779011413599,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3317,NCT01508910,Death,Treatment,FG002,0.0380755447966169,0.8527334902518098,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3318,NCT00446511,Adverse Event,Overall Study,FG000,0.0380638012161111,0.8526890793622596,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3319,NCT00739674,Adverse Event,Overall Study,FG000,0.0380229974794841,0.8526446684727095,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3320,NCT00838903,Adverse Event,Treatment Period (156 Weeks),FG002,0.0380046937865971,0.8526002575831594,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3321,NCT00350779,Withdrawal by Subject,Overall Study,FG001,0.0379777144601686,0.8525558466936093,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3322,NCT01023581,Withdrawal by Subject,Overall Study,FG002,0.037962894721111,0.8525114358040592,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3323,NCT00637273,Lost to Follow-up,Overall Study,FG002,0.0379258890691098,0.852467024914509,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3324,NCT01850615,Protocol Violation,Overall Study,FG000,0.0379234269093253,0.8524226140249589,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3325,NCT01215253,Physician Decision,Overall Study,FG001,0.0378646458299405,0.8523782031354088,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3326,NCT00765817,Subject decision,Overall Study,FG000,0.0378623066233558,0.8523337922458587,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3327,NCT01215253,Other,Overall Study,FG001,0.0378485535435416,0.8522893813563086,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3328,NCT03469349,Adverse Event,Overall Study,FG001,0.0378364696491369,0.8522449704667584,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3329,NCT03268005,Withdrawal by Subject,Overall Study,FG001,0.0378071911172817,0.8522005595772083,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3330,NCT03574597,Withdrawal by Subject,Overall Study,FG001,0.0377417166070238,0.8521561486876582,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3331,NCT03268005,Withdrawal by Subject,Overall Study,FG000,0.0377330506812996,0.8521117377981081,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3332,NCT00440193,Adverse Event,Treatment Period,FG001,0.0377179999191666,0.852067326908558,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3333,NCT03772041,Adverse Event,Overall Study,FG001,0.037698032180992,0.8520229160190078,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3334,NCT03772041,Physician Decision,Overall Study,FG001,0.0376956005367658,0.8519785051294577,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3335,NCT00330759,Participant request,Overall Study,FG000,0.0376891606227687,0.8519340942399076,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3336,NCT05462756,Withdrawal by Subject,Treatment Period,FG000,0.0376538945790574,0.8518896833503575,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3337,NCT04520256,Lost to Follow-up,Overall Study,FG018,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3338,NCT04520256,Lost to Follow-up,Overall Study,FG019,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3339,NCT04520256,Lost to Follow-up,Overall Study,FG014,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3340,NCT04520256,Lost to Follow-up,Overall Study,FG013,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3341,NCT04520256,Lost to Follow-up,Overall Study,FG010,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3342,NCT04520256,Lost to Follow-up,Overall Study,FG022,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3343,NCT04520256,Lost to Follow-up,Overall Study,FG021,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3344,NCT04520256,Lost to Follow-up,Overall Study,FG026,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3345,NCT04520256,Lost to Follow-up,Overall Study,FG028,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3346,NCT04520256,Lost to Follow-up,Overall Study,FG009,0.0376429130643351,0.8516454234578319,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3347,NCT00830960,Withdrawal by Subject,Overall Study,FG004,0.0376409529250198,0.8514011635653063,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3348,NCT04520256,Lost to Follow-up,Overall Study,FG003,0.0376388854035018,0.8513567526757561,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3349,NCT00345839,Lost to Follow-up,Overall Study,FG001,0.0376085361275297,0.851312341786206,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3350,NCT00095238,Other Reasons,Overall Study,FG001,0.0375935288493849,0.8512679308966559,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3351,NCT00604383,Death,Overall Study,FG001,0.0375520779351587,0.8512235200071058,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3352,NCT00095238,Other Reasons,Overall Study,FG000,0.0375276850816865,0.8511791091175557,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3353,NCT02507687,Lost to Follow-up,Overall Study,FG002,0.0375145799918156,0.8511346982280055,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3354,NCT04298229,Did not receive IV loop diuretics,Overall Study,FG000,0.0375038679918432,0.8510902873384554,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3355,NCT02507687,Protocol Violation,Overall Study,FG002,0.0374919904547323,0.8510458764489053,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3356,NCT02507687,"Other, Not Specified",Overall Study,FG002,0.0374783588588989,0.8510014655593552,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3357,NCT03087773,Withdrawal by Subject,Overall Study,FG001,0.0374613443591026,0.8509570546698051,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3358,NCT03495102,Lost to Follow-up,Overall Study,FG001,0.037439372336498,0.8509126437802549,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3359,NCT05362058,Lost to Follow-up,Treatment Period,FG000,0.0374387264057242,0.8508682328907048,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3360,NCT00676338,Withdrawal by Subject,Overall Study,FG000,0.0374294820027579,0.8508238220011547,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3361,NCT01599650,Physician Decision,Overall Study,FG002,0.0374155961076984,0.8507794111116046,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3362,NCT00082407,Protocol Violation,Overall Study,FG000,0.0374114977846329,0.8507350002220544,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3363,NCT00734474,"Sponsor Decision, Arm Discontinued",Overall Study,FG005,0.0373984906801199,0.8506905893325043,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3364,NCT02427802,Lost to Follow-up,Overall Study,FG002,0.0373980937757638,0.8506461784429542,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3365,NCT00316082,Withdrawal of Consent by Subject,Overall Study,FG000,0.0373974192225297,0.8506017675534041,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3366,NCT00734474,Withdrawal by Subject,Overall Study,FG008,0.0373958723628084,0.850557356663854,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3367,NCT01582854,Withdrawal by Participant,Overall Study,FG000,0.0373933190541071,0.8504907403295288,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3368,NCT01582854,Death,Overall Study,FG000,0.0373933190541071,0.8504907403295288,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3369,NCT00622336,Progressive Disease,Extension Phase,FG000,0.0373924039116251,0.8504241239952036,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3370,NCT02277691,Lack of Efficacy,Overall Study,FG000,0.0373844701133333,0.8503797131056535,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3371,NCT00429364,Underwent aortic root surgery,Overall Study,FG000,0.037380368457113,0.8503353022161034,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3372,NCT01582854,Recurrent Stroke,Overall Study,FG001,0.0373725614654166,0.8502908913265532,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3373,NCT02100514,Other,Treatment Period,FG000,0.0373685486406845,0.8502464804370031,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3374,NCT02427802,Lost to Follow-up,Overall Study,FG001,0.0373631839857936,0.850202069547453,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3375,NCT00823212,Missed 12-month visit,Overall Study,FG001,0.0373540002768353,0.8501576586579029,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3376,NCT02446990,Withdrawal by Subject,Overall Study,FG000,0.0373420737101091,0.8501132477683528,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3377,NCT00823212,Missed 12-month visit,Overall Study,FG000,0.0373312144984722,0.8500688368788026,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3378,NCT02507687,Adverse Event,Overall Study,FG002,0.0373211844072491,0.8500244259892525,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3379,NCT02836873,Adverse Event,Overall Study,FG001,0.0373104920804365,0.8499800150997024,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3380,NCT00571649,Death,Follow-up Period,FG001,0.0373041508082142,0.8499356042101524,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3381,NCT00700817,Adverse Event,Week 0-26 (Main Period),FG001,0.0373028886267757,0.8498911933206023,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3382,NCT00715624,Lack of Efficacy,Overall Study,FG001,0.0373016466772618,0.849846782431052,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3383,NCT02447172,Lost to Follow-up,Overall Study,FG000,0.0373003808630951,0.849802371541502,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3384,NCT02447172,Adverse Event,Overall Study,FG002,0.0373000114710217,0.8497579606519519,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3385,NCT00620542,Withdrawal by Subject,Part A (Run-in - 2 Weeks),FG001,0.0372999839576253,0.8497135497624018,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3386,NCT01422304,Lost to Follow-up,Overall Study,FG001,0.0372945372417856,0.8496691388728517,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3387,NCT02507687,Adverse Event,Overall Study,FG003,0.0372927208817134,0.8496247279833015,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3388,NCT02507687,Adverse Event,Overall Study,FG001,0.0372873806394912,0.8495803170937514,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3389,NCT00715624,Withdrawal by Subject,Overall Study,FG000,0.0372812012702353,0.8495359062042013,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3390,NCT01210001,Non compliant with protocol,Overall Study,FG002,0.0372764535465872,0.8494914953146512,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3391,NCT03353350,Adverse Event,30-week Core Treatment Period,FG001,0.0372708562905456,0.8494470844251011,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3392,NCT01134393,Lost to Follow-up,Overall Study,FG000,0.037255965592242,0.8494026735355509,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3393,NCT00715624,Lack of Efficacy,Overall Study,FG000,0.0372533136491936,0.8493582626460008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3394,NCT00395512,Hyperglycemic Rescue,Overall Study,FG000,0.0372395034248611,0.8493138517564507,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3395,NCT01210001,Lost to Follow-up,Overall Study,FG001,0.0372361746242063,0.8492694408669006,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3396,NCT00106704,Withdrawal by Subject,Overall Study,FG000,0.0372048740097519,0.8492250299773505,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3397,NCT01713530,Adverse Event,Overall Study,FG001,0.0372010008046608,0.8491806190878003,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3398,NCT00377676,Withdrawal by Subject,Overall Study,FG001,0.0371641893639086,0.8491362081982502,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3399,NCT00781937,Unclassified,Main Trial Period Through Week 56,FG000,0.0371583200158332,0.8490917973087001,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3400,NCT01237223,Abnormal laboratory value(s),"Single Blind(Run-in Period, 4 Weeks)",FG000,0.0371409195074468,0.84904738641915,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3401,NCT03548987,Lost to Follow-up,Run-in Period (Week 0 to Week 20),FG000,0.0371385212928075,0.8490029755295999,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3402,NCT00571649,Death,Follow-up Period,FG000,0.0371313960613393,0.8489585646400497,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3403,NCT04233801,Withdrawal by Subject,Overall Study,FG001,0.037128853800486,0.8489141537504996,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3404,NCT01676220,Received Rescue Therapy,Overall Study,FG000,0.0371109948423512,0.8488697428609495,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3405,NCT01968967,Other,Treatment Period,FG001,0.037100861742619,0.8488253319713994,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3406,NCT03259789,Lost to Follow-up,Overall Study,FG002,0.037074756825119,0.8487809210818492,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3407,NCT00614120,Adverse Event,Overall Study,FG001,0.0370732844698466,0.8487365101922991,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3408,NCT02059187,Lost to Follow-up,Overall Study,FG001,0.037069948690496,0.848692099302749,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3409,NCT02463071,Adverse Event,Overall Study,FG001,0.0370611155100992,0.8486476884131989,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3410,NCT02059187,Withdrawal by Subject,Overall Study,FG001,0.0370568912607936,0.8486032775236488,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3411,NCT00550953,Not able to visit the site,Overall Study,FG000,0.0370558186025992,0.8485588666340986,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3412,NCT02866175,Other,Overall Study,FG001,0.0370448136435615,0.8485144557445485,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3413,NCT01968967,Other,Treatment Period,FG000,0.0370392639741071,0.8484700448549984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3414,NCT01320722,Not Compliant with Study Procedures,Overall Study,FG003,0.0370238091125396,0.8484256339654483,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3415,NCT00601250,Withdrawal by Subject,Overall Study,FG000,0.0370208714222122,0.8483812230758982,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3416,NCT02111564,Death,Overall Study,FG000,0.0370193399504762,0.848336812186348,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3417,NCT00420849,Other,Overall Study,FG000,0.0370173044874133,0.848292401296798,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3418,NCT00283686,Less than full participation,Overall Study,FG001,0.0369874662935615,0.8482479904072479,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3419,NCT04788511,Death,Overall Study,FG001,0.0369806939678198,0.8482035795176978,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3420,NCT03018028,Withdrawal by Subject,Overall Study,FG000,0.0369397066313094,0.8481591686281477,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3421,NCT01853072,Reason not specified,Overall Study,FG000,0.0369010532555754,0.8481147577385975,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3422,NCT00594399,Too busy,Initial 3 Month Counseling,FG000,0.0368921381854437,0.8480703468490474,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3423,NCT01029886,Withdrawal by Subject,Overall Study,FG001,0.036887883480367,0.8480259359594973,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3424,NCT00542386,Withdrawal by Subject,Overall Study,FG004,0.0368533935778273,0.8479815250699472,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3425,NCT01734785,Adverse Event,Open-Label Period,FG003,0.0368450649981547,0.8479371141803971,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3426,NCT00960661,Withdrawal by Subject,Interventional Phase,FG001,0.0368411090479572,0.8478927032908469,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3427,NCT02207634,Withdrawal by Subject,Overall Study,FG000,0.036808082330873,0.8478482924012968,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3428,NCT01618669,Adverse Event,Overall Study,FG000,0.0368078200267956,0.8478038815117467,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3429,NCT01167881,Lost to Follow-up,Overall Study,FG001,0.0367773261558631,0.8477594706221966,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3430,NCT00630877,Adverse Event,Overall Study,FG001,0.0367765364999007,0.8477150597326465,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3431,NCT01590771,Withdrawal by Subject,Overall Study,FG000,0.0367463427865674,0.8476706488430963,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3432,NCT00273052,Withdrawal by Subject,Overall Study,FG000,0.036744948460367,0.8476262379535462,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3433,NCT01103960,Withdrawal by Subject,Overall Study,FG000,0.0366950110766765,0.8475818270639961,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3434,NCT00159861,Withdrawal by Subject,Extension Study - up to 3 Years,FG001,0.0366776557075396,0.847537416174446,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3435,NCT01335399,Death,Treatment Period,FG001,0.0366736422781547,0.8474930052848959,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3436,NCT04252287,Lost to Follow-up,Overall Study,FG000,0.0366632948681845,0.8474485943953457,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3437,NCT00996281,Lost to Follow-up,Overall Study,FG001,0.03663757404874,0.8474041835057956,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3438,NCT00618956,Protocol Violation,Overall Study,FG000,0.0366354516665973,0.8473597726162455,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3439,NCT00103662,Other,Overall Study,FG001,0.0366347069390873,0.8473153617266954,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3440,NCT01617434,Protocol Violation,Overall Study,FG000,0.0366299195857918,0.8472709508371453,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3441,NCT00618956,Lack of Efficacy,Overall Study,FG000,0.0366277693990972,0.8472265399475951,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3442,NCT00618956,Protocol Violation,Overall Study,FG001,0.0366264344903472,0.847182129058045,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3443,NCT00618956,"did not meet criteria, non-compliance",Overall Study,FG000,0.0366241815115972,0.8471377181684949,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3444,NCT01003184,Adverse Event,Overall Study,FG001,0.0366176639272321,0.8470933072789448,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3445,NCT00732641,Physician Decision,Overall Study,FG000,0.0365975880640178,0.8470488963893947,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3446,NCT03436693,Physician Decision,Overall Study,FG000,0.0365947992750793,0.8470044854998445,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3447,NCT01103960,Adverse Event,Overall Study,FG000,0.0365943686898313,0.8469600746102944,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3448,NCT04740905,Physician Decision,Part 2 (Week 24 to Week 72),FG001,0.0365786845975668,0.8469156637207443,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3449,NCT03436693,Physician Decision,Overall Study,FG001,0.0365631144714484,0.8468712528311942,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3450,NCT01326026,Withdrawal Criteria,Overall Study,FG000,0.036550818068244,0.846826841941644,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3451,NCT00877929,Withdrawal by Subject,Overall Study,FG001,0.0365403489690971,0.8467824310520939,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3452,NCT04252287,Protocol Violation,Overall Study,FG001,0.0365214643823809,0.8467380201625438,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3453,NCT00877929,Withdrawal by Subject,Overall Study,FG000,0.0365174234197717,0.8466936092729938,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3454,NCT04560998,Lost to Follow-up,Overall Study,FG001,0.0365134824036308,0.8466491983834437,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3455,NCT01310777,Inadequate Control of IOP,Overall Study,FG002,0.036510979740119,0.8466047874938935,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3456,NCT05662332,Assigned Treatment by Mistake,Overall Study,FG000,0.0365039779281547,0.8465603766043434,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3457,NCT04740905,Adverse Event,Part 2 (Week 24 to Week 72),FG001,0.0365032311924294,0.8465159657147933,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3458,NCT04093752,Adverse Event,Overall Study,FG000,0.0364839661983531,0.8464715548252432,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3459,NCT00286455,Hyperglycemia rescue,Overall Study,FG002,0.0364696317514583,0.8464271439356931,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3460,NCT02607865,Withdrawal by Subject,Overall Study,FG001,0.0364431401652479,0.8463827330461429,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3461,NCT01392573,Site closure,Overall Study,FG000,0.0364368080056899,0.8463383221565928,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3462,NCT00423319,Withdrawal by Subject,Overall Study,FG001,0.0364274463827678,0.8462939112670427,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3463,NCT00494871,Withdrawal by Subject,Double-blind (DB) Treatment Period,FG000,0.0364113350847222,0.8462495003774926,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3464,NCT02900378,Protocol Deviation,Randomization (Visit 2),FG001,0.0364066880805754,0.8462050894879425,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3465,NCT01565941,Randomized; did not receive intevention,Overall Study,FG000,0.0364039502440873,0.8461606785983923,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3466,NCT00663260,Adverse Event,Overall Study,FG002,0.0363996136508631,0.8461162677088422,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3467,NCT02681094,Participant decision,2 - Enrolled Participants Set,FG001,0.0363926725356547,0.8460718568192921,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3468,NCT00663260,Withdrawal by Subject,Overall Study,FG002,0.036387558187113,0.846027445929742,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3469,NCT02250651,Personal Reasons,Treatment Period 1 (Day 1 to Week 15),FG002,0.0363757985556051,0.8459830350401919,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3470,NCT02607865,Withdrawal by Subject,Overall Study,FG000,0.036373071670992,0.8459386241506417,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3471,NCT04184622,Withdrawal by Subject,Safety Follow-up Period,FG001,0.0363692692352976,0.8458942132610916,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3472,NCT02681094,Adverse Event,2 - Enrolled Participants Set,FG000,0.0363530639744047,0.8458498023715415,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3473,NCT02681094,Participant decision,1 -Modified Enrolled Participants Set,FG001,0.0363487077854166,0.8458053914819914,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3474,NCT01027949,PI Decision,Overall Study,FG000,0.0363452683980158,0.8457609805924413,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3475,NCT00397631,Withdrawal by Subject,Overall Study,FG001,0.0363261628292857,0.8457165697028911,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3476,NCT02284893,Withrawal of the consent by the subject,52 Week (Long Term),FG001,0.036312045337361,0.845672158813341,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3477,NCT02681094,Adverse Event,1 -Modified Enrolled Participants Set,FG000,0.0363090992241666,0.8456277479237909,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3478,NCT02294474,Adverse Event,Overall Study,FG000,0.0362803142868452,0.8455833370342408,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3479,NCT02229383,Withdrawal by Subject,Overall Study,FG001,0.0362773961266071,0.8455389261446907,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3480,NCT03514641,Withdrawal by Subject,603A: 0-12 Week Study Period,FG000,0.0362571045527678,0.8454945152551405,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3481,NCT02294474,Adverse Event,Overall Study,FG001,0.0362322115416964,0.8454501043655904,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3482,NCT01042977,Withdrawal by Subject,Overall Study,FG001,0.0362305496294642,0.8454056934760403,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3483,NCT00497146,Withdrawal by Subject,Treatment Period,FG000,0.0362288718481249,0.8453612825864902,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3484,NCT00249795,Other adverse events (non-serious),Overall Study,FG001,0.0362199167331944,0.8453168716969401,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3485,NCT01182441,Lost to Follow-up,Overall Study,FG000,0.0362174627741071,0.8452724608073899,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3486,NCT00497146,Change in RAAS inhibitor therapy,Treatment Period,FG000,0.0362030238193749,0.8452280499178398,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3487,NCT00497146,Lost to Follow-up,Long-term Follow-up Period,FG000,0.0361963185919345,0.8451836390282897,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3488,NCT01926782,Other than specified,Overall Study,FG005,0.0361922687824206,0.8451392281387397,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3489,NCT04184622,Lost to Follow-up,Primary Treatment Period,FG003,0.036182965023869,0.8450948172491896,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3490,NCT01472185,Subject Noncompliance,Overall Study,FG000,0.0361534403390079,0.8450504063596394,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3491,NCT01517412,Poor compliance to protocol,Overall Study,FG000,0.0361507693221608,0.8449837900253142,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3492,NCT01517412,Other than specified above,Overall Study,FG000,0.0361507693221608,0.8449837900253142,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3493,NCT03768427,Physician Decision,Overall Study,FG002,0.0361351278951487,0.8449171736909891,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3494,NCT00385697,Adverse Event,Double-blind Segment 2,FG002,0.0361162206913194,0.8448727628014389,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3495,NCT00827606,Other,Overall Study,FG000,0.0361047509733811,0.8448283519118888,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3496,NCT04740931,Adverse Event,Part 2 (Week 24 to Week 72),FG000,0.0361042193239926,0.8447839410223387,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3497,NCT01568866,Death,Overall Study,FG000,0.0361015576970734,0.8447395301327886,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3498,NCT05275400,Assigned Treatment by Mistake,Treatment Period,FG000,0.0360923720989583,0.8446951192432385,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3499,NCT00327015,Lost to Follow-up,Overall Study,FG002,0.0360767826464781,0.8446507083536883,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3500,NCT00327015,Lack of Efficacy,Overall Study,FG003,0.0360708889977876,0.8446062974641382,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3501,NCT03768427,Physician Decision,Overall Study,FG003,0.0360418339991963,0.8445618865745881,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3502,NCT04740931,Adverse Event,Part 2 (Week 24 to Week 72),FG001,0.0360377187201235,0.844517475685038,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3503,NCT02413398,Lost to Follow-up,Overall Study,FG001,0.0360272987665476,0.8444730647954879,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3504,NCT03325556,Withdrawal by Subject,Double-blind Period,FG002,0.0360207348095238,0.8444286539059377,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3505,NCT01126580,Lost to Follow-up,Overall Study,FG000,0.0360154447130654,0.8443842430163876,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3506,NCT00360334,Adverse Event,Overall Study,FG000,0.0360009576064285,0.8443398321268375,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3507,NCT00818883,Withdrawal by Subject,Overall Study,FG001,0.0359733699712112,0.8442954212372874,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3508,NCT00507416,Did not Receive Study Treatment,Overall Study,FG001,0.0359672071985696,0.8442510103477373,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3509,NCT04074161,Lost to Follow-up,Overall Study,FG002,0.0359483737065773,0.8442065994581871,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3510,NCT01778049,Withdrawal by Subject,Open Label Treatment Period,FG001,0.0359313867079265,0.844162188568637,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3511,NCT03861039,Withdrawal by Subject,Overall Study,FG002,0.0359169759703273,0.8441177776790869,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3512,NCT00121667,Lost to Follow-up,Short Term (ST) + Long Term (LT) Period,FG003,0.0359080192987003,0.8440733667895368,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3513,NCT00649389,Adverse Event,Overall Study,FG003,0.0359023163835019,0.8440289558999867,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3514,NCT03325556,Protocol Violation,Open-label Period,FG000,0.0358964693402381,0.8439845450104365,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3515,NCT02501161,Withdrawal by Subject,Overall Study,FG000,0.0358898653976984,0.8439401341208864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3516,NCT01986881,Withdrawal by Subject,Overall Study,FG001,0.0358872632692063,0.8438957232313363,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3517,NCT00332488,Protocol Violation,Initial Treatment Phase (Weeks 0 - 12),FG000,0.0358826666120634,0.8438513123417862,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3518,NCT00121641,Subject Withdrew Consent,24-week Short-term Treatment Period,FG001,0.0358733141453868,0.8438069014522361,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3519,NCT00332488,Lost to Follow-up,Initial Treatment Phase (Weeks 0 - 12),FG001,0.0358684058452578,0.8437624905626859,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3520,NCT02298192,Adverse Event,Overall Study,FG000,0.0358640636265476,0.8437180796731358,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3521,NCT00542178,did not complete year 4 follow-up,Overall Study,FG004,0.0358546121160813,0.8436736687835857,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3522,NCT00121641,Lost to Follow-up,48-month Short Term + Long Term Period,FG003,0.0358507839558035,0.8436292578940356,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3523,NCT00763815,Lack of Efficacy,Overall Study,FG000,0.0358423982960119,0.8435848470044855,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3524,NCT02298192,Withdrawal by Subject,Overall Study,FG000,0.0358399031002381,0.8435404361149353,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3525,NCT00332488,Physician Decision,Transfer Treatment Phase (Weeks 12 - 24),FG002,0.0358376993973412,0.8434960252253852,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3526,NCT03552757,Withdrawal by Subject,Overall Study,FG000,0.0358295675167758,0.8434516143358352,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3527,NCT01644500,Withdrawal by Subject,Overall Study,FG000,0.0358267540444047,0.8434072034462851,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3528,NCT01370590,Adverse Event,Period 1,FG000,0.035819088524742,0.843362792556735,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3529,NCT01674647,Adverse Event,Treatment Period,FG001,0.0358107726730357,0.8433183816671848,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3530,NCT00558064,Adverse Event,Overall Study,FG000,0.0358101957195337,0.8432739707776347,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3531,NCT03284853,Other - Reason not reported in CSR,Overall Study,FG000,0.0358007440367658,0.8432295598880846,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3532,NCT00359762,Subject Decision,Period III,FG003,0.0358006996183928,0.8431851489985345,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3533,NCT00094770,Protocol Specified Discontinuation,Year 2 (Week 0 to Week 104),FG001,0.0357911925705159,0.8431407381089844,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3534,NCT01674647,Protocol Violation,30-day Safety Follow-up Period,FG001,0.0357841576016071,0.8430963272194342,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3535,NCT03284853,Adverse Event,Overall Study,FG001,0.0357793956309028,0.8430519163298841,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3536,NCT00961636,Withdrawal by Subject,Overall Study,FG001,0.0357790737120039,0.843007505440334,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3537,NCT01732822,Withdrawal by Subject,Overall Study,FG000,0.0357702323949702,0.8429630945507839,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3538,NCT02773368,Withdrawal by Subject,Overall Study,FG000,0.0357601498073611,0.8429186836612337,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3539,NCT01663402,Other than specified above,Overall Study,FG001,0.035750498845744,0.8428742727716836,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3540,NCT00332488,Adverse Event,Transfer Treatment Phase (Weeks 12 - 24),FG002,0.0357464031063293,0.8428298618821335,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3541,NCT02592824,Protocol Violation,Overall Study,FG001,0.0357460938648115,0.8427854509925834,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3542,NCT01791153,Withdrawal by Subject,Part 2: Open-label Period,FG006,0.0357317538922023,0.8427410401030333,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3543,NCT02991118,Death,Overall Study,FG001,0.0357100554729662,0.8426966292134831,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3544,NCT00306384,Major protocol deviation,Overall Study,FG001,0.0357097526152678,0.842652218323933,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3545,NCT05413369,Withdrawal by Subject,Overall Study,FG001,0.0357005800209523,0.8426078074343829,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3546,NCT01648582,Adverse Event,Overall Study,FG001,0.0356983342086706,0.8425633965448328,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3547,NCT01619059,Withdrawal by Subject,Short-Term (ST) Treatment Period,FG001,0.0356931660144344,0.8425189856552827,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3548,NCT01791153,Lack of Efficacy,Part 1: Blinded Period,FG001,0.0356882771159523,0.8424745747657325,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3549,NCT02735044,"Other, not specified above",Overall Study,FG000,0.035680170290754,0.8424301638761824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3550,NCT01272232,Withdrawal criteria,Weeks 0-56,FG001,0.0356763809478174,0.8423857529866323,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3551,NCT00152971,Lost to Follow-up,Overall Study,FG002,0.0356623582664069,0.8423413420970822,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3552,NCT01841762,"Other, including non-compliance",Treatment Period,FG000,0.0356612072250297,0.8422969312075321,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3553,NCT03136484,Lost to Follow-up,Overall Study,FG001,0.0356600128230555,0.8422525203179819,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3554,NCT00385697,Lost to Follow-up,Open-label Segment 1,FG000,0.0356544050191765,0.8422081094284318,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3555,NCT03180736,randomized but not treated,Overall Study,FG000,0.0356351275920536,0.8421636985388817,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3556,NCT01791153,Adverse Event,Part 1: Blinded Period,FG001,0.0356182124733332,0.8421192876493316,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3557,NCT00839527,Adverse Event,Treatment Period (TP) (156 Weeks),FG000,0.0356045855644444,0.8420748767597815,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3558,NCT02023879,Other than specified above,Period 1: 24-Week Double-blind Treatment,FG001,0.0355979917500594,0.8420304658702313,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3559,NCT00770653,Protocol Violation,Overall Study,FG000,0.0355626823078174,0.8419860549806812,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3560,NCT00426751,Other Reasons,Overall Study,FG001,0.0355611403028075,0.8419416440911311,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3561,NCT00591578,Adverse Event,Double-Blind Treatment Phase,FG000,0.0355213012741864,0.841897233201581,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3562,NCT02414841,Lost to Follow-up,Overall Study,FG001,0.0355173938964445,0.841852822312031,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3563,NCT02023879,Adverse Event,Extension Open Label Treatment,FG002,0.0355159753289483,0.8418084114224808,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3564,NCT01026194,Adverse Event,Period 2Open-label Period,FG001,0.0355126390098313,0.8417640005329307,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3565,NCT00982644,Adverse Event,Main: Week 0 to 52 (NN1250-3579),FG000,0.0355021519285218,0.8417195896433806,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3566,NCT01908816,Withdrawal by Subject,Overall Study,FG001,0.0355005508413798,0.8416751787538305,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3567,NCT02414841,Randomized But Not Treated,Overall Study,FG000,0.0355001930066826,0.8416307678642804,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3568,NCT00289900,Participant had flushing,Overall Study,FG001,0.035498121678492,0.8415863569747302,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3569,NCT01621178,Physician Decision,Overall Study,FG002,0.0354919092928968,0.8415419460851801,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3570,NCT00532935,Adverse Event,Overall Study,FG001,0.0354825978820138,0.84149753519563,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3571,NCT01908816,Lost to Follow-up,Overall Study,FG002,0.035479173154475,0.8414531243060799,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3572,NCT01621178,Death,Overall Study,FG001,0.0354486299764087,0.8414087134165298,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3573,NCT00902174,Lack of Efficacy,Overall Study,FG001,0.0354464939404861,0.8413643025269796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3574,NCT02073682,No reason provided,Overall Study,FG000,0.0354451291783631,0.8413198916374295,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3575,NCT01729871,Other,Overall Study,FG000,0.0354446441092063,0.8412754807478794,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3576,NCT00968812,Withdrawal by Subject,Overall Study,FG001,0.0354259581370535,0.8412310698583293,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3577,NCT00305604,Adverse Event,Overall Study,FG000,0.0353988194610218,0.8411866589687792,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3578,NCT05352815,Lost to Follow-up,Overall Study,FG001,0.0353954104064285,0.841142248079229,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3579,NCT02558296,Adverse Event,Completed the Study,FG000,0.0353888799753571,0.8410978371896789,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3580,NCT00978627,Unclassified,Main: Week 0 to 26 (NN5401-3594),FG001,0.0353847616577182,0.8410534263001288,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3581,NCT00413413,Withdrawal by Subject,Single-Blind,FG001,0.0353746837267063,0.8410090154105787,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3582,NCT01652729,Lost to Follow-up,Overall Study,FG001,0.0353626343400396,0.8409646045210285,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3583,NCT00978627,Unclassified,Extension: Week 27 to 52 (NN5401-3645),FG000,0.0353593245549801,0.8409201936314784,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3584,NCT01375647,Lost to Follow-up,Overall Study,FG003,0.0353217845039682,0.8408757827419283,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3585,NCT01652729,Lost to Follow-up,Overall Study,FG000,0.0353164573467063,0.8408313718523782,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3586,NCT00308139,Loss of Glucose Control,Overall Study,FG000,0.0353113774702678,0.8407869609628281,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3587,NCT00423319,Adverse Event,Overall Study,FG000,0.0353084177764682,0.8407425500732779,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3588,NCT03214380,Natural Disaster,Lead-in,FG000,0.0353075071024405,0.8406981391837278,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3589,NCT00542178,did not complete year 4 follow-up,Overall Study,FG003,0.0352923831160515,0.8406537282941777,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3590,NCT00289887,Withdrawal by Subject,Overall Study,FG001,0.0352760903700892,0.8406093174046276,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3591,NCT01435616,Lost to Follow-up,Overall Study,FG000,0.0352745687667757,0.8405649065150775,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3592,NCT00553267,Adverse Event,Overall Study,FG002,0.0352679596355059,0.8405204956255273,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3593,NCT01363440,Death,Overall Study,FG001,0.035232061167113,0.8404760847359772,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3594,NCT00719563,Unknown reasons,Overall Study,FG001,0.0352215714003851,0.8404316738464271,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3595,NCT00719563,Personal reasons,Overall Study,FG000,0.035218995040147,0.840387262956877,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3596,NCT01167881,Lost to Follow-up,Overall Study,FG000,0.035205228885744,0.840342852067327,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3597,NCT04058067,Adverse Event,Overall Study,FG000,0.0351996148290755,0.8402984411777767,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3598,NCT00501059,Clinical endpoint reached,Overall Study,FG000,0.0351983590937202,0.8402540302882266,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3599,NCT00813995,Clinical adverse event,Overall Study,FG000,0.0351731473231222,0.8402096193986766,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3600,NCT00838903,Lost to Follow-up,Treatment Period (156 Weeks),FG001,0.0351725239279761,0.8401652085091265,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3601,NCT01194830,Protocol Violation,Overall Study,FG000,0.0351321890809821,0.8401207976195764,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3602,NCT00082407,Patient Decision,Overall Study,FG000,0.0351257240587401,0.8400763867300262,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3603,NCT01345019,Administrative Decision,Open Label Treatment Phase,FG001,0.0351235015459226,0.8400319758404761,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3604,NCT04592419,Sponsor Request,Primary Study (Through Year 1),FG000,0.0351165850225404,0.839987564950926,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3605,NCT00689611,Death,Overall Study,FG001,0.0351028833791666,0.8399431540613759,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3606,NCT01137812,Adverse Event,Overall Study,FG001,0.0350952257995733,0.8398987431718258,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3607,NCT00689611,Withdrawal by Subject,Overall Study,FG001,0.0350919749387499,0.8398543322822756,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3608,NCT01959529,Other,Overall Study,FG000,0.0350786725629464,0.8398099213927255,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3609,NCT00649389,Adverse Event,Overall Study,FG001,0.0350581369418452,0.8397655105031754,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3610,NCT00657150,Adverse Event,Overall Study,FG001,0.0350574893797997,0.8397210996136253,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3611,NCT00657150,Non-compliant with protocol,Treatment,FG000,0.0350376419661092,0.8396766887240752,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3612,NCT00786474,Withdrawal by Subject,Overall Study,FG000,0.035002216505119,0.839632277834525,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3613,NCT00661999,Other Reasons,Overall Study,FG001,0.0349855612948015,0.8395878669449749,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3614,NCT03495102,Lost to Follow-up,Overall Study,FG000,0.0349765538445139,0.8395434560554248,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3615,NCT01272219,Adverse Event,Main + Extension Period: Week 0-172,FG005,0.0349554454891666,0.8394990451658747,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3616,NCT00975286,Adverse Event,Overall Study,FG000,0.0349337543414583,0.8394546342763246,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3617,NCT04807400,Lost to Follow-up,Overall Study,FG002,0.0349326814849008,0.8394102233867744,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3618,NCT01467466,Procedure Cancelled,Overall Study,FG000,0.0349270571775297,0.8393658124972243,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3619,NCT01733758,Adverse Event,Overall Study,FG001,0.0349191908032639,0.8393214016076742,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3620,NCT00168818,Protocol Violation,Overall Study,FG000,0.0349164635410299,0.8392769907181241,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3621,NCT00838916,Withdrawn from Follow-up Participation,Follow-up Period (8 Weeks),FG001,0.0348915905507837,0.839232579828574,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3622,NCT00838916,Protocol Violation,Treatment Period (156 Weeks),FG000,0.0348855211425694,0.8391881689390238,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3623,NCT04807400,Lost to Follow-up,Overall Study,FG001,0.0348805218657936,0.8391437580494737,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3624,NCT01183013,Reasons other than stated above,Overall Study,FG005,0.0348759775954266,0.8390993471599236,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3625,NCT02229227,Adverse Event,Overall Study,FG001,0.0348704577132837,0.8390549362703735,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3626,NCT01183013,Reasons other than stated above,Overall Study,FG000,0.0348646091595932,0.8390105253808233,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3627,NCT01467466,Procedure Cancelled,Overall Study,FG001,0.0348305852598214,0.8389661144912732,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3628,NCT00152971,Adverse Event,Overall Study,FG000,0.0347368688007322,0.8389217036017231,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3629,NCT04657016,Adverse Event,Overall Study,FG001,0.034733130817232,0.838877292712173,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3630,NCT00300274,Withdrawal by Subject,Overall Study,FG002,0.0347141165353679,0.8388328818226229,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3631,NCT00700817,Unclassified,Week 0-26 (Main Period),FG000,0.0347014660559433,0.8387884709330727,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3632,NCT00736099,Protocol Violation,Overall Study,FG000,0.0346901551627362,0.8387440600435226,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3633,NCT00700817,Protocol Violation,Week 0-26 (Main Period),FG000,0.0346843250119552,0.8386996491539725,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3634,NCT01456169,Adverse Event,Overall Study,FG002,0.0346754144510894,0.8386552382644225,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3635,NCT02585713,Other,Overall Study,FG000,0.034663060505744,0.8386108273748724,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3636,NCT00094770,Protocol Specified Discontinuation,Year 2 (Week 0 to Week 104),FG000,0.0346610052761408,0.8385664164853222,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3637,NCT02561078,Adverse Event,Overall Study,FG000,0.034658092133373,0.8385220055957721,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3638,NCT00327015,Withdrawal of Consent by Subject,Overall Study,FG002,0.0346549606242757,0.838477594706222,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3639,NCT02585778,Other than specified above,Overall Study,FG000,0.0346548899414583,0.8384331838166719,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3640,NCT00700817,Adverse Event,Week 0-26 (Main Period),FG000,0.0346529794493858,0.8383887729271218,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3641,NCT01006291,Other,Overall Study,FG000,0.0346516382703183,0.8383443620375716,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3642,NCT01006291,Other,Overall Study,FG001,0.0346493753959731,0.8382999511480215,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3643,NCT00091949,Lost to Follow-up,Overall Study,FG001,0.0346451152266964,0.8382555402584714,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3644,NCT00715624,Familial and personal reasons,Overall Study,FG000,0.0346332341263392,0.8382111293689213,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3645,NCT01730053,Other than specified,Overall Study,FG002,0.0346217934792261,0.8381667184793712,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3646,NCT00661362,Withdrawal by Subject,Overall Study,FG000,0.0346205421813302,0.838122307589821,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3647,NCT01106625,Withdrawal by Subject,Core Period: Baseline to Week 26,FG001,0.0346146681349206,0.8380778967002709,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3648,NCT00736099,Other reason,Overall Study,FG001,0.0346061765892243,0.8380334858107208,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3649,NCT01126580,Withdrawal by Subject,Overall Study,FG002,0.0345962592159721,0.8379890749211707,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3650,NCT03211858,Adverse Event,Overall Study,FG001,0.0345865705593017,0.8379446640316206,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3651,NCT01959529,Other,Overall Study,FG001,0.0345655260776487,0.8379002531420704,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3652,NCT00707031,Poor Compliance to Protocol,Overall Study,FG001,0.0345566880354076,0.8378558422525203,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3653,NCT01217892,Subject no longer meets study criteria,Overall Study,FG003,0.0345349630842857,0.8378114313629702,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3654,NCT01059812,Withdrawal Criteria,Overall Study,FG000,0.0345289585428571,0.8377670204734201,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3655,NCT01730534,Withdrawal by Subject,Overall Study,FG001,0.0345229348577182,0.83772260958387,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3656,NCT01126580,Adverse Event,Overall Study,FG000,0.0345054240629761,0.8376781986943198,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3657,NCT01435616,Adverse Event,Overall Study,FG001,0.0345046725570436,0.8376337878047697,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3658,NCT00345839,Lost to Follow-up,Overall Study,FG000,0.0345000736710515,0.8375893769152196,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3659,NCT01059812,Adverse Event,Overall Study,FG000,0.0344951572339484,0.8375449660256695,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3660,NCT00536744,Lost to Follow-up,Overall Study,FG001,0.0344870065155456,0.8375005551361194,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3661,NCT03211858,Poor compliance to protocol,Overall Study,FG000,0.0344589218730517,0.8374561442465692,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3662,NCT02926937,Reason not Specified,Overall Study,FG001,0.0344394920931547,0.8374117333570191,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3663,NCT03861052,Withdrawal by Subject,Overall Study,FG001,0.0344254091214979,0.837367322467469,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3664,NCT01539083,Progressive Disease,After Randomization (TP and VTP),FG002,0.0343948573930131,0.8373229115779189,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3665,NCT02926937,Lost to Follow-up,Overall Study,FG000,0.0343807899864285,0.8372785006883688,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3666,NCT01272219,Unclassified,Main Period: Week 0 to Week 56,FG004,0.0343705430017658,0.8372340897988186,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3667,NCT03472040,Physician Decision,Overall Study,FG001,0.0343657739486949,0.8371896789092685,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3668,NCT03472040,Intercurrent Illness/Medical Condition,Overall Study,FG001,0.034355427802564,0.8371452680197184,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3669,NCT02025621,No longer eligible,Overall Study,FG000,0.0343534290656746,0.8371008571301684,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3670,NCT00380068,Not compliant,Overall Study,FG000,0.0343497951648809,0.8370564462406181,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3671,NCT04039503,Withdrawal by Subject,Overall Study,FG000,0.0343188560123214,0.837012035351068,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3672,NCT03064126,Lost to Follow-up,Overall Study,FG001,0.0343188235386805,0.836967624461518,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3673,NCT03064126,Physician Decision,Overall Study,FG000,0.0343135407989186,0.8368788026824178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3674,NCT03064126,Other reason for early termination,Overall Study,FG000,0.0343135407989186,0.8368788026824178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3675,NCT03064126,Missed Visit,Overall Study,FG000,0.0343135407989186,0.8368788026824178,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3676,NCT02849080,Withdrawal by Subject,Main Phase: 0 - 52 Weeks,FG000,0.0342943070334523,0.8367899809033175,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3677,NCT00536510,Withdrawal by Subject,Overall Study,FG000,0.0342764921626777,0.8367455700137674,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3678,NCT00960661,Adverse Event,Interventional Phase,FG001,0.0342498396292767,0.8367011591242173,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3679,NCT01682759,Lost to Follow-up,Overall Study,FG000,0.0342466222745733,0.8366567482346672,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3680,NCT01243424,Consent Withdrawn (Status Alive),Discontinuation From Study (Treated Set),FG000,0.0342316298488528,0.836612337345117,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3681,NCT00608023,Withdrawal by Subject,Overall Study,FG002,0.0342302953991865,0.8365679264555669,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3682,NCT01177813,Withdrawal by Subject,Overall Study,FG003,0.0342235731340259,0.8365235155660168,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3683,NCT01830543,Death,Overall Study,FG001,0.0342195339790079,0.8364791046764667,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3684,NCT00722371,Withdrawal by Subject,Overall Study,FG001,0.0342189461948214,0.8364346937869166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3685,NCT01623115,Site closure,Overall Study,FG001,0.0342188731802083,0.8363902828973664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3686,NCT01177813,Other reason not defined above,Overall Study,FG000,0.0342183483268731,0.8363458720078163,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3687,NCT00289900,Adverse Event,Overall Study,FG001,0.0342082298301587,0.8363014611182662,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3688,NCT01045707,Unclassified,Main: Week 0 to 26 (NN5401-3590),FG001,0.0342019369360119,0.8362570502287161,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3689,NCT01830543,Death,Overall Study,FG002,0.0341971934639781,0.836212639339166,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3690,NCT01177813,Lost to Follow-up,Overall Study,FG001,0.0341967347517342,0.8361682284496158,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3691,NCT01045707,Withdrawal Criteria,Main: Week 0 to 26 (NN5401-3590),FG001,0.0341964548403869,0.8361238175600657,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3692,NCT03115112,Withdrawal by Subject,Overall Study,FG000,0.034196143600615,0.8360794066705156,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3693,NCT00463606,Adverse Event,Overall Study,FG001,0.0341933136155906,0.8360349957809655,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3694,NCT04509674,Not treated,Overall Study,FG000,0.0341917579305654,0.8359905848914154,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3695,NCT00313313,Withdrawal of consent by subject,Overall Study,FG000,0.034185617329504,0.8359461740018652,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3696,NCT00894387,Patient's request,Overall Study,FG000,0.0341837596541765,0.8359017631123151,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3697,NCT00386607,Patient withdrew consent,Core,FG000,0.0341774494411607,0.835857352222765,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3698,NCT01712789,Participants Did Not Receive Study Drug,Overall Study,FG000,0.0341633036385813,0.8358129413332149,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3699,NCT00402363,Adverse Event,Overall Study,FG001,0.034150722431112,0.8357685304436648,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3700,NCT01387737,Adverse Event,Overall Study,FG000,0.0341489205913789,0.8357241195541146,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3701,NCT01215097,Withdrawal by Subject,Overall Study,FG000,0.0341430079924404,0.8356797086645645,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3702,NCT00808067,Patient refused to take study medication,Overall Study,FG001,0.0341191051911607,0.8356352977750144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3703,NCT01456195,Voluntary Withdrawal,Overall Study,FG002,0.0341121376104662,0.8355908868854643,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3704,NCT01872611,Lost to Follow-up,Overall Study,FG000,0.0340966499921329,0.8355464759959143,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3705,NCT01451398,Lost to Follow-up,Overall Study,FG000,0.0340953253336309,0.835502065106364,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3706,NCT01045447,Withdrawal Criteria,Overall Study,FG001,0.0340851125515575,0.835457654216814,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3707,NCT00000620,Death,Overall Study,FG003,0.0340803677260119,0.8354132433272639,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3708,NCT01045447,Withdrawal Criteria,Overall Study,FG000,0.0340765801055853,0.8353688324377138,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3709,NCT01029886,Protocol Violation,Overall Study,FG000,0.0340751845229067,0.8353244215481637,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3710,NCT02545049,GCP violations,Overall Study,FG001,0.0340528068845635,0.8352800106586135,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3711,NCT01159600,Adverse Event,Overall Study,FG006,0.0340501727847997,0.8352355997690634,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3712,NCT01159600,Adverse Event,Overall Study,FG000,0.0340460822707719,0.8351911888795133,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3713,NCT01159600,Other reason not defined above,Overall Study,FG005,0.0340258670088473,0.8351467779899632,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3714,NCT01159600,"Patient refusal to continue,not due toAE",Overall Study,FG000,0.0340191830094029,0.835102367100413,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3715,NCT02551874,Did not receive randomized treatment,Overall Study,FG001,0.0340073945117857,0.8350579562108629,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3716,NCT01101035,Major Protocol Deviation,Overall Study,FG000,0.0339896540047456,0.8350135453213128,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3717,NCT01243424,Protocol Violation,Discontinuation From Treatment,FG001,0.0339596005485254,0.8349691344317627,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3718,NCT01289990,did not continue in extension,Overall Study,FG007,0.0339566528157837,0.8349247235422126,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3719,NCT01877915,Withdrawal by Subject,Overall Study,FG000,0.0339532792731484,0.8348803126526624,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3720,NCT00086502,Adverse Event,Overall Study,FG000,0.033941293218115,0.8348359017631123,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3721,NCT01590797,Withdrawal by Subject,Overall Study,FG000,0.0339312334225595,0.8347914908735622,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3722,NCT00514735,Withdrawal by Subject,Overall Study,FG001,0.0339271257982241,0.8347470799840121,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3723,NCT00094770,Withdrawal by Subject,Year 1 ( Week 0 to Week 52),FG001,0.0339188644000396,0.834702669094462,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3724,NCT02648204,Withdrawal by Subject,Overall Study,FG000,0.0339170306478968,0.8346582582049118,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3725,NCT00654381,Adverse Event,1st Stage,FG000,0.0338746319159622,0.8346138473153617,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3726,NCT00094770,Withdrawal by Subject,Year 2 (Week 0 to Week 104),FG000,0.0338440678799585,0.8345694364258116,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3727,NCT00654381,Adverse Event,1st Stage,FG003,0.0338435150181149,0.8345250255362615,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3728,NCT02398188,Protocol Violation,Overall Study,FG001,0.0338398414605654,0.8344806146467114,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3729,NCT01467466,No Endpoint Blood Draw,Overall Study,FG003,0.0338364972510949,0.8344362037571612,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3730,NCT02942576,Adverse Event,Overall Study,FG001,0.0338332702742025,0.8343917928676111,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3731,NCT01986881,Lost to Follow-up,Overall Study,FG002,0.0338331989425,0.834347381978061,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3732,NCT04809220,Adverse Event,Overall Study,FG000,0.0338246158134523,0.8343029710885109,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3733,NCT00654381,Adverse Event,2nd Stage,FG003,0.0338236498385317,0.8342585601989608,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3734,NCT00654381,Adverse Event,1st Stage,FG001,0.0338139170541566,0.8342141493094106,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3735,NCT00484198,Hyperglycemia Meeting Discontinuation Criteria,Overall Study,FG003,0.033807434006865,0.8341697384198605,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3736,NCT00654381,Adverse Event,1st Stage,FG002,0.0337992415416567,0.8341253275303104,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3737,NCT02161562,Lack of Efficacy,Overall Study,FG000,0.0337989495896626,0.8340809166407603,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3738,NCT02161562,Protocol Violation,Overall Study,FG001,0.0337877165488888,0.8340365057512102,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3739,NCT00415532,Withdrawal by Subject,Treatment Period,FG001,0.0337859665279166,0.83399209486166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3740,NCT01350999,Adverse Event,Overall Study,FG002,0.0337719573698412,0.8339476839721099,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3741,NCT02234843,Adverse Event,Overall Study,FG000,0.0337127202743154,0.8339032730825598,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3742,NCT01557166,Adverse Event,Overall Study,FG001,0.0337101171176587,0.8338588621930098,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3743,NCT03585270,Death,Overall Study,FG001,0.0337074056983958,0.8338144513034597,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3744,NCT02030600,Withdrawal by Subject,Treatment Period 2,FG001,0.0337045747738393,0.8337700404139095,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3745,NCT02104804,Study specific discontinuation criteria,Overall Study,FG000,0.0336815399326586,0.8337256295243594,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3746,NCT00789737,Other,Overall Study,FG001,0.0336755891445436,0.8336812186348093,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3747,NCT00086515,Lack of Efficacy,Phase B (Weeks 24-104),FG001,0.0336754326838789,0.8336368077452592,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3748,NCT02234843,Withdrawal by Subject,Overall Study,FG000,0.0336730555322916,0.8335923968557091,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3749,NCT01042977,Subject no longer meets study criteria,Overall Study,FG000,0.0336685061541468,0.8335479859661589,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3750,NCT02607865,Withdrawal by Subject,Overall Study,FG002,0.0336679317544444,0.8335035750766088,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3751,NCT00571649,Patient convenience,Follow-up Period,FG001,0.0336582407965674,0.8334591641870587,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3752,NCT03096314,Lost to Follow-up,Screened Vitamin D Deficient,FG001,0.0336379622844047,0.8334147532975086,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3753,NCT00449930,Withdrawal by Subject,Overall Study,FG001,0.0336126254230952,0.8333703424079585,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3754,NCT00705575,Adverse Event,Overall Study,FG001,0.0336030476527334,0.8333259315184083,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3755,NCT00415532,Withdrawal by Subject,Treatment Period,FG000,0.0336029044604166,0.8332815206288582,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3756,NCT01167881,Non compliant with protocol,Overall Study,FG001,0.0335910233270833,0.8332371097393081,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3757,NCT03877237,Death,Overall Study,FG000,0.0335477248757043,0.833192698849758,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3758,NCT00799903,Withdrawal by Subject,Overall Study,FG001,0.033530211346865,0.8331482879602078,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3759,NCT02468232,Subject/Guardian decision,OLE Part of Study,FG002,0.0335023290324404,0.8331038770706577,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3760,NCT00683878,Withdrawal by Subject,Overall Study,FG000,0.0334878204022123,0.8330594661811076,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3761,NCT01850524,Lost to Follow-up,Overall Study,FG000,0.0334701354152182,0.8330150552915575,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3762,NCT03914326,Lost to Follow-up,Overall Study,FG000,0.0334692230500279,0.8329706444020074,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3763,NCT00915772,Lack of Efficacy,Overall Study,FG002,0.0334551080533234,0.8329262335124572,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3764,NCT01272219,Protocol Violation,Main Period: Week 0 to Week 56,FG004,0.0334461024342559,0.8328818226229071,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3765,NCT02324569,Voluntary Withdrawal,Overall Study,FG000,0.0334344890335118,0.832837411733357,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3766,NCT00799903,Withdrawal by Subject,Overall Study,FG000,0.033429160328869,0.8327930008438069,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3767,NCT00168818,Lost to Follow-up,Overall Study,FG002,0.0334188575515971,0.8327485899542568,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3768,NCT02468232,Death,OLE Part of Study,FG003,0.0334187850664285,0.8327041790647066,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3769,NCT02324569,Lack of Efficacy,Overall Study,FG001,0.0334083153262797,0.8326597681751565,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3770,NCT04848480,Withdrawal by Subject,Extension Phase (26 Weeks),FG000,0.0334027488114682,0.8326153572856064,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3771,NCT00782340,Randomized in error,Open Label Titration,FG000,0.0333907616741341,0.8325709463960563,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3772,NCT02307513,Lack of Efficacy,Active Treatment Phase (Weeks 13-64),FG000,0.0333902507234921,0.8325265355065062,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3773,NCT04707469,Lost to Follow-up,Overall Study,FG000,0.0333843342170337,0.832482124616956,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3774,NCT02314637,Physician Decision,Overall Study,FG000,0.0333764829283631,0.8324377137274059,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3775,NCT00713830,Lack of Efficacy,Overall Study,FG001,0.0333747153787103,0.8323933028378558,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3776,NCT00116831,Adverse Event,Overall Study,FG001,0.0333725217654356,0.8323488919483057,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3777,NCT00316082,Withdrawal of Consent by Subject,Overall Study,FG003,0.033370586468244,0.8323044810587557,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3778,NCT02314637,Withdrawal by Subject,Overall Study,FG000,0.0333700450383631,0.8322600701692054,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3779,NCT02307513,Lack of Efficacy,Active Treatment Phase (Weeks 13-64),FG001,0.0333601340294445,0.8322156592796554,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3780,NCT00094302,Lost to Follow-up,Overall Study,FG000,0.0333575956805059,0.8321712483901053,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3781,NCT05412004,Lost to Follow-up,Overall Study,FG000,0.0333568965575694,0.8321268375005552,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3782,NCT01627327,Protocol Violation,Overall Study,FG001,0.0333542137969246,0.8320824266110051,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3783,NCT02762578,Unclassified,Overall Study,FG000,0.0333453400541765,0.8320380157214549,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3784,NCT02446990,Withdrawal by Subject,Overall Study,FG001,0.0333441885240972,0.8319936048319048,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3785,NCT00976391,Lost to Follow-up,Treatment Period (52 Weeks),FG000,0.0333429270168551,0.8319491939423547,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3786,NCT01827046,Lost to Follow-up,Overall Study,FG001,0.0333429239328472,0.8319047830528046,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3787,NCT02158806,Lost to Follow-up,Overall Study,FG001,0.0333419080151262,0.8318603721632545,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3788,NCT01076075,Withdrawal by Subject,Overall Study,FG000,0.0333416559226587,0.8318159612737043,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3789,NCT01954394,Adverse Event,Overall Study,FG000,0.0333247605869841,0.8317715503841542,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3790,NCT01954394,Other than specified above,Overall Study,FG000,0.0333194941419841,0.8317271394946041,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3791,NCT03952143,Physician Decision,Lead-In Period,FG000,0.0333065667893451,0.831682728605054,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3792,NCT02762578,Adverse Event,Overall Study,FG001,0.0332997294790873,0.8316383177155039,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3793,NCT04929249,Lost to Follow-up,Overall Study,FG000,0.0332904981363041,0.8315939068259537,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3794,NCT01406717,Protocol Violation,Overall Study,FG000,0.0332898386650793,0.8315494959364036,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3795,NCT03952143,Due to COVID 19 restrictions,Treatment Period,FG002,0.0332848121149404,0.8315050850468535,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3796,NCT00657150,Non-compliant with protocol,Overall Study,FG001,0.0332838411118433,0.8314606741573034,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3797,NCT03952143,Protocol Violation,Lead-In Period,FG000,0.0332724817957142,0.8314162632677533,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3798,NCT00657150,Non-compliant with protocol,Treatment,FG001,0.0332700950368433,0.8313718523782031,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3799,NCT00094757,Lack of Efficacy,Overall Study,FG001,0.0332650007420436,0.831327441488653,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3800,NCT00174785,Prohibited antiarrhythmic medication,Overall Study,FG001,0.033203931947371,0.8312830305991029,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3801,NCT03952143,Withdrawal by Subject,Treatment Period,FG001,0.0331925908220832,0.8312386197095528,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3802,NCT01137812,Withdrawal by Subject,Overall Study,FG001,0.0331913057424007,0.8311942088200026,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3803,NCT01442038,Death,Overall Study,FG001,0.0331821822891666,0.8311497979304525,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3804,NCT04184622,Other - as reported by the investigator,Primary Treatment Period,FG003,0.0331493206152462,0.8311053870409024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3805,NCT02427802,Adverse Event,Overall Study,FG002,0.0331425915244246,0.8310609761513523,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3806,NCT01272232,Protocol Violation,Weeks 0-56,FG002,0.0331367771875397,0.8310165652618022,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3807,NCT01732822,Withdrawal by Subject,Overall Study,FG001,0.0331290210860551,0.830972154372252,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3808,NCT00286442,Withdrawal by Subject,Overall Study,FG001,0.0331070357343551,0.8309277434827019,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3809,NCT00982644,Protocol Violation,Main: Week 0 to 52 (NN1250-3579),FG001,0.0330804037876885,0.8308833325931518,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3810,NCT00359762,Protocol Violation,Period II,FG000,0.0330683629557143,0.8308389217036017,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3811,NCT01396083,Consent withdrawn,Overall Study,FG000,0.0330670781790277,0.8307945108140516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3812,NCT01435616,Physician Decision,Overall Study,FG000,0.0330515203075892,0.8307500999245014,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3813,NCT00291330,Lost to Follow-up,Overall Study,FG001,0.0330500647718948,0.8307056890349513,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3814,NCT00571649,Withdrawal by Subject,Follow-up Period,FG000,0.0330489284292261,0.8306612781454012,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3815,NCT02555878,Adverse Event,Overall Study,FG001,0.0330463012610416,0.8306168672558512,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3816,NCT00877890,Adverse Event,Overall Study,FG001,0.033034336295119,0.8305724563663011,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3817,NCT00600483,Lost to Follow-up,Overall Study,FG000,0.0330000975109127,0.8305280454767509,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3818,NCT02681094,Participant decision,2 - Enrolled Participants Set,FG002,0.0329997282907638,0.8304836345872008,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3819,NCT00809965,Death,Overall Study,FG002,0.0329956329360515,0.8304392236976507,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3820,NCT01499082,Adverse Event,Overall Study,FG000,0.0329951274686011,0.8303948128081006,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3821,NCT01763905,Decision by sponsor,Overall Study,FG000,0.0329926437477182,0.8303504019185505,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3822,NCT00877890,Adverse Event,Overall Study,FG000,0.0329773959487499,0.8303059910290003,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3823,NCT00877890,Withdrawal of Consent,Overall Study,FG000,0.0329705778779166,0.8302615801394502,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3824,NCT02681094,Participant decision,1 -Modified Enrolled Participants Set,FG002,0.0329704475774305,0.8302171692499001,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3825,NCT00708435,Death / Serious Adverse Event,Overall Study,FG001,0.0329690970560912,0.83017275836035,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3826,NCT00838903,Lost to Follow-up,Treatment Period (156 Weeks),FG002,0.0329470692574702,0.8301283474707999,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3827,NCT01809327,Other,Overall Study,FG001,0.0329355721971428,0.8300839365812497,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3828,NCT00273052,Protocol Violation,Overall Study,FG000,0.0329322977944742,0.8300395256916996,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3829,NCT01698775,Adverse Event,Phase B,FG001,0.0329233990808144,0.8299951148021495,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3830,NCT00996281,Lost to Follow-up,Overall Study,FG000,0.0329161910295138,0.8299507039125994,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3831,NCT03917472,Physician Decision,Overall Study,FG000,0.032915592892361,0.8299062930230493,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3832,NCT02512042,Other,Overall Study,FG001,0.032908774964127,0.8298618821334991,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3833,NCT01606007,Lost to Follow-up,Overall Study,FG001,0.0329020341960416,0.829817471243949,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3834,NCT01698775,Withdrawal by Subject,Phase A,FG000,0.0328947870402787,0.8297730603543989,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3835,NCT00121641,Adverse Event,48-month Short Term + Long Term Period,FG001,0.0328943067950893,0.8297286494648488,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3836,NCT01555164,Adverse Event,Overall Study,FG001,0.0328806748674801,0.8296842385752987,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3837,NCT00121641,Subject Withdrew Consent,24-week Short-term Treatment Period,FG003,0.0328789488501587,0.8296398276857485,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3838,NCT01606007,Withdrawal by Subject,Overall Study,FG000,0.0328724565116071,0.8295954167961984,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3839,NCT02512042,Other,Overall Study,FG000,0.0328686400871924,0.8295510059066483,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3840,NCT03066804,Withdrawal by Subject,Overall Study,FG000,0.0328506914945039,0.8295065950170982,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3841,NCT00121641,Adverse Event,48-month Short Term + Long Term Period,FG002,0.0328499757371726,0.8294621841275481,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3842,NCT00439777,Withdrawal by Subject,Treatment Period,FG000,0.0328382692168849,0.8294177732379979,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3843,NCT03001076,Adverse Event,Overall Study,FG000,0.0328367167752155,0.8293733623484478,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3844,NCT00121641,Subject Withdrew Consent,48-month Short Term + Long Term Period,FG004,0.0328353547919643,0.8293289514588977,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3845,NCT03001076,Adverse Event,Overall Study,FG001,0.0328275215098881,0.8292845405693476,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3846,NCT01499095,Adverse Event,Overall Study,FG000,0.0328158702102083,0.8292401296797974,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3847,NCT00591578,Adverse Event,Double-Blind Treatment Phase,FG002,0.0328148014125,0.8291957187902473,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3848,NCT00809965,Death,Overall Study,FG000,0.0328036752223213,0.8291513079006972,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3849,NCT00662831,Lack of Efficacy,Overall Study,FG000,0.0327910291384126,0.8291068970111471,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3850,NCT03917472,Withdrawal by Subject,Overall Study,FG001,0.0327824656561508,0.829062486121597,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3851,NCT00662831,Lack of Efficacy,Overall Study,FG001,0.0327632779494841,0.8290180752320468,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3852,NCT01890122,Voluntary Withdrawal,Overall Study,FG001,0.0327600814097123,0.8289736643424968,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3853,NCT00858637,Withdrawal by Subject,Active Comparison Phase,FG003,0.0327452613915178,0.8289292534529467,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3854,NCT00722371,Withdrawal by Subject,Overall Study,FG006,0.0327422700319543,0.8288848425633966,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3855,NCT00602472,Adverse Event,Overall Study,FG000,0.0327186480299386,0.8288404316738465,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3856,NCT01798706,Other than specified above,Overall Study,FG000,0.0327166668982539,0.8287960207842963,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3857,NCT00311402,Protocol Violation,Overall Study,FG001,0.0327163906390755,0.8287516098947462,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3858,NCT01663402,Participant moved,Overall Study,FG000,0.0327153980671726,0.8287071990051961,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3859,NCT01890122,Voluntary Withdrawal,Overall Study,FG000,0.0327078452229861,0.828662788115646,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3860,NCT01243424,Protocol Violation,Discontinuation From Treatment,FG000,0.0326900393967261,0.8286183772260959,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3861,NCT02634333,Completed out of Window,Overall Study,FG000,0.032665458325431,0.8285739663365457,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3862,NCT00688701,Withdrawal by Subject,Overall Study,FG003,0.0326598816145337,0.8285295554469956,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3863,NCT02525939,Withdrawal by Subject,Overall Study,FG001,0.0326124426770039,0.8284851445574455,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3864,NCT01568866,Randomized but Not Dosed,Overall Study,FG000,0.0326098117824405,0.8284407336678954,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3865,NCT01535261,Death,Overall Study,FG000,0.032609331523373,0.8283963227783453,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3866,NCT00508820,Physician Decision,Overall Study,FG000,0.0325771063812996,0.8283519118887951,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3867,NCT00532935,Adverse Event,Overall Study,FG000,0.032575991350486,0.828307500999245,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3868,NCT00532935,Protocol Specific Criteria,Overall Study,FG000,0.032571120044861,0.8282630901096949,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3869,NCT01421459,Withdrawal by Subject,Overall Study,FG000,0.0325697020791369,0.8282186792201448,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3870,NCT01830543,Subject Decision,Overall Study,FG001,0.0325650160147817,0.8281742683305947,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3871,NCT00508820,Death,Overall Study,FG001,0.0325589684096825,0.8281298574410445,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3872,NCT02505334,Adverse Event,Extension Treatment Period,FG000,0.0325561689429067,0.8280854465514944,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3873,NCT00846365,Adverse Event,Overall Study,FG000,0.0325494065619543,0.8280410356619443,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3874,NCT02558296,Withdrawal by Subject,Completed the Study Through Week 24,FG001,0.0325478992303372,0.8279966247723942,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3875,NCT01126580,Lost to Follow-up,Overall Study,FG001,0.0325371086400297,0.8279522138828441,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3876,NCT01590771,Adverse Event,Overall Study,FG001,0.0325147088653571,0.8279078029932939,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3877,NCT02195479,Other,Overall Study,FG001,0.0325113954816964,0.8278633921037438,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3878,NCT02227875,Protocol Violation,Overall Study,FG001,0.0325046311381349,0.8278189812141937,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3879,NCT02787551,Other than specified,Extension Period:26 Weeks(Upto 52 Weeks),FG000,0.0325030794288988,0.8277745703246436,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3880,NCT00810693,Adverse Event,Treatment Period,FG000,0.0325003317003273,0.8277301594350935,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3881,NCT00542386,Adverse Event,Overall Study,FG004,0.0324923535313898,0.8276857485455433,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3882,NCT00542386,Lack of Efficacy,Overall Study,FG003,0.0324738239309731,0.8276413376559932,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3883,NCT01151410,Lost to Follow-up,Overall Study,FG000,0.0324611864286309,0.8275969267664431,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3884,NCT01617434,Protocol Violation,Overall Study,FG001,0.032461155511498,0.827552515876893,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3885,NCT03439254,Withdrawal by Subject,Double-blind Phase (18 Months),FG001,0.0324583654320734,0.827508104987343,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3886,NCT00630877,Adverse Event,Overall Study,FG002,0.0324565288900694,0.8274636940977927,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3887,NCT00362232,Adverse Event,Treatment (12 +/- 2 Days),FG000,0.0324414847584208,0.8274192832082427,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3888,NCT01151410,Withdrawal by Subject,Overall Study,FG000,0.0324395666186904,0.8273748723186926,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3889,NCT03354273,Adverse Event,Overall Study,FG000,0.0324230793332539,0.8273304614291425,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3890,NCT02715726,Adverse Event,Overall Study,FG001,0.0324130257422618,0.8272860505395923,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3891,NCT00152971,Protocol Violation,Overall Study,FG001,0.0324052898481745,0.8272416396500422,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3892,NCT00391872,Withdrawal by Subject,Overall Study,FG000,0.0324004210125496,0.8271972287604921,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3893,NCT00739674,Screening failures,Overall Study,FG000,0.0323993863655357,0.8271306124261669,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3894,NCT00739674,Site 212 removal,Overall Study,FG000,0.0323993863655357,0.8271306124261669,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3895,NCT00563368,Adverse Event,Overall Study,FG006,0.0323983341513346,0.8270639960918417,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3896,NCT03354273,Other,Overall Study,FG000,0.0323930662440872,0.8270195852022916,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3897,NCT01392573,Site closure,Overall Study,FG001,0.0323876506684524,0.8269751743127415,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3898,NCT00379769,Death,Observational Follow-up,FG004,0.0323767543885416,0.8269307634231914,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3899,NCT04620135,Adverse Event,Study Completion,FG000,0.0323733448312202,0.8268863525336413,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3900,NCT00152971,Other,Treatment,FG001,0.0323724698896924,0.8268419416440911,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3901,NCT00773747,Death,Overall Study,FG001,0.0323685572519246,0.826797530754541,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3902,NCT00318461,Adverse Event,"Double-Blind, 6 Months",FG001,0.0323684322750648,0.8267531198649909,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3903,NCT01302691,Blood Pressure/Potassium Criteria Met,Overall Study,FG000,0.0323684280827579,0.8267087089754408,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3904,NCT00680186,Lost to Follow-up,Overall Study,FG000,0.0323667136133531,0.8266642980858907,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3905,NCT04620135,Withdrawal by Subject,Study Completion,FG000,0.0323561431574106,0.8266198871963405,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3906,NCT01674647,Withdrawal by Subject,Treatment Period,FG000,0.032344207037738,0.8265754763067904,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3907,NCT03541174,Death,Part 2 Single-Blind,FG003,0.0323411173814682,0.8265310654172403,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3908,NCT03541174,Adverse Event,Part 1 Double-Blind,FG001,0.0323346934042361,0.8264866545276902,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3909,NCT00082407,Protocol Violation,Overall Study,FG001,0.0323257941227679,0.8264422436381401,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3910,NCT00689611,Withdrawal by Subject,Overall Study,FG000,0.0323217201318651,0.8263978327485899,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3911,NCT03448419,Withdrawal by Subject,Overall Study,FG000,0.0323058115040575,0.8263534218590398,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3912,NCT02188784,Death,Overall Study,FG000,0.0322981048110119,0.8263090109694897,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3913,NCT01027949,Limited Study Drug Effectiveness,Overall Study,FG000,0.0322940942678968,0.8262423946351646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3914,NCT01027949,Non-compliance with Study Procedures,Overall Study,FG000,0.0322940942678968,0.8262423946351646,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3915,NCT02188784,Withdrawal by Subject,Overall Study,FG000,0.0322862423980952,0.8261757783008393,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3916,NCT02607306,Adverse Event,Overall Study,FG000,0.0322794572285615,0.8261313674112892,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3917,NCT01485614,Withdrawal by Parent/Guardian,Weeks 20-54,FG000,0.0322722018883333,0.8260869565217391,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3918,NCT00571649,Withdrawal by Subject,Follow-up Period,FG001,0.0322714582885714,0.826042545632189,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3919,NCT02188784,Physician Decision,Overall Study,FG001,0.0322700445178571,0.825998134742639,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3920,NCT01676220,Protocol Violation,Overall Study,FG001,0.0322588512817956,0.8259537238530887,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3921,NCT01046110,Adverse Event,Overall Study,FG000,0.0322405854702678,0.8259093129635386,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3922,NCT03078478,Withdrawal by Subject,Maintencance Period 2 (36 Weeks),FG001,0.032235211811571,0.8258649020739885,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3923,NCT01485614,Withdrawal by Parent/Guardian,Weeks 20-54,FG001,0.0322309989120833,0.8258204911844385,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3924,NCT01485614,Lost to Follow-up,Weeks 0-20,FG000,0.03223067568625,0.8257760802948884,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3925,NCT01064414,Other,Extension Period: Week 26 to Week 52,FG000,0.0322282547031231,0.8257316694053382,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3926,NCT03859427,Decision by sponsor,Overall Study,FG001,0.0322273208324305,0.8256872585157881,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3927,NCT02607306,Withdrawal by Subject,Overall Study,FG000,0.0322117607132936,0.825642847626238,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3928,NCT01485614,Withdrawal by Subject,Weeks 0-20,FG001,0.03220212904875,0.8255984367366879,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3929,NCT00809965,Other Reason,Overall Study,FG002,0.0321999993910118,0.8255540258471378,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3930,NCT03859427,Lost to Follow-up,Overall Study,FG000,0.0321977372397321,0.8255096149575876,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3931,NCT01485614,Withdrawal by Parent/Guardian,Weeks 0-20,FG001,0.03218836005125,0.8254652040680375,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3932,NCT00393718,Lack of Efficacy,Overall Study,FG000,0.0321869617246925,0.8254207931784874,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3933,NCT01289990,did not continue in extension,Overall Study,FG011,0.0321516037285714,0.8253763822889373,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3934,NCT00626392,Adverse Event,Coadministration Period,FG002,0.032148680958998,0.8253319713993871,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3935,NCT01336023,Adverse Event,Week 0 to Week 26,FG002,0.0321400971557142,0.825287560509837,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3936,NCT01734928,Withdrew informed consent,Randomization,FG001,0.0321343910272321,0.8252431496202869,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3937,NCT00249873,Thromboembolic/outcome event,Overall Study,FG001,0.0321298037402678,0.8251987387307368,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3938,NCT02099110,Withdrawal by Subject,Overall Study,FG004,0.0321208062403769,0.8251543278411867,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3939,NCT02099110,Withdrawal by Subject,Overall Study,FG002,0.0321143725982936,0.8251099169516365,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3940,NCT04795531,Withdrawal by Subject,Overall Study,FG001,0.0321111937080456,0.8250655060620864,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3941,NCT04795531,Withdrawal by Subject,Overall Study,FG000,0.0321037018689682,0.8250210951725363,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3942,NCT00507416,Lack ofEfficacy / Physician Decision,Overall Study,FG002,0.0320974101851389,0.8249766842829862,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3943,NCT02073682,Cancer Cured,Overall Study,FG000,0.0320782700017821,0.8249100679486611,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3944,NCT02073682,ID: Palliative Treatment Only,Overall Study,FG000,0.0320782700017821,0.8249100679486611,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3945,NCT00838916,Adverse Event,Treatment Period (156 Weeks),FG001,0.0320475632372916,0.8248434516143358,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3946,NCT00414609,Adverse Event,Extension Study,FG002,0.0320447401608531,0.8247990407247857,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3947,NCT00673231,Withdrawal by Subject,Overall Study,FG000,0.0320416832013293,0.8247546298352356,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3948,NCT00541450,Hyperglycemia,Phase B,FG000,0.0320405211687896,0.8247102189456855,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3949,NCT00313313,Withdrawal of consent by subject,Overall Study,FG001,0.0320369446429761,0.8246658080561353,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3950,NCT00414609,Death,Core Study,FG001,0.0320329578375793,0.8246213971665852,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3951,NCT02906930,Lost to Follow-up,Overall Study,FG001,0.0320103449614484,0.8245769862770351,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3952,NCT00763815,Familial and Personal Reasons,Overall Study,FG000,0.0319917898384027,0.824532575387485,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3953,NCT01068665,Withdrawal Criteria,Overall Study,FG001,0.0319488749057738,0.8244881644979349,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3954,NCT02990338,Randomized and not treated,Overall Study,FG001,0.0319437983696131,0.8244437536083847,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3955,NCT02990338,Physician's decision,Overall Study,FG000,0.0319371581624702,0.8243993427188346,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3956,NCT00456521,Lost to Follow-up,Overall Study,FG001,0.0319364018517063,0.8243549318292845,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3957,NCT01294423,subject no longer meets study criteria,Overall Study,FG001,0.0319345356552579,0.8243105209397344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3958,NCT03110562,Death,Crossover Period,FG003,0.0319113589602425,0.8242661100501844,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3959,NCT00707031,Familial or Personal Reasons,Overall Study,FG000,0.0319078576163988,0.8242216991606341,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3960,NCT01076647,Protocol Violation,Overall Study,FG001,0.0319067066951785,0.824177288271084,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3961,NCT00452530,Withdrawal by Subject,Overall Study,FG001,0.031893577701488,0.824132877381534,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3962,NCT00839527,Termination of Study by Sponsor,Follow-up Period (FUP) (8 Weeks),FG001,0.0318911427402182,0.8240884664919839,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3963,NCT03110562,Randomized but never treated,Initial Treatment Period,FG001,0.0318831119868145,0.8240440556024338,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3964,NCT05142722,Death,Overall Study,FG000,0.0318770448800198,0.8239996447128836,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3965,NCT03110562,Participants withdrawn due to company goals,Crossover Period,FG003,0.0318730823726776,0.8239552338233335,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3966,NCT01468181,Adverse Event,Overall Study,FG002,0.0318691592114583,0.8239108229337834,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3967,NCT02541383,Consent withdrawn,Overall Study,FG001,0.031868778990744,0.8238664120442333,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3968,NCT01106690,Adverse Event,Core Period: Baseline to Week 26,FG000,0.0318634453334821,0.8238220011546832,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3969,NCT02769481,Undefined,Overall Study,FG000,0.0318573289259226,0.823777590265133,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3970,NCT01032629,Lost to Follow-up,Overall Study,FG002,0.0318544133290016,0.8237331793755829,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3971,NCT00553787,Lost to Follow-up,Overall Study,FG001,0.0318494492037301,0.8236887684860328,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3972,NCT00276380,Adverse Event,Overall Study,FG000,0.0318450490760615,0.8236443575964827,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3973,NCT00604383,Lost to Follow-up,Overall Study,FG001,0.0318409521643849,0.8235999467069326,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3974,NCT01106690,Other,Core Period: Baseline to Week 26,FG002,0.0318360343509523,0.8235555358173824,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3975,NCT00243919,Lost to Follow-up,Overall Study,FG001,0.0318253866040674,0.8235111249278323,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3976,NCT00366249,Lack of Efficacy,Overall Study,FG000,0.0318041967478571,0.8234667140382822,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3977,NCT00853827,Lost to Follow-up,Double Blind Period (103 Weeks),FG001,0.0317982268143254,0.8234223031487321,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3978,NCT02833844,Protocol Violation,Double-Blind Period,FG001,0.0317829621241567,0.8233778922591819,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3979,NCT00276380,Death,Overall Study,FG000,0.0317827526202281,0.8233334813696318,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3980,NCT00139659,Lost to Follow-up,Overall Study,FG000,0.0317540941961408,0.8232890704800817,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3981,NCT02229227,Protocol Violation,Overall Study,FG001,0.0317522275391134,0.8232446595905316,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
3982,NCT00576693,Lost to Follow-up,Overall Study,FG000,0.0317459769055655,0.8232002487009815,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3983,NCT01095666,"Non-compliance, not met criteria etc.",Overall Study,FG000,0.0317372173922123,0.8231558378114313,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3984,NCT04264819,Lost to Follow-up,Overall Study,FG000,0.0317340208705754,0.8231114269218812,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3985,NCT04264819,Death,Overall Study,FG000,0.0317331676518254,0.8230670160323311,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3986,NCT01388361,Withdrawal criteria,Overall Study,FG001,0.0317315350904166,0.823022605142781,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3987,NCT00366249,Lack of Efficacy,Overall Study,FG001,0.0317273845895238,0.8229781942532309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3988,NCT00759681,Death,Overall Study,FG001,0.0317204346699106,0.8229337833636807,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3989,NCT02229227,Withdrawal by Subject,Overall Study,FG000,0.0316778641167622,0.8228893724741306,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3990,NCT00798161,Adverse Event,Overall Study,FG001,0.0316560989160201,0.8228449615845805,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
3991,NCT02136134,Lost to Follow-up,Overall Study,FG001,0.0316531069555456,0.8228005506950304,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3992,NCT00759681,Lost to Follow-up,Overall Study,FG001,0.0316489757703273,0.8227561398054803,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3993,NCT02136134,Lost to Follow-up,Overall Study,FG000,0.0316460656447122,0.8227117289159301,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
3994,NCT00917267,Withdrawal by Subject,Overall Study,FG001,0.0316425121551686,0.82266731802638,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3995,NCT01106625,Other,Core Period: Baseline to Week 26,FG000,0.0316328759086805,0.82262290713683,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3996,NCT00423319,Withdrawal by Subject,Overall Study,FG000,0.0316301207113392,0.8225784962472799,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3997,NCT01032629,Withdrawal by Subject,Overall Study,FG001,0.0316212402576424,0.8225340853577298,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
3998,NCT01475825,Non-compliance with Study Drug,Overall Study,FG002,0.0316170039713988,0.8224896744681796,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
3999,NCT01106625,Adverse Event,Core Period: Baseline to Week 26,FG001,0.0316138723738591,0.8224452635786295,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4000,NCT01106625,Adverse Event,Core Period: Baseline to Week 26,FG002,0.0315979847448114,0.8224008526890794,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4001,NCT00103857,Lack of Efficacy,50-Week Extension Study,FG000,0.0315891276578472,0.8223564417995293,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4002,NCT00614939,Poor/non-compliance,Overall Study,FG000,0.0315809823666071,0.822289825465204,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4003,NCT00614939,Death,Overall Study,FG000,0.0315809823666071,0.822289825465204,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4004,NCT00798161,Withdrawal by Subject,Overall Study,FG001,0.031572616647151,0.8222232091308789,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4005,NCT00798161,Adverse Event,Overall Study,FG006,0.0315694127726867,0.8221787982413288,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4006,NCT00474630,"Drug noncompliance, other",Overall Study,FG000,0.0315657509204464,0.8221343873517787,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4007,NCT00732641,Other,Overall Study,FG001,0.0315600886893651,0.8220899764622286,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4008,NCT01986881,Lost to Follow-up,Overall Study,FG000,0.0315497191181944,0.8220455655726784,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4009,NCT00633893,Other,Overall Study,FG001,0.0315480561989285,0.8220011546831283,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4010,NCT03214380,Withdrawal by Subject,Treatment Period,FG002,0.0315441554492261,0.8219567437935782,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4011,NCT00689936,Withdrawal by Subject,Active Treatment Phase,FG000,0.0315406171051388,0.8219123329040281,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4012,NCT02419612,Other,Long-term Treatment Period,FG000,0.0315335934215674,0.821867922014478,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4013,NCT03136484,Lost to Follow-up,Overall Study,FG000,0.0315076406789385,0.8218235111249278,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4014,NCT00798161,Lost to Follow-up,Overall Study,FG002,0.031504209309651,0.8217791002353777,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4015,NCT00798161,Lost to Follow-up,Overall Study,FG004,0.0314994017554844,0.8217346893458276,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4016,NCT00661999,Adverse Event,Overall Study,FG000,0.0314972018473512,0.8216902784562775,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4017,NCT00798161,Withdrawal by Subject,Overall Study,FG003,0.0314937197842344,0.8216458675667274,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4018,NCT00860262,Lack of Efficacy,Overall Study,FG001,0.0314891869117343,0.8216014566771772,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4019,NCT02419612,Other,Long-term Treatment Period,FG001,0.0314825029887103,0.8215570457876271,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4020,NCT00798161,Other reason (incl. lack of efficacy),Overall Study,FG005,0.031482057748401,0.821512634898077,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4021,NCT00689936,Withdrawal by Subject,Active Treatment Phase,FG001,0.0314798554980555,0.8214682240085269,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4022,NCT01755156,Lost to Follow-up,Phase B (Weeks 24-104),FG001,0.0314761481042658,0.8214238131189767,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4023,NCT02419612,Subject Decision,Long-term Treatment Period,FG001,0.0314742727262103,0.8213794022294266,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4024,NCT01755156,Lost to Follow-up,Phase A (Weeks 0-24),FG000,0.0314702509174602,0.8213349913398765,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4025,NCT02419612,Lost to Follow-up,Long-term Treatment Period,FG001,0.0314594714256151,0.8212905804503264,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4026,NCT02068443,Pretreatment Event/Adverse Event,Overall Study,FG001,0.0314585523502579,0.8212461695607763,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4027,NCT00094302,Lost to Follow-up,Overall Study,FG001,0.0314392042402083,0.8212017586712261,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4028,NCT00300274,Withdrawal by Subject,Overall Study,FG000,0.0314337570472519,0.821157347781676,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4029,NCT02991118,Withdrawal by Subject,Overall Study,FG001,0.0314325824476785,0.8211129368921259,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4030,NCT00763451,Withdrawal by Subject,Overall Study,FG002,0.0314152805046726,0.8210685260025758,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4031,NCT02630706,Withdrawal by Subject,Overall Study,FG001,0.0314075732083233,0.8210241151130258,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4032,NCT02994927,Physician Decision,Overall Study,FG001,0.0313909717278571,0.8209797042234755,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4033,NCT02994927,Withdrawal by Subject,Overall Study,FG000,0.0313766608021428,0.8209352933339255,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4034,NCT01178073,Withdrawal by Subject,Overall Study,FG002,0.0313730103296726,0.8208908824443754,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4035,NCT00860262,Withdrawal by Subject,Overall Study,FG000,0.0313706313760399,0.8208464715548253,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4036,NCT03285594,At the Participant's Own Request,Overall Study,FG001,0.0313565856609127,0.8208020606652752,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4037,NCT02480764,Pretreatment Event/Adverse Event,Overall Study,FG001,0.0313359408809424,0.820757649775725,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4038,NCT00849017,Adverse Event,Treatment Period (156 Weeks),FG000,0.0313254113940178,0.8207132388861749,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4039,NCT00838903,Subject Withdrawn from Follow-up,Follow-up Period (8 Weeks),FG003,0.0313007248437499,0.8206688279966248,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4040,NCT00838903,Subject Withdrawn from Follow-up,Follow-up Period (8 Weeks),FG002,0.0312968842954166,0.8206244171070747,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4041,NCT00433836,Adverse Event,Overall Study,FG000,0.0312931471642658,0.8205800062175246,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4042,NCT01809327,Other,Overall Study,FG000,0.0312887586611706,0.8205355953279744,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4043,NCT00086515,Adverse Event,Phase A (Weeks 0-24),FG000,0.0312876692548809,0.8204911844384243,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4044,NCT00432276,Adverse Event,Overall Study,FG001,0.0312787889563789,0.8204467735488742,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4045,NCT02480764,Voluntary Withdrawal,Overall Study,FG000,0.0312733511101686,0.8204023626593241,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4046,NCT02305381,Unclassified,Overall Study,FG000,0.0312632127784423,0.820357951769774,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4047,NCT02305381,Unclassified,Overall Study,FG001,0.0312553347417757,0.8203135408802238,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4048,NCT01968954,Other,Overall Study,FG001,0.0312406236632638,0.8202691299906737,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4049,NCT00371683,Adverse Event,DB Treatment Period-Randomized Patients,FG000,0.0312292454603851,0.8202247191011236,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4050,NCT00849056,Lost to Follow-up,Treatment Period (TP) (156 Weeks),FG001,0.0312250012247321,0.8201803082115735,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4051,NCT04460885,Withdrawal by Subject,Overall Study,FG000,0.031221551576488,0.8201358973220234,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4052,NCT00637273,Adverse Event,Overall Study,FG000,0.0312179251978571,0.8200914864324732,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4053,NCT00972283,Unclassified,Main: Week 0 to 52 (NN1250-3582),FG001,0.0312164938284424,0.8200470755429231,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4054,NCT01365507,Withdrawal Criteria,Overall Study,FG001,0.0312110916813987,0.820002664653373,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4055,NCT00094770,Adverse Event,Year 1 ( Week 0 to Week 52),FG001,0.0312110709811309,0.8199582537638229,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4056,NCT02128932,No reason for withdrawal,Overall Study,FG000,0.031205597858005,0.8199138428742728,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4057,NCT00286494,Hyperglycemic rescue,Overall Study,FG000,0.0312042915605555,0.8198694319847226,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4058,NCT01177384,Adverse Event,Overall Study,FG000,0.0311784894336111,0.8198250210951725,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4059,NCT03514641,Lost to Follow-up,603B: 24-36 Week Study Period,FG003,0.0311686758012897,0.8197806102056224,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4060,NCT00568178,Lost to Follow-up,Open Label Extension,FG004,0.031155269865377,0.8197361993160723,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4061,NCT02064439,Withdrawal by Subject,Overall Study,FG000,0.0311533842737634,0.8196917884265222,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4062,NCT03514641,Lost to Follow-up,603B: 24-36 Week Study Period,FG002,0.0311319185600397,0.819647377536972,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4063,NCT00439725,Withdrawal by Subject,Treatment Period,FG000,0.0311293638335714,0.8196029666474219,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4064,NCT00271817,Adverse Event,Part 1,FG001,0.0311292259447122,0.8195585557578718,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4065,NCT01396057,Protocol deviation,Overall Study,FG001,0.0311246167304067,0.8195141448683217,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4066,NCT01556997,Adverse Event,Overall Study,FG002,0.031122288159494,0.8194697339787715,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4067,NCT00594100,Discontinued Prior to Visit,Follow-up Through 30 Days Post Procedure,FG000,0.0311172449635218,0.8194253230892214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4068,NCT01076088,Withdrawal by Subject,Overall Study,FG004,0.0311058154241071,0.8193809121996714,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4069,NCT01556997,Adverse Event,Overall Study,FG001,0.0310973770034226,0.8193365013101213,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4070,NCT00641043,Protocol Violation,Overall Study,FG000,0.0310937453381745,0.8192920904205712,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4071,NCT01621178,Death,Overall Study,FG000,0.0310862136883035,0.819247679531021,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4072,NCT02104817,Withdrawal by Subject,Overall Study,FG001,0.0310805449499107,0.8192032686414709,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4073,NCT01350999,Adverse Event,Overall Study,FG001,0.031063900819494,0.8191588577519208,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4074,NCT01023581,Withdrawal by Subject,Overall Study,FG000,0.0310626975632043,0.8191144468623707,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4075,NCT00641043,Other incl. lack of efficacy,Overall Study,FG001,0.031059906133988,0.8190700359728206,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4076,NCT01396057,Protocol deviation,Overall Study,FG000,0.0310549547042757,0.8190256250832704,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4077,NCT00641043,Lost to Follow-up,Overall Study,FG001,0.031047457215238,0.8189812141937203,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4078,NCT00734474,Withdrawal by Subject,Overall Study,FG002,0.0310456901763095,0.8189368033041702,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4079,NCT03080883,Physician Decision,Overall Study,FG001,0.031044475815119,0.8188923924146201,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4080,NCT00434161,Adverse Event,Overall Study,FG000,0.0310355859423908,0.81884798152507,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4081,NCT03080883,Disease Progression,Overall Study,FG000,0.0310281475180257,0.8188035706355198,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4082,NCT03080883,Physician Decision,Overall Study,FG000,0.0310267972107638,0.8187591597459697,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4083,NCT00359762,Adverse Event,Period II,FG000,0.0309985775455853,0.8187147488564196,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4084,NCT00318461,Withdrawals between 6 and 24 months,"Open-Label Extension, 18 Months",FG004,0.0309958591897321,0.8186703379668695,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4085,NCT00359762,Physician Decision,Period II,FG000,0.0309924788895139,0.8186259270773194,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4086,NCT04509674,Lost to Follow-up,Overall Study,FG000,0.0309903056061904,0.8185815161877692,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4087,NCT00546754,Adverse Event,Overall Study,FG001,0.0309792325655754,0.8185371052982191,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4088,NCT00108082,Amendment 4: > Month 12,Overall Study,FG001,0.0309507223962499,0.818492694408669,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4089,NCT00286429,Physician Decision,Overall Study,FG000,0.0309473793781944,0.8184482835191189,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4090,NCT00770653,Withdrawal by Subject,Overall Study,FG001,0.0309442468510515,0.8184038726295688,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4091,NCT00108082,Lost to Follow-up,Overall Study,FG002,0.0309402230569642,0.8183594617400186,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4092,NCT01830543,Death,Overall Study,FG000,0.0309199452139384,0.8183150508504685,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4093,NCT00403767,Investigator dec./not protocol-related,Overall Study,FG000,0.0309120302162896,0.8182706399609184,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4094,NCT04986202,Withdrawal by Subject,Overall Study,FG002,0.0309082985687301,0.8182262290713683,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4095,NCT03481634,Death,Overall Study,FG000,0.030906965525744,0.8181818181818182,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4096,NCT04986202,Withdrawal by Subject,Overall Study,FG000,0.0309048663128968,0.818137407292268,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4097,NCT03481634,Lost to Follow-up,Overall Study,FG002,0.0309037517869543,0.8180929964027179,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4098,NCT01032629,Withdrawal by Subject,Overall Study,FG002,0.0309036881701623,0.8180485855131678,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4099,NCT03481634,Lost to Follow-up,Overall Study,FG001,0.0308960375456745,0.8180041746236177,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4100,NCT01272232,Protocol Violation,Weeks 0-56,FG000,0.0308554334831547,0.8179597637340676,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4101,NCT01272232,Unclassified,Weeks 0-56,FG002,0.0308512973106548,0.8179153528445174,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4102,NCT01191268,Adverse Event,Overall Study,FG001,0.0308239829552976,0.8178709419549673,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4103,NCT01294436,Withdrawal by Subject,Overall Study,FG000,0.0308172516630158,0.8178265310654173,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4104,NCT01045707,Unclassified,Main: Week 0 to 26 (NN5401-3590),FG000,0.0308117849604761,0.8177821201758672,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4105,NCT04093752,Withdrawal by Subject,Overall Study,FG001,0.0307603693589385,0.817737709286317,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4106,NCT02453555,Other than specified above,24-week Double-blind Treatment Period,FG001,0.0307590534408107,0.8176932983967669,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4107,NCT01355159,Spontaneous abortion (<20 weeks),Overall Study,FG000,0.0307583862157142,0.8176488875072168,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4108,NCT04093752,Withdrawal by Subject,Overall Study,FG000,0.0307465089810813,0.8176044766176667,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4109,NCT00094757,Withdrawal by Subject,Overall Study,FG000,0.0307199356884028,0.8175600657281166,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4110,NCT02741596,Physician Decision,Overall Study,FG000,0.0306991706961011,0.8175156548385664,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4111,NCT02371759,Protocol Violation,Overall Study,FG000,0.0306962787805951,0.8174712439490163,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4112,NCT01183013,Reasons other than stated above,Overall Study,FG006,0.030678166506369,0.8174268330594662,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4113,NCT02371759,Protocol Violation,Overall Study,FG007,0.0306714669318451,0.817360216725141,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4114,NCT02371759,Protocol Violation,Overall Study,FG004,0.0306714669318451,0.817360216725141,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4115,NCT02197416,Withdrawal by Subject,Overall Study,FG001,0.030668804272113,0.8172936003908158,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4116,NCT00976391,Withdrawal by Subject,Treatment Period (52 Weeks),FG000,0.0306574736004563,0.8172491895012657,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4117,NCT02197416,Other reasons,Overall Study,FG001,0.030647861970863,0.8172047786117156,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4118,NCT01183013,Withdrawal by Subject,Overall Study,FG001,0.0306324486184821,0.8171603677221655,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4119,NCT00549302,Withdrawal by Subject,Open-Label,FG002,0.0306251391292757,0.8171159568326154,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4120,NCT00739674,No follow-up data,Overall Study,FG001,0.0306221238866188,0.8170715459430652,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4121,NCT00508820,Requirement for alternative therapy,Overall Study,FG000,0.0306153585225992,0.8170271350535151,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4122,NCT05763875,Subject decision,Overall Study,FG001,0.0306090607922618,0.816982724163965,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4123,NCT00371683,Adverse Event,DB Treatment Period-Randomized Patients,FG001,0.0305886035480456,0.8169383132744149,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4124,NCT05763875,Lost to Follow-up,Overall Study,FG002,0.0305873819114285,0.8168939023848648,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4125,NCT03086330,Withdrawal by Subject,Overall Study,FG000,0.0305833949587004,0.8168494914953146,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4126,NCT05093933,Withdrawal by Subject,Overall Study,FG001,0.0305716283418055,0.8168050806057645,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4127,NCT00444600,Dropped,Overall Study,FG001,0.0305462040519048,0.8167606697162144,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4128,NCT01101035,Major Protocol Deviation,Overall Study,FG001,0.0305409424428571,0.8167162588266643,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4129,NCT01413178,Ineligible,Overall Study,FG001,0.030538675126617,0.8166718479371142,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4130,NCT00289887,Other,Overall Study,FG000,0.0305156982226587,0.816627437047564,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4131,NCT03987919,Lost to Follow-up,Overall Study,FG003,0.0305134785330158,0.8165830261580139,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4132,NCT00444600,Dropped,Overall Study,FG000,0.0305132518326786,0.8165386152684638,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4133,NCT02851407,Consent withdrawn by participant,Overall Study,FG001,0.0305120145845932,0.8164942043789137,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4134,NCT01345019,Adverse Event,Blinded Treatment Phase,FG001,0.0305041114086606,0.8164497934893636,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4135,NCT02110901,Death,Overall Study,FG001,0.0304721592707936,0.8164053825998134,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4136,NCT05462756,Withdrawal by Subject,Follow-Up Period,FG001,0.0304718947315873,0.8163609717102633,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4137,NCT00523978,Screen Failures,Overall Study,FG000,0.0304678322614682,0.8163165608207132,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4138,NCT02586155,Other reasons,Overall Study,FG001,0.0304553212405456,0.8162721499311631,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4139,NCT02110901,Withdrawal by Subject,Overall Study,FG001,0.0304388181674007,0.816227739041613,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4140,NCT05462756,Assigned Treatment by Mistake,Treatment Period,FG000,0.0304331162114087,0.8161833281520628,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4141,NCT02738879,Withdrawal by Subject,Overall Study,FG001,0.0304091916966369,0.8161389172625128,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4142,NCT02054897,Missing follow-up information,Overall Study,FG001,0.0304045459326984,0.8160945063729627,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4143,NCT00234533,Withdrawal by Subject,Overall Study,FG000,0.0304031828200595,0.8160500954834126,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4144,NCT01894568,Withdrawal by Subject,Overall Study,FG000,0.0304019634486507,0.8160056845938625,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4145,NCT01624142,Death,Overall Study,FG000,0.0303979405519444,0.8159612737043123,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4146,NCT01894568,Withdrawal by Subject,Overall Study,FG001,0.0303870272176388,0.8159168628147622,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4147,NCT02033889,Lost to Follow-up,Overall Study,FG002,0.030341742628363,0.8158724519252121,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4148,NCT02463071,Reason not specified,Overall Study,FG002,0.0303293265237797,0.815828041035662,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4149,NCT01999218,Study Terminated By Sponsor,Overall Study,FG002,0.0303206008689484,0.8157836301461118,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4150,NCT00313313,Adverse Event,Overall Study,FG001,0.0302903130282394,0.8157392192565617,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4151,NCT03066804,Death,Overall Study,FG001,0.0302628474558134,0.8156948083670116,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4152,NCT00306384,Major protocol deviation,Overall Study,FG000,0.0302596180687003,0.8156503974774615,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4153,NCT05275400,Non-Compliance with Study Drug,Treatment Period,FG000,0.0302457729228868,0.8156059865879114,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4154,NCT00501059,Missing end-of-study page,Overall Study,FG001,0.0302434288035416,0.8155615756983612,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4155,NCT00713830,Poor Compliance to Protocol,Overall Study,FG001,0.0302428447486111,0.8155171648088111,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4156,NCT05275400,Physician Decision,Treatment Period,FG000,0.0302375596883035,0.815472753919261,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4157,NCT02648217,Withdrawal by Subject,Overall Study,FG001,0.0302359607023584,0.8154283430297109,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4158,NCT00781937,Protocol Violation,Main Trial Period Through Week 56,FG000,0.0302337044918254,0.8153839321401608,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4159,NCT00094770,Adverse Event,Year 1 ( Week 0 to Week 52),FG000,0.0302215380595437,0.8153395212506106,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4160,NCT00000620,Death,Overall Study,FG002,0.0302151197750992,0.8152951103610605,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4161,NCT05275400,Death,Treatment Period,FG000,0.0302132003124702,0.8152506994715104,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4162,NCT00094770,Protocol Specified Discontinuation,Year 1 ( Week 0 to Week 52),FG001,0.0302131567453175,0.8152062885819603,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4163,NCT01730040,Adverse Event,Overall Study,FG002,0.0301992755244886,0.8151618776924102,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4164,NCT00094770,Lost to Follow-up,Year 2 (Week 0 to Week 104),FG000,0.030194963850377,0.81511746680286,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4165,NCT01730040,Other than specified,Overall Study,FG004,0.0301785945761552,0.8150730559133099,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4166,NCT01730040,Other than specified,Overall Study,FG002,0.0301765820511552,0.8150286450237598,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4167,NCT01730040,Other than specified,Overall Study,FG003,0.0301764118011552,0.8149842341342097,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4168,NCT05275400,Lost to Follow-up,Treatment Period,FG001,0.0301725809238392,0.8149398232446596,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4169,NCT00286455,Withdrawal by Subject,Overall Study,FG001,0.0301722327702777,0.8148954123551094,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4170,NCT01182441,Implant Not Attempted,Overall Study,FG000,0.0301641470864384,0.8148510014655593,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4171,NCT00327015,Withdrawal of Consent by Subject,Overall Study,FG003,0.0301155501466269,0.8148065905760092,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4172,NCT02284893,Subject no longer meets study criteria,26 Week (Short Term),FG000,0.0300460826331249,0.8147621796864591,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4173,NCT01467466,No Endpoint Blood Draw,Overall Study,FG000,0.030043582033869,0.814717768796909,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4174,NCT01272219,Protocol Violation,Main + Extension Period: Week 0-172,FG005,0.030033561471121,0.8146733579073588,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4175,NCT01830543,Subject Decision,Overall Study,FG000,0.0300299937162499,0.8146289470178087,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4176,NCT00321919,Death,Overall Study,FG001,0.0300210246259623,0.8145845361282587,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4177,NCT01272219,Lack of Efficacy,Main + Extension Period: Week 0-172,FG005,0.0300108020872322,0.8145401252387086,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4178,NCT00094770,Withdrawal by Subject,Year 1 ( Week 0 to Week 52),FG000,0.0300074795908234,0.8144957143491585,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4179,NCT01676220,Protocol Violation,Overall Study,FG000,0.0300018588802174,0.8144513034596083,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4180,NCT02099110,Lost to Follow-up,Overall Study,FG001,0.0299982667752976,0.8144068925700582,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4181,NCT01676220,Lost to Follow-up,Overall Study,FG000,0.0299968827648007,0.8143624816805081,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4182,NCT02897349,Lost to Follow-up,Overall Study,FG001,0.0299883145021527,0.814318070790958,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4183,NCT00789191,Protocol Violation,Overall Study,FG000,0.0299846362257539,0.8142736599014079,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4184,NCT00789191,Lack of Efficacy,Overall Study,FG001,0.0299821942427083,0.8142292490118577,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4185,NCT00789191,Unclassified,Overall Study,FG000,0.0299755871340873,0.8141848381223076,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4186,NCT02897349,Lost to Follow-up,Overall Study,FG000,0.0299654060142361,0.8141404272327575,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4187,NCT01664247,Protocol Violation,Overall Study,FG001,0.0299487192609469,0.8140960163432074,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4188,NCT01664247,Adverse Event,Overall Study,FG000,0.0299367570721076,0.8140516054536573,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4189,NCT01272219,Unclassified,Main Period: Week 0 to Week 56,FG000,0.029934941398244,0.8140071945641071,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4190,NCT01664247,Unclassified,Overall Study,FG000,0.0299343123179409,0.813962783674557,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4191,NCT02229383,Lost to Follow-up,Overall Study,FG000,0.0299267573590475,0.8139183727850069,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4192,NCT00362232,Adverse Event,Treatment (12 +/- 2 Days),FG001,0.0299266957621527,0.8138739618954568,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4193,NCT00321919,Adverse Event,Overall Study,FG000,0.0299167774153075,0.8138295510059066,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4194,NCT01126580,Adverse Event,Overall Study,FG002,0.029885813611617,0.8137851401163565,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4195,NCT04560998,Physician Decision,Overall Study,FG000,0.029883729863758,0.8137407292268064,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4196,NCT00633893,Other,Overall Study,FG002,0.0298779122755654,0.8136963183372563,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4197,NCT01243424,Lack of Efficacy,Discontinuation From Treatment,FG001,0.0298567647617559,0.8136519074477062,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4198,NCT01106677,Adverse Event,Core Period: Baseline to Week 26,FG001,0.0298510663023313,0.813607496558156,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4199,NCT01958671,Adverse Event,Overall Study,FG002,0.0298315196450495,0.8135630856686059,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4200,NCT00249795,Symptomatic hypotension,Overall Study,FG000,0.0298296656253075,0.8135186747790558,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4201,NCT01876368,Adverse Event,Overall Study,FG001,0.0298159484391964,0.8134742638895057,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4202,NCT00414609,Withdrawal by Subject,Extension Study,FG002,0.0297774013369047,0.8134298529999556,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4203,NCT00056160,Withdrawal by Subject,Up to Unblinding (07 Jun 2005),FG001,0.0297562399051685,0.8133854421104054,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4204,NCT00056160,Withdrawal by Subject,Up to Unblinding (07 Jun 2005),FG000,0.0297460398740376,0.8133410312208553,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4205,NCT00379769,Withdrawal by Subject,Main Study,FG002,0.0297382535893055,0.8132966203313052,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4206,NCT01033071,Withdrawal by Subject,Overall Study,FG000,0.029731818336498,0.8132522094417551,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4207,NCT05662332,Non-compliance with study drug,Overall Study,FG000,0.0297303337431331,0.813207798552205,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4208,NCT01898923,One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY,Overall Study,FG001,0.0297218394406547,0.8131633876626548,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4209,NCT01986855,Withdrawal by Subject,Overall Study,FG002,0.0297108376587499,0.8131189767731047,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4210,NCT01369069,Lost to Follow-up,Overall Study,FG001,0.0297097277285515,0.8130745658835546,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4211,NCT00056160,Other,Up to Unblinding (07 Jun 2005),FG000,0.0296935904825495,0.8130301549940046,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4212,NCT03868124,Adverse Event,Overall Study,FG002,0.0296910807121879,0.8129857441044545,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4213,NCT00271817,Lost to Follow-up,Part 1,FG002,0.0296659294859821,0.8129413332149042,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4214,NCT00002850,Death,Overall Study,FG000,0.0296546658282142,0.8128969223253542,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4215,NCT00379769,Death,Main Study,FG003,0.029645934892619,0.8128525114358041,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4216,NCT00129545,Physician Decision,Overall Study,FG002,0.0296356424182233,0.812808100546254,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4217,NCT01991795,Withdrawal by Subject,Overall Study,FG000,0.0296203271450495,0.8127636896567039,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4218,NCT00501059,Missing end-of-study page,Overall Study,FG000,0.0296141830290178,0.8127192787671537,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4219,NCT01369069,Withdrawal by Subject,Overall Study,FG000,0.0295945870689186,0.8126748678776036,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4220,NCT00683878,Withdrawal by Subject,Overall Study,FG001,0.0295762201497024,0.8126304569880535,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4221,NCT00232180,Withdrawal by Subject,Open Label Phase,FG002,0.0295613324412364,0.8125860460985034,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4222,NCT02865850,Withdrawal by Subject,Overall Study,FG000,0.0295573901077381,0.8125416352089533,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4223,NCT00121641,Subject Withdrew Consent,24-week Short-term Treatment Period,FG000,0.0295550016498313,0.8124972243194031,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4224,NCT00121641,Adverse Event,48-month Short Term + Long Term Period,FG000,0.0295526572721825,0.812452813429853,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4225,NCT01442038,Adverse Event,Overall Study,FG000,0.0295497063860119,0.8124084025403029,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4226,NCT00121641,Lost to Follow-up,48-month Short Term + Long Term Period,FG000,0.0295407012420932,0.8123639916507528,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4227,NCT00377676,Other,Overall Study,FG001,0.0295322147745734,0.8123195807612027,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4228,NCT00252694,Death,Overall Study,FG000,0.0295262734022303,0.8122751698716525,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4229,NCT02865850,Lost to Follow-up,Overall Study,FG000,0.0295146986203571,0.8122307589821024,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4230,NCT05425745,Lost to Follow-up,Overall Study,FG001,0.0295123919680411,0.8121863480925523,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4231,NCT00796367,Withdrawal by Subject,Overall Study,FG002,0.0295096345478571,0.8121419372030022,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4232,NCT05425745,Death,Overall Study,FG000,0.0294874692372077,0.8120975263134521,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4233,NCT00532935,Withdrawal by Subject,Overall Study,FG000,0.0294754911313979,0.8120531154239019,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4234,NCT00698932,Withdrawal by Subject,Overall Study,FG000,0.0294661442051181,0.8120087045343518,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4235,NCT01854918,Lost to Follow-up,All-IP Period (Years 2 and 3),FG000,0.029465373973373,0.8119642936448017,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4236,NCT00380068,Lack of Efficacy,Overall Study,FG000,0.0294605712488194,0.8119198827552516,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4237,NCT01026194,Adverse Event,Period 2Open-label Period,FG000,0.0294517688542027,0.8118754718657014,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4238,NCT00532935,Lost to Follow-up,Overall Study,FG000,0.0294436195045824,0.8118310609761513,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4239,NCT01627327,Lack of Efficacy-Sub-Reason Exacerbation,Overall Study,FG001,0.0294294634719642,0.8117866500866012,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4240,NCT00116831,Adverse Event,Overall Study,FG000,0.0294281561497175,0.8117422391970511,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4241,NCT03759392,Death,Overall Study,FG000,0.0293872084246627,0.811697828307501,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4242,NCT00281580,Adverse Event,Overall Study,FG009,0.0293825209307719,0.8116534174179508,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4243,NCT01026194,Physician Decision,Period 1Double Blind Period,FG001,0.0293690733927741,0.8116090065284007,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4244,NCT02540993,GCP violations,Overall Study,FG000,0.0293567485796825,0.8115645956388506,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4245,NCT03759392,Withdrawal by Subject,Overall Study,FG000,0.0293494035457936,0.8115201847493005,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4246,NCT03759392,Protocol Violation,Overall Study,FG000,0.0293472760682341,0.8114757738597504,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4247,NCT00810693,Adverse Event,Treatment Period,FG002,0.0293451140614384,0.8114313629702002,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4248,NCT00316082,Withdrawal of Consent by Subject,Overall Study,FG001,0.0293435850859496,0.8113869520806501,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4249,NCT00316082,Lost to Follow-up,Overall Study,FG003,0.0293423599961282,0.8113425411911,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4250,NCT00281580,Lack of Efficacy,Overall Study,FG003,0.0293378005351172,0.81129813030155,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4251,NCT01026194,Withdrawal by Subject,Period 2Open-label Period,FG001,0.0293349523231908,0.8112537194119999,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4252,NCT02798471,Death,Overall Study,FG000,0.0293345821686805,0.8112093085224497,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4253,NCT03242252,Adverse Event,Overall Study,FG001,0.0293312614375,0.8111648976328996,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4254,NCT01301833,Adverse Event,Overall Study,FG000,0.0293291477823809,0.8111204867433495,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4255,NCT00249873,Other non serious Adverse Event,Overall Study,FG000,0.0293280534943254,0.8110760758537994,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4256,NCT00838916,Adverse Event,Follow-up Period (8 Weeks),FG000,0.0293111244426091,0.8110316649642493,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4257,NCT02798471,Adverse Event,Overall Study,FG001,0.029295995957197,0.8109872540746991,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4258,NCT01572740,unclassified,Overall Study,FG000,0.0292949907677182,0.810942843185149,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4259,NCT02798471,Data entry error (reported as study completion and study discontinuation),Overall Study,FG000,0.0292937118002823,0.8108984322955989,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4260,NCT02798471,"Randomized, but not treated",Overall Study,FG001,0.029291498569697,0.8108540214060488,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4261,NCT01296412,Lost to Follow-up,Overall Study,FG000,0.0292387285429761,0.8108096105164987,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4262,NCT01713530,Unclassified,Overall Study,FG000,0.0292297153712499,0.8107651996269485,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4263,NCT01818752,Physician Decision,Overall Study,FG000,0.0292194739828373,0.8107207887373984,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4264,NCT00542386,Lack of Efficacy,Overall Study,FG001,0.0292070003133847,0.8106763778478483,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4265,NCT00366249,Most due to osteomylitis status,Overall Study,FG001,0.0292029657621924,0.8106319669582982,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4266,NCT01296412,Withdrawal by Subject,Overall Study,FG000,0.0291914616166071,0.8105875560687481,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4267,NCT01042977,Subject no longer meets study criteria,Overall Study,FG001,0.0291859315448412,0.8105431451791979,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4268,NCT01760447,Randomized but not treated,Weeks 0-20,FG002,0.0291828895734821,0.8104987342896478,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4269,NCT00395343,Adverse Event,Overall Study,FG000,0.0291772417600198,0.8104543234000977,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4270,NCT01326026,Adverse Event,Overall Study,FG000,0.029174974802867,0.8104099125105476,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4271,NCT00661362,Study specific discontinuation criteria,Overall Study,FG001,0.0291468130384812,0.8103655016209975,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4272,NCT00393718,Lack of Efficacy,Overall Study,FG001,0.0291297802204933,0.8103210907314473,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4273,NCT01760447,Withdrawal by Subject,Weeks 0-20,FG000,0.0291242289498512,0.8102766798418972,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4274,NCT01760447,Lost to Follow-up,Weeks 20-54,FG003,0.0291206386147321,0.8102322689523471,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4275,NCT00739674,Screening failures,Overall Study,FG001,0.0291189493822537,0.810187858062797,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4276,NCT00306384,Lost to Follow-up,Overall Study,FG001,0.0291074566430059,0.8101434471732469,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4277,NCT01760447,Withdrawal by Subject,Weeks 20-54,FG000,0.0291027552436012,0.8100990362836967,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4278,NCT00086515,Adverse Event,Phase B (Weeks 24-104),FG000,0.0290975785206448,0.8100546253941466,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4279,NCT00497146,Required dialysis,Treatment Period,FG000,0.0290937479898511,0.8099880090598215,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4280,NCT00497146,Unable to dose reduce per protocol,Treatment Period,FG000,0.0290937479898511,0.8099880090598215,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4281,NCT01760447,Withdrawal by Subject,Weeks 20-54,FG003,0.0290920847636607,0.8099213927254962,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4282,NCT01080391,Randomized but not treated,Overall Study,FG000,0.0290800644187102,0.8098769818359461,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4283,NCT01237223,Unsatisfactory therapeutic effect,"Double Blind (Treatment Period, 8 Weeks)",FG000,0.0290798152167955,0.809832570946396,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4284,NCT00402103,Patient withdrew consent,Overall Study,FG000,0.0290751776906745,0.809788160056846,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4285,NCT00809965,Other Reason,Overall Study,FG001,0.0290580111085119,0.8097437491672959,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4286,NCT00545584,Two or more reasons for discontinuation,Overall Study,FG001,0.0290400038660714,0.8096993382777457,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4287,NCT00086515,Patient received Phase A rescue therapy,Phase A to Phase B Transition Period,FG000,0.0290210141618055,0.8096549273881956,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4288,NCT00327015,Withdrawal of Consent by Subject,Overall Study,FG001,0.0290208385489285,0.8096105164986455,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4289,NCT00424047,Other,On Study at Time of Unblinding,FG000,0.0290195808918452,0.8095661056090954,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4290,NCT01181167,Adverse Event,Overall Study,FG000,0.0290073595713095,0.8095216947195453,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4291,NCT02250651,Adverse Event,Treatment Period 3 (Week 32 to Week 52),FG000,0.0289836270318849,0.80945507838522,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4292,NCT02250651,Adverse Event,Treatment Period 2 (Week 16 to Week 31),FG000,0.0289836270318849,0.80945507838522,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4293,NCT00808067,Patient refused to take study medication,Overall Study,FG000,0.0289728021951885,0.8093884620508949,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4294,NCT00532779,"Drug noncompliance, moved, other",Overall Study,FG002,0.0289660629433333,0.8093440511613448,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4295,NCT02414841,Withdrawal by Subject,Overall Study,FG001,0.0289577976262004,0.8092996402717947,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4296,NCT00680017,Withdrawal by Subject,Overall Study,FG001,0.0289566338315674,0.8092552293822445,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4297,NCT03682185,Withdrawal by Subject,Overall Study,FG003,0.0289561419659523,0.8092108184926944,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4298,NCT00168818,Lost to Follow-up,Overall Study,FG000,0.0289426174913491,0.8091664076031443,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4299,NCT01648582,Lost to Follow-up,Overall Study,FG000,0.0289204761699107,0.8091219967135942,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4300,NCT03682185,Withdrawal by Subject,Overall Study,FG001,0.0289160243516369,0.8090775858240441,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4301,NCT04740931,Withdrawal by Subject,Part 1 (Baseline up to Week 24),FG001,0.0289118877513789,0.8090331749344939,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4302,NCT00152971,Other,Treatment,FG002,0.0288944483211706,0.8089887640449438,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4303,NCT02073682,No reason provided,Overall Study,FG001,0.0288625052738356,0.8089443531553937,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4304,NCT00838903,Lost to Follow-up,Treatment Period (156 Weeks),FG003,0.028846305080615,0.8088999422658436,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4305,NCT04740931,Death,Part 2 (Week 24 to Week 72),FG000,0.0288460846533432,0.8088555313762935,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4306,NCT00838903,Adverse Event,Treatment Period (156 Weeks),FG001,0.028837670113115,0.8088111204867433,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4307,NCT00484198,Adverse Event,Overall Study,FG002,0.0288365534092559,0.8087667095971932,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4308,NCT00838903,Subject Withdrawn from Follow-up,Follow-up Period (8 Weeks),FG001,0.028834795529246,0.8087222987076431,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4309,NCT02128932,Withdrawal by Subject,Overall Study,FG000,0.0288343104225732,0.808677887818093,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4310,NCT00838903,Noncompliance,Treatment Period (156 Weeks),FG001,0.028831382900496,0.8086334769285429,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4311,NCT00094770,Other,Year 2 (Week 0 to Week 104),FG001,0.028828993251369,0.8085890660389927,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4312,NCT00391872,Withdrawal by Subject,Overall Study,FG001,0.0288128519691964,0.8085446551494426,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4313,NCT02128932,No reason for withdrawal,Overall Study,FG001,0.0288022792831387,0.8085002442598925,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4314,NCT00660907,Various,Overall Study,FG000,0.0288007007727579,0.8084558333703424,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4315,NCT00283686,Less than full participation,Overall Study,FG000,0.0287896980448313,0.8084114224807923,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4316,NCT00980174,Withdrawal by Subject,Overall Study,FG001,0.0287841759984325,0.8083670115912421,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4317,NCT00121667,Adverse Event,Short Term (ST) + Long Term (LT) Period,FG002,0.0287788535106249,0.808322600701692,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4318,NCT00377676,Lost to Follow-up,Overall Study,FG001,0.0287777172829464,0.808278189812142,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4319,NCT00152971,Adverse Event,Overall Study,FG001,0.0287769063994128,0.8082337789225919,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4320,NCT02513303,Death,Overall Study,FG002,0.0287713573095039,0.8081893680330418,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4321,NCT02058147,Adverse Event,Overall Study,FG000,0.0287709228015018,0.8081449571434915,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4322,NCT00489541,Not Evaluable for 9-Month Angiography,9-Month Angiographic Follow-up,FG001,0.0287702317245535,0.8081005462539415,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4323,NCT00121667,Lost to Follow-up,Short Term (ST) + Long Term (LT) Period,FG002,0.0287688678726487,0.8080561353643914,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4324,NCT00131664,Adverse Event,First Period (First 6 Months),FG000,0.0287615598122817,0.8080117244748413,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4325,NCT00282984,Lost to Follow-up,Overall Study,FG000,0.0287573008653769,0.8079673135852911,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4326,NCT00719563,Lost to Follow-up,Overall Study,FG000,0.0287477315041368,0.807922902695741,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4327,NCT00121667,Subject Withdrew Consent,Short Term (ST) Period,FG001,0.0287445436685037,0.8078784918061909,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4328,NCT02513303,Lost to Follow-up,Overall Study,FG000,0.0287392499987148,0.8078340809166408,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4329,NCT01075282,Withdrawal by Subject,Overall Study,FG002,0.0287363000205258,0.8077896700270907,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4330,NCT02513303,Withdrawal by Subject,Overall Study,FG002,0.0287360543972962,0.8077452591375405,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4331,NCT00379769,Withdrawal by Subject,Main Study,FG003,0.0287326027724305,0.8077008482479904,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4332,NCT01075282,Withdrawal by Subject,Overall Study,FG000,0.0287301810908234,0.8076564373584403,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4333,NCT00152971,Protocol Violation,Treatment,FG002,0.0287294833350396,0.8076120264688902,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4334,NCT00403767,Investigator dec./not protocol-related,Overall Study,FG001,0.0287155947551289,0.8075676155793401,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4335,NCT00152971,Protocol Violation,Overall Study,FG000,0.0286822655047501,0.8075232046897899,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4336,NCT00553787,Withdrawal by Subject,Overall Study,FG001,0.0286720775797817,0.8074787938002398,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4337,NCT00541450,Hyperglycemia,Phase B,FG001,0.0286661486258847,0.8074343829106897,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4338,NCT00433966,Lost to Follow-up,Stent Intervention/Randomization,FG003,0.0286654612802975,0.8073899720211396,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4339,NCT01986881,Withdrawal by Subject,Overall Study,FG002,0.0286619884679762,0.8073455611315895,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4340,NCT00719563,Medical condition changed,Overall Study,FG001,0.028649813546994,0.8073011502420393,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4341,NCT00379769,Death,Observational Follow-up,FG005,0.0286488166340773,0.8072567393524892,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4342,NCT01215253,Physician Decision,Overall Study,FG000,0.0286421396331646,0.8072123284629391,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4343,NCT01646320,Lost to Follow-up,Short-term Period (Day 1 to Week 24),FG001,0.0286359285575496,0.807167917573389,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4344,NCT01646320,Lost to Follow-up,Short-term Period (Day 1 to Week 24),FG000,0.0286212310325495,0.8071235066838389,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4345,NCT01646320,Adverse Event,Long-term Period (Weeks 24 to 52),FG000,0.028614689154871,0.8070790957942887,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4346,NCT00567255,"Drug noncompliance,moved,other",Overall Study,FG000,0.0286038470208928,0.8070346849047386,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4347,NCT02164864,"Consent withdrawn, not due to AE",Overall Study,FG000,0.0285925581519444,0.8069902740151885,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4348,NCT00809965,Other Reason,Overall Study,FG000,0.0285879916407143,0.8069458631256384,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4349,NCT00782340,Protocol Violation,Open Label Titration,FG000,0.0285757942754762,0.8069014522360883,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4350,NCT00614380,Adverse Event,Overall Study,FG001,0.0285719878177462,0.8068570413465381,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4351,NCT00782340,Withdrawal by Subject,Open Label Titration,FG000,0.0285460163859821,0.806812630456988,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4352,NCT01294436,Adverse Event,Overall Study,FG000,0.0285337700062698,0.8067682195674379,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4353,NCT00782340,Lost to Follow-up,Open Label Titration,FG000,0.0285286310606845,0.8067238086778878,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4354,NCT02836873,Lost to Follow-up,Overall Study,FG001,0.0285245494187202,0.8066793977883377,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4355,NCT01076088,Withdrawal by Subject,Overall Study,FG003,0.0285203347259424,0.8066349868987875,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4356,NCT00313313,Adverse Event,Overall Study,FG000,0.028504404424365,0.8065905760092374,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4357,NCT01189890,Lack of Efficacy,Overall Study,FG000,0.0284904915992883,0.8065461651196874,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4358,NCT00853827,Adverse Event,Single Blind Period (1 Week),FG000,0.0284818584207142,0.8065017542301373,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4359,NCT00722371,Withdrawal by Subject,Overall Study,FG003,0.0284797465646392,0.8064573433405872,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4360,NCT01494987,Adverse Event,Overall Study,FG000,0.0284760968675919,0.806412932451037,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4361,NCT01623115,Consent withdrawn by participant,Overall Study,FG001,0.0284753181343452,0.8063685215614869,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4362,NCT01159600,Adverse Event,Overall Study,FG005,0.0284702470122997,0.8063241106719368,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4363,NCT01494987,Hyperglycemia,Overall Study,FG000,0.0284661820092586,0.8062796997823867,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4364,NCT00252694,Death,Overall Study,FG001,0.0284632977091071,0.8062352888928366,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4365,NCT04445519,Lost to Follow-up,Overall Study,FG002,0.0284577514857639,0.8061908780032864,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4366,NCT01545388,Lack of Efficacy,Overall Study,FG002,0.0284505766227678,0.8061464671137363,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4367,NCT01189890,Lost to Follow-up,Overall Study,FG001,0.0284465098492288,0.8061020562241862,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4368,NCT02064439,Withdrawal by Subject,Overall Study,FG002,0.0284437720019841,0.8060576453346361,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4369,NCT00271817,Withdrawal by Subject,Part 1,FG000,0.028441264832857,0.8060132344450859,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4370,NCT04760626,Death,Overall Study,FG001,0.0284249085158432,0.8059688235555358,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4371,NCT00877890,Lost to Follow-up,Overall Study,FG000,0.0284125833931412,0.8059244126659857,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4372,NCT04788511,Death,Overall Study,FG000,0.0284099682978472,0.8058800017764356,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4373,NCT00853827,Withdrawal by Subject,Single Blind Period (1 Week),FG000,0.0283931309202381,0.8058355908868855,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4374,NCT03470545,Adverse Event,Overall Study,FG000,0.0283855207630059,0.8057911799973353,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4375,NCT02863328,Withdrawal by Subject,Overall Study,FG000,0.0283844094965277,0.8057467691077852,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4376,NCT02773368,Lost to Follow-up,Overall Study,FG000,0.0283715191950496,0.8057023582182351,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4377,NCT00327015,Lost to Follow-up,Overall Study,FG001,0.0283645899052678,0.805657947328685,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4378,NCT03021187,Withdrawal by Subject,Overall Study,FG001,0.0283642860583631,0.8056135364391349,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4379,NCT03158688,Lost to Follow-up,Overall Study,FG001,0.0283642308084072,0.8055691255495847,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4380,NCT00877890,Lost to Follow-up,Overall Study,FG001,0.0283602821119606,0.8055247146600346,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4381,NCT00666718,Withdrawal by Subject,Overall Study,FG000,0.0283485275370139,0.8054803037704845,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4382,NCT01890122,Lack of Efficacy,Overall Study,FG002,0.0283253927048054,0.8054358928809344,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4383,NCT02207491,Protocol Violation,Overall Study,FG001,0.0283124513996428,0.8053914819913843,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4384,NCT00113087,Family or MD withdrew subject,Overall Study,FG001,0.0283117834320111,0.8053470711018341,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4385,NCT00859898,Lost to Follow-up,Overall Study,FG001,0.0283010561005573,0.805302660212284,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4386,NCT00308139,Administrative,Overall Study,FG001,0.0282976992165476,0.8052582493227339,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4387,NCT00103662,Entered Rescue Procedure,Overall Study,FG001,0.028296729699623,0.8052138384331838,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4388,NCT01031680,Withdrawal by Subject,Overall Study,FG000,0.028295268243621,0.8051694275436337,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4389,NCT00159861,Withdrawal by Subject,Extension Study - up to 3 Years,FG000,0.0282905108662202,0.8051250166540835,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4390,NCT01663402,Withdrawal by Subject,Overall Study,FG000,0.0282888099023214,0.8050806057645334,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4391,NCT01128894,Withdrawal by Subject,Overall Study,FG001,0.0282876534648809,0.8050361948749833,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4392,NCT02942576,Withdrawal by Subject,Overall Study,FG001,0.0282796137325099,0.8049917839854333,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4393,NCT00859898,Withdrawal by Subject,Overall Study,FG002,0.028275136071875,0.8049473730958832,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4394,NCT00103662,Death,Overall Study,FG000,0.0282748880289087,0.804902962206333,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4395,NCT01555164,Subject Non-compliance,Overall Study,FG001,0.0282708788580158,0.8048585513167829,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4396,NCT00859898,Withdrawal by Subject,Overall Study,FG000,0.0282704204227083,0.8048141404272328,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4397,NCT01555164,Subject Withdrew Consent,Overall Study,FG000,0.0282695943074206,0.8047697295376827,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4398,NCT00827606,Adverse Event,Overall Study,FG000,0.0282394211310118,0.8047253186481326,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4399,NCT00087516,Withdrawal by Subject,Overall Study,FG000,0.0282316718005059,0.8046809077585824,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4400,NCT01183013,Reasons other than stated above,Overall Study,FG004,0.0282232007319841,0.8046364968690323,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4401,NCT00827606,LDL below 2.59 mmol/L,Overall Study,FG000,0.028220871906488,0.8045920859794822,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4402,NCT01183013,Reasons other than stated above,Overall Study,FG003,0.0282202076224008,0.8045476750899321,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4403,NCT01297920,Adverse Event,Overall Study,FG001,0.0282200040410516,0.804503264200382,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4404,NCT00827606,Protocol Violation,Overall Study,FG000,0.0282192741731547,0.8044588533108318,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4405,NCT00249873,Other non serious Adverse Event,Overall Study,FG001,0.0282181990758333,0.8044144424212817,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4406,NCT00103662,Death,Overall Study,FG001,0.028214279957123,0.8043700315317316,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4407,NCT03469349,Withdrawal by Subject,Overall Study,FG001,0.0282051143496131,0.8043256206421815,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4408,NCT00649389,Adverse Event,Overall Study,FG002,0.028190470776875,0.8042812097526314,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4409,NCT00306384,Lack of Efficacy,Overall Study,FG001,0.0281860336521428,0.8042367988630812,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4410,NCT01516879,Lost to Follow-up,Overall Study,FG001,0.0281859508246699,0.8041923879735311,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4411,NCT01619059,Lost to Follow-up,Short-Term (ST) Treatment Period,FG001,0.0281709963033531,0.804147977083981,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4412,NCT00507416,Lack ofEfficacy / Physician Decision,Overall Study,FG000,0.0281701352531249,0.8041035661944309,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4413,NCT01663233,Protocol Deviation,Overall Study,FG001,0.0281583911927678,0.8040591553048807,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4414,NCT01785472,Subject/guardian decision,Overall Study,FG000,0.0281459622114484,0.8040147444153306,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4415,NCT04657003,Adverse Event,Overall Study,FG000,0.0281401974859424,0.8039703335257805,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4416,NCT01516879,Withdrawal by Subject,Overall Study,FG001,0.0281310097818127,0.8039259226362304,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4417,NCT04657003,Adverse Event,Overall Study,FG002,0.0281213242426091,0.8038815117466803,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4418,NCT00507416,Lack ofEfficacy / Physician Decision,Overall Study,FG001,0.0281134481566964,0.8038371008571301,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4419,NCT00306384,Adverse Event,Overall Study,FG002,0.0281071702587202,0.80379268996758,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4420,NCT03882970,Lost to Follow-up,Overall Study,FG001,0.0280903729224206,0.8037482790780299,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4421,NCT00546754,Lost to Follow-up,Overall Study,FG001,0.028073224229365,0.8037038681884798,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4422,NCT00708435,Lost to Follow-up,Overall Study,FG001,0.0280717434222023,0.8036594572989297,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4423,NCT01345019,Disease Progression,Blinded Treatment Phase,FG000,0.0280319994292162,0.8036150464093795,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4424,NCT00773279,Unclassified,Period 1,FG000,0.0280245378594345,0.8035706355198294,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4425,NCT00168805,Protocol Violation,Overall Study,FG002,0.0280162046466964,0.8035262246302793,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4426,NCT00232180,Lost to Follow-up,Double-blind (DB) Phase,FG000,0.0280023841469805,0.8034818137407292,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4427,NCT01730534,Withdrawal by Subject,Overall Study,FG000,0.0280012463231151,0.8034374028511791,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4428,NCT01194830,Non-compliance issues,Overall Study,FG000,0.0279959871618452,0.8033929919616289,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4429,NCT01986881,Lost to Follow-up,Overall Study,FG001,0.0279831676394643,0.8033485810720788,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4430,NCT00168805,Withdrawal by Subject,Treatment,FG002,0.0279781183406547,0.8033041701825288,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4431,NCT00841672,Administrative problems,Overall Study,FG000,0.0279758768236706,0.8032597592929787,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4432,NCT01717313,Study Terminated by Sponsor,Phase B (Weeks 24 to 54),FG001,0.027967437224623,0.8032153484034286,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4433,NCT01557166,Protocol Violation,Overall Study,FG001,0.0279673482434523,0.8031709375138784,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4434,NCT00262600,Other,Overall Study,FG002,0.0279568623864384,0.8031265266243283,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4435,NCT01557166,Unclassified,Overall Study,FG001,0.0279451762822023,0.8030821157347782,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4436,NCT01047683,Withdrew Consent,Overall Study,FG001,0.0279441025018154,0.8030377048452281,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4437,NCT02683746,Adverse Event,Overall Study,FG000,0.0279403351850171,0.802993293955678,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4438,NCT01717313,Study Terminated by Sponsor,Phase B (Weeks 24 to 54),FG000,0.0279356764365277,0.8029488830661278,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4439,NCT00841672,Administrative problems,Overall Study,FG001,0.0279338038292279,0.8029044721765777,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4440,NCT01243424,LostToFollowUpfor3P-MACE(StatusAlive),Discontinuation From Study (Treated Set),FG000,0.0279323032035416,0.8028600612870276,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4441,NCT01194830,Non-compliance issues,Overall Study,FG001,0.0279129255466666,0.8027934449527024,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4442,NCT01194830,Protocol Violation,Overall Study,FG001,0.0279129255466666,0.8027934449527024,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4443,NCT01717313,Adverse Event,Phase A (Weeks 0 to 24),FG000,0.0279120649913194,0.8027268286183772,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4444,NCT03353350,Withdrawal by Subject,26-week Treatment Extension Period,FG002,0.027893996512867,0.8026824177288271,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4445,NCT04576988,Death,Long Term Double Blind (LTDB),FG000,0.0278886423832439,0.802638006839277,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4446,NCT03259789,Adverse Event,Overall Study,FG000,0.0278869309903571,0.8025935959497269,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4447,NCT03353350,Adverse Event,30-week Core Treatment Period,FG003,0.0278794323186011,0.8025491850601768,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4448,NCT03353350,Withdrawal by Subject,26-week Treatment Extension Period,FG001,0.0278736257734622,0.8025047741706266,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4449,NCT00918879,Withdrawal by Subject,Overall Study,FG000,0.0278697131039385,0.8024603632810765,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4450,NCT00219141,Adverse Event,Overall Study,FG001,0.0278682827017162,0.8024159523915264,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4451,NCT04576988,Clinical worsening event,Double Blind Placebo Controlled (DBPC),FG001,0.0278681644883828,0.8023715415019763,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4452,NCT01042977,Adverse Event,Overall Study,FG001,0.0278636563993624,0.8023271306124262,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4453,NCT04576988,Adverse Event,Long Term Double Blind (LTDB),FG000,0.0278594208869939,0.802282719722876,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4454,NCT04576988,Withdrawal by Subject,Double Blind Placebo Controlled (DBPC),FG000,0.0278532287992856,0.8022383088333259,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4455,NCT02547935,Withdrawal by Subject,Overall Study,FG002,0.0278370791987103,0.8021938979437758,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4456,NCT03338010,Lost to Follow-up,Overall Study,FG000,0.0278225084177678,0.8021494870542257,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4457,NCT01126580,Withdrawal by Subject,Overall Study,FG000,0.0278209981669345,0.8021050761646755,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4458,NCT02586155,Lost to Follow-up,Overall Study,FG001,0.027820840745992,0.8020606652751254,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4459,NCT00918879,Withdrawal by Subject,Overall Study,FG001,0.0278017154879067,0.8020162543855753,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4460,NCT00713830,Withdrawal by Subject,Overall Study,FG000,0.0277701752285515,0.8019718434960252,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4461,NCT00960076,Hyperglycemia,Overall Study,FG001,0.0277492790886607,0.8019052271617001,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4462,NCT00960076,No longer met study criteria,Overall Study,FG001,0.0277492790886607,0.8019052271617001,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4463,NCT00484198,Adverse Event,Overall Study,FG003,0.0277112191617857,0.8018386108273748,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4464,NCT02827708,Lost to Follow-up,Overall Study,FG000,0.0277081877359127,0.8017941999378247,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4465,NCT01176240,Stop due to diverse problems,Study 306A,FG000,0.0276979960986903,0.8017497890482747,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4466,NCT00484198,Other,Overall Study,FG002,0.0276901544124404,0.8017053781587246,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4467,NCT00086515,Withdrawal by Subject,Phase B (Weeks 24-104),FG000,0.0276886350865377,0.8016609672691744,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4468,NCT01064687,Lost to Follow-up,Overall Study,FG002,0.0276679051813988,0.8016165563796243,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4469,NCT00601250,Protocol Violation,Overall Study,FG000,0.0276602358219643,0.8015721454900742,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4470,NCT01181102,Withdrawal by Subject,Overall Study,FG001,0.0276587016433549,0.8015277346005241,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4471,NCT00449930,Adverse Event,Overall Study,FG001,0.0276415680594444,0.801483323710974,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4472,NCT01392573,Unclassified,Overall Study,FG001,0.0276371765306249,0.8014389128214238,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4473,NCT00286468,Withdrawal by Subject,Overall Study,FG002,0.0276326281888068,0.8013945019318737,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4474,NCT01176240,Protocol Violation,Study 306A,FG001,0.0276276904751784,0.8013500910423236,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4475,NCT01176240,Lack of Efficacy,Study 306A,FG001,0.0276259368251784,0.8013056801527735,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4476,NCT01176240,Withdrawal by Subject,Study 306A,FG001,0.0276170207718451,0.8012612692632234,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4477,NCT01176240,Supine Hypertension,Study 306B,FG000,0.0276095977824403,0.8012168583736732,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4478,NCT00601250,Adverse Event,Overall Study,FG000,0.027595130254881,0.8011724474841231,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4479,NCT01177813,Adverse Event,Overall Study,FG002,0.0275844990247619,0.801128036594573,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4480,NCT00984867,Adverse Event,Overall Study,FG001,0.0275793176214087,0.8010836257050229,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4481,NCT00437645,Withdrawal by Subject,Overall Study,FG001,0.0275541283480059,0.8010392148154728,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4482,NCT02099110,Lost to Follow-up,Overall Study,FG002,0.0275497903283134,0.8009948039259226,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4483,NCT01176240,Lost to Follow-up,Study 306B,FG001,0.0275397526026784,0.8009059821468224,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4484,NCT01176240,withdrew prior to dosing,Study 306B,FG001,0.0275397526026784,0.8009059821468224,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4485,NCT01176240,Physician Decision,Study 306B,FG001,0.0275397526026784,0.8009059821468224,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4486,NCT02833948,scans could not be evaluated,Overall Study,FG001,0.0275305597872321,0.8008171603677222,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4487,NCT03214380,Withdrawal by Subject,Treatment Period,FG004,0.0275290773673511,0.800772749478172,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4488,NCT01106625,Withdrawal by Subject,Core Period: Baseline to Week 26,FG002,0.0275250855895337,0.8007283385886219,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4489,NCT01176240,Withdrawal by Subject,Study 306B,FG001,0.0275242285847617,0.8006839276990718,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4490,NCT01620489,Adverse Event,Overall Study,FG001,0.0275201223595238,0.8006395168095217,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4491,NCT00308737,Protocol Violation,Overall Study,FG000,0.0275166472451488,0.8005951059199716,high,Reinforce site protocol training and participant instruction clarity.,Reinforce site protocol training and participant instruction clarity.,2026-02-06,2026-02-13,,new,,,
4492,NCT01106625,Other,Core Period: Baseline to Week 26,FG001,0.0275143030769444,0.8005506950304214,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4493,NCT02099110,Withdrawal by Subject,Overall Study,FG001,0.0275091457671825,0.8005062841408713,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4494,NCT02833948,Death,Overall Study,FG000,0.0275086197697023,0.8004618732513212,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4495,NCT03861039,Withdrawal by Subject,Overall Study,FG001,0.0275018712275694,0.8004174623617711,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4496,NCT04509674,Not treated,Overall Study,FG001,0.0274999873895237,0.800373051472221,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4497,NCT00532935,Withdrawal by Subject,Overall Study,FG001,0.0274987150285335,0.8003286405826708,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4498,NCT00542386,Withdrawal by Subject,Overall Study,FG003,0.0274930699735714,0.8002842296931207,high,Run expectation alignment and motivational touchpoints before next visit.,Run expectation alignment and motivational touchpoints before next visit.,2026-02-06,2026-02-13,,new,,,
4499,NCT01320722,Adverse Event,Overall Study,FG002,0.0274889829159126,0.8002398188035706,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4500,NCT01320722,Not Available for the 8 Week Visit,Overall Study,FG001,0.0274874327108234,0.8001954079140206,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
4501,NCT02229396,Adverse Event,Overall Study,FG000,0.0274855253426289,0.8001509970244703,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4502,NCT01320722,Lost to Follow-up,Overall Study,FG004,0.0274854208860614,0.8001065861349203,high,"Strengthen retention logistics: reminders, transport, and re-contact workflow.","Strengthen retention logistics: reminders, transport, and re-contact workflow.",2026-02-06,2026-02-13,,new,,,
4503,NCT00106704,Adverse Event,Overall Study,FG000,0.0274762242774972,0.8000621752453702,high,Prioritize safety follow-up cadence and symptom triage outreach.,Prioritize safety follow-up cadence and symptom triage outreach.,2026-02-06,2026-02-13,,new,,,
4504,NCT01164501,"Patient refusal to continue,not due toAE",Overall Study,FG000,0.0274753476999702,0.8000177643558201,high,Review participant burden and site workflow for targeted retention intervention.,Review participant burden and site workflow for targeted retention intervention.,2026-02-06,2026-02-13,,new,,,
